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TLR Toll-like receptor 
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Abstract 
P.aeruginosa is an extracellular, Gram-negative opportunistic pathogen. One of 
the most important virulence factors during infection is the type III secretion 
system (T3SS). This system is found exclusively in Gram-negative bacteria and it 
forms a conduit between the bacteria and the host cell through which effector 
molecules can be translocated. These effectors alter the function of the host 
cell to promote survival of the bacterium. Infections are detected initially by the 
innate immune system via germ-line encoded receptors, pathogen recognition 
receptors (PRRs). These receptors recognise conserved microbial patterns, 
known as pathogen-associated molecular patterns and molecules which signal 
danger, danger-associated molecular patterns. PRRs are both membrane bound, 
such as Toll-like receptors (TLRs), and cytosolic, such as Nod-like receptors 
(NLRs). Some NLRs are involved in the formation of multimeric protein 
complexes, the Nod-signalosome and inflammasomes. These lead to the 
activation of NF-κB and the activation of caspase-1 and subsequent proteolytic 
processing of interleukin-1β (IL-1β) into its mature form. Both processes 
contribute to the inflammatory response following infection.  
In this study we sought to elucidate whether P.aeruginosa is able to trigger 
cytosolic PRRs and the mechanism of this activation. Initially we studied 
inflammasome activation by P.aeruginosa. We demonstrated that P.aeruginosa is 
able to activate the NLRC4/ASC-inflammasome complex. This was found to be 
dependent on a functional T3SS, but independent of any effectors passing 
through the system. The activation was discovered by detection of processed, 
and thus active caspase-1 fragments, as well as by secretion of mature IL-1β.  
The mechanism of the inflammasome activation was then investigated. We found 
that the NLRC4-dependent inflammasome activation is also dependent on 
extracellular potassium. An increase of extracellular potassium leads to a 
complete abrogation of inflammasome activation by P.aeruginosa and 
Salmonella. To further elucidate this finding, we investigated the leakiness of 
the pore formed by the T3SS in the host cell membrane. No flux of ions or small 
molecules could be detected in the host cell membrane following infection. 
However, host-membrane repair mechanisms were triggered, which could be 
detected by lysosomal-associated membrane protein (LAMP)-1-specific staining 
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of the plasma membrane. We hypothesize a role for membrane potential in 
triggering of inflammasome activation by bacteria possessing a secretion system. 
Potassium-efflux has previously been identified as a activator of the NLRP3 
inflammasome, but no changes in intracellular potassium could be found during 
this study.  
The activation of the NLRC4 inflammasome by the Pseudomonal strain PA103 was 
shown, in this study, to be independent of flagellin. Instead, the bacterial 
molecule responsible for inflammasome activation was shown to be pilin. Pilin is 
important for attachment to the host cell and the function of the T3SS. We 
showed that a strain lacking pilin were still able to translocate effectors through 
its T3SS. However, it was unable to activate the inflammasome complex. 
Transfection of purified pilin into cells was shown to trigger inflammasome 
activation. This was found to be dependent on caspase-1 but independent of 
NLRC4 and ASC, which is not in agreement with the results found for live 
bacteria. We hypothesised that the reason for this is the delivery method used, 
since a T3SS and infection delivers proteins and molecules differently compared 
to a transfection reagent.  
Finally, the role for Nod1 in infection by P.aeruginosa was explored. We could 
not identify Nod1-dependent NF-κB-activation using luciferase reporter gene 
assays. We therefore hypothesise that Nod1 does not have a role in the innate 
immune response to P.aeruginosa.  
In conclusion, we have identified NLRC4- and ASC-dependent inflammasome 
activation by P.aeruginosa. This activation was shown to be dependent on a 
functional T3SS and the surface protein pilin, as well as extracellular potassium. 
This describes a novel NLRC4-activation mechanism dependent on potassium and 
identifies pilin as a PRR-trigger for the first time. 
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1 Introduction 
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1.1 Introduction 
The initial defence against infections is mediated by the innate immune system. 
Germ-line encoded receptors respond to pathogen-derived products and mount a 
response against the pathogen, to promote survival of the host. Pathogen 
recognition receptors include the well studied group of Toll-like receptors, as 
well as a more recent addition of Nod-like receptors (NLRs). Pseudomonas 
aeruginosa is an opportunistic pathogen and an important nosocomial pathogen. 
It possess several virulence factors, one of the most important being the type III 
secretion system (T3SS). Recent reports have implicated the bacterial T3SS not 
only as a virulence factor but also as a conduit for bacterial products which 
triggers the innate immune response. 
The work presented in this thesis explores the mechanism by which the 
extracellular pathogen P.aeruginosa can activate intracellular NLRs. This chapter 
provides an overview to the pathogen P.aeruginosa and its virulence factors, as 
well as an introduction to the innate immune response via pathogen recognition 
receptors. Particular attention is paid to the NLR-proteins. The aim of this 
chapter is to emphasise the key role of NLRs and place in context the 
importance of the results presented in this thesis for the complex innate immune 
response.  
1.2 Pseudomonas aeruginosa 
P.aeruginosa is a Gram-negative opportunistic pathogen which belongs to the 
family Pseudomonadaceae. It is a free-living pathogen commonly found in soil 
and water but also on surfaces of plants and animals in contact with soil or 
water. It can survive in environments with minimal nutritional components due 
to its ability to metabolise a wide range of carbon sources and it is also able to 
survive in temperatures up to 42°C [1]. Healthy individuals can be carriers of the 
bacterium on their skin and in their throat and stool [2].  
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1.2.1 Pseudomonas aeruginosa infections 
P.aeruginosa rarely causes infection in healthy tissues, but it can cause acute as 
well as chronic infection in almost any immuno-compromised tissue, where it 
exploits breaches in host defence such as skin or mucosal damage [3]. It can 
cause urinary tract infections, respiratory system infections, dermatitis, soft 
tissue infections, bacteraemia, bone and joint infections, gastrointestinal 
infections and a variety of systemic infections in severely immuno-compromised 
patients, such as burn victims, cystic fibrosis sufferers, cancer and AIDS patients, 
as well as ulcerative keratitis in contact-lens wearers [3]. The fatality rate in 
patients hospitalized with cancer, cystic fibrosis and burns is near 50 percent. In 
cystic fibrosis patient’s infection by P.aeruginosa often contributes to 
destructive lung disease eventually leading to respiratory failure and death [4-
6]. P.aeruginosa is a primarily nosocomial pathogen and it is responsible for 10.1 
percent of all hospital-acquired infections in the USA. The natural properties of 
the bacterium explain its success as an opportunistic and nosocomial pathogen. 
It has minimal nutritional needs; it is able to grow at 37°C as well as in 
temperatures up to 42°C and it is resistant to high concentrations of salts and 
dyes, weak antiseptics and many antibiotics. It has been successfully isolated in 
the hospital environment from disinfectants, respiratory equipment, food, sinks, 
taps, toilets, showers and mops [4]. Furthermore, constant reintroduction occurs 
via fruits, plants, vegetables, visitors and patients. The bacterium can then 
spread from patient to patient via direct contact, hospital personnel or contact 
with contaminated reservoirs, foods or water [7]. 
P.aeruginosa is naturally resistant to many antibiotics greatly limiting the 
treating potential of infections. The resistance can be explained by the 
permeability barrier afforded by its Gram-negative outer membrane and its 
tendency to form biofilms on colonized surfaces, which results in resistance to 
therapeutic concentrations of antibiotics. Due to its natural habitat of soil it has 
developed resistance to naturally occurring antibiotics from bacilli, 
actinomycetes and molds. In addition P.aeruginosa possess several multidrug 
efflux pumps which also contributes to the resistance [8-12]. Finally 
P.aeruginosa is capable of horizontal gene transfer such as transduction and 
conjugation which enables transfer of antibiotic resistance plasmids. The 
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antibiotics still effective against P.aeruginosa include fluoroquinolones, 
gentamicin and imipenem, but these are not effective against all strains.  
1.2.1.1 Burns 
Skin is the largest organ in the human body and it is an important barrier against 
pathogens. This barrier is compromised after severe burns and it opens up an 
opportunity for P. aeruginosa to infect the moist tissue underlying burn wounds 
[3]. Infection results in destruction of healthy tissue and it can lead to sepsis. 
There is a burned mouse model of infection which shows only a few bacteria can 
lead to lethality in mice with burnt skin compared to 106-107 colony forming 
units (CFU) in healthy mice [13]. 
1.2.1.2 Cystic fibrosis 
Cystic fibrosis sufferers have an imbalance in the fluid and electrolyte 
composition of epithelial cell secretions due to defective chloride permeability. 
This results in accumulation of sticky dehydrated mucus in lung airways, 
pancreatic ducts and in the male sex ducts [14]. The defective chloride 
permeability is caused by a mutation in the gene for cystic fibrosis 
transmembrane conductance regulator (CFTR) protein, a cyclic adenosine 
monophosphate (cAMP)-regulated chloride channel [3]. The main cause (90%) of 
death in cystic fibrosis sufferers are pulmonary disease and P.aeruginosa has 
been shown to contribute to this [15]. P.aeruginosa infection can lead to 
progressive lung damage via the aggressive inflammatory response it causes upon 
infection. As mentioned above, there is a great problem with antibiotic resistant 
P.aeruginosa strains and most cystic fibrosis patients eventually become 
infected with a strain which cannot be treated due to antibiotic resistance [16]. 
1.2.2 Virulence factors 
P.aeruginosa has a wide array of virulence factors, which results in a 
multifactorial pathogenesis where normal host defences are altered or 
circumvented. This wide array of virulence factors contribute to the ability of 
the bacterium to cause such a wide variety of infections throughout the body. 
There are three stages of P.aeruginosa infection; bacterial attachment and 
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colonization, local invasion and finally disseminated systemic disease, but the 
disease process may stop at any of these three stages. P.aeruginosa has 
particular virulence factors that mediate each stage and results in the 
characteristic symptoms. P.aeruginosa has several cell-associated and secreted 
proteins which contribute to its virulence. Examples are elastase A, 
phospholipase C and the effector proteins translocated via the T3SS [17]. Some 
P.aeruginosa strains have a single polar flagellum, which contributes to the 
motility of the bacterium, but it is also an important virulence factor [6]. All P. 
aeruginosa strains have multiple surface pili. In following sections these 
virulence factors responsible for adherence to host tissue, avoidance of host 
immune response and multiplication of the bacterium will be discussed. 
1.2.2.1 Flagella 
Some P.aeruginosa strains produce a single polar flagellum. A flagellum is a whip 
like process extending from the bacterial surface. The flagellum spans the 
bacterial membrane and distal components are secreted through the base of the 
structure via a T3SS [18, 19]. The flagellum consists of these key proteins; FliC, 
the flagellin subunit protein and FliD, the flagellar cap protein, as well as 
multiple other proteins. There are over 50 genes involved in the synthesis and 
function of the flagella and it has been extensively studied [20]. Most 
environmental and nosocomical isolates of P.aeruginosa produce flagella. 
However, strains isolated from chronically infected cystic fibrosis patients have 
usually lost the ability to produce flagella [21].  
The flagellum is an important virulence factor, but strains lacking this structure 
are still capable of causing infection. It was shown that antibodies and a vaccine 
raised against flagella are effective at protecting animals from infection [22, 
23]. The importance of the flagellum as a virulence factor is partly due to its 
ability to bind host cells. The flagellum has been shown to bind via its FliD cap 
protein to neutral and acidic oligosaccharides in mucin but also to asialo GM1 
(asialo-gangliotetraosylceramide receptors 1), GM1 and GD1a [24, 25]. The 
binding to mucin might lead to removal of the bacteria from the host by 
mechanical mucociliary clearance. However, during a pulmonary infection this is 
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reduced, as well as when mucus is trapped under a contact lens, which allows 
mucin binding to contribute to the survival and proliferation of the bacterium.  
The host has developed a range of receptors which are capable of detecting 
flagellin and direct a host response against the infection; this will be described 
in more detail below and in chapter 5.  
1.2.2.2 Pili 
Pili are thin surface extensions from bacteria (Figure 1.1). All Gram-negative 
bacteria have type IV pili. The pilins of the type IV pili class share an N-
methylated N-terminus, a conserved hydrophobic N-terminal and a C-terminal 
disulphide bond [26]. There are two subclasses of type IV pili, type IVa and type 
IVb, which differ in amino acid sequence and length [26]. P.aeruginosa has a pili 
structure belonging to the type IVa pilin class [27-29]. This class also includes pili 
from, for example, pathogenic Neisseria spp and Moraxella bovis [26]. Bacteria 
with pilin from the type IVb class includes V.cholerae, Salmonella enterica 
serovar Typhi, as well as both enteropathogenic and enterotoxigenic E.coli (EPEC 
and ETEC) [26].  
 
Figure 1.1; Piliated P.aeruginosa strain PAK 
Electron micrographs of P.aeruginosa PAK. Left panel shows PAK WT (x 35.000) and right panel 
shows PAK/2PfS (x 19.920), which is a multipiliated mutant derived from PAK. Figure is adapted 
from [30].  
 
32 
Type IV pili consists of a homopolymer made of thousands of copies of the 15 
kDa pilin monomer. These monomers form an extremely thin (50-80 Å) filament, 
which are several microns in length. The pilin monomer of P.aeruginosa is 
encoded by the pilA gene [31]. In addition to the pilA gene there are about 40 
genetic loci which control pilin synthesis and pili production [32]. Pili, like 
flagella, are believed to act as adhesins and mediate binding to host cells, which 
has been demonstrated in vitro where pili have been shown to bind to the 
glycolipids asialo-GM1 and asialo-GM2 [33-35]. This, however, is disputed [36]. 
Pili can bind to these glycolipids through a C-terminal disulphide loop of pilin 
[37-39]. Initial X-ray crystallography studies suggested that the disulphide loop is 
buried within the pilus structure, which contradicts the possibility for this 
domain to be involved in host cell binding [40, 41]. However, recent studies 
suggest that this area is exposed in the assembled pilus filament [37, 42]. In 
addition, the disulphide loop is essential for pilus assembly and it is formed by 
two conserved C-terminal cysteines [43]. Type IV pili have been identified as the 
major epithelial cell adhesion protein and type IV pili mediated attachment has 
been implicated in efficient delivery of effector molecules via the T3SS [44-46]. 
The adherence of pili may be aided by production of protease enzymes, which 
will expose pilin receptors on the cell surface, such as specific galactose, 
mannose or sialic acid receptors. The attachment may also be aided by tissue 
injury. In addition to attachment, pili have been implicated in surface motility, 
microcolony and biofilm formation, cell signalling, immune evasion, DNA uptake 
by natural transformation and phage attachment [26].  
Pili are responsible for twitching motility, a name based on microscopic 
observation of the bacteria [27] (Figure 1.2). Twitching motility is mediated by 
extension, tethering and then retraction of the pilus structure [27, 47, 48]. 
Retraction is mediated by disassembly of pili into pilin subunits, which are 
distributed throughout the inner and outer membranes and can subsequently be 
recycled back into new pili [48-50]. Twitching motility has been shown to be 
important for in vitro biofilm formation on abiotic surfaces. Furthermore, it is 
believed the twitching motility is involved in avoidance of host phagocytes. Two 
proteins, pilT and pilU are responsible for providing the energy needed for pilus 
retraction via an ATPase motor [47, 50, 51]. Mutants defective in twitching 
motility have reduced cytotoxicity towards various epithelial cells, as well as 
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reduced virulence in mouse models of acute pneumonia and corneal disease [31, 
45, 52]. PilQ is a multimeric membrane protein that form gated pores in the 
outer membrane through which the pilus is thought to extrude [53], and 
homologs in bacterial type II secretion system (T2SS) have a similar role [54].  
 
Figure 1.2; Light microscopy of zones of twitching motility 
Twitching motility for PAK. Scale bar is 50 µm, c indicates the colony and m indicates the 
uncolonized medium. The arrow indicates the radial direction of colony expansion. Adapted from 
[55].  
 
It has been shown that mutants lacking pili are less virulent than pili-expressing 
bacteria [31, 45]. Pili are involved in a mouse model for acute pulmonary 
infection as well as burn wound infection, but it is not required in the corneal 
scratch-injury eye model [31, 39, 56].  
1.2.2.3 Lipopolysaccharide 
Lipopolysaccharide (LPS) is a major component of the outer membrane of Gram-
negative bacteria. This means it is an important target for the innate immune 
response, which will be described below.  
P.aeruginosa has two isoforms of LPS, smooth and rough, which are found on 
most environmentally and nosocomical isolated strains and on isolates from 
chronically infected cystic fibrosis sufferers, respectively. LPS consists of a 
hydrophobic lipid A component, which anchors the molecule to the bacterial 
membrane and a core oligosaccharide. The smooth LPS contains a long 
polysaccharide O-chain (5-100 kDa) consisting of tri- or tetra-saccharide 
repeating units; however, only 20-30% of the LPS molecules on each bacterium 
c 
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contain O-chains. The O-chains have been reported to be involved in resisting 
host defence by a mechanism which prevents lysis by complement [57].  
1.2.2.4 Other virulence factors 
P.aeruginosa has a wide range of other virulence factors which are important 
during infection and biofilm formation. One important virulence factor is iron 
acquisition. Like all living organisms P.aeruginosa needs iron for survival and 
growth. The bacteria have siderophores which have a high affinity for iron and 
can thus capture iron from host proteins such as transferrin and haemoglobin. 
P.aeruginosa has two siderophores called pyoverdin and pyochelin and these are 
secreted when the iron concentrations are low. Upon binding of iron these 
siderophores can bind receptors on the bacterial surface, where they are taken 
up, and the iron is used for various molecules. The siderophore is recirculated 
[58]. P.aeruginosa is also capable of utilising siderophores from other organisms 
[59]. This demonstrates an absolute requirement for iron for the survival of the 
bacterium and thus a requirement for siderophores in virulence. 
Invasion of tissues by P.aeruginosa is dependent on production of extracellular 
enzymes and toxins, which break down physical barriers and damage host cells, 
as well as mediating resistance to phagocytosis and the host immune response. 
Examples of proteases being produced are LasA protease, protease IV, elastase 
and alkaline protease, which have wide substrate specificity [60, 61]. LasA 
protease cleaves collagen, IgG, IgA and complement and in addition to this it 
lyses fibronectin, disrupts the respiratory epithelium and interferes with ciliary 
function. In addition, elastase is capable of inhibiting monocyte chemotaxis [62]. 
Alkaline protease lyses fibrin and interferes with fibrin formation and together 
with elastase it inactivates interferon-γ (IFNγ) and tumor necrosis factor α 
(TNFα).  
P.aeruginosa also produces exotoxin A, which is an adenosine diphosphate (ADP)-
ribosyltransferase (ADPRT) [63]. Exotoxin A results in inhibited protein synthesis 
and cell death, which means it contributes to virulence by causing tissue damage 
and diminishing the activity of phagocytes [64]. In addition, P.aeruginosa also 
produces haemolysins, phospholipase C (PlcHR) and Rhamnolipid, which results 
in degradation of host cell phospholipids [65, 66].  
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Alignate, a muciod exopolysaccharide, is also produced by P.aeruginosa. It is a 
repeating polymer of mannuronic and glucuronic acid, which anchors the cells to 
their environment and forms the matrix for biofilms. Alginate also protects from 
lymphocytes, phagocytes, the ciliary action of the respiratory tract, antibodies 
and complement. These mucoid strains of P.aeruginosa are also more resistant 
to antibiotics [16]. 
Pyocyanin is a blue redox-active secondary metabolite produced by 
P.aeruginosa. It has a role in virulence by disrupting cell respiration, ciliary 
function, epidermal cell growth, prostacyclin release, calcium homeostasis and 
induction of apoptosis in neutrophils [67].  
1.3 Bacterial Secretion Systems 
Secretion systems are important virulence factors for bacterial species. In the 
case of Gram-negative bacteria, secretion requires translocation across the 
outer, as well as the inner membranes. In addition, a number of secreted 
proteins are destined to enter the host cell, thus several secretion systems 
include a portion which span the plasma membrane of host cells. Several 
secretion systems have been identified, these are classified into seven different 
types [68]. In Gram-negative bacteria, secreted proteins can be exported across 
the inner and outer membrane into the host cell in one single step via the type I, 
type III, type IV or type VI secretion pathways. Other proteins are first secreted 
into the periplasmic space via the general secretion (Sec) or two-arginine (Tat) 
pathways. These proteins can then be translocated across the outer membrane 
via the type II, type V, type I or type IV secretion system. The type VII secretion 
system is exclusive to the Gram-positive bacteria strains that possess a nearly 
impermeable cell wall, the mycomembrane [68]. 
The work presented in this thesis focus mainly on the T3SS of P.aeruginosa; 
however, T4SS and T2SS are also mentioned. This introduction will therefore 
mainly focus on the T3SS and briefly mention the T2SS and T4SS. Other secretion 
systems have no implications for the work in this thesis and will therefore be 
excluded.  
36 
1.3.1 Type III secretion system 
T3SS are exclusive to Gram-negative bacteria and structurally related to the 
flagellum [69]. There are over twentyfive species of Gram-negative bacteria 
equipped with this secretion apparatus, also known as the ‘injectisome’. These 
include Yersinia, Salmonella, Shigella, Bordetella, Chlamydia, E.coli and 
P.aeruginosa. The secretion system allows the bacteria to inject protein 
effectors into the host cell in one single step, which alters the function of the 
host cell and promotes survival of the bacteria. The effectors have a wide range 
of biochemical consequences for the host cell, with effects such as down-
regulated pro-inflammatory responses, inhibited phagocytosis, induction of 
apoptosis and modulated intracellular trafficking. The effectors secreted by 
various pathogens vary in their structure and function whereas the components 
for the secretion system apparatus are conserved. 
The T3SS of P.aeruginosa is closely related to that found in Yersinia species at 
both the structural and functional level. Bacterial attachment to the host cell 
membrane is required for delivery of proteins via the T3SS. Several surface 
structures of P.aeruginosa mediate attachment to epithelial cells [32, 34, 39, 
44]. 
The biosynthesis and regulation of the type III secretion apparatus involve 36 
genes encoded in five operons that are clustered together into the exoenzyme S 
regulon [70]. This regulon can then be divided into five parts, proteins for the 
needle complex, proteins which translocate secreted proteins, proteins that 
regulate the secretion process, chaperones which facilitate secretion and 
effector proteins [71]. 
The T3SS of P.aeruginosa is not required for infection [72] but it has been shown 
to enhance disease severity in models for acute pneumonia [73-76], keratitis 
[77], bacteraemia [78], ventilator-associated pneumonia [72] and burn-
infections [79].  
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1.3.1.1 The needle complex 
The needle complex allows proteins to pass the inner and outer membrane of 
the bacteria. The needle complex of P.aeruginosa is similar to that of Yersinia 
spp., as well as that of Salmonella enterica and Shigella flexneri. It consists of 
two parts; a multi-ring base and a needle-like filament (Figure 1.3). This 
filament has similar dimensions to that of S.enterica, S.flexneri and Yersinia; 
60-120 nm long and 6-10 nm wide, and consists of subunits of the protein PscF 
(Figure 1.3) [6, 80-82]. Functional assignments can be inferred from the related 
Yersinia type III needle to the other components of the P.aeruginosa needle 
complex. PscN is believed to be an ATPase, which powers the secretion system. 
PscN is regulated by PscL (Figure 1.3) [83, 84]. The secretin-like protein PscC 
oligomerizes with the help of PscW to form a channel through the bacterial 
outer membrane [85, 86]. PscP is the protein responsible for the needle length 
through its presumed function as a molecular ruler, based on studies of YscP of 
Yersinia [87]. PscJ is predicted to be a lipoprotein component of the basal 
substructure of the needle complex [88]. Further studies are needed to fully 
understand the function of the needle complex in the secretion process [71]. 
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Figure 1.3; Pseudomonas aeruginosa T3SS 
The T3SS has five components; the needle complex (green), translocation apparatus (blue), the 
effector proteins (red), chaperones (brown) and regulatory proteins (not presented in this figure). 
The needle complex and translocation apparatus work together to form a conduit for the effector 
proteins, allowing translocation into the host cell cytoplasm. PM; plasma membrane, OM; outer 
membrane, PGN; peptidoglycan layer, IM; inner membrane, T; ExoT, S; ExoS, Y; ExoY, U; ExoU. 
Figure adapted from [71].  
 
1.3.1.2 The translocation apparatus 
The effector proteins that are secreted by the needle complex are accepted by 
the translocation apparatus, which then delivers them across the host cell 
membrane (Figure 1.3). Less than 0.1% of secreted effectors escape to the 
extracellular milieu [89]. Translocation of the secreted effectors, Yops, in 
Yersinia into eukaryotic cells depends on the secreted translocator proteins, 
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LcrV, YopB and YopD [90, 91]. The translocators of Yersinia share high sequence 
similarity with P.aeruginosa proteins, PcrV, PopB and PopD (approximately 40% 
amino acid identity) (Figure 1.3) [92-94]. In addition, these proteins are 
conserved at the functional level. PopD and PopB are secreted by the needle 
complex and form a translocation pore, 2.8-6.0 nm in diameter, via interactions 
with each other and the host cell membrane (Figure 1.3) [92-96]. PcrV is also 
secreted by the T3SS needle. However, it is not part of the pore but still 
required for translocation (Figure 1.3) [97-99]. A pcrV mutant strain was unable 
to kill macrophages, or cause lethal infection and lung injury in an acute mouse 
infection model [93]. In addition, immunisation of mice with purified PcrV 
markedly increased survival in lung infection and burn injury models [93, 100, 
101]. The LscV of Yersinia has been shown to form a multimeric scaffold at the 
tip of the T3SS needle, which facilitates assembly of the PopB-PopD 
translocation pore, therefore PcrV is presumed to have a similar function [98, 
102]. However, PcrV might also function as a link between the needle complex 
to the pre-formed PopB-PopD pores [103]. Translocator mutants of Yersinia can 
be complemented with pcrV, pcrG, pcrH, popB and popD which restore function 
and mediate delivery of Yop effectors [99, 104]. Delivery of Yop effectors by 
Yersinia is contact-dependent and polarized; effectors are only translocated at 
the zone of contact between the bacterium and the eukaryotic cell [105]. In 
addition, the expression, secretion and delivery of Yop effectors are triggered 
following interaction of the bacteria with the eukaryotic cell [106]. Similarly, 
expression of effectors in P.aeruginosa is induced upon contact with epithelial 
cells [107, 108]. The translocation pore alone has also been shown to cause 
death of the host cells through pore-mediated increases in membrane 
permeability [75, 78, 92, 98].  
1.3.1.3 Regulation of the T3SS 
The T3SS is regulated both at the transcription level and at the initiation of 
secretion. Upon activation of the secretion process the transcription is induced, 
which allows expression of T3SS products at high levels following contact with 
the host cell [109]. The transcription of T3SS genes is controlled by ExsA, which 
binds to the promoter of T3SS genes (Figure 1.4B) [110]. In addition to ExsA, 
ExsC, ExsD and ExsE are also involved in the transcriptional regulation of the 
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T3SS (Figure 1.4). When ExsA is bound by ExsD secretion is prevented; under 
these conditions ExsC is bound to ExsE (Figure 1.4A) [111-114]. EsxE is exported 
through the T3SS needle complex during secretion, which allows ExsC to bind 
ExsD resulting in transcriptional activation of T3SS genes by ExsA (Figure 1.4B) 
[111, 114-116]. The result is that the production of T3SS proteins, needle 
complexes and effector proteins is expressed at low levels, which is then 
increased upon activation of secretion. Triggering of secretion is not very well 
described. Contact with the host cell will trigger secretion, as well as exposure 
to calcium-depleted medium [107].  
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Figure 1.4; Regulation of the T3SS 
T3SS transcription is linked to the effector protein secretion through the interaction of four 
regulatory proteins; ExsA, ExsC, ExsD and ExsE. A; When no secretion occurs ExsE is present in 
the bacterial cell and binds to ExsC. This allows ExsD to bind to ExsA which prevents transcription 
of the T3SS genes. B; Upon initiation of secretion, ExsE is secreted from the bacterial cell which 
allows ExsC to bind ExsD, thus freeing ExsA, the transcriptional activator, and transcription of the 
T3SS genes is initiated. Figure adapted from [71]. 
 
1.3.2 Effector proteins of Pseudomonas aeruginosa 
P.aeruginosa is one of the Gram-negative bacteria which have a T3SS, as 
previously described. Four different effectors have been identified, ExoS, ExoT, 
ExoY and ExoU (Figure 1.3) [73, 109, 117, 118]. Not all Pseudomonas strains 
express all four effectors; instead it varies between the strains, which gives 
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them particular properties such as cytotoxic strains (e.g. PA103) and invasive 
strains (e.g. PAO1). PA103 injects ExoT and ExoU into the host cell whereas 
PAO1 injects ExoS, ExoT and ExoY [70, 75, 119, 120]. Strains usually possess 
either ExoS or ExoU but not both, the reason for which is unclear [119]. ExoS, 
ExoT and ExoY have clearly defined enzymatic activities, which in general 
results in altering of cellular cytoskeletal components. All three toxins cause cell 
rounding, detachment and inhibit or prevent bacterial uptake and phagocytosis 
(Figure 1.5). Together the effectors inhibit wound repair and the host innate 
immune response, which perpetuate tissue injury, and render the host 
susceptible to further colonization and injury by P.aeruginosa and other 
pathogens [121]. Some of the effectors have cognate chaperones to which they 
bind before secretion (Figure 1.3). The chaperones facilitate storage of their 
protein partners, as well as the delivery to the secretion apparatus [122].  
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Figure 1.5; The effect of secreted P.aeruginosa effectors on host cells 
ExoT inhibits cell division and cell migration, it can also induce cell death. ExoS induce apoptosis 
and inhibits cell migration, as well as disrupts tight junctions and actin in epithelial cells. Both ExoS 
and ExoT inhibits bacterial uptake into epithelial and phagocytic cells. ExoU cause rapid cell death 
and ExoY disrupts the actin cytoskeleton. Figure adapted from [121]. 
 
1.3.2.1 ExoS 
ExoS is one of the best characterized effectors of P.aeruginosa. It is a 
bifunctional protein of 48 kDa, which shows GTPase-activating protein (GAP)-
activity in vitro on the Rho-family proteins (Figure 1.6) [123]. These are small 
GTPases that maintain the organization of the host cell actin cytoskeleton. The 
active form is GTP-bound whereas the inactive form is GDP-bound. The effect of 
ExoS GAP-domain leads to disruption of the host cell actin cytoskeleton by 
switching towards the GDP-bound state [123]. The C-terminal domain of ExoS 
displays ADP-ribosyltransferase (ADPRT) activity that results in modification of 
members of the Ras family of GTP binding proteins in vivo (Figure 1.6) [124-
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128]. The ADPRT activity correlates with cellular cytotoxicity [127], and requires 
a host cell cofactor, a 14-3-3 protein [129]. 14-3-3 proteins act as regulatory 
factors that modulate cell cycle progression, protein trafficking and apoptosis 
[71]. Intracellular delivery of ExoS results in an impaired phagocytic function of 
infected macrophages, as well as in a morphological change of the infected cells 
due to the disruption of the actin microfilaments (Figure 1.5) [118, 130]. In 
addition, ExoS inhibits DNA synthesis, vesicular trafficking and endocytosis [71, 
127]. The enzymatic activity of ExoS has also been shown to induce apoptosis in 
macrophages and neutrophils (Figure 1.5) [131]. In addition, ExoS has been 
shown to be involved in the regulation of T3SS-mediated secretion through host 
cell membranes [132]. The chaperone of ExoS is SpcS (Figure 1.3) [133]. The 
extreme N-terminal of ExoS carries the information for its targeting to the T3SS 
apparatus (Figure 1.6) [109]. In addition, ExoS possess a binding site for the SpcS 
and a membrane localization domain (MLD), which is responsible for the initial 
transient localization of ExoS to the plasma membrane (Figure 1.6) [134, 135].  
1.3.2.2 ExoT 
ExoT, similar to ExoS, has an N-terminal domain that encodes GAP and a C-
terminal encoded ADPRT activity (Figure 1.6) [123]. In addition, ExoT has the 
same chaperone, SpcS, as ExoS (Figure 1.3) [133]. The two proteins share 76% 
amino acid identity, and it is believed that ExoT has a similar secretion, SpcS 
chaperone binding and MLD domain (Figure 1.6) [136]. ExoT causes reversible 
disruption of the actin cytoskeleton resulting in cell rounding, cell detachment, 
inhibited migration and phagocytosis (Figure 1.5) [130, 137]. It also results in 
inhibited host cell division (Figure 1.5) [138]. The ADPRT domain of ExoT also 
requires binding of 14-3-3 for activation [139].  
1.3.2.3 ExoU 
ExoU possess a unique cytotoxic effect, both rapid and potent (Figure 1.5) [73, 
74]. The P.aeruginosa strains which produce ExoU can destroy cellular 
monolayers during short infection periods [73, 74]. Production of ExoU is 
associated with cell death, accelerated lung injury in animals and patients, 
bacterial dissemination and it also has a role in the development of septic shock 
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[73, 140, 141]. ExoU functions as a phospholipase A2 via its patatin-like domain 
(Figure 1.6) [142, 143]. It has a broad substrate specificity including hydrolysis of 
neutral lipids, such as diacylglycerols, triacylglycerols and phospholipids, which 
allows it to cause damage to internal and plasma membrane components [142, 
143]. It is believed that ExoU possess a serine-aspartate catalytic dyad, which 
involves Ser142 and Asp344 (Figure 1.6), which is required for its function [142-
144]. ExoU is delivered by the T3SS directly into the host cell cytosol, where it 
requires a host cell cofactor for activation [142, 143]. The copper-zinc-
superoxide dismutase (SOD1) has been identified as a potential cofactor [145]. 
Similar to the other effectors, the secretion signal directing ExoU to the T3SS is 
believed to be located in the extreme N-terminus (Figure 1.6) [71]. ExoU has a 
chaperone called SpcU, which binds to the N-terminal of the protein (Figure 1.6) 
[146]. Furthermore, ExoU contains a MLD domain in its C-terminal which targets 
it to the plasma membrane of the host cell (Figure 1.6) [147, 148].  
1.3.2.4 ExoY 
ExoY is an adenylyl cyclase [117]. It contains two domains which are similar to 
the extracellular adenylyl cyclases of Bordetella pertussis (CyaA) and Bacillus 
anthracis (edema factor) [117]. These two domains act together and bind ATP 
(Figure 1.6). Full enzymatic activity can only be obtained in the presence of a 
host cell cofactor, which is not yet identified [117]. ExoY translocation results in 
elevated intracellular cAMP concentrations [117, 149]. The effects of ExoY on 
the host cell are disruption of the actin cytoskeleton, inhibition of bacterial 
uptake by host cells and increased endothelial permeability (Figure 1.5) [117, 
150-152]. The chaperone of ExoY is yet to be identified.  
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Figure 1.6; The gene structure of the effector proteins from P.aeruginosa 
ExoS and ExoT both have GTPase activating protein (GAP) and ADP ribosyl transferase (ADPRT) 
activity. In addition, they both have a secretion signal domain (S), chaperone binding domain 
(CBD), membrane localization domain (MLD) and a cofactor binding site (CF). ExoU has a patatin-
like domain necessary for its phospholipase A2 activity (PLA2 activity). This domain contains the 
Ser142 and Asp344, which are required for its activity. ExoU also contains a secretion signal 
domain (S), chaperone binding domain (CBD) and a membrane localization domain (MLD). ExoY is 
an adenylyl cyclase. It contains two domains which together bind ATP (ATP binding) and a 
secretion signal domain (S). Figure adapted from [71].  
 
1.3.3 Type II secretion system 
The T2SS is also known as the Sec-dependent system, since several proteins first 
reach the periplasm via the Sec-system and then are secreted via the T2SS. The 
Sec-dependent pathway is universal, but the T2SS is only found in Gram-negative 
proteobacteria [153, 154]. This secretion system is required for virulence of 
Vibrio cholerae, Legionella pneumophila and enterotoxigenic E.coli. Toxins 
secreted via the T2SS include ADP-ribosylating toxins, such as cholera toxin and 
the exotoxin A from P.aeruginosa [154]. The structure of the inner membrane 
complex and the pseudopilins, which span the periplasm, are homologs to the 
type IV pilus system. This suggests a common evolutionary origin [154].  
1.3.4 Type IV secretion system 
The T4SS can transport nucleic acids as well as proteins into plant, animal and 
yeast cells and other bacteria [155]. It can span both membranes of Gram-
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negative bacteria or the membrane and cell envelope of Gram-positive bacteria. 
The type IV secretion system is classified into three subfamilies, the conjugation 
systems, DNA uptake and release systems and the effector translocator systems 
[156]. Bacterial species which possess a T4SS used for effector translocation 
include Helicobacter pylori and Legionella pneumophila [157, 158].  
1.4 Inflammation 
The word inflammation comes from the word inflamatio, which in Latin means 
to set on fire. It is a non-specific immune response to any injury such as 
pathogens, damaged cells or irritants. There are five cardinal signs of 
inflammation: redness, swelling, heat, pain and loss of function. The first four 
were described by Cornelius Celsus, a Roman encyclopaedist, and loss of 
function was added several centuries later by Rudolf Virchow. These signs can be 
explained by increased blood flow, elevated cellular metabolism, vasodilatation, 
release of soluble mediators, extravasation of fluids and cellular influx. 
Inflammation is normally a self-limiting process, whereby the organism tries to 
remove the injurious stimuli, as well as to initiate the healing process. If it 
becomes continuous chronic inflammation can develop [159]. Inflammation is 
the response of the organism to bodily injuries and it is not synonymous to 
infection, which is caused by an exogenous pathogen. The inflammation process 
requires great amount of metabolic energy and results in damage and 
destruction of the host tissue. It also has the potential to lead to sepsis, multiple 
organ failure and death. Infection or tissue injury disrupts the homeostasis of 
the tissue and the main goal of the inflammation is to repair the damage, clear 
the infection and return to homeostasis. Therefore, a rapid, accurate and self-
limiting response is necessary to limit the damage caused [160].  
The innate immune system mediates the first response in an inflammation 
process and thus plays an important role by secreting cytokines, chemokines and 
inducing the expression of adhesion and costimulatory molecules [159, 161]. The 
acute inflammation is characterized by infiltration of innate immune response 
cells such as neutrophils and macrophages [159]. Acute inflammation is a short-
term process, which usually appears in a few minutes or hours and ceases once 
the injurious stimulus has been removed. The acute inflammation is 
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characterized by the five cardinal signs described above. During a chronic 
inflammation there are also influx of T lymphocytes and plasma cells [159]. The 
T lymphocytes and plasma cells are part of the adaptive immune response. This 
is triggered following an antigenic challenge to the organism. The adaptive 
immune response has a high degree of specificity and also the property of 
memory.  
1.5 Innate immune system 
Immunity is defined as a state of protection from infectious disease. The innate 
immune system provides the first line of defence in an immune response against 
danger and is usually sufficient to clear the infection. This response includes a 
range of processes which are not specific to a particular pathogen; as a result, it 
is able to recognize a wide range of pathogens such as viruses, bacteria and 
fungi. Important features of the innate immune system are barriers, such as 
anatomic (skin), physiologic, phagocytic and inflammatory, as well as the 
synthesis of antimicrobial products and phagocytosis by macrophages and 
neutrophils. Physical and anatomic barriers such as skin and mucosal surfaces, 
prevent entry of pathogens into the host and provide the first line of defence 
against infections. Skin has an acidic pH (between 3-5) which inhibits the growth 
of most microorganisms. Breaches of the integrity of the skin, such as wounds, 
provide a route of entry for pathogens. Mucosal surfaces can be found in the 
conjunctivae, alimentary, respiratory and urogenital tracts. Saliva, tears and 
mucous secretions prevent microorganisms from entering via these routes. 
Physiologic barriers include temperature, pH and a variety of soluble and cell 
associated molecules. High temperature can prevent growth of pathogens as 
well as low pH. Examples of soluble molecules are: lysozyme, which digests 
peptidoglycan in bacterial cell walls; interferon, which results in an antiviral 
response; and complement, which is able to damage the walls of pathogens or 
facilitating their clearance.  
The innate immune system can recognize and respond to danger signals and non-
self, which are a limited number of highly conserved structures of 
microorganisms, known as pathogen-associated molecular patterns (PAMPs), and 
cell products associated with a breach in host defence also known as danger-
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associated molecular patterns (DAMPs) [159, 162, 163]. This is a fundamental 
feature of the host defence against bacterial infections. If the pathogens were 
able to change their PAMPs they would escape the immune response. However, 
the immune system has evolved to recognize structures that are essential for the 
survival of the microbe and are therefore less prone to modifications. PAMPs can 
be sugars, flagellin, peptidoglycan and lipopolysaccharide (LPS), while examples 
of DAMPs are mammalian dsDNA and uric acid crystals [161, 164]. DAMPs are 
often released during infections, as a result of tissue damage and cell lysis [161]. 
The wide variety of pathogens, PAMPs and DAMPs can be recognized by a limited 
number of germline-encoded receptors called pattern-recognition receptors 
(PRRs) [165]. It is not clear whether these are actual receptors, so a more 
accurate term for them would therefore be pattern recognition molecules 
(PRMs) [159]. These PRRs do therefore not only recognize invading pathogens but 
also the damage caused by them. PRRs are expressed by several cell types such 
as macrophages, monocytes, dendritic cells (DCs), neutrophils and epithelial 
cells [161]. PRRs include soluble receptors; pentaxins, membrane-bound 
receptors: Toll-like receptors, TLRs [166] and C-type lectin receptors, CLRs 
[167], as well as cytosolic receptors: Nod-like receptors, NLRs [161], RIG-like 
helicases, RLRs [168] and DNA sensors [169-171] (Figure 1.7).  
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Figure 1.7; Comparison of basic structure of different PRRs 
Schematic representation of PRRs. Abbreviations; TLR; Toll-like receptor, CLR; C-type lectin 
receptor, RLR, RIG-1-like receptor; NLR. NOD-like receptor, NLRP and NLRC; major subfamilies in 
the NLR-protein family, AIM2; absent in melanoma 2 (DNA sensor), LRR; leucine-rich repeats, TIR; 
Toll-interleukin-1 receptor interacting domain, ITAM; immunoreceptor tyrosine-based activation 
motif, NAD; NACHT associated domain, NACHT; nucleotide binding and oligomerization domain, 
PYD; pyrin domain, CARD; caspase recruitment domain and HIN200; HIN200 domain. Figure is 
adapted from [172].  
 
1.5.1 Toll-like receptors (TLRs) 
Toll-like receptors (TLRs) were first discovered as homologues of Drosophila Toll 
[173]. Drosophila Toll was shown to be involved in antifungal immune responses 
[174]. TLRs are expressed by several cell types such as mononuclear, endothelial 
and epithelial cells. These are type I transmembrane proteins, which contain 
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extracellular leucine-rich repeat domains (LRR). These LRR domains functions as 
the pathogen sensor (Figure 1.7). The LRR transmit signals through the 
cytoplasmic Toll-interleukin (IL)-1 receptor (TIR) domain (Figure 1.7) [166, 175]. 
The TIR-domain functions as a platform for downstream signalling, which 
involves recruitment and interactions with TIR-domain containing adaptor 
proteins (Table 1.1), for example, myeloid differentiation primary response gene 
88 (MyD88) and TIR domain-containing adaptor inducing IFN-β (TRIF) [176]. The 
signalling event triggered is dependent on the associated adaptor protein, but 
they ultimately lead to activation of transcription factors nuclear factor kappa B 
(NF-κB), activator protein (AP)-1 and interferon-regulatory factor (IRF)-3 [161]. 
Generally, the MyD88-pathway controls inflammatory responses, while TRIF 
mainly mediate type I IFN responses [177]. Activation of TLRs leads to the 
production of antimicrobial peptides, inflammatory cytokines and chemokines, 
TNFα, costimulatory and adhesion molecules and upregulation of major 
histocompatibility complexes (MHCs).  
TLRs can recognize and/or sense the presence of LPS, lipoproteins, flagellin and 
RNA from viruses or bacteria, directly or indirectly via homo- or hetero-dimers. 
To date, 10 human and 13 mouse TLRs have been identified and these are either 
surface expressed (TLR1, 2, 4, 5, 6 and 10) or endosome localised (TLR3, 7, 8 
and 9) [166] (Table 1.1). Surface expressed TLRs recognize bacterial and fungal 
cell wall components, as well as viral proteins. In contrast, endosomal TLRs 
recognize nucleic acids; such as viral DNA/RNA (Table 1.1) [178-180]. Direct 
binding of dsRNA and lipopeptides to TLR3 and TLR1/TLR2 has been shown [181]. 
In contrast LPS is sensed indirectly by TLR4, which involves MD-2 [182]. TLRs 
were discovered as a class of membrane receptors that sense extracellular 
microbes and trigger antipathogen signalling cascades. One pathogen triggers 
several TLRs, which leads to the most appropriate response against one 
particular pathogen. Following studies of TLR signalling pathways and TLR-
deficient mice it was shown that TLRs were not alone as innate immune 
receptors.  
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Table 1.1; Mouse TLRs with PAMPs and adaptors 
Localization TLRs PAMPs Adaptors 
TLR1/2 Triacyl lipopeptides (Bacteria and 
mycobacteria) 
MyD88, 
TIRAP 
TLR2 Hemagglutinin protein (Measles virus), 
Glycosylphosphophatidyl-Inositol mucin 
(Trypanosoma), Phopholipomannan 
(Candida albicans), Lipoarabinomannan 
(Mycobacteria), Porins (Neisseria) 
MyD88, 
TIRAP 
TLR4 LPS (Gram-negative bacteria), Mannan 
(Candida albicans), 
Glycoinositolphospholipids (Trypanosoma), 
Envelope proteins (RSV, MMTV) 
MyD88, 
TIRAP, 
TRAM, 
TRIF 
TLR5 Flagellin (flagellated bacteria) MyD88 
TLR6/2 Zymosan (Saccharomyces cerevisiae), 
Lipoteichoic acid (Streptococcus), Diacyl 
lipopeptides (Mycoplasma) 
MyD88, 
TIRAP 
Surface 
expressed 
TLR11 Uropathogenic bacteria, Profilin like 
molecule (Toxoplasma gondii) 
MyD88 
TLR3 poly I:C, dsRNA (Reovirus), ssRNA (WNV),  TRIF 
TLR7 ssRNA viruses (Influenza virus, VSV), RNA 
(bacteria) 
MyD88 
Endosome 
expressed 
TLR9 dsDNA virus (HSV, MCMV), CpG-DNA motifs 
(bacteria and viruses), Hemozoin 
(Plasmodium) 
MyD88 
The PAMPs for mouse TLR8, TLR12 and TLR13 have not yet been identified. Abbreviations; 
MyD88; myeloid differentiation primary response gene 88, TIRAP; TIR-containing adaptor protein, 
TRAM; TRIF-related adaptor molecule, TRIF; TIR-containing adaptor-inducing IFN-β, RSV; 
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Respiratory Syncytical Virus, MMTV; Mouse Mammary Tumour Virus, WNV; West Nile Virus, VSV; 
Vesicular Stomatitis Virus, HSV; Herpes Simplex Virus, MCMV; Mouse Cytomegalovirus. Table 
adapted from [180, 183]. 
 
1.5.2 RIG-I-like receptors (RLRs) 
RLRs are soluble proteins that survey the cytoplasm for intracellular invaders. 
The RLRs that have been identified so far are involved in antiviral responses by 
recognizing viral RNA. Helicases identified include the RNA helicases RIG-1 
(retinoic acid-inducible gene I) and MDA-5 (melanoma differentiation-associated 
gene-5) [184-186]. RIG-1 and MDA-5 have two N-terminal CARD domains, a 
central helicase domain and a C-terminal regulatory domain [186]. RIG-1 has 
been shown to sense hepatitis C virus, Sendai virus, influenza virus, vesicular 
stomatitis virus, Newcastle disease virus, rabies virus and Japanese encephalitis 
virus, while MDA-5 senses picornaviruses and poly I:C (poly-cytidylic acid) [187, 
188]. Furthermore, RIG-1 is triggered by short dsRNAs, whereas MDA-5 is 
triggered by long dsRNAs [189]. In addition Dengue virus triggers both RIG-1 and 
MDA-5 [189]. The viral RNA is distinguished from cellular RNA by a 5´-
triphosphate modification [190]. Viral nucleic acids are also recognized within 
the endosomes by TLR7 and TLR9, mainly in plasmacytoid DCs. Other cell types 
recognize viral RNA via RLRs in the cytoplasm [184, 186]. Activation of these 
receptors results in NF-κB and IRF3/7 activation which leads to transcription of 
type I IFN, which in turn leads to antiviral immunity and triggering of adaptive 
immunity [168].  
1.5.3 C-type lectin receptors (CLRs) 
CLRs are important in antifungal immunity [191]. The CLR family of proteins is a 
large family where all proteins possess a C-type lectin-like domain (CTLD). Out 
of the 17 groups of this family, the mannose receptor (MR), Dectin-1 and -2, 
dendritic cell-specific ICAM-3-grabbing non-integrin (DC-SIGN) and the collectins 
have been shown to be involved in antifungal immunity [191]. These receptors 
result in fungal binding, uptake and killing, as well as contributing to the 
immune response.  
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The MR can be both membrane-bound and soluble, with the majority located 
within the endocytic pathway. MR recognizes carbohydrates, such as mannose, 
fucose and N-acetyl glucosamine from bacteria and viruses. In addition, MR is 
involved in recognition of fungi, which contain mannose-based structures on 
their cell walls [192, 193]. In response to fungi, MR activation leads to NF-κB 
activation and secretion of IL-12, IL-8, IL-1β and IL-6 [191, 193].  
Dectin-1 recognizes β-1,3-glucans and mediates signalling through its 
cytoplasmic ITAM-like motif [167]. This results in activation of the respiratory 
burst, activation and regulation of phospholipase A2 (PLA2) and cyclooxygenase 2 
(COX2), endocytosis and phagocytosis and TNF, macrophage inflammatory 
protein 2 (MIP-2), IL-2, IL-10, IL-6 and IL-23 production [167]. The production of 
proinflammatory cytokines requires collaborative signalling from TLRs [167]. 
Dectin-2, on the other hand, has been shown to recognize mannose structures 
and fucose [194]. Upon activation it induces TNF and IL-1R antagonist, but the 
role of this receptor in antifungal immunity is still unclear [195].  
The collectins are an example of secreted multimeric complexes [191]. Several 
collectins have been implicated in antifungal immunity, such as mannose-binding 
lectin (MBL) and surfactant protein A and D (SP-A, SP-D) [191]. Collectins lead to 
activation of complement, which promotes opsonic fungal recognition, triggering 
of microbial agglutination, as well as modulation of phagocytosis, cytokine 
production and respiratory burst [191].  
1.5.4 NOD-like receptors (NLRs) 
NLRs (NOD (Nucleotide oligomerization domain)-like receptors) have been 
identified as intracellular microbial sensors [161]. They are a large family of 
proteins with 23 members in humans and 34 in mice so far identified [172]. They 
contain LRRs and resemble plant disease-resistance genes. Plants have a wide 
range of intracellular pathogen detectors; these were the first receptors that 
revealed the importance of intracellular pathogen detection [196]. The first NLR 
to be identified was Nod1 (nucleotide-binding oligomerization domain 1), as a 
homologue to a C.elegans protein (CED-4) responsible for regulating apoptosis 
[197]. Several different names have been used for the same NLRs in different 
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publications, but recently a standard nomenclature was described for these 
proteins [198]. This nomenclature will be used in this thesis.  
NLRs are multidomain proteins consisting of C-terminal LRRs, a central 
nucleotide domain (called NACHT, domain in NAIP, CIITA, HET-E and TP1, or 
NBD, nucleotide binding domain) and N-terminal effector domain (Figure 1.8). 
The LRRs have been implicated in ligand sensing and autoregulation of NLRs and 
TLRs, as mentioned above. The mechanism by which the LRRs sense their ligands 
is still unknown, as no direct binding has been identified. Therefore it is 
believed that the sensing via NLR-LRRs is indirect, which has also been described 
for some TLRs. The LRR contain 20-30 amino acids rich in Leucine, which form a 
horseshoe-shaped molecule via its tandem repeats of a β-strand and α-helix 
[199]. The NACHT domain is present in all NLRs and is similar to a motif (NB-
ARC) in the apoptotic mediator APAF-1 [161]. Binding of cytochrome c to APAF-1 
results in oligomerization of APAF-1 via its NB-ARC domain, which initiates 
apoptosis. Similarly it has been shown that oligomerization of the NACHT domain 
is important for activation of the NLR protein. This results in the formation of 
active multimeric protein complexes, such as inflammasomes and NOD 
signalosomes [200, 201]. The N-terminal effector domain of NLRs divides them 
into different subfamilies (Figure 1.8). These effector domains mediate signal 
transduction to downstream targets, such as inflammatory caspases for the 
inflammasomes and NF-κB activation for the NOD signalosomes. Most NLRs have 
a death-fold domain in their N-terminal, such as a caspase recruitment domain 
(CARD) or pyrin domain (PYD). These death-fold domains were described for 
proapoptotic signalling pathways and include, in addition to CARD and PYD, the 
death domain (DD) and the death effector domain (DED) [202]. Death-domains 
can form homologous dimers or trimers, which allows receptors to bind to 
adaptors and effector proteins. This allows CARD- or PYD-containing NLRs to 
recruit other CARD or PYD containing proteins to the signalling platforms.  
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Figure 1.8; Domain organization of NLRs 
NLRs have three distinct domains, a C-terminal leucine-rich repeats, involved in ligand sensing, a 
central NACHT domain, involved in oligomerization and an N-terminal effector domain, which is a 
CARD, PYD or BIR depending on NLR subfamily. Some NLRs have a NAD domain at the C-
terminal side of NACHT. NLRs are divided into five subfamilies, NLRPs, NLRCs and NAIP, NLRX1 
and CIITA. A comparison with plant NLR-like gene is also shown. Abbreviations; CARD, caspase 
recruitment domain, PYD, pyrin domain, FIIND, function to find, NACHT, domain conserved in 
NAIP, CIITA, HET-E and TP1, NAD, NACHT associated domain and BIR, baculovirus IAP repeat, 
NAIP, NLR family apoptosis inhibitory protein, AD, activation domain, CIITA, class II transcription 
activator. Figure adapted from [161, 198]. 
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There are five different NLR subfamilies, characterized by a specific molecular 
structure (Table 1.2) [198, 203, 204]. The largest subfamily is NLRP, which has 
14 genes in the human genome [204]. NLRP1, NLRP2 and NLRP3 have been 
identified as proteins present in the inflammasome complexes. Proteins in the 
NLRP subfamily contain an N-terminal PYD. In contrast, another NLR subfamily 
called NLRC contains an N-terminal CARD-domain. This subfamily includes Nod1, 
Nod2, NLRC3, NLRC4 and NLRC5 [198, 203, 205]. The remaining subfamilies are 
called NLRA, NLRB and NLRX and only contain one identified NLR protein in each 
family; CIITA, NAIP and NLRX1 respectively [198]. NLRC4 and NAIP are also 
involved in the formation of inflammasome complexes, together or separately. 
CIITA is involved in the transcriptional regulation of MHC II [206]. The function of 
NLRX1 is not fully understood; it is recruited to the outer membrane of 
mitochondria and might function as a negative regulator of antiviral response or 
promoting the production of reactive oxygen species [207-209]. Nod3 and Nod4 
have no described function yet.  
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Table 1.2; NLRs  
Nomenclature NLR 
subfamily 
Human Mouse 
Names and 
aliases 
Structure 
NLRA CIITA CIITA MHC2TA, C2TA, 
NLRA 
(CARD)-AD-NACHT-NAD-
LRR 
NLRB NAIP NAIP a-g BIRC1, NAIP1-7, 
Birc1 a-g, NLRB1, 
CLR5.1 
BIR-BIR-BIR-NACHT-LRR 
Nod1 Nod1 CARD4, CLR7.1, 
NLRC1 
CARD-NACHT-NAD-LRR 
Nod2 Nod2 CARD15, CD, 
BLAU, IBD1, 
PSORAS1, 
CLR16.3, NLRC2 
CARD-CARD-NACHT-NAD-
LRR 
NLRC3 NLRC3 Nod3, CLR16.2 CARD-NACHT-NAD-LRR 
NLRC4 NLRC4 IPAF, CARD12, 
CLAN, CLR2.1 
CARD-NACHT-LRR 
NLRC 
NLRC5 NLRC5 Nod4, NOD27, 
CLR16.1 
CARD-NACHT-LRR 
 NALP1, DEFCAP, 
NAC, CARD7 
PYD-NACHT-NAD-LRR-
FIIND-CARD 
NLRP1 
NLRP1a  NACHT-NAD-LRR-FIIND-
CARD 
NLRPs 
NLRP2 NLRP2 NALP2, Pypaf2, 
NBS1, PAN1 
PYD-NACHT-NAD-LRR 
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NLRP3 NLRP3 NALP3, 
Cryopyrin, 
Pypaf1, CIAS1 
PYD-NACHT-NAD-LRR 
NLRP4 NLRP4 a-
g 
NALP4, Pypaf4, 
PAN2, RNH2 
PYD-NACHT-NAD-LRR 
 NALP5, Pypaf8, 
Mater, PAN11 
PYD-NACHT-NAD-LRR NLRP5 
NLRP5  NACHT-NAD-LRR 
NLRP6 NLRP6 NALP6, Pypaf5, 
PAN3 
PYD-NACHT-NAD-LRR 
NLRP7  NALP7, Pypaf3, 
NOD12 
PYD-NACHT-NAD-LRR 
NLRP8  NALP8, PAN4, 
NOD16 
PYD-NACHT-NAD-LRR 
NLRP9 NLRP9 a-
c 
NALP9, NOD6 PYD-NACHT-NAD-LRR 
NLRP10 NLRP10 NALP10, PAN5, 
NOD8, Pynod 
PYD-NACHT-NAD 
NLRP11  NALP11, Pypaf6, 
NOD17 
PYD-NACHT-NAD-LRR 
NLRP12 NLRP12 NALP12, Pypaf7, 
Monarch1, RNO2, 
PAN6 
PYD-NACHT-NAD-LRR 
 
NLRP13  NALP13, NOD14 PYD-NACHT-NAD-LRR 
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 NLRP14 NLRP14 NALP14, NOD5 PYD-NACHT-NAD-LRR 
NLRX NLRX1 NLRX1 Nod5, NOD9, 
CLR11.3 
X-NACHT-LRR 
Table adapted from [161, 198].  
 
NLRs are mainly expressed in cells and tissues that have a role in immunity. 
Epithelial cells form the first barrier against infection, as mentioned above, and 
several NLRs are expressed by these cells such as Nod1, Nod2, NLRP3 and NAIP 
[210-212]. NLRP3 is also expressed by immune cells and osteoblasts [213]. In 
contrast, NLRP1 is widely expressed. NAIP and NLRC4 are expressed in 
macrophages and brain, spleen, liver and lung [214, 215]. The expression of NLRs 
such as Nod1, Nod2 and NLRP3 are increased by TLR stimulation [216].  
1.5.4.1 Nod1 and Nod2 
Nod1 was the first NLR protein identified, as mentioned above [197, 217]. Upon 
activation of Nod1 and Nod2 the receptor-interacting protein 2 (RIP2) caspase-
like apoptosis-regulator protein (CLARP) kinase (RICK) is recruited via CARD-
CARD interactions. This leads to activation of NF-κB [218]. Both proteins detect 
peptidoglycan derived muropeptides, Nod2 detects muramyl dipeptides (MDP) 
and Nod1 detects meso-diaminopimelic acid (meso-DAP) [219, 220]. Nod1 and 
Nod2 are crucial for the innate immune response in epithelial cells. They control 
infection via the gastro-intestinal route, for example by H.pylori and Listeria 
monocytogenes [221, 222]. Nod1 and Nod2 will be discussed in more detail in 
chapter 6.  
Mutations, mainly in the LRR-region, of the Nod2 gene are associated with 
Crohn’s disease (inflammatory bowel disease) [223]. The disease is believed to 
develop as a consequence of loss of tolerance toward commensal bacteria or 
allowing proliferation of pathogenic bacteria in the gut. In addition, a gain-of-
function mutation in the Nod2 gene results in Blau syndrome (autoinflammatory 
disorder resulting in skin rashes and joint inflammation) [224]. Nod2 has also 
been shown to be involved in the MDP- and NLRP3-dependent inflammasome 
activation [225, 226]. 
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1.5.4.2 Inflammasome complexes 
Some of the NLR proteins have been shown to form large protein complexes in 
the cytosol, called inflammasomes. These complexes link the sensing of 
microbial products and metabolic stress to the proteolytic activation of the pro-
inflammatory cytokines IL-1β and IL-18 [227]. The name inflammasome comes 
from the word inflammation, which reflects the function of the complex, and 
“some”, which is from the Greek word soma (body). The name also reflects 
similarities with the apoptosome, which triggers apoptosis [228].  
So far, four inflammasome complexes have been identified; the NLRP1, NLRP3, 
NLRC4 and AIM2 inflammasome. In addition, several NLRP proteins might be 
involved as scaffolding proteins of the inflammasome complexes [229]. The 
three inflammasome complexes, NLRP1, NLRP3 and NLRC4 described are 
prototypes. Evidence suggests that other NLRs are also involved in the complex 
formation or modulation of their activity, for example, NAIP or Nod2. The 
mechanism of this is not yet identified. Furthermore, it has been suggested that 
multiple NLR proteins form heterocomplex inflammasomes [230, 231]. Therefore 
the complexity and diversity of inflammasomes might be greater than previously 
anticipated [232]. The adaptor protein ASC (apoptosis-associated speck-like 
protein containing a CARD) contains an N-terminal PYD and a C-terminal CARD. It 
is essential for inflammasome formation and it is believed to be recruited to 
NLRP proteins via PYD-PYD interactions [227, 233, 234]. The CARD of ASC can 
then interact with the CARD of caspase-1. ASC is also involved in the NLRC4 
inflammasome complex via an unknown mechanism, since NLRC4 is able to 
recruit caspase-1 directly via CARD-CARD interactions [215]. In addition, it has 
recently been shown that ASC is redistributed to the cytosol from the nucleus 
upon infection, suggesting an additional role for ASC in inflammasome regulation 
[235].  
The inflammasome complexes respond to a wide variety of signals both DAMPs 
and PAMPs (Figure 1.9). The NLRP3 inflammasome is triggered following 
disruption of cellular integrity and potassium efflux [227, 236-238]. The NLRP3 
inflammasome is triggered by a wide variety of stimuli such as danger signals, 
bacterial toxins and viral DNA, as well as MDP [161]. Known mediators that 
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activate the NLRP3 inflammasome will be described in more detail in chapter 4. 
In contrast to NLRP3, NLRC4 has been shown to respond to bacterial derived 
products delivered via secretion systems. The NLRC4 inflammasome will be 
discussed in more detail in chapter 5. The NLRP1 inflammasome has been shown 
to be activated following exposure to anthrax lethal toxin and MDP [200, 239]. 
Anthrax is caused by Bacillus anthracis through the action of its secreted toxins. 
One of these toxins is anthrax lethal toxin. It has been shown that a 
polymorphism in the NLRP1 gene results in impaired caspase-1 activation [239]. 
In the commonly used mouse strain C57BL/6, NLRP1 is inactive [239]. The role of 
NLRP1 in the pathology of anthrax is still unknown. In order to activate the 
NLRP1 inflammasome the toxin requires binding, uptake and endosome 
acidification to mediate translocation of the lethal factor (subunit of anthrax 
lethal toxin) into the host cell. Furthermore, it has been shown that catalytically 
active lethal factor activates caspase-1 by a mechanism involving proteasome 
activity and potassium efflux [240-242]. AIM2 (absent in melanoma 2) was 
recently identified as the key sensor for cytoplasmic dsDNA [169-171]. AIM2 is a 
member of the PYHIN (pyrin and HIN domain-containing protein) family. Double-
stranded DNA triggers AIM2 oligomerization, which results in AIM2 inflammasome 
formation together with ASC and caspase-1 [170]. 
The inflammasome complexes sense both DAMPs and PAMPs, as previously 
mentioned. The resulting outcome of activation, independent of stimulus, is 
activation of inflammatory caspases, mainly caspase-1. The NACHT domain in 
the NLR-proteins of the inflammasome complex oligomerize upon activation. 
Binding of ATP/dATP by both NLRC4 and NLRP3 is necessary for oligomerization 
[243].This leads to proteolytic processing of pro-caspase-1 to its active form, 
caspase-1. This protease then processes pro-IL-1β and IL-18, which contribute to 
the inflammatory response, discussed below. Secretion of mature IL-1β requires 
two separate signals (Figure 1.9). Upon activation of TLRs, transcription of the 
IL-1β gene is induced, which results in the accumulation of pro-IL-1β. This pro-
form is then processed following activation of the inflammasome complex and 
caspase-1 (Figure 1.9). The mature form of IL-1β is then secreted from the cell. 
In addition to maturation of IL-1β and IL-18, inflammasome activation can lead 
to cell death. This cell death is called pyroptosis from “pyro” meaning fire, 
which indicate the release of proinflammatory mediators, and “ptosis” meaning 
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falling, which is commonly used to describe cell death (Figure 1.9) [244]. 
Pyroptosis is dependent on caspase-1 activation and is associated with a high 
inflammatory activation state. Pyroptosis has been described for S.flexneri since 
cell death caused by this pathogen is dependent on caspase-1 but independent 
of caspase-3 [245, 246]. Pyroptosis has also been reported for macrophages 
infected with Y.pseudotubercolosis [247], S.typhimurium [248], P.aeruginosa 
[249], F.tularensis [250], L.pneumophila [251] and L.monocytogenes [252]. The 
requirements differ between caspase-1-dependent IL-1β and IL-18 secretion 
compared to pyroptosis. Salmonella induced pyroptosis is dependent on NLRC4, 
whereas both NLRC4 and ASC is required for cytokine production [234]. Similar 
results have been observed for both P.aeruginosa and S.flexneri [249, 253, 254]. 
Pyroptosis was shown to be triggered in the pyroptosome, which is dependent on 
ASC but NLRP-independent [255]. However, this was challenged by the fact that 
pyroptosis caused by B.anthracis is NLRP1-dependent [240].  
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Figure 1.9; Caspase-1 activation and processing of IL-1β and IL-18 
Upon activation of the inflammasome complex by a wide range of stimuli pro-caspase-1 is 
proteolytic processed and active caspase-1 is formed via the formation of p10/p20 heterodimer. 
Active caspase-1 leads processing of pro-IL-1β and pro-IL-18, and it can lead to inflammatory cell 
death; pyroptosis. TLR activation is required for the transcriptional activation and accumulation of 
pro-IL-1β and pro-IL-18. Figure is adapted from [256]. 
 
Inflammasome activation is believed to be a regulated process via synergism, 
feedback loops and checkpoints. NF-κB is involved in the down-modulation of 
the inflammatory response, which includes inflammasome activation [257]. Two 
major forms of inflammasome regulators have been identified; one group has a 
CARD domain and the other contains a PYD domain. The group containing a PYD 
domain is believed to interfere with interactions between NLRP proteins and ASC 
[258]. These proteins include Pyrin, Pyrin-only proteins; POP1 and POP2, as well 
as viral PYDs. These short proteins mainly contain a PYD domain [258]. The 
mouse genome does not contain any of the POPs, but upon disruption of Pyrin in 
mice there is enhanced caspase-1 activation [259]. Pyrin has been shown to 
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interact with ASC via PYD-PYD interactions, which possibly blocks the 
recruitment of ASC to the inflammasome complex [259]. The regulators 
containing a CARD domain include iceberg, inhibitory CARD (INCA), CARD-only 
protein (COP) and caspase-12 [260]. It is believed that these proteins prevent 
recruitment of ASC or caspase-1 via CARD-CARD interactions. Caspase-12 is the 
only one of these proteins that is present in the mouse genome. Caspase-12-
deficiency results in enhanced bacterial clearance and production of IL-1β and 
IL-18 [261]. In addition, the plant orthologs of the proteins SGT1 and HSP90 have 
been shown to regulate and interact with plant NB-LRR proteins. They are 
therefore presumed to have a similar effect in mammals since NLRC4 and NLRP3 
have been shown to bind these proteins [262, 263]. 
Mutations of genes involved in inflammasome complex formation have been 
linked to hereditary periodic fevers (HPFs) [264]. These heritable disorders cause 
recurrent episodes of fever and severe inflammation. Gain-of-function mutations 
in the NLRP3 gene, resulting in a hyperactive inflammasome, can result in 
familial cold autoinflammatory syndrome (FCAS), Muckle-Wells syndrome (MWS) 
and chronic infantile cutaneous neurological articular syndrome (CINCA, also 
known as neonatal-onset multisystem inflammatory disease (NOMID)) [265, 266]. 
Macrophages from patients with mutations in the NLRP3 gene have increased 
secretion of IL-1β [265, 267]. A HPF called familial Mediterranean fever (FMF) is 
caused by mutations in the gene of the inflammasome regulator Pyrin [267]. 
Chronic exposure to inflammasome activating agents such as monosodium urate 
(MSU), calcium pyrophosphate dihydrate (CPPD) and dust particles, asbestos and 
silica can result in aberrant NLRP3 inflammasome activation [268]. This results in 
the autoinflammatory diseases gout, pseudogout, silicosis and asbestosis [268].  
Several inflammasome activators also have adjuvant properties; these include 
MDP, MSU and alum [269-271]. Adjuvants enhance the immune response to an 
antigen. Both MSU and alum are dependent on NLRP3, ASC and caspase-1 for 
their adjuvant properties [272-274].  
1.5.4.3 Caspases 
Caspases are produced as inactive zymogens; upon activation they undergo 
proteolytic processing which results in a catalytically active protease [275]. 
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Caspases are involved in apoptosis where they cleave substrates. There are 
executioner caspases (caspase-3, -6 and -7 in mammals), which are activated by 
initiator caspases (caspase-8, -10, -2 or -9). The initiator caspases have an N-
terminal death-fold domain (similar to NLR-proteins), which is required for the 
activation of the C-terminal catalytic region. Different initiator caspases are 
activated via different molecular platforms, for example, caspase-9 is activated 
by the apoptosome [161].  
Activation of the inflammasome complexes results in the activation of 
inflammatory caspases [201, 276]. These include caspase-1 and -12 (human and 
murine), caspase-11 (murine) and caspase-4 and -5 (caspase-1 related human) 
[260]. The N-terminal domain of inflammatory caspases is a CARD-domain 
adjacent to a catalytic residue cysteine. The inflammatory caspase, caspase-1, 
processes cytokines such as IL-1β [277], IL-18 and possibly IL-33, hence the name 
inflammatory as these cytokines are crucial in the inflammatory response. The 
involvement of caspase-1 in proteolytic processing of IL-33 is still unclear [278, 
279]. The cytokines can be processed by caspase-1 following proteolytic 
processing of the pro-caspase-1 which occurs upon inflammasome activation. 
Pro-caspase-1 is processed into a p10 and p20 fragment. Active caspase-1 
consists of a heterodimer of these fragments (Figure 1.9). Other roles for 
caspase-1, such as regulation of unconventional protein secretion and proteolysis 
of glycolysis enzymes, have also been identified, which might result in the 
description of new inflammasome functions in the future [280-283]. Caspase-1 
was the first caspase to be identified in mammals, by the discovery that cell 
lysis in hypotonic buffer can lead to the processing of pro-IL-1β [284], but the 
activation pathway via inflammasome complexes were only recently identified 
[227]. Caspase-1 activation has been associated with human caspase-5 and 
murine caspase-11, but the substrates of these caspases have not been 
identified. The CARD-domain of NLRP1 has been shown to recruit caspase-5, 
which suggests a role in the NLRP1 inflammasome complex. Caspase-4 and 
caspase-12 are activated upon endoplasmic reticulum (ER) stress but the role of 
this activation is not described [276]. Caspase-12 has also been shown to inhibit 
inflammasome activation by interfering with caspase-1 activation [261].  
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1.5.4.4 Interleukin-1β 
IL-1β is a member of the IL-1 family of ligands, which include, for example, IL-
1α, IL-1 receptor antagonist (IL-1Ra), IL-18 and IL-33 [285]. IL-1β is related to IL-
18 and IL-33 and all of these cytokines result in the initiation of a MyD88-
dependent signalling pathway, similar to the pathway initiated by TLR signalling. 
Inflammasome activation therefore leads to the activation of a TLR-like receptor 
such as IL-1R and IL-18R. The data presented in this thesis will focus on IL-1β 
secretion resulting from inflammasome activation, therefore this cytokine will 
be described in more detail.  
IL-1β, a proinflammatory cytokine, is one of the most important mediators of 
inflammation [159, 286]. It is produced mainly by blood monocytes but also by 
macrophages, dendritic cells and a variety of other cells in the body [159]. IL-1β 
production results in fever [285], hypotension, and the release of 
adrenocorticotrophic hormone and the production of other cytokines such as IL-6 
[159]. Other effects on the central nervous system except fever include; 
induction of slow-wave sleep, anorexia and inflammatory pain hypersensitivity 
[285]. These effects are mediated via the ability of IL-1β to induce 
cyclooxygenase type 2 (COX-2), type 2 phospholipase A and inducible nitric oxide 
synthase (iNOS) [285]. IL-1β is also able to increase the expression of adhesion 
molecules. All these effects of IL-1β result in infiltration of inflammatory and 
immunocompetent cells from the circulation into tissues, via the extravascular 
space. 
As described above, maturation of IL-1β require two signals; translation is 
initiated following TLR activation and proteolytic processing is mediated by 
active caspase-1 following inflammasome activation. The molecular mechanisms 
regulating the transcription of pro-IL-1β are not fully understood, but reports 
have shown a role for both NF-κB and mitogen-activated protein (MAP) kinase 
[287, 288]. Pro-IL-1β amounts are usually low within the cell, therefore 
transcriptional activation is required in order to secrete IL-1β. Several pathways 
have been described for the secretion of mature IL-1β [289]. These include; 
exocytosis of secretory lysosomes [290-292], shedding of plasma membrane 
microvesicles [293], export through the plasma membrane using specific 
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membrane transporters [294], multivesicular bodies containing exosomes [295] 
or release upon cell lysis [296, 297]. IL-1β is generally released before a 
significant release of lactate dehydrogenase (LDH) can be observed [294]. The 
secretion of IL-1β has also been shown to be dependent on an increase in 
intracellular calcium and phospholipase C [292]. The diversity of IL-1β secretion 
pathways might be due to different methods used during the investigation of this 
subject, or there is a possibility that IL-1β is secreted via more than one 
exclusive pathway [289]. In addition to proteolytic processing by caspase-1, pro-
IL-1β can be processed by neutrophil proteinase-3, elastase, matrix 
metalloprotease 9 and granzyme A in the extracellular space [257, 285, 298].  
IL-1β is believed to be the major mediator of inflammation in the periodic fever 
syndromes caused by mutations in the NLRP3 gene. It has been shown that 
treatment of these patients with an inhibitor of IL-1 (IL-1Ra) improves their 
symptoms [299, 300]. IL-1Ra has also been shown to help patients with 
rheumatoid arthritis [285]. 
The IL-1 receptor family encodes 10 members, from which IL-1R 1-3 respond to 
IL-1β [285]. IL-1R1 has a cytoplasmic TIR-domain, similar to TLRs. Upon binding 
of IL-1β to IL-1R1, MyD88 is recruited and signalling via IRAK and TRAF lead to 
degradation of IκB and activation of NF-κB. In addition, mitogen-activated 
protein kinase (MAPK) and JNK is also activated. The IL-1R2 is a decoy receptor, 
which binds IL-1β but does not signal [285].  
1.5.5 Plant immunity 
The ability to detect and respond to an infection is important in all living 
organisms, even plants. Plants have both PAMP-triggered immunity and effector-
triggered immunity [301]. Pathogens have developed means to suppress the 
PAMP-triggered immunity, which then triggers effector immunity. The effector-
triggered immunity mainly detects, directly or indirectly, pathogen-driven 
modifications, stress or danger signals in the infected host cell [302]. This 
immunity is mediated by single genetic loci that control the resistance to 
specific plant pathogens [303]. These genes are called resistance (R) genes, and 
sequencing has revealed a similar structure to NLR-proteins with C-terminal 
LRRs, a central nucleotide-binding domain, related to NB-ARC, and an N-
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terminal effector domain [304, 305]. The N-terminal effector domain can be 
either a TIR domain or a coiled-coil domain [306]. The proteins encoded by the R 
genes, nucleotide binding leucine-rich repeat (NB-LRR) proteins, are 
intracellular and recognize avirulence factors, which are pathogenic bacterial 
effector proteins [304]. Direct binding between NB-LRR protein and the 
corresponding avirulence factor has rarely been described [301]. Instead, NB-LRR 
proteins indirectly detect the activity of pathogenic effectors, via the 
modifications the virulence proteins inflict on host target proteins [301]. The 
avirulence factors gain access to the intracellular environment by T3SS. The 
resulting response is a form of programmed cell death [305]. Plants express 
several R-genes, which imply that a specific R-gene recognize a specific 
avirulence gene [307].  
NLR-proteins and plant R-genes are structurally similar but no evidence for 
common evolutionary origin can be found. These innate immune sensors are a 
result of convergent evolution [308].  
1.5.6 Collaboration between innate immune receptors 
There are several examples of collaboration between innate immune receptors. 
Receptors may transduce intracellular signals within a phagocyte that interact 
with each other to define the net transcriptional and cellular response. Another 
possibility is that not all cells express the same repertoire of receptors, thus the 
set of receptors that recognise a specific microbe may also define the type(s) of 
cells that become activated. Collaboration between receptors defines whether a 
phagocyte becomes activated or not and the amounts and types of cytokines and 
chemokines produced, as well as shaping of the downstream adaptive immune 
response. Upon infection it is likely that a Gram-negative bacterium is 
recognized both by TLR4 (LPS) and TLR5 (flagellin), providing that the pathogen 
is flagellated. Collaboration has been shown for TLR4 and TLR7 in vitro [309]. 
More cytokines are produced upon stimulation of TLR3 or TLR4 together with 
TLR7, TLR8 or TLR9 than with either receptor alone [310]. It has been shown 
that coactivation of TLRs have this effect when one receptor relies on MyD88-
dependent signalling and the other one is independent of MyD88, such as 
TLR2/TLR4 [311]. TLR5, NLRC4 and NAIP5 all respond to flagellin, although the 
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parts of flagellin required are not the same for these receptors [312]. Due to the 
different location of TLR5 and the NLR-proteins it is possible that the immune 
detection of flagellin is mediated via cooperation between these proteins in a 
synergistic or concurrent manner [231]. Secretion of mature IL-1β requires 
activation of both TLRs and NLRs, as mentioned above. In addition, other PRRs, 
other than TLRs, trigger NF-κB activation and might therefore be involved in the 
translation initiation of pro-IL-1β [172]. The CLR-receptor dectin-1 also requires 
collaborative signalling from TLRs for the production of proinflammatory 
cytokines [167], and a collaboration between Dectin-1 and NLRP3 in the 
response to Candida albicans has recently been described [313]. Furthermore, it 
has been recently shown that NF-κB activation by TLRs, as well as cytokine 
receptors such as the TNF-receptor, not only controls IL-1β gene transcription, 
but also initiates NLRP3 transcription [314, 315]. This provides evidence for an 
additional control of inflammasome expression, Nod1 and Nod2 have been shown 
to synergize with TLR4 and TLR3, which results in enhanced production of TNF-
α, IL-1β, IL-6, IL-8, IL-10, IL-12p40 and IL-12p70 as well as dendritic cell 
maturation (CD40, CD80 and CD86) [316-318]. Current experimental models fail 
to explain how and whether more than two receptors collaborate [310]. 
Collaboration potentially provides advantages for the host by providing a robust 
response, since several receptors are harder to evade. It also provides 
compensation for potential genetic weaknesses as a more accurate and potent 
response can be triggered [310]. 
1.5.7 Link between PRRs and adaptive immunity 
TLRs have been shown to control adaptive immune responses by control of 
antigen uptake, antigen selection for presentation in DCs, control of DC 
maturation and cytokine production as well as control of survival of activated T-
cells [319]. Inflammasome activation is important in linking innate immunity to 
adaptive immunity. This is demonstrated by the adjuvant activities by MSU and 
alum, which triggers an influx of neutrophils and in the presence of antigen an 
efficient Th2-dependent immune response [164, 272-274]. In addition, silicosis 
triggered by silica dust is dependent on NLRP3 and results in a Th2 response 
[320]. The IL-1β, IL-18 and IL-33 cytokines are known to trigger various aspects 
of Th2 immune responses [321, 322]. It has also been shown that signalling 
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through Dectin-1 can trigger Th17-cell responses [323]. Furthermore, a role for 
T-cells in dampening the innate immune response was recently described. The T-
cells suppress activation of NLRP1 and NLRP3 via cell-cell contact [324]. This 
suggests a novel role of T-cells in suppressing a potentially damaging 
inflammatory response.  
1.6 Aims 
NLR proteins have been studied extensively after their discovery. They have 
been shown to be important innate immune sensors of PAMPs and DAMPs. We 
hypothesised that the Gram-negative extracellular bacterium P.aeruginosa can 
activate intracellular inflammation responses via its T3SS. The aim of this study 
was to investigate whether NLR-proteins, such as Nod1 and inflammasome 
complexes could be activated by P.aeruginosa. This would be studied by 
investigating cellular responses dependent of activation of these proteins, for 
example NF-κB activation, caspase-1 processing and IL-1β secretion. 
Furthermore, the aim was to investigate the mechanism of activation and role of 
bacterial mediators. Finally, the role of the T3SS in triggering of membrane 
repair mechanisms would be investigated.  
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2 Materials and Methods 
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2.1 Tissue culture 
2.1.1 Cell lines 
2.1.1.1  HeLa, CHO and HEK293 cells 
Human Negroid cervix epitheloid carcinoma cells (HeLa), Chinese Hamster Ovary 
(CHO) cells and Human Embryonic Kidney 293 cells (HEK293) [325] were grown 
routinely in Dulbecco’s Modified Eagle’s Medium (DMEM with 4500 mg/l D-
glucose and sodium pyruvate) supplemented with 2 mM L-glutamine, 10% foetal 
bovine serum (FBS, Sigma), 100 µg/ml Streptomycin and 100 U/ml Penicillin. To 
maintain the culture, cells were split at approximately 80% confluence (1 in 5 
dilution). Briefly, cells were washed twice with sterile PBS or Hank’s buffered 
salt solution (HBSS). One ml Trypsin (0.05%) with EDTA was added or enough to 
cover the cells. The flask was incubated for 5 min at 37°C until cells had 
completely detached. Complete media was added to stop the Trypsin and 
appropriate dilution was added to a new flask. 
Prior to infection cells were grown 12 h in DMEM supplemented as above, but 
without Penicillin and Streptomycin. 
2.1.1.2  RAW264.7 cells 
RAW264.7 cells are a murine macrophage cell line from blood. Cells were grown 
as described for HeLa cells except for the treatment with Trypsin; instead the 
RAW264.7 cells were scraped off with a cell scraper (Greiner BioOne), and the 
appropriate dilution was added to a new flask. 
Twelve hours before infection, cells were seeded in complete DMEM without 
Penicillin and Streptomycin. 
2.1.1.3  L929 cells 
L929 cells are a murine cell line which produces M-CSF in culture. They were 
derived from normal murine subcutaneous areolar and adipose tissue. Cells were 
obtained from Prof A Mowat, Glasgow. The L929s were cultured in order to 
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obtain M-CSF for culturing of BMDM. They were cultured in RPMI 1640 
supplemented with 10% FBS, 100 µg/ml Streptomycin, 100 U/ml Penicillin and 2 
mM L-glutamine. When cells were around 80% confluent they were scraped off 
and resuspended in fresh media. When culturing to obtain M-CSF, cells were split 
into large (T150) TC-flasks and cultured for 3 days following full confluency. 
Supernatant was taken off, sterile filtered and then stored at -20°C until used 
for culturing of BMDM. Each batch was tested for the ability to obtain F4/80+ 
cells from bone marrow progenitors, typically results were between 90-95% 
F4/80+ (Figure 2.1).  
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Figure 2.1; F4/80 staining of BMDMs 
BMDM analysed for F4/80 after propagation in L929 conditioned media. F4/80 staining (right 
column) compared to isotype staining (left column). BMDM were gated based on forward and side 
scatter (top panels, 60.7% for isotype, 59% for F4/80), these events were then gated based on PI 
staining (middle panel, PI negative are alive cells, 83,2% isotype, 82,2% F4/80). Alive cells were 
gated based on F4/80 staining (bottom panels, 1,54% isotype, 91,2% F4/80). 
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2.1.1.4  PT-67 retroviral packaging lines 
The PT-67 cell line was obtained from Dr. A.M. Michie, Glasgow. This packaging 
cell line is based on NIH-3T3 cells expressing the 10A1 viral envelope. Viruses 
packed from PT-67s can enter cells via the amphotropic retrovirus receptor or 
via the GALV receptor [326]. These cells were maintained in DMEM (4500 mg/l 
glucose and with L-glutamine, Lonza, Basel, Switzerland) supplemented with 10% 
FBS (Sigma), 100 U/ml penicillin, 100 µg/ml Streptomycin, 2 mM L-glutamine, 1 
mM sodium pyruvate, 10 mM HEPES, 50 µM β-mercaptoethanol (2-ME) and 10 
µg/ml gentamicin (Sigma). Cells were split when they reached approximately 
80% confluency. Cells were covered with Trypsin (0.05%) with EDTA and left until 
cells had completely detached. Media was added to stop the effect of the 
Trypsin and cells were centrifuged at 400 x g for 6 min at 4°C. The pellet was 
resuspended in complete media and added at an appropriate dilution to a new 
culture flask. 
2.1.1.5  GP+E.86 retroviral packaging lines 
The GP+E.86 cell line was obtained from Dr. A.M. Michie, Glasgow. GP+E.86 are 
a gag-pol and env retroviral packaging line which was used for retroviral gene 
transfer. These cells were generated by co-transfection of the plasmid 
containing the gag and pol genes derived from Moloney murine leukaemia virus 
(MMLV) and the plasmid containing the env gene derived from the helper virus 
into NIH-3T3 cells [327, 328]. These cells were cultured in the same media as 
the PT-67s and maintained using the same method. 
2.1.1.6  Generation of retroviral packaging lines 
Retroviral vectors can be used to introduce a nonviral gene into mitotic cells in 
vivo and in vitro. This requires active cell division [329]. Stable proviral 
integration in the target chromosomal DNA can be mediated by retrovirus-
mediated gene transfer. Most cells including primary cells express viral receptors 
on the surface. The retroviral vector used (pMigR1) lack genes encoding virion 
structural proteins (pol, env), which disable the retrovirus from replicating by 
itself, but still retaining the efficiency of infection. Infectious viral particles can 
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be produced using this retroviral vector and a retrovirus-packaging cell line. 
These cells express gag, pol and env, which are necessary for encapsidation, 
infection, reverse transcription and integration into the genome of infected 
cells. Two packaging cell lines with different tropism, ecotropic and 
amphotropic, are used to obtain a high viral titer. When env is overexpressed 
the cognate receptor is bound and blocked, which means cells cannot be 
infected by viruses of the same tropism. One cell line is transiently transfected 
with the retroviral vector and the viruses produced are used to obtain a second 
stable virus producing cell line. The viruses produced by this cell line can then 
be used to infect other cells. 
The gene of interest was subcloned into the retroviral vector pMigR1, as 
described below in section 2.3.1.1. At day one of the experiment, 1x105 PT-67 
retroviral packaging cells were seeded per well into a 6-well plate in complete 
medium. The retroviral vectors were transfected into the PT-67 on day two, 
using Lipofectamine 2000 (Invitrogen) as per manufacturer’s instructions. 
Briefly, vectors (1 µg per sample) were diluted into 200 µl Opti-MEM I Reduced-
Serum medium (Invitrogen), simultaneously 8 µl Lipofectamine 2000 was diluted 
into 200 µl Opti-MEM. After 5 min at room temperature the vector mix was 
added to the Lipofectamine to allow for complex formation, which proceeded 
over 15 min. The complex mixture was added to the PT-67s, which were washed 
and new media was added, final total volume was 2 ml/well. After 24 h, media 
was complemented with 0.5 ml complete media, after further 24 h, supernatant 
containing the viral particles was filter-sterilised using a 0.2 µm filter membrane 
(Minisart, Sartorius) attached to a 5 ml syringe (BD Biosciences). This ensured no 
carry over of PT-67 cells into the next part of the experiment. 1 x 105 GP+E.86 
retroviral packaging cells per tube were added to FACS tubes (BD Biosciences) 
and resuspended in supernatants from the PT-67s supplemented with 6 µg/ml 
polybrene (Sigma). The GP+E.86s were spin-infected by centrifugation at 620 x g 
on a Jouan CR322 centrifuge for 45 min at room temperature (RT). Cells were 
resuspended in complete media supplemented with 4 µg/ml polybrene and 
supernatant from the PT-67s and placed in culture for 48 h. After 24 h, cells 
were further supplemented with complete media and 4 µg/ml polybrene. 
Retrovirally transduced GP+E.86 packaging cells were trypsinised and 
resuspended in sterile PBS, passed through Nitex mesh (Cadish) and sorted on 
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the basis of GFP-expression using a FACSAria cell sorter (BD Biosciences) and 
FACSDiva software (BD Biosciences). After 2-3 weeks the GP+E.86s were resorted 
to a purity of >98 % GFP+, thus establishing stable retroviral packaging cell lines. 
These cells were maintained as described for the GP+E.86s. 
2.1.2 Primary cell preparations 
2.1.2.1  Bone-marrow derived macrophages 
Mice were sacrificed by cervical dislocation and femurs and tibias were dissected 
out, obtained from Prof A Mowat, Glasgow. Cells were isolated as previously 
described [330]. Briefly, femurs and tibias were flushed with media using a 21G 
needle to obtain bone marrow mononuclear phagocytic precursor cells. To 
remove tissue and debris the cell suspension was passed through a Nitex mesh. 
Culture media used was RPMI 1640 supplemented with 20% heat inactivated FBS, 
100 µg/ml Streptomycin, 100 U/ml Penicillin, 2 mM L-glutamine, 2.5 µg/ml 
Fungizone (amphotericin B) and 100 µM/ml Sodium pyruvate. Bone marrow 
mononuclear phagocytic precursor cells were seeded into untreated 9 cm petri 
dishes (Sterilin) at a concentration of 3x106 cells/plate. Complete media was 
further supplemented with M-CSF. M-CSF was obtained from 10 ng/ml 
recombinant murine M-CSF (Peprotech) or supernatant of L929 cells. Cells were 
cultured 3 days, after which media and M-CSF were added and cells were grown 
for further 3-4 days. Matured macrophages were scraped off and seeded into TC-
dishes before experiments.  
2.2 Methods 
2.2.1 Bacterial cultures 
Bacterial cultures were grown routinely in Luria-Bertani (LB) media (Invitrogen) 
containing the appropriate antibiotics depending on bacterial strain (Table 2.4). 
A single colony or 50 µl of a glycerol stock was added into 10 ml of LB and grown 
overnight at 37°C at 225 rpm. The next morning, the overnight culture was 
diluted 1 in 30 in LB and allowed to grow for another 90 min or until OD600 was 
between 0.4 and 0.6. The bacteria were then centrifuged at 3000 x g for 10 min 
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at 4°C, the pellet was washed twice in sterile PBS and then resuspended in the 
same media as the cells being infected to a concentration of approximately 1 x 
106 cfu/µl, = (OD600 / 0.4) x 1.8 ml. Cells were then infected at indicated 
multiplicity of infection (MOI) and time. 
2.2.2 Microscope studies 
All microscope studies were done using a Zeiss Axiovert S100 microscope and 
OpenLab software (Improvision).  
2.2.2.1  LAMP-1 staining 
Cells were seeded into 2-well glass chamber slides with cover (Nunc), 5 x 105 
cells/well, one day prior to treatment or infection. On the day of experiment 
cells were infected or treated as indicated. Cells were then washed in icecold 
PBS (3x), followed by incubation in the primary antibody, anti-human LAMP-1 
(BD Biosciences) or mouse IgG1 isotype control 2 µg/ml in PBS with 10% goat 
serum (Sigma) for 60 min at 4°C. Following three washes cells were then fixed in 
1% paraformaldehyde (PFA) in PBS for 30 min at 4°C. After another wash, cells 
were stained using the tyramide amplification kit (TSA kit #2 with HRP-goat anti-
mouse IgG and Alexa Fluor 488 tyramide, Invitrogen) according to 
manufacturer’s instructions. Briefly slides were incubated with 20 ng/µl anti-
mouse IgG-HRP (diluted 1 in 100) in PBS/10% goat serum for 25 min at 4°C. 
Slides were then washed in icecold PBS (3x) and incubated in AF488 tyramide 
diluted 1 in 100 in amplification diluent with 0.0015% H2O2 for 10 min at RT. 
Following washes in PBS, slides were mounted in Vectashield containing DAPI 
(Vector labs) and then imaged. The amount of LAMP-1 specific staining was 
quantified by Dr. A. Morton, University of Glasgow, using a Laser scanning 
cytometer (LSC).  
LSC can be used to quantify specific immunofluorescence staining on cells which 
are located on a microscopic slide. The LSC has the sensitivity of flow cytometry 
and allows gating of relevant cells on the slides. The threshold value is used to 
identify the cells and their nuclei; in this study DAPI was used to stain the cell 
nucleus. The intregration value is set according to the cell surface, which in this 
study was stained for LAMP-1 and the peripheral contour is set between the 
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threshold and the intregration value which can be used to quantify intracellular 
staining and subcellular localisation of markers [331]. This was not used in this 
thesis.  
2.2.2.2  Lucifer Yellow exclusion assay 
The method was adapted from Neyt et al. [332]. Cells (5x105 per chamber) were 
seeded onto 2-well glass chamber slides with cover (Nunc, NY) a day before the 
experiment. Cell culture media used was complete media without Penicillin and 
Streptomycin appropriate for each cell type. Cells were washed in prewarmed 
(37°C) complete media with 30 mM dextran 6000 (Sigma). The dextran 6000 acts 
as an osmoprotectant and prevents cells from flattening [332]. Cells were then 
infected or treated accordingly in 1 ml complete media with 30 mM dextran per 
well. After infection or treatment, slides were placed on ice and cells were 
washed for 10 min in PBS with 30 mM dextran. Following the wash, 0.625 mg/ml 
Lucifer Yellow CH lithium salt (Invitrogen) in complete media with 30 mM 
dextran was added and incubated on ice for 60 min. Cells were washed seven 
times with ice-cold PBS with 30 mM dextran and then fixed with 2% 
paraformaldehyde dissolved in PBS with 30 mM dextran for 20 min on ice. 
Following this, cells were washed twice in ice-cold PBS / 30 mM dextran. After 
washing, chambers were removed from the slides and 2 drops of Vectashield 
with DAPI (Vectorlabs) was added per slide. Coverslips were mounted and edges 
sealed with clear nail varnish. 
2.2.2.3  Potassium imaging 
The potassium indicator potassium-binding benzofuran isophthalate (PBFI) is 
used for fluorometric determination of potassium concentrations (Invitrogen). 
When potassium binds to the dye the ratio of energy absorbed at 340/380 nm 
changes, but the emission wavelength of 500 nm remains constant. The 
excitation wavelength of 340 nm is sensitive to potassium whereas 380 nm is 
very near the isobestic point. Increasing amounts of potassium results in 
increasing fluorescence intensity, which can be plotted as mean fluorescence 
intensity (MFI) against time. The acetoxymethyl (AM) ester of PBFI AM allows the 
dye to be loaded into cells as it makes the dye cell-permeant by resulting in an 
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uncharged molecule. Once the dye has entered the cell the ester is cleaved off 
by nonspecific esterases resulting in a charged molecule, which diffuses from the 
cell at a much slower rate compared to the uncharged molecule. 
BMDM were seeded onto chamber slides, 5 x 105 cells/well (Nunc), in complete 
RPMI without Phenol red (Invitrogen). Cells were allowed to settle and the media 
was changed to RPMI with 5% FBS and 25 mM HEPES, cells were loaded with 2 µM 
PBFI AM cell permeant (Invitrogen), together with Pluronic F-127 (a non-ionic 
detergent polyol used to facilitate cell loading of large dye molecules, 
Invitrogen) for 60 min at RT, as per manufacturer’s instructions. After one wash 
in media, cells were outlined and imaged using time lapse and tracing on a 37°C 
heated stage with the ratio between 340 and 380 nm being plotted. After an 
initial period of imaging, cells were infected or treated as indicated; this was 
done without disrupting the stage or time lapse imaging.  
2.2.2.4  Calcium imaging 
Fluo-4 is a calcium indicator analogous to Fluo-3 (Invitrogen). It is excited at 488 
nm and the emission wavelength is 516 nm. Upon binding of calcium the 
intensity is significantly increased with no shift in the fluorescence spectra.  
Cells were imaged in Phenol Red free complete media appropriate for each cell 
line. Cells were loaded with 3 µM fluo-4 AM (Invitrogen) for 60 min at 37°C. Cells 
were then washed with media for 30 min at 37°C. Cells were outlined and 
calcium changes were measured, using time lapse and tracing on a 37°C heated 
stage. 
2.2.2.5  Zinc imaging 
Fluo-Zin 3 is a zinc sensitive fluorescent indicator, which upon binding of zinc 
has increased fluorescence intensity (Invitrogen). It has an excitation wavelength 
of 496 nm and emission wavelength of 516 nm.  
BMDM were seeded at a concentration of 5 x 105 cells/well in complete RPMI 
without PenStrep in chamber slides (Nunc). Media was then changed to RPMI 
without Phenol Red supplemented with 25 mM HEPES. Cells were loaded with 2 
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µM FluoZin3 AM (Invitrogen) together with Pluronic F-127 for 45 min at RT. After 
loading, cells were washed three times in media and then imaged. Just before 
imaging 5 µg/ml propidium iodide (PI, Sigma) and 20 µM Zinc sulphate (ZnSO4, 
Sigma) was added. Cells were outlined and imaged using time lapse and tracing 
on a 37°C heated stage. Cells were infected without disturbing stage or time 
lapse. Finally 20 µM Pyrithione (Sigma) was added, again without disturbing 
stage or time lapse. 
2.2.2.6  Ethidium bromide uptake assay 
The method was adapted from [333]. BMDM were seeded at 5 x 105 cells/well 
onto chamber slides in complete RPMI. Before imaging media was changed to 
standard physiological extracellular solution [333] (147 mM NaCl, 10 mM HEPES, 
13 mM glucose, 2 mM CaCl2, 1 mM MgCl2 and 2 mM KCl). Cells were preincubated 
with 500 µM pannexin-1 or control peptide for 15 min at 37°C, following the 
addition of 20 µM ethidium bromide. Cells were traced in brightfield and then 
imaged 2 min before the addition of 5 mM ATP on a 37°C heated stage. The 
result was followed 20 to 30 min with imaging every 10 s. Ethidium bromide 
fluorescence was measured at 543 nm excitation and 590 nm emission. Mean 
fluorescence intensity were obtained by measuring ethidium bromide 
fluorescence for isolated (non touching) cells, which was then averaged.  
2.2.3 Spectrofluorimeter methods 
2.2.3.1 BCECF release assay 
BCECF [28,78-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein, acetoxymethyl 
ester], can be used to measure changes to the cytosolic pH. It is classified as a 
small intracellular marker molecule with a molecular weight of 623 Da. Similar 
to other esters, BCECF is cell-permeable and only becomes fluorescent after 
cleavage inside the cell by esterases. It can be used to investigate pore-
formation in the host cell membrane. Cells are loaded with the dye which 
becomes fluorescent, this fluorescent species can then be detected in the 
extracellular media only if a pore is formed in the plasma membrane.  
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The BCECF release assay was adapted from Neyt et al. [332] which was based on 
the principle described by Bhakdi et al. [334]. Cells were seeded into a 6-well 
plate (1 x 106 cells/well) one day before experiments in media without 
antibiotics. Cells were washed twice with pre-warmed HBSS (37°C) and 
incubated with 5 µM BCECF-AM (Invitrogen) for 20 min at 37°C. Cells were then 
washed twice in DMEM without Phenol red. After infection, at indicated times, 
section 4.2.4.3, supernatants were collected and centrifuged for 10 min at 
16100 x g. The supernatant was immediately measured using a 
spectrofluorimeter with an excitation wavelength at 490 nm and emission at 535 
nm and with measurement for 5 s. Cells treated with 1% Triton X-100 for 10 min 
at 37°C were used as a positive control. Percentage of BCECF release was 
calculated according to % BCECF release = (sample - uninfected) / (Triton X-100 
- uninfected) x 100. 
2.2.3.2  β-hexosaminidase assay 
The method was adapted from [335, 336]. Cells were seeded into a 6-well plate, 
1 x 106 cells/well, in media appropriate for each cell type but without PenStrep, 
one day before experiment. On the day of experiment, cells were washed twice 
in 37°C PBS and 1 ml of media was added into each well. Cells were then 
treated or infected as indicated in section 4.2.5.2. Supernatants were collected 
and centrifuged at 13400 x g for 10 min at 4°C. Samples were then diluted 1 in 
100 in HBSS (Invitrogen) and mixed as follows; 200 µl sample with pre-warmed 
(37°C) 200 µl 2.6 mM substrate (4-methylumbelliferyl N-acetyl-βD-Glucosaminide 
dihydrate; Sigma) in 330 mM citrate / phosphate buffer pH 4.8 and 200 µl dH2O. 
The mixture was incubated at 37°C for 10 min and reactions were terminated by 
the addition of 600 µl 0.1 M glycine pH 10 and 2 M Na2CO3. The formation of 
reaction product (4-methylumbelliferone) was measured using a 
spectrofluorimeter (LS 55 Luminescence Spectrometer, Perkin Elmer) with a 
single cell reader and excitation at 358 nm, emission at 448 nm and 5 s read 
time. % total was calculated using sample / Triton X-100 x 100 and % β-
hexaminidase release was calculated from (sample – uninfected sample) / 
(Triton X-100 – uninfected) x 100. 
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2.2.4 Western blotting 
Cells were infected, or stimulated as indicated. Then, the supernatant was kept 
for ELISA and LDH assays. The cell samples were washed in PBS and lysed in lysis 
buffer (50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 5 mM EDTA, 1% (v/v) Triton X-100 
supplemented with a EDTA-free protease inhibitor cocktail (Complete Mini EDTA-
free; Roche) [249]). After lysis for 15 min at RT, cells were scraped off and 
stored at -70°C before Western blot analysis. 
Cell lysates were resolved using SE 260 Mini-vertical Unit (GE Healthcare) with 
NuPAGE Novex pre-cast 4-12% Bis-Tris gels and NuPAGE buffers and reagents 
(Invitrogen). Lysates were diluted in LDS sample buffer (Invitrogen) 
supplemented with 100 mM DTT (Sigma). Samples were heated at 70°C for 10 
min before being loaded onto the gel. Samples were resolved using the NuPAGE 
MES SDS running buffer at 100 V for 90 min or until loading dye reached the 
bottom of the gel. As a protein size marker, the prestained marker SeeBlue Plus 
2 standard (Invitrogen) was used. Polyvinyliden difluoride (PVDF) membrane 
Hybond-P (GE Healthcare) was activated by immersing it in methanol. The 
resolved proteins were transferred from the gel onto the PVDF membrane using 
Hoefer TE 22 tank transfer unit (GE Healthcare) and NuPAGE transfer buffer 
(Invitrogen) supplemented with 20% methanol at 30 V for 2 h. 
Following transfer, PVDF membranes were blocked in PBS/0.1% (v/v) Tween-20 
with 5% non-fat milk (Marvel powdered milk) for at least an hour at RT on an 
orbital shaker (AROS 160 Thermolyne). All antibodies were diluted in PBS/0.1 % 
Tween with 5% milk and all steps were carried out on an orbital shaker. 
Membranes were then incubated with the appropriate primary detection 
antibody (Table 2.3), for 1 h at RT or overnight at 4°C. The membranes were 
washed (3 x for at least 10 min) with PBS/Tween and the appropriate secondary 
biotinylated antibody was added at 1.5 µg/ml for 1 h at RT (Table 2.3). 
Following three washes, streptavidin HRP ELISA grade (Invitrogen) was added for 
30 min at RT. After another three washes, protein bands were visualised using 
ECL Plus Western blotting detection reagent (GE Healthcare) as per 
manufacturer’s instructions. Membranes were incubated in the detection 
reagent for 5 min before exposure to Kodak X-Ray film. 
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When membranes needed to be reprobed with a new primary antibody, they 
were stripped in stripping buffer (100 mM 2-mercaptoethanol, 2% (w/v) SDS and 
62.5 mM Tris-HCl pH 6.7, all from Sigma) at 50°C for 30 min. Membranes were 
then washed (3 x 10 min) in PBS/Tween following a block in 5% milk / PBS / 
Tween. Reprobe of membranes were performed as described above. 
2.2.5 Lactate dehydrogenase (LDH) assay 
Cells were incubated in media lacking Phenol red. Lactate dehydrogenase 
release determinations were performed using the CytoTox 96 cytotoxicity assay 
kit (Promega). The amount of LDH in the supernatant is coupled to the 
enzymatic conversion of tetrazolium salt (INT) into a red formazan product: 
NAD+ + lactate -> pyruvate + NADH (reaction mediated by LDH) 
NADH + INT -> NAD+ + formazan (reaction mediated by Diaphorase) 
After infection supernatants were collected and centrifuged at 16100 x g for 5 
min at 4°C. Supernatants were transferred to a new tube and 100 µl of sample 
was added to a 96-well plate. In addition, all samples were diluted 1 in 10 in 
Phenol red free media. The substrate mix (50 µl) was then added and the plate 
was incubated in the dark at RT for 30 min. The reaction was terminated by the 
addition of 50 µl stop solution and the absorbance at 490 nm was recorded using 
a Tecan sunrise plate reader and the Magellan software. Background values were 
subtracted from the sample readings. As a positive control for total cell-
associated LDH, cells were lysed with 1% Triton X-100 at 37°C for 20 min. The % 
cell death was determined according to % cytotoxicity = (experimental LDH 
release / maximum LDH release) x 100. 
2.2.6 Protein precipitation 
When supernatants were analysed for protein expression, proteins were first 
precipitated before being resolved by SDS-PAGE.  
TCA precipitation was performed as follows; 5 volumes of 10% (w/v) TCA in 
acetone were added per 1 volume of protein solution. After 30 min incubation at 
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-20°C, samples were centrifuged at 13200 x g at 4°C for 15 min. The pellet was 
washed with ice cold acetone and centrifuged again at 13200 x g for 5 min at 
4°C. The pellet formed was dried and resuspended in LDS sample buffer. 
Proteins were resolved as described for Western blotting in section 2.2.4.  
Chloroform precipitation was performed in a similar manner. Protocol was 
provided by Dr. O. Gross, University of Lausanne. The supernatant was mixed 
with an equal volume of methanol and 1/3 volume of chloroform. Samples were 
then vortexed and centrifuged at 13200 x g for 5 min at RT. The supernatant was 
removed, except for the protein interface on top of the chloroform. The 
proteins were washed with methanol and following vortexing the samples were 
centrifuged again at 13200 x g for 5 min at RT. The pellet was dried at 37°C for 
15 min and then resuspended in LDS sample buffer, as described for Western 
blotting in section 2.2.4.  
2.2.7 Enzyme-Linked immunosorbent assay (ELISA) 
ELISA for IL-1β was performed according to manufacturer’s instructions (BD 
Biosciences). Briefly Immunolon 4HBX flat bottom 96-well plates (Thermo) were 
coated with capture antibody diluted in PBS overnight at RT. Plates were washed 
with PBS / 0.025% Tween 20 and blocked in PBS / 1% BSA. After three washes, 
samples (100 µl/well) and standards were added with a top standard of 1000 
pg/ml serially diluted 1:2 10 times. After 2 h incubation at RT and three washes, 
detection antibody was added and incubated at RT for 2 h. Following three 
washes, streptavidin was added for 20 min at RT and after a final wash step, 
Tetramethylbenzidine (TMB) substrate was added for 20 min at RT. Development 
was stopped by the addition of TMB stop solution and plates were read at 405 
nm with correction set at 630 nm on a Tecan sunrise plate reader using the 
Magellan software. The release of pro-IL-1β from dead cells was controlled for 
by analysing Triton X-100 treated wells for mature IL-1β, since the ELISA kit is 
less sensitive to pro-IL-1β, as previously described [337]. Mature IL-1β = total IL-
1β signal – pro-IL-1β lysis x percent release of LDH.  
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2.2.8 Flame photometry 
Flame photometry can be used to determine the concentration of metal ions 
such as sodium, potassium, lithium and calcium. It is an atomic emission method 
where quantitative analysis is performed by measuring the flame emission of 
solutions containing the metal salts. There is little interference as the emission 
lines from the gas-phase atoms in the flame are very narrow and characteristic 
for each atom. The sample is first aspirated into the flame, which due to its 
heat evaporates the solvent and atomizes the metal. During this a valence 
electron is excited to an upper state and as the electron returns to the ground 
state light is emitted, at characteristic wavelengths. Each metal is selected for 
by different optical filters. Samples with unknown concentrations are then 
compared to that of standard solutions, which allows quantitative analysis of the 
metal in the sample. The standard solutions used cover the range of 
concentrations expected of the samples [338].  
The method is limited to easily ionized metals, alkali and alkali earth metals, 
due to the low temperature of the natural gas and air flame. The low 
temperature renders the method sensitive to interference and lack of stability of 
the flame and aspiration. These are affected by rates and purity of fuel and 
oxidant flow, aspiration rates, solution viscosity and concomitants in the sample. 
Due to this it is important to measure the emission of the standards and samples 
under conditions which are as close to identical as possible [338].  
BMDMs were seeded at 1 x 106 cells per well in a 6-well plate (Corning) in 
complete media without antibiotics. Cells were allowed to settle and were then 
infected or stimulated for indicated time points. Cells were washed twice in 
Tris-buffered saline pH 7.4 and then lysed in 10% nitric acid. Samples were 
centrifuged at 13100 x g for 5 min at 4°C and then diluted 1 in 4 in dH2O. 
Intracellular K+ content were measured using a Sherwood MA10C Flame 
Photometer and compared with standards ranging between 1 mg/l to 8 mg/l.  
2.2.9 Polymerase chain reactions (PCR) 
PCRs were performed on a Techne gene cycler by T.J. Evans. Reaction volume 
was 50 µl in a thin walled PCR tube. The Taq polymerase, Expand High Fidelity 
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PCR System (Roche) was used and dNTPs were bought from Sigma. For primers 
used see Table 2.2. 
2.2.10 Agarose gel electrophoresis 
PCR products, plasmid preparations and restriction enzyme digests were 
resolved using agarose gel electrophoresis and a Horizon 58 Gibco Horizontal gel 
electrophoresis apparatus. 1% agarose (Invitrogen) were dissolved in Tris / 
Borate / EDTA (TBE) buffer and 50 µg/ml ethidium bromide was added. Gels 
were viewed and photographed using Gel Logic 200 imaging system (KODAK). 
2.2.11 NF-κB luciferase reporter gene assay 
Prior to transfection, HEK293 cells were seeded onto a collagen coated 12-well 
tissue culture plate. The plate was coated with 0.25 mg/ml collagen type I from 
Rat tail (BD Biosciences) by diluting it in HBSS. After addition to the plate the 
solution was aspirated and the plate allowed to airdry. The plates were kept at 
4°C and washed before use. HEK293 cells were transfected with 0.4 µg/ml 
reporter plasmid for NF-ΚB (pNF-ΚB-Luc Stratagene) and 0.5 µg/ml control β-gal 
plasmid (Galacto-Star β-Galactosidase Reporter Gene assay system, Applied 
Biosystems). Where indicated cells were cotransfected with a DN-NOD1 (ΔCARD) 
construct or a human NOD1 construct, kindly supplied by Richard L Ferrero 
(Monash University, Melbourne, Australia) at indicated concentrations. 
Transfections were carried out using Lipofectamine 2000 (Invitrogen) according 
to manufacturer’s instructions. Briefly, DNA and transfection reagent were 
mixed with OPTI-MEM (Invitrogen) separately, left for five minutes before 
mixing. The DNA-reagent solution was left for 20 minutes before addition to the 
cells. Transfections were left at 37°C 5 hours before the media was replaced 
with fresh complete DMEM, and then left overnight before cells were infected or 
treated.  
On the day of infections bacteria was grown to mid log-phase, as described in 
section 2.2.1., and then washed twice with phosphate buffered saline (PBS). The 
pellet was resuspended in DMEM to a concentration of 1x106 bacteria/µl. Cells 
were then infected using indicated multiplicity of infections (MOI). After 
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infections cells were washed once in HBSS and media was replaced with DMEM 
supplemented with 10% FCS, 2 mM L-glu and 50 µg/ml Gentamicin. Cells were 
also treated, where indicated, with peptidoglycan (PGN) or lipopolysaccharide 
(LPS, Sigma) and were incubated at 37°C overnight. 
Luciferase assay was carried out in duplicate for each well according to 
manufacturer’s instructions (Stratagene). Briefly, cells were washed once with 
PBS and then 500 µl lysis buffer was added to each well. Lysis was allowed to 
continue for 15 minutes. Lysates was scraped with cell scrapers and transferred 
to Eppendorf tubes. Lysates were then centrifuged in a bench top centrifuge at 
16000 x g 2 minutes at RT. Just before measuring luciferase activity, 5 µl lysate 
was added to 100 µl luciferase substrate. Luciferase activity was measured in a 
luminometer (Lumat LB 9507, Berthold Technologies) over a 10 s period.  
Luciferase catalyzes the following chemiluminescent oxidation-reduction 
reaction: 
Luciferin + ATP + O2 -> Oxyluciferin + light (560 nm) + AMP + PPi + CO2 
The amount of light is a measure of the amount of luciferase present, which 
correlates with the amount of NF-κB.  
After measurement, 300 µl Galacto Star (Applied Biosystems) substrate was 
added to each sample according to manufacturer’s instructions. Briefly, after 
addition, samples were left for 45 minutes before measurement in a 
luminometer. Results were calculated using Excel software and Graph Pad Prism 
4 software (GraphPad Software Inc). Calculations were; luciferase activity / β-
gal activity, fold NF-κB differences were then calculated from ratio (luc / β-gal) 
/ mean of control sample. 
2.2.12 DOTAP transfection 
BMDM were seeded, 2.5x105 cells per well, into 24-well plates (Corning) in 
complete media with 2 µg/ml LPS. After three hours at 37°C in a humidified 
incubator, cells were washed and media was replaced with 300 µl RPMI without 
Phenol Red (Invitrogen) supplemented with 2 mM L-glutamine and 2 µg/ml LPS. 
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Proteins were diluted in media to a final volume of 50 µl and 2 µg DOTAP 
(dioleoyl trimethylammonium propane) liposomal transfection reagent (Roche) 
was added to appropriate tubes. After 15 min incubation at RT the transfection 
mixture was added to the cells and plates were swirled to allow for even 
distribution. Plates were incubated at 37°C for 3.5 h or as indicated. Following 
this incubation cell lysates were prepared as described in section 2.2.4 and 
supernatants were kept and analyzed for LDH release and IL-1β secretion. 
2.2.13 Lipofectamine 2000 transfection 
Transfections with Lipofectamine 2000 (Invitrogen) were carried out according 
to manufacturer’s instructions. Briefly DNA and Lipofectamine 2000 were diluted 
in Opti-MEM I Reduced serum media (Invitrogen) and left at RT for 5 min. 
Following the incubation the DNA mixture was added into the Lipofectamine 
mixture and complexes were allowed to form during 15 min at RT. Complexes 
were then added to the cells and plates were swirled to allow even distribution 
of mixture. Plates were incubated in a humidified incubator at 37°C until 
analysis. 
2.2.14 Gentamicin protection assay 
This assay was preformed as described by Travassos et al. [17, 339]. BMDM were 
seeded at 5x105 cells per well into a 12-well plate (Corning) in complete media 
without Penicillin and Streptomycin. After infection (90 min) cells were washed 
twice in sterile PBS and complete media supplemented with 100 µg/ml 
Gentamicin (Sigma) was added. The Gentamicin containing media was kept on 
the cells for 90 min, in order to kill off any extracellular bacteria. Cells were 
then washed twice in sterile PBS and then lysed in 250 µl 0.1% SDS / 1% Triton X-
100 / PBS. The lysates and initial inoculums were diluted and plated onto agar 
plates. The agar plates were incubated at 37°C overnight and the following 
morning the colonies were counted. Percent invasion was calculated using # CFU 
after / # CFU added x 100 and # CFU after was calculated using # CFU on the 
plate x total volume x dilution factor.  
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2.2.15 Transformation of electrocompetent E.coli (EC100) 
TransforMax EC100 electrocompetent E.coli (Epicentre Biotechnologies) were 
transformed according to manufacturer’s instructions. Briefly, electroporation 
cuvettes GenePulser Cuvettes 0.2 cm (BioRad) were chilled on ice and 50 µl 
electrocompetent cells were defrosted on ice. Plasmids were added and mixed 
gently with the bacteria, immediately following this, cells were transferred to 
an electroporation cuvette and pulsed on a Gene Pulser X cell system (BioRad) 
using a preset program for E.coli (2500 V, 25 µF, 200 Ω, 4 s time constant). 
Pulsed bacteria were then added to RT 950 µl super optimal broth with 
catabolite repression (SOC) medium (Invitrogen) and placed in a shaking 
incubator (225 rpm) at 37°C for 1 hour to allow expression of antibiotic 
resistance marker. Bacteria (250 µl) were then plated onto appropriate LB-Agar 
plates (Luria Bertani medium with 1% w/v agar) with antibiotic selection and 
allowed to grow at 37°C overnight. 
2.2.16 Plasmid purification, restriction enzyme digests and 
ligations 
Plasmids were purified using QIAprep spin mini prep kit (Qiagen), HiSpeed 
plasmid maxi kit (Qiagen) or PureLink HiPure Plasmid filter maxiprep kit 
(Invitrogen) all according to manufacturer’s instructions. Ligations were 
preformed using Rapid DNA Ligation kit (Roche) according to manufacturer’s 
instructions.  
2.2.17 Transformation of P.aeruginosa 
Tranformation of P.aeruginosa was performed according to the protocol 
described by Choi et.al [340]. P.aeruginosa strains were grown overnight in a 10 
ml LB medium culture at 37°C, from this culture 3 ml was pelleted at 16100 x g 
and then washed twice in 300 mM sucrose. Bacteria were resuspended in 100 µl 
300 mM sucrose and 1 µg/ml plasmid. Transformation mixture was transferred to 
a prechilled electroporation cuvette Gene Pulser cuvette 0.2 cm (BioRad) and 
pulsed on a Gene Pulser X cell system (BioRad) using a preset protocol for 
P.aeruginosa (2500 V, 25 µF, 200 Ω, 4 ms). Cells were allowed to recover and to 
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express antibiotic resistance markers in 1 ml LB at 37°C 225 rpm for 1.5 hours. 
Following this, transformed bacteria were plated onto LB/agar plates with 
appropriate antibiotic selection and left overnight at 37°C. 
2.2.18 Pilin purification 
The pilin purification method used was based on a modified flagellin purification 
method and a method described by Smedley et al. [341]. Bacterial strains were 
grown in Trypticase Soy Broth (TSB) at 60 rpm and 37°C overnight. The overnight 
culture was pelleted at 8000 rpm for 13 min at 4°C in a Beckman Coulter Avanti 
J-26 XP centrifuge. The pellet was resuspended in 25 ml PBS and vortexed hard, 
which was followed by rough stirring using a magnetic stirrer for 30 min at RT 
with intermediate vortexing. Bacterial suspension was then centrifuged at 16000 
rpm in a Beckman Coulter Avanti J-26 XP centrifuge at 4°C for 30 min. The 
supernatant was kept and NaCl concentration was increased to 0.5 M by the 
addition of 0.36 M NaCl, polyethylene glycol PEG 3000 was added to a final 
concentration of 3% v/v. The solution was kept at 4°C for at least 18 hours. This 
was followed by pelleting of the precipitated proteins at 9500 rpm (10917 x g) at 
4° for 20 min. The proteins were dissolved in 1 ml water and analysed using SDS 
PAGE, as described for Western Blotting, and BioRad protein assay. After 
resolving the proteins on a NuPage 4-12% Bis-Tris gel, the results were visualised 
using Instant Blue one step protein staining, a colloidal Coomassie blue staining 
solution (Expedeon) according to manufacturer’s instructions. Briefly, the gel 
was placed in 20 ml of staining solution for 1 hour and then washed in water for 
at least an hour. The gel was then dried using the Dry-Ease Mini gel drying 
system (Invitrogen) according to manufacturer’s instructions. Briefly, the 
cellophane sheets were soaked in the gel drying solution for 2 min, the gel was 
placed between them and allowed to air dry in the vertical cassette system. 
The BioRad protein assay was performed according to manufacturer’s 
instructions. BSA was used as standard with a high standard of 20 µg/ml. 
Samples were diluted and 100 µl of each sample or standard was added to each 
well following an addition of 100 µl Coomassie Brilliant Blue G-250 Dye. The 
plate was read on Tecan Sunrise ELISA plate reader at 595 nm and protein 
concentration was calculated based on the standard curve. 
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2.2.19 Flagellin purification 
Bacterial strains were grown in TSB at 225 rpm and 37°C overnight. The culture 
was pelleted at 8000 rpm for 10 min at 4°C and resuspended in PBS by vortexing 
for 3 min. The washed bacteria were then pelleted at 11000 rpm for 15 min at 
4°C. The NaCl concentration in the supernatant was then increased from 0.14 M 
in PBS to 0.5 M and PEG was added to a final concentration of 1%. The proteins 
were allowed to precipitate at 4°C for 18h.  
Following precipitation, the proteins were centrifuged at 9500 rpm for 20 min at 
4°C. The pellet was resuspended in 10% ammonium sulphate ((NH4)2SO4) and 
chilled for 2 h at 4°C, which was followed by centrifugation at 7000 x g for 20 
min at 4°C. The pellet was then resuspended in dH2O and dialysed against PBS at 
4°C overnight using Slide-A-Lyzer dialysis cassettes (Pierce) according to 
manufacturer’s instructions. The proteins were finally extracted from the 
dialysis cassette and analysed using SDS-PAGE and Instant Blue staining, as well 
as BioRad protein assay.  
2.2.20 Peptidoglycan purification 
Bacteria were grown overnight at 37°C and then cooled on ice before being 
pelleted at 12000 x g for 15 min at 4°C. Pellet was resuspended in boiling 4% SDS 
for 20 min including vortexing to ensure resuspension. The mixture was then 
pelleted at 12000 x g for 8 min at RT and the boiling in 4% SDS and 
centrifugation was repeated. The pellet was washed 5 times in 60°C dH2O and 
centrifuged as above. After the wash steps, the pellet was resuspended in 50 mM 
Tris pH 7.0 and 1 mg/ml α-amylase (Sigma) was added, this was allowed to 
digest for 1 h at 37°C. Following the digest 2 mg/ml Pronase (Sigma) was added 
and incubated for 1 h at 60°C. The enzymes were inactivated at 95°C for 10 min 
and digested material was pelleted at 16000 x g for 8 min at 4°C and washed 
once in dH2O. The pellet was resuspended in sodium phosphate buffer pH 6.0 
with 1 mM MgCl2 and 125 U mutanolysin (Sigma) and incubated overnight at 
37°C. Insoluble material was removed by centrifugation at 16000 x g at 4°C for 
15 min. Muramyl peptides in the supernatant were then freeze dried using a 
Christ Freeze-drier according to instructions. Material obtained were quantified 
by weighing and resuspended in dH2O. 
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2.2.21 Twitch and swimming assays 
Twitch agar plates were made up according to Huang et al. [342], 0.5% yeast 
extract, 100 mM potassium phosphate buffer pH 7.0, 1% agar and 5% tryptone. 
Colonies from an agar plate were picked with a p200 pipette tip and stabbed 
through the agar of a twitch agar plate. Plates were left at RT for 2 days and 
then analyzed for twitch zones. 
2.2.22 Recombinant pilin 
PA103 pilin was amplified using PCR and cloned into the pET41c vector, which 
results in PA103 pilin fused with a Glutathione S-transferase (GST) protein, 
containing a His-tag. The vector was transformed into chemically competent 
Rosetta cells according to manufacturer’s instructions. The competent cells 
were thawed on ice and 1 µl of plasmid DNA was added. This was incubated on 
ice for 30 min, which was followed by heat shock at 42°C for 30 s and then 
transfer to ice. Bacteria were allowed to recover in 80 µl SOC medium at 37°C 
for 30 min. The entire transformation mixture was then added to 10 ml of LB 
with 50 µg/ml Kanamycin and were allowed to grow overnight at 37°C with 225 
rpm shaking. The following day 2.5 ml of culture was added to 250 ml of LB with 
50 µg/ml Kanamycin and allowed to grow at 30°C and 225 rpm until OD600 
reached 0.5. The expression of pilin-GST was then induced by the addition of 1 
mM isopropyl β-D-1-thiogalactopyranoside (IPTG) and this was allowed to 
proceed for 3 h at 30°C and 225 rpm. Samples to check induction were taken at 
time points 0, 1, 2 and 3 h.  
The bacterial culture was centrifuged for 10 min at 7500 rpm and 4°C in a 
Beckman Coulter Avanti J-26 XP centrifuge. The bacterial pellet was 
resuspended in 10 ml ice-cold PBS by vortexing and then centrifuged at 8739 x g 
and 4°C for 10 min. The pellet was stored at -20°C overnight.  
A cleared bacterial lysate was prepared using the Ni-NTA His-Bind resin 
(Novagen). The bacterial pellet was thawed on ice for 15 min followed by 
resuspension by vortexing in 5 ml 1x NiNTA bind buffer with Roche protease 
inhibitors added. When the pellet was completely resuspened, 0.5 mg/ml 
lysozyme was added and lysates were incubated at 30°C for 10 min. The lysates 
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were chilled on ice and the viscosity was reduced by sonication with 10 s bursts 
at 80% power for a total of 1.5 min with cooling on ice between bursts. The 
lysate was then centrifuged at 8500 rpm and 4°C for 20 min, after which 
supernatant was carefully removed and kept on ice.  
Recombinant pilin was purified using 1 ml Ni-NTA agarose slurry which was 
allowed to settle to 0.5 ml. The agarose was mixed with 4 ml of 1 x bind buffer 
and then the agarose was allowed to settle again. Supernatant was removed and 
the cleared lysate was added to the agarose, which was allowed to mix at 4°C 
using a rotating wheel for 1 h. The mixed slurry was then poured into a mini-
column (Sigma) and allowed to settle; all remaining steps were performed at 
4°C. The settled resin was washed with total of 8 ml 1 x Ni-NTA His Bind wash 
buffer, which was added in aliquots and allowed to drip through. The pilin-GST 
with a His-tag was then eluted in four fractions by adding 4 x 0.5 ml of 1 x Ni-
NTA elution buffer. The protein concentrations were determined using the 
BioRad protein assay as described for pilin purification in section 2.2.18. Samples 
were stored in at 4°C until further purification was performed.  
The GST protein with a His-tag was cleaved off from the eluted fusion protein 
using Tag-off high activity recombinant enterokinase (rEK, Novagen). The 
protocol was optimised by Alexandrea MacPherson and she found the 1 in 50 
ratio i.e. 1 U rEK for 50 µg of protein to work best. 1 mg of His-tagged pilin was 
digested with 20 U rEK in 1 x rEK cleavage/capture buffer at RT for 16 h. 
Following cleavage the rEK was captured with 1 ml EKapture agarose. The 
EKapture agarose was centrifuged at 1000 x g for 5 min, washed once in 1 x rEK 
cleavage/capture buffer and then centrifuged again at 1000 x g for 5 min. The 
agarose was then resuspended in 1 x rEK cleavage/capture buffer and the 
protein rEK mixture was added and incubated at RT for 5 min, which was 
followed by centrifugation at 1000 x g for 5 min. The supernatant containing 
pilin and GST-His-tagged proteins was kept and a sample was taken for SDS-Page 
analysis.  
The recombinant pilin was further purified using 1 ml Ni-NTA agarose, which was 
allowed to settle and the supernatant was removed. The elution buffer contains 
250 mM imidazole whereas the wash buffer contains 20 mM, the protein mixture 
was therefore diluted to a final concentration of 20 mM imidazole. The protein 
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mixture was then mixed with the settled Ni-NTA agarose and allowed to mix 
using the rotating wheel at 4°C for 60 min. Finally, the slurry protein mixture 
were centrifuged at 1000 x g for 5 min and the supernatant with pure 
recombinant pilin was stored at -20°C in aliquots.  
The purified recombinant pilin and samples prepared during the purification was 
analysed using the BioRad protein assay, as previously described, and SDS-Page 
analysis followed by staining in Instant Blue solution.  
2.2.23 Retroviral transduction 
Retroviral transduction was preformed as previously described [312, 327]. 
Briefly, BMDM were seeded at 7 x 105 cells per well in a 6-well plate in complete 
medium. Plates were centrifuged at 400 x g for 5 min and media was replaced 
with filtered supernatant from retroviral packaging line GP+E.86s containing 6 
µg/ml polybrene. Plates were then centrifuged again at 2500 rpm at 21°C for 2h, 
followed by incubation at 37°C for 1 h. After an additional centrifugation at 2500 
rpm for 5 min, media was replaced with complete media supplemented with 4 
µg/ml polybrene. Plates were incubated at 37°C in a humified incubator for 
indicated time points.  
Before FACS analysis, cells were scraped off and resuspended in complete media 
in FACS tubes (BD Biosciences). Following centrifugation at 400 x g for 5 min, 
cells were resuspended in FACS buffer (PBS with 1% FCS and 2 mM EDTA) and 
analysed using a BD FACS Calibur and the Cell Quest software (BD Biosciences). 
Prior to analysis, 4 µl 7-AAD (BD Biosciences) was added to each sample to 
exclude dead cells.  
2.2.24 Statistical analysis 
Statistical evaluations were carried out using the GraphPad Prism 4 software and 
an unpaired two-tailed Student’s t-test with a confidence interval of 95 %. The 
results are showed as mean and standard error of the mean (SEM). Statistical 
significance was defined as p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***). 
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2.3 Materials 
2.3.1 Plasmids 
Table 2.1; Plasmids used in this study 
Construct Resistance Origin Ref 
p-NF-κB-Luc Amp Stratagene  
p-β-gal Amp   
pCDNA3 Amp R.L. Ferrero [222, 343] 
pCDNA3 ΔCARD Nod1 Amp R.L. Ferrero [217, 222] 
pCDNA3 hNod1 Amp D.J. Philpott [222, 343] 
pucp20 Amp/Carb H. Schweizer  
pucp20 PA103 pilA Amp/Carb This study  
pucp20 PAO1 pilA Amp/Carb This study  
pucp20 ExoY Amp/Carb F.S Stirling  
MigR1 Amp A.M. Michie [344] 
MigR1 PA103 pilin Amp This study  
MigR1 PA103 pilin C134A Amp This study  
MigR1 PA103 pilin T133* Amp This study  
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2.3.1.1 Construction of plasmids 
Restriction enzymes used were from Promega, all were used according to 
manufacturer’s instructions in suitable buffers (provided with enzyme).  
PA103 pilin was amplified using the upstream and downstream PA103 pilin 
primers (Table 2.2) from the genome of PA103 (accession number M14850). The 
resulting product was cloned into pucp20 between EcoR1 and BamH1.  
PAO1 pilin was amplified using the forward and reverse PAO1 pilin primers 
(Table 2.2) from PAO1 (accession number M11323). The resulting product was 
cloned into pucp20 between EcoR1 and PstI. Both pucp20 pilin constructs, PA103 
and PAO1, were verified by sequencing.  
PA103 pilin was amplified using forward and reverse PA103 pilin primers for the 
MigR1 construct (Table 2.2), same accession number as previous for PA103. The 
product was cloned into the MigR1 vector between BglII and EcoR1. The 
retroviral sequence was checked using the sequencing primers for MigR1 (Table 
2.2).  
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2.3.2 Primers, siRNAs and peptides 
Table 2.2; Primers, siRNA and peptides used in this study 
Construct Sequence (5´-3´) Origin Ref 
SYT7 siRNA CATCATCACCGTCAGCCTTAG Ambion [345] 
Silencer negative 
control #1 siRNA 
not provided Ambion  
hNod1 siRNA 1 ACAACTTGCTGAAGAATGACT D.J. 
Philpott 
[222] 
Control hNod1 
siRNA 
GCAAGCTGACCCTGAAGTTCA D.J. 
Philpott 
[222] 
SYT7 hairpin siRNA 
pSilencer 4.1 CMV 
(sense) 
GATCCTCATCACCGTCAGCCTTAGTTCAA
GAGACTAAGGCTGACGGTGATGATG 
Ambion [345] 
SYT7 hairpin siRNA 
pSilencer 4.1 CMV 
(antisense) 
AGCTTCATCATCACCGTCAGCCTTAGTCT
CTTGAACTAAGGCTGACGGTGATGAG 
Ambion [345] 
PA103 pilin 
forward MigR1 
construct 
CTGAGATCTGCTTGTTGAGGTTCAGGCG
TTAG 
T.J. 
Evans 
 
PA103 pilin reverse 
MigR1 construct 
TCAGAATTCTGCTCTACCGACTGAGCTAA
TCCG 
T.J. 
Evans 
 
MSCV - sequencing 
primer for MigR1 
CCCTTGAACCTCCTCGTTCGACC T.J. 
Evans 
 
IRES – sequencing 
primer for MigR1 
CCTCACATTGCCAAAAGACG T.J. 
Evans 
 
100 
Upstream PA103 
pilin for pucp20 
construct 
TCAGAATTCCCAGCTTGTTCTGCACCAGG 
 
T.J. 
Evans 
 
Downstream PA103 
pilin for pucp20 
construct 
CGCGGATCCCAAAAACAGCTATTAAGGCT
CATT 
T.J. 
Evans 
 
Forward PAO1 pilin 
for pucp20 
construct 
TCAGAATTCCGAGTAGATTGGCTTGGAC
GAG 
T.J. 
Evans 
 
Reverse PAO1 pilin 
for pucp20 
construct 
CATCTGCAGAACCCCCGACCTTCTCATTA
CG 
T.J. 
Evans 
 
Pannexin peptide H-WRQAAFVDSY-NH2 Euro- 
gentec 
[346] 
Control peptide H-SGILRNDSTVPDQF-NH2 Euro- 
gentec 
[346] 
Underlined parts of primer sequences indicate RE-sites. 
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2.3.3 Antibodies 
Table 2.3; Antibodies used in this study 
Description Reactive 
species 
Clone Format Isotype Use Manufacturer 
Rabbit 
polyclonal 
Caspase-1 p10 
Mouse 
Rat 
M-20 Affinity 
purified 
 WB Santa Cruz 
Biotechnology 
Rabbit 
polyclonal 
Synaptotagmin 
7 
Rat 
Mouse 
Hamster 
Human 
 Lyophilized 
serum 
 WB Synaptic 
Systems 
Mouse 
monoclonal 
anti-FliC 
(Flagellin) 
FliC 
protein 
FLIC-1 Affinity 
purified 
Mouse 
IgG1 κ 
WB Bio Legend 
Rabbit 
polyclonal 
CARD4 (Nod1) 
Human 
Mouse 
Monkey 
 Whole 
antiserum 
IgG WB Abcam 
Rabbit 
polyclonal 
Nod1 
Human 
Mouse 
Rat 
Monkey 
 Affinity 
purified 
 WB Cell signalling 
Technology 
Mouse 
monoclonal 
CD107a 
(LAMP-1) 
Human H4A3 Affinity 
purified 
Mouse 
IgG1 κ 
IF BD 
Biosciences 
Mouse IgG 
Kappa 
    IF Serotec 
102 
myeloma 
Purified rat 
CD16/CD32 
(Mouse FC 
block) 
Mouse 2.4G2 Affinity 
purified 
Rat 
IgG2b κ 
FACS BD 
Biosciences 
Alexa Fluor 
488 goat IgG 
Mouse    IF Molecular 
Probes 
Mouse 
monoclonal 
beta Actin 
Multiple AC-15 Ascites Mouse 
IgG1 
WB Abcam 
Biotinylated 
goat IgG 
Rabbit  Affinity 
purified 
 WB Vector labs 
Biotinylated 
rabbit IgG 
Rat  Affinity 
purified 
 WB Vector labs 
Biotinylated 
horse IgG 
Mouse  Affinity 
purified 
 WB Vector labs 
WB; western blotting, IF; immunofluorescence staining; FACS; used for flow cytometry straining 
 
103 
2.3.4 Bacterial strains 
Table 2.4; Bacterial strains used in this study 
Strain Description Resistance Origin Ref 
PA103 WT P.aeruginosa strain PA103 
wild type which lacks 
flagellin 
 Long term in 
the lab 
[347] 
PA103 pilA- P.aeruginosa strain PA103 
lacking pilin, functional 
T3SS and translocated toxins 
Gent B. I. 
Kazmierczak 
[348] 
PA103 ΔUΔT P.aeruginosa strain PA103 
lacking translocated toxins 
(exoU and exoT) with a 
functional T3SS 
Tet  D.W. Frank [150] 
PA103 ΔUΔT 
pilA- 
P.aeruginosa strain PA103 
lacking pilin and 
translocated toxins (exoU 
and exoT) with a functional 
T3SS 
Tet 
Gent 
This study  
PA103 
ΔpcrV 
P.aeruginosa strain PA103 
lacking the pore-forming 
protein of the T3SS (pcrV), 
which makes it unfunctional 
Tet D.W. Frank [93] 
PA103 
ΔUΔT:exoU 
P.aeruginosa strain PA103 
lacking translocated toxins 
(exoU and exoT) with a 
functional T3SS, 
complemented with a 
functional exoU toxin 
Tet 
Carb 
F.R. Stirling  
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PA103 
ΔUΔT:exoU 
S142A 
P.aeruginosa strain PA103 
lacking translocated toxins 
(exoU and exoT) with a 
functional T3SS, 
complemented with a non-
functional exoU toxin 
Tet  
Carb 
F.R. Stirling [143] 
PAO1 WT P.aeruginosa strain PAO1 
wild type with flagellin 
 J. 
Mekalanos, 
A. Rietsch 
[78] 
PAO1 ΔSTY P.aeruginosa strain PAO1 
lacking translocated toxins 
(exoS, exoT and exoY) with 
a functional T3SS 
 J. 
Mekalanos, 
A. Rietsch 
[78] 
PAO1 ΔpopB P.aeruginosa strain PAO1 
lacking popB which makes 
the T3SS unfunctional  
 J. 
Mekalanos, 
A. Rietsch 
[78] 
PAO1 pilA- P.aeruginosa strain PAO1 
lacking pilin, functional 
T3SS and translocated toxins 
 B. I. 
Kazmierczak 
[348] 
PAO1 FliC- P.aeruginosa strain PAO1 
lacking flagellin, functional 
T3SS and translocated toxins 
Tet B. I. 
Kazmierczak 
[348] 
PAO1 FliC- 
pilA- 
P.aeruginosa strain PAO1 
lacking flagellin and pilin, 
functional T3SS and 
translocated toxins 
Tet B. I. 
Kazmierczak 
[348] 
PAO1 FliC- 
pilA-:PA103 
P.aeruginosa strain PAO1 
lacking flagellin and pilin, 
recomplemented with pilin 
Tet This study  
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pilA pucp20 from PA103 Carb 
PAO1 FliC- 
pilA-:PAO1 
pilA pucp20 
P.aeruginosa strain PAO1 
lacking flagellin and pilin, 
recomplemented with pilin 
from PAO1 
Tet 
Carb 
This study  
PAO1 FliC- 
pilA-:pucp20 
P.aeruginosa strain PAO1 
lacking flagellin and pilin, 
recomplemented with the 
empty plasmid pucp20 
Tet  
Carb 
This study  
PAOC : 
PAO1 FliC 
P.aeruginosa strain PAOC 
wild type complemented 
with PAO1 flagellin 
 R. Ramphal [349] 
Salmonella Salmonella enterica 
Typhimurium strain SL1344 
 M. Roberts  
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2.3.5 Reagents 
Table 2.5; Reagents used during this study 
Reagent Use Manufacturer 
RNase-free DNase Set DNaseI treatment of pilin 
preparations 
Qiagen 
Glybenclamide / 
Glyburide 
Inhibition of ATP-dependent 
potassium channels 
Sigma 
Methyl Arachidonyl 
Fluorophosphonate 
(MAFP) 
Inhibition of ExoU-dependent 
cytotoxicity 
Calbiochem 
Ionomycin calcium salt Permeabilisation of cells for Lucifer 
Yellow assay and calcium imaging 
Sigma 
Streptolysin O from 
Streptococcus pyogenes 
Permeabilisation of cells for Lucifer 
yellow assay 
Sigma 
Proteinase K (Fungal) Proteinase K treatment of pilin 
preparation 
Invitrogen 
LPS from E.coli O127:B8 
purified by ion-
exchange 
chromatography 
Priming of BMDM 2 µg/ml for 3 h 
Stimulation of HEK293 cells 
Sigma 
LPS from E.coli O127:B8 
purified by phenol 
extraction 
Stimulation of HEK293 cells, a 
source of PGN 
Sigma 
ATP Activation of inflammasomes after 
LPS priming. 5 mM for 20 min 
Sigma 
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Flagellin recombinant 
E.coli from Salmonella 
muenchen 
Flagellin-dependent inflammasome 
activation 
Calbiochem 
Pluronic F-127 Dispersion of acetoxymethyl (AM) 
esters of fluorescent ion indicators 
Invitrogen 
Carbenoxolone (CBX) Blocking reagent of the P2X7R and 
thus pannexin-1 channel.  
Sigma 
 
2.3.6 Buffers used for potassium-dependence studies 
A range of buffers were used when the potassium-dependent inflammasome 
activation was studied, described in chapter 4. These were adapted from known 
extracellular buffers and previous publications. 
High and low potassium buffer contained 147 mM NaCl, 10 mM HEPES, 13 mM 
glucose, 2 mM CaCl2, 1 mM MgCl2 and 2 or 130 mM KCl. Hank’s buffer [280] were 
supplemented with 1 x MEM vitamin solution, 2 mM L-glutamine, 1 x MEM amino 
acids solution and 100 µM/ml sodium pyruvate (all from Invitrogen), in order to 
keep the buffer as close to normal media as possible, high K+-buffer had 140 mM 
KCl and 5 mM NaCl. Isotonic buffers were supplemented Hank’s buffers with 
varied concentrations of KCl and NaCl. The combined total of KCl and NaCl were 
always 145 mM i.e. 5 mM KCl with 140 mM NaCl, 45 mM KCl with 100 mM NaCl, 
90 mM KCl with 55 mM NaCl and 120 mM KCl with 25 mM NaCl. Finally, complete 
media (RPMI), which normally contains 5 mM KCl was also used. This was 
supplemented with 130 mM KCl, for high KCl concentration. 
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3 Inflammasome activation by Pseudomonas 
aeruginosa 
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3.1 Introduction 
3.1.1 Inflammasome activation by Gram-negative bacteria 
The inflammasome complexes involved in the detection of Gram-negative 
bacteria are NLRC4 and NAIP5. It has been shown that both Salmonella 
typhimurium and Shigella flexneri activate the NLRC4 inflammasome, an 
activation which is dependent on ASC [234, 350]. In contrast, Legionella 
pneumophila requires NLRC4 and NAIP5 for activation of the inflammasome but 
this is ASC-independent [251, 351, 352]. However, a recent study challenged 
these findings and found a role for ASC in inflammasome activation by 
L.pneumophila independent of NLRC4 [353]. Furthermore, it was shown, 
subsequently to results presented in this chapter, that inflammasome activation 
by P.aeruginosa is dependent on NLRC4 and ASC [249, 253, 354]. Francisella 
tularensis infection results in activation of the inflammasome [250]. This 
activation is dependent on ASC but not NLRC4 or NLRP3 [250, 355]. F.tularensis 
activates a type I IFN response upon entry into the cells, which has been shown 
to be required for inflammasome activation by this bacteria [356]. This was also 
shown for L.monocytogenes but not for the inflammasome activation by ATP or 
S.typhimurium [356].  
So far, activation of the NLRC4 inflammasome has been shown to be dependent 
on a functional bacterial secretion system, such as a T3SS or a T4SS. 
Inflammasome activating proteins can pass through these secretion systems, for 
example flagellin [248, 337, 354]. However, there must be other factors passing 
through the T3SS or T4SS, as S.flexneri is able to activate the NLRC4 
inflammasome despite the fact that it lacks flagellin [254]. Similar results were 
obtained with a strain of P.aeruginosa which lacks flagellin [249].  
3.1.2 Role of NAIP5 in inflammasome activation 
The A/J mouse strain has a mutation in the gene for the NLR protein NAIP5 (also 
known as NLRB5). This mutation results in susceptibility to L.pneumophila 
infection [357, 358]. Thus, NAIP5 restricts infection by L.pneumophila [251, 351, 
357]. This is true both for mouse and human cells [212, 251, 351, 357]. Further 
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studies in NAIP5 KO mice confirmed the role for NAIP5 in resistance to 
L.pneumophila [312]. This study also demonstrated that NAIP5 together with 
NLRC4 and ASC is required for the inflammasome activation in response to 
flagellin from L.pneumophila [312]. The Naip5 mutated allele in the A/J mice is 
partially functional and as a result the use of KO mice is more relevant in NAIP5 
investigations [312]. Furthermore, a role of NAIP5 could not be detected in the 
inflammasome activation by P.aeruginosa, S.typhimurium and L.monocytogenes 
[354].  
We hypothesised that P. aeruginosa could activate the inflammasome and that 
this might occur through molecules introduced via its T3SS. The results reported 
here show that P.aeruginosa is able to activate the inflammasome in a T3SS-
dependent manner, but independent on any effectors being translocated. This is 
described for the PA103 and PAO1 strains. In addition, inflammasome activation 
by PA103 and PAO1 is dependent on NLRC4, ASC and caspase-1. The differences 
observed are not due to differences in internalization.  
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3.2 Results 
3.2.1 Pseudomonas aeruginosa activates the inflammasome in a 
T3SS-dependent manner 
Several bacteria have been shown to activate inflammasome complexes, as 
previously discussed. In order to investigate whether P.aeruginosa is able to 
activate the inflammasome, BMDM were infected with PA103 ΔUΔT and PA103 
ΔpcrV. ATP is a known activator of the NLRP3 inflammasome and this was used 
as a positive control. LPS-primed BMDM were treated with ATP, which resulted in 
IL-1β secretion (Figure 3.1). PA103 ΔUΔT were also able to induce secretion of 
IL-1β from the cells (Figure 3.1), significantly more than PA103 ΔpcrV. These 
results indicate that the inflammasome activation by P.aeruginosa requires a 
functional T3SS.  
 
Figure 3.1; PA103 activates the inflammasome in a T3SS-dependent manner 
BMDM were infected with PA103 ΔUΔT or PA103 ΔpcrV at a MOI of 100 for 90 min in the absence 
of LPS priming, or BMDM were primed with LPS for 3 h followed by treatment with ATP for 20 min 
as a control. Secreted IL-1β released immediately following incubation is measured by ELISA. 
Columns are means of triplicates and error bars are SEM. *** indicates a significant difference, 
where p<0.001, unpaired Student’s t-test. Results are representative of at least 6 experiments.  
 
Secretion of mature IL-1β requires processing of pro-IL-1β by active caspase-1. 
Upon activation of the inflammasome pro-caspase-1 is processed into p10 and 
p20 fragments, which form an active heterodimer capable of processing pro-IL-
1β. Caspase-1 processing was investigated using immunoblotting in cell lysates 
from BMDM infected with PA103 ΔUΔT or PA103 ΔpcrV or cells primed with LPS 
and then treated with ATP. Pro-caspase-1 could be detected in all samples 
(Figure 3.2), whereas the active form of caspase-1 (p10) could only be detected 
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in the samples where IL-1β secretion was observed, ATP treated and PA103 ΔUΔT 
infected cells (Figure 3.2).  
 
Figure 3.2; Inflammasome activation by PA103 is dependent on a functional T3SS. 
Cell lysates from Figure 3.1 were analysed for caspase-1 processing by immunoblot with caspase-
1 antibody. The 45 kDa pro-caspase-1 and processed form, p10, is shown, as well as a reprobe 
with actin (lower panel) showing even loading of the gel. Results are representative of at least 6 
experiments.  
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PA103 ΔUΔT lacks all its T3SS effectors and thus have an empty T3SS with no 
effectors being translocated during infection. In order to investigate whether 
translocated effectors would have an effect on the inflammasome activation by 
P.aeruginosa, PA103 ΔUΔT was compared to a strain which translocates a non-
functional effector PA103 ΔUΔT:ExoUS142A. BMDM were infected with these 
strains and PA103 ΔpcrV was used as a control. There was no significant 
difference in the IL-1β secretion from PA103 ΔUΔT compared to PA103 
ΔUΔT:ExoUS142A (Figure 3.3A). These two strains also resulted in comparable 
cytotoxicity of the cells (Figure 3.3B). The percent cytotoxicity was below 10% 
for all samples, which indicate that the IL-1β secretion seen is not due to 
increased cell death in these samples. Thus, there is no effect on the 
inflammasome activation by P.aeruginosa when effectors are translocated 
through the T3SS.  
 
Figure 3.3; PA103 activates the inflammasome independent of translocated effectors.  
BMDM were infected with PA103 strains at a MOI of 20 for 90 min. A, Secreted IL-1β released 
during infection is measured by ELISA. B, Supernatants were analysed for cytotoxicity caused by 
measurement of LDH release. Columns are means of triplicates and error bars are SEM, where *** 
is p<0.001, untreated cells with infected samples, unpaired Student’s t-test. Results are 
representative of at least 3 experiments.  
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Following infection with PA103 ΔUΔT and PA103 ΔpcrV of BMDM, IL-1β secretion 
can be detected after 90 min of infection at a MOI of 20 (Figure 3.4A). PA103 
ΔpcrV does not result in IL-1β secretion even after 180 min of infection (Figure 
3.4A), as expected since this strain lacks a functional T3SS. The cytotoxicity 
caused by PA103 ΔUΔT increases with increasing infection time, whereas the 
cytotoxicity by PA103 ΔpcrV remains low and constant (Figure 3.4B). 
 
Figure 3.4; Inflammasome activation by PA103 can be detected after 90 min of infection. 
BMDM were infected with PA103 ΔUΔT and PA103 ΔpcrV at a MOI of 20 for indicated time 
periods. A, IL-1β secretion was measured by ELISA from supernatants. B, Percent cytotoxicity 
were analysed in supernatants by measurement of LDH release. Means of triplicates are plotted 
and error bars are SEM. 
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The amount of IL-1β secretion caused by PA103 ΔUΔT is dependent on MOI. 
BMDM were infected with PA103 ΔUΔT and PA103 ΔpcrV at varied MOIs for 90 
min. Increasing MOIs results in increasing amounts of IL-1β secretion following 
infection with PA103 ΔUΔT (Figure 3.5A). PA103 ΔpcrV does not result in IL-1β 
secretion at any MOI investigated (Figure 3.5A). Furthermore, increasing MOIs 
also result in increasing amount of cytotoxicity caused by PA103 ΔUΔT (Figure 
3.5B). 
 
Figure 3.5; Higher MOI results in more inflammasome activation by PA103. 
BMDM were infected with PA103 ΔUΔT and PA103 ΔpcrV at indicated MOIs for 90 min. A, IL-1β 
secretion was analysed by ELISA in supernatants. B, Percent cytotoxicity were analysed by 
measurement of LDH release in supernatants. Means of triplicates are plotted and error bars are 
SEM. 
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Active caspase-1 (p10) can be detected following infection with PA103 ΔUΔT at 
all MOIs tested (Figure 3.6). In general, levels of p10 increased with MOI over 10 
although levels at MOIs of 20 and 50 were less than the amount seen at 10 
(Figure 3.6). No caspase-1 activation could be detected following infection with 
PA103 ΔpcrV as expected (Figure 3.6). The amount of pro-caspase-1 was similar 
in all samples (Figure 3.6, lower panel).  
 
Figure 3.6; More caspase-1 is activated at higher MOIs by PA103. 
Cell lysates from Figure 3.5 were immunoblotted with caspase-1 antibody. Top panel shows 
processed caspase-1 (p10) and pro-caspase-1 (45 kDa). Lower panel shows pro-caspase-1 
following a shorter exposure.  
 
PA103 activates the inflammasome in a T3SS-dependent manner. In order to 
investigate whether other strains of P.aeruginosa also activate the 
inflammasome in a similar manner, the PAO1 strain was tested. BMDM were 
infected with various strains of PAO1; PAO1 WT, which has a functional T3SS as 
well as effectors passing through the system; PAO1 ΔSTY, has a functional T3SS 
but no translocated effectors (equivalent to PA103 ΔUΔT); and PAO1 ΔpopB; 
which has a non-functional T3SS resulting from the deletion of the essential T3SS 
protein popB. PAO1 also activated the inflammasome in a T3SS-dependent 
manner which is independent of any effectors passing through the T3SS (Figure 
3.7). IL-1β secretion was detected following infection with PAO1 WT and ΔSTY, 
and levels were not changed when there are effectors being translocated (Figure 
3.7). These strains resulted in significantly more IL-1β secretion compared to 
PAO1 ΔpopB, similar to the results seen with PA103 ΔUΔT and PA103 ΔpcrV.  
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Figure 3.7; PAO1 activates the inflammasome in a T3SS-dependent manner, independent of 
translocated effectors. 
BMDM were infected with PAO1 strains as indicated for 90 min at a MOI of 100. Supernatants 
were analysed for IL-1β secretion using ELISA. Columns show means of triplicates and error bars 
are SEM. ** indicate significant difference where p<0.01, ns is non significant difference, p>0.05, 
unpaired Student’s t-test.  
 
Following infection with the different PAO1 strains, active caspase-1 (p10) was 
detected in samples infected with PAO1 WT or PAO1 ΔSTY, but not after 
infection with PAO1 ΔpopB (Figure 3.8). These results show that PA103, as well 
as PAO1 activate the inflammasome in a T3SS-dependent but effector-
independent manner. 
 
Figure 3.8; Inflammasome activation by PAO1 is dependent on a functional T3SS. 
Cell lysates from Figure 3.7 were immunoblotted with caspase-1 antibody. Pro-caspase-1 and 
processed p10 of activated caspase-1 is shown.  
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3.2.2 Inflammasome activation by Pseudomonas aeruginosa 
strain PA103 and PAO1 is dependent on NLRC4 and ASC 
The NLRC4 inflammasome has previously been described to respond to bacterial 
products secreted via a functional secretion system. The inflammasome 
component dependence during infection with P.aeruginosa was investigated 
using BMDM from mice with specific homozygous deletion of genes encoding 
inflammasome components. These were kindly provided by Prof Jürg Tschopp 
from University of Lausanne, Switzerland. The BMDM from KO mice were primed 
with LPS and then infected with PA103 ΔUΔT or treated with ATP. No IL-1β or 
cytotoxicity could be detected from LPS-primed cells alone, as expected (Figure 
3.9A and B). Cells treated with ATP were dependent on NLRP3, ASC and caspase-
1, but not NLRC4 (Figure 3.9A), which has been described previously [238]. ATP 
treatment did not result in significantly higher cytotoxicity compared to LPS-
primed cells (Figure 3.9B). Inflammasome activation by PA103 ΔUΔT was 
dependent on NLRC4, ASC and caspase-1, but not NLRP3 (Figure 3.9A). The 
cytotoxicity caused during infection with PA103 ΔUΔT was less than 15% for all 
samples; however, the cell death corresponded to the IL-1β secretion seen.  
 
Figure 3.9; Inflammasome activation by PA103 ΔUΔT is dependent on NLRC4, ASC and 
caspase-1. 
BMDM with specific homozygous deletions of genes encoding inflammasome components were 
primed with LPS for 3h and then infected with PA103 ΔUΔT at a MOI of 30 for 90 min or treated 
with ATP for 20 min. Columns are means of triplicates and error bars are SEM. A, Supernatants 
were analysed for IL-1β secretion using ELISA. Nd; non detected. ** indicates a significant 
difference analysed by unpaired Student’s t test (** p<0.01, ns; non significant difference p>0.05). 
B, Percent cytotoxicity were analysed by measurement of LDH release in supernatants.  
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The inflammasome dependence following infection with PAO1 ΔSTY was also 
investigated. LPS-primed BMDM were infected with PAO1 ΔSTY. ATP treatment 
and LPS-primed cells alone are shown as reference; these are described in Figure 
3.9. Inflammasome activation by PAO1 ΔSTY was also dependent on NLRC4, ASC 
and caspase-1 (Figure 3.10A), which is similar to PA103 ΔUΔT. Infection with 
PAO1 ΔSTY results in very high cytotoxicity, dependent on NLRC4 and caspase-1, 
but not ASC (Figure 3.10B).  
 
Figure 3.10; Inflammasome activation by PAO1 ΔSTY is dependent on NLRC4, ASC and 
caspase-1. 
BMDM with specific homozygous deletions of genes encoding inflammasome components were 
primed with LPS for 3h and then infected with PAO1 ΔSTY at a MOI of 30 for 90 min or treated with 
ATP for 20 min. Columns are means of triplicates and error bars are SEM. A, Supernatants were 
analysed for IL-1β secretion using ELISA. Nd; non detected. ** and *** indicates a significant 
difference analysed by unpaired Student’s t test (*** p<0.001, ** p<0.01, ns; non significant 
difference p>0.05). B, Percent cytotoxicity were analysed by measurement of LDH release in 
supernatants.  
 
The inflammasome KO cell lysates were analysed for caspase-1 activation 
following infection with PA103 ΔUΔT and PAO1 ΔSTY, as well as following 
treatment with ATP. The caspase-1 activation corresponds to the IL-1β secretion 
observed. ATP treated cells are dependent on NLRP3, ASC and caspase-1 for 
caspase-1 activation (Figure 3.11). PA103 ΔUΔT and PAO1 ΔSTY are dependent 
on NLRC4, ASC and caspase-1 (Figure 3.11).  
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Figure 3.11; Inflammasome activation by P.aeruginosa is dependent on NLRC4, ASC and 
caspase-1. 
Cell lysates from Figure 3.9 and 3.10 were immunoblotted with caspase-1 antibody. Pro-caspase-1 
(45 kDa) and processed caspase-1, p10, are shown.  
 
The inflammasome dependence was also investigated at a higher MOI (100 
compared to 30 during previous experiments) following infection with PA103 
ΔUΔT and PAO1 WT. KO BMDM were primed with LPS and treated with ATP or 
left unprimed and infected with PA103 ΔUΔT and PAO1 WT. As previously seen, 
ATP dependent inflammasome activation is dependent on NLRP3 and ASC and it 
does not result in significant cytotoxicity (Figure 3.12A and B). Furthermore, 
PA103 ΔUΔT remains dependent on NLRC4 and ASC for its inflammasome 
activation at this MOI (Figure 3.12A). The cytotoxicity caused by PA103 ΔUΔT is 
not significantly different compared to cells alone in WT, NLRC4 and ASC. 
However, the cytotoxicity is very high in the NLRP3 KO, suggesting a protective 
effect of NLRP3 for cell death at this higher MOI (Figure 3.12B). PAO1 WT 
showed some differences at this higher MOI compared to the lower value used 
before. There was now some dependence on NLRP3, although as before most of 
the response seems to be dependent on NLRC4 and ASC (Figure 3.12A). This 
strain seems to be just dependent on NLRC4 for the cytotoxicity seen at this MOI 
(Figure 3.12B).  
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Figure 3.12; Inflammasome activation by P.aeruginosa is dependent on NLRC4 and ASC. 
BMDM with specific homozygous deletions of genes encoding inflammasome components were 
primed with LPS for 3h and then treated with ATP for 20 min, or left unprimed and were infected 
with PA103 ΔUΔT or PAO1 WT at a MOI of 100 for 90 min. Columns are means of triplicates and 
error bars are SEM. A, Supernatants were analysed for IL-1β secretion using ELISA. * and ** 
indicates a significant difference analysed by unpaired Student’s t test (* p<0.05, ** p<0.01, ns; non 
significant difference; p>0.05). B, Percent cytotoxicity were analysed by measurement of LDH 
release in supernatants. 
 
3.2.3 NAIP5 is not critical for the response to Pseudomonas 
aeruginosa infection 
Inflammasome activation by Legionella pneumophila has previously been shown 
to be dependent on NAIP5 [312]. The A/J mouse strain has a mutation in the 
Naip5 gene [357]. In order to investigate the role of NAIP5 in inflammasome 
activation by P.aeruginosa BMDM were obtained from A/J mice, as well as 
C57/BL6, the strain normally used for inflammasome studies in BMDM. BMDM 
from these mice were primed with LPS and then infected with PA103 ΔUΔT, 
Salmonella SL1344 or PAO1 WT. No effect could be seen on IL-1β secretion 
following infection with these bacteria in the A/J strain compared to the 
C57/BL6 (Figure 3.13A). However, upon a repeat of the experiment at a slightly 
higher MOI, there was an effect on IL-1β secretion from PA103 ΔUΔT and PAO1 
WT infected cells. Significantly less IL-1β was secreted from A/J cells compared 
to C57/BL6 (Figure 3.13C). The Salmonella infected samples remained the same 
between the two mice strains (Figure 3.13C). These results suggest that NAIP5 
may have a role in inflammasome activation by Pseudomonas but definitive 
proof will require the use of Naip5 knockout animals. These cells were also 
analysed for percent cytotoxicity caused following infection. In both 
experiments the cytotoxicity was significantly less in the A/J cells compared to 
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C57/BL6 for all infected samples (Figure 3.13B and D). This indicates an effect of 
NAIP5 on cytotoxicity seen following inflammasome activation by Gram-negative 
bacteria.  
 
Figure 3.13; NAIP5 is not critical for the response to infection with Gram-negative bacteria.  
BMDM from C57/BL6 and A/J mice were primed with LPS for 3h and then infected with indicated 
strains at a MOI of 20 (A and B) and 30 (C and D) for 90 min. Columns are means of triplicates and 
error bars are SEM. Two separate experiments are shown (A, B and C, D). A and C, Secretion of 
IL-1β were analysed in supernatants using ELISA. B and D, Percent cytotoxicity were analysed by 
measurement of LDH release. *, ** and *** indicates a significant difference between the two 
different mouse strains. Unpaired Student’s t test where * is p<0.05, ** is p<0.01 and *** is 
p<0.001. 
 
Caspase-1 activation was also investigated in these cells, comparing cell lysates 
from A/J mice to C57/BL6 infected at a MOI of 30 (Figure 3.14). As observed 
with the levels of secreted IL-1β,  there was little difference between the mouse 
strains in the degree of activation of caspase-1 following P.aeruginosa infection 
(Figure 3.14).  
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Figure 3.14; NAIP5 is not critical for the inflammasome activation by Gram negative 
bacteria. 
Cell lysates from Figure 3.13A were immunoblotted with caspase-1 antibody. Top panel shows pro-
caspase-1 (45 kDa) and processed caspase-1 (p10). Lower panel shows reprobe with actin 
antibody, to show even loading of the gel.  
 
3.2.4 Internalisation does not account for differences in 
inflammasome activation 
P.aeruginosa is an extracellular pathogen. However, small amounts of bacteria 
are internalised, and these might affect the degree of inflammasome activation. 
Following infection, extracellular bacteria were killed with Gentamicin and the 
intracellular microbes were counted following culture and compared to the 
initial inoculums. Following infection with PA103 ΔUΔT and PA103 ΔpcrV, less 
than 1.5% of bacteria are internalised (Figure 3.15A). Furthermore, as expected, 
no bacteria could be detected in cells alone treated with Gentamicin (Figure 
3.15A). In addition significantly more PA103 ΔpcrV were internalised compared 
to PA103 ΔUΔT (Figure 3.15A), which is a strain that has no effect on 
inflammasome activation. PAO1 ΔSTY is also not significantly internalised during 
infection of BMDM, with less than 1.5% of bacteria internalised (Figure 3.15B). 
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Finally, the internalisation in a fibroblast cell line (HEK293T cells) was 
investigated. Less than 0.5% of bacteria were internalised during infection of 
these cells (Figure 3.15C). Thus, differences in the degree of P.aeruginosa 
internalisation between the strains cannot account for the differences observed 
in inflammasome activation. 
 
Figure 3.15; P.aeruginosa is not significantly internalised upon infection. 
Various cell types were infected with indicated P.aeruginosa strains for 90 min. Gentamicin was 
then added for 60 min to kill extracellular bacteria. Cells were then lysed and intracellular bacteria 
were counted following culture, which was compared to initial inoculum. Results are means of 
triplicates and error bars are SEM. Nd; non detected, * indicates significant difference between the 
strains, unpaired Student’s t test where * is p<0.05. A, BMDM infected at a MOI of 100. B, BMDM 
infected at a MOI of 50. C, HEK293T cells infected at a MOI of 100. 
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3.3 Discussion 
There have been several reports about bacterial strains which trigger 
inflammasome activation. Gram-negative bacteria such as Salmonella 
typhimurium, Shigella flexneri, Legionella pneumophila, Francisella tularensis 
and Pseudomonas aeruginosa have all been reported to activate the 
inflammasome [234, 249-251, 253, 350-352, 354, 355]. In this study it was first 
investigated whether P.aeruginosa can activate the inflammasome. It was found 
that PA103 activates the inflammasome in a process which is dependent on a 
functional T3SS. After we had performed these experiments, this was also 
described by Franchi et al., Miao et al., and Sutterwala et al. [249, 253, 354]. 
The study by Sutterwala et al. investigates the same strain of P.aeruginosa 
(PA103). The inflammasome activation by PA103 is independent of any effectors 
being translocated through the T3SS. This is also seen in the study by Sutterwala 
et al. and Franchi et al. [249, 253]. Importantly, PA103 lacks flagellin and thus 
inflammasome activation by this strain is independent of flagellin, discussed 
further in chapter 5. 
The cytotoxicity resulting from infection with PA103 ΔUΔT is dependent on MOI 
and infection time, as expected. At a higher MOI the bacterial burden is 
increased for the cell which leads to increased cell stress. Furthermore, 
inflammasome activation and processing of pro-caspase-1 to active caspase-1 
can result in pyroptosis [359]. Increased bacterial burden can therefore be 
assumed to lead to increased activation of the inflammasome and thus increased 
pyroptosis, as well as IL-1β secretion. An increased infection time will have the 
same effect.  
The inflammasome activation by PAO1 is also dependent on a functional T3SS 
and independent of translocated effectors. The study by Miao et al. also found 
that PAO1 activates the inflammasome in a process which is dependent on a 
functional T3SS [354].  
During this study both LPS-primed and unprimed BMDM have been used for the 
investigation whether P.aeruginosa can activate the inflammasome. The amount 
of IL-1β released following LPS-priming compared to unprimed cells is higher due 
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to increased time for the pro-IL-1β to accumulate. To secrete mature IL-1β two 
signals are needed. Firstly, a signal which stimulates pro-IL-1β transcription and 
translation is required, usually mediated by TLR signalling. The second signal 
needed is activation of a NLR-protein in an inflammasome complex leading to 
active caspase-1 and processing of pro-IL-1β to mature IL-1β [260, 360], as 
described in section 1.5.4.2. P.aeruginosa can activate the inflammasome 
complex in BMDM, a process which does not require LPS-priming of the cells. 
P.aeruginosa is a Gram-negative bacterium, and thus has LPS in its outer 
membrane. The LPS on P.aeruginosa will act on TLR4 [361, 362] and induce 
transcription of pro-IL-1β, thus LPS-priming of the BMDM occurs during infection. 
During an infection in vivo the cells will not have encountered LPS prior to the 
bacterium and they will thus not be primed prior to infection. The unprimed 
cells therefore portray the most accurate response believed to happen in vivo 
using an in vitro model. Interestingly, it was found that inflammasome activation 
by Salmonella typhimurium require LPS-priming of the BMDM in order to be able 
to detect IL-1β secretion. Salmonella is an intracellular pathogen, which might 
influence the LPS-priming on the cellular surface. P.aeruginosa on the other 
hand is an extracellular pathogen and continuous priming therefore occurs.  
The dependence on various inflammasome components by P.aeruginosa was 
tested using BMDM from KO mice. Inflammasome activation following ATP 
treatment was found to be dependent on NLRP3, ASC and caspase-1, which has 
been reported previously [164, 297, 355, 363, 364]. The inflammasome 
activation by PA103 ΔUΔT and PAO1 ΔSTY was shown in this study to be 
dependent on NLRC4, ASC and caspase-1. Subsequently to these results, this was 
also published [249, 253, 354]. This ties in well with other Gram-negative 
bacteria which have also been shown to be dependent on NLRC4 and ASC, such 
as S.typhimurium and S.flexneri [234, 350]. At higher MOIs the dependence for 
PA103 ΔUΔT was still on NLRC4 and ASC, but an increased cell death was 
observed in the absence of NLRP3. This suggests that NLRP3 may protect against 
cell death in this model, which has previously been described by Sutterwala et 
al. [364].  
Interestingly, during infection at a higher MOI with PAO1 WT, the inflammasome 
activation seems to be dependent on NLRC4 and ASC, as expected, but also to a 
lesser degree on NLRP3. PAO1 WT has flagellin, a functional T3SS, as well as 
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effectors being translocated. This might influence the inflammasome 
dependence. Further studies are needed to evaluate these results. In addition, 
the cell death following infection with PAO1 WT is dependent on NLRC4, which 
indicates that the cell death is mediated via NLRC4 activation and subsequently 
leads to pyroptosis. This effect might be dependent on inflammasome activation 
mediated by the flagellin protein, a process which will be discussed further in 
chapter 5.  
NAIP5 have been extensively investigated in the inflammasome activation by 
L.pneumophila [212, 251, 312, 351, 357, 358, 365]. It was shown that NAIP5 is 
required for the inflammasome activation by L.pneumophila [312] and that it is 
involved in restriction of infection by L.pneumophila [251, 351, 357]. NAIP5 KO 
mice were only recently constructed [312] and previous studies were done in the 
A/J mouse strain. This strain has a mutation in the gene encoding Naip5. BMDM 
from this strain were used in this study, to investigate whether NAIP5 has a role 
in inflammasome activation by P.aeruginosa. No effect could be seen on 
inflammasome activation, such as IL-1β secretion and caspase-1 activation. This 
has previously been described by Miao et al. for PAO1 [354]. Interestingly, there 
was an effect on cytotoxicity observed following infection in A/J cells compared 
to C57/BL6 cells. Following infection of BMDMs from A/J mice, less cytotoxicity 
were observed in samples infected with P.aeruginosa or S.typhimurium 
compared to the C57/BL6 BMDMs. The reason for this difference is not clear. It 
might reflect varied sensitivity to infection between the different mouse strains 
and further studies are needed to draw any conclusions. Furthermore, the 
involvement of NAIP5 during inflammasome activation by various Gram-negative 
bacteria should be confirmed in the NAIP5 KO mouse. The mutation in the A/J 
strain is partially functional and for more definite answers the KO should be used 
[312].  
P.aeruginosa is an extracellular pathogen [366]. The percent invasion was 
investigated in this study. The inflammasome complexes are located in the 
cytosol and if a significant amount of bacteria were internalised upon infection 
this might have an effect on inflammasome activation, rather than being 
mediated by extracellular bacteria. However, the results presented in this 
chapter demonstrate that the internalisation of P.aeruginosa does not account 
for the inflammasome activation seen. Only a fraction of inoculated bacteria are 
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internalised. In addition, more of the T3SS mutant strain, PA103 ΔpcrV, is 
internalised and yet this strain does not activate the inflammasome.  
In conclusion, the results presented in this chapter demonstrate that the 
extracellular bacterium P.aeruginosa activates the NLRC4 inflammasome. This 
process is dependent on a functional T3SS but independent of translocated 
effectors. It is also dependent on ASC and caspase-1. Furthermore, no effect of 
NAIP5 could be attributed to the inflammasome activation by P.aeruginosa. 
Further studies are needed using NAIP5 KO mice rather than the mutated A/J 
mouse strain to confirm or contradict these results. Finally, it was shown in this 
chapter that PA103 ΔUΔT can activate the NLRC4 inflammasome independent of 
flagellin. Other bacterial inflammasome activators must therefore exist. This 
will be discussed in the following chapters of this thesis.  
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4 Potassium-dependent inflammasome activation 
by Pseudomonas aeruginosa and leaky pore 
formation by the T3SS 
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4.1 Introduction 
4.1.1 Potassium-dependent inflammasome activation 
Potassium-dependent IL-1β release was first described by Walev et al. [367]. 
This study described release of IL-1β from cells which had been depleted of 
potassium using agents such as α-toxin and the ionophores nigericin and 
valinomycin. The IL-1β release was shown to be inhibited when the extracellular 
potassium was increased.  
The NLRP3 inflammasome has been shown to spontaneously assemble after 
disruption of cellular integrity. This assembly is inhibited in extracellular 
potassium concentrations higher than 70 mM, which is the concentration of 
potassium found in the cytosol of healthy cells [227, 237, 238]. These results 
imply that the NLRP3 inflammasome can sense drops in intracellular potassium 
concentration. It has been shown that danger signals and stimuli that activate 
the NLRP3 inflammasome also lead to triggering of potassium efflux, which 
further strengthens the hypothesis that the NLRP3 sense drops in intracellular 
potassium concentration (Figure 4.1) [236, 238]. In addition, it has been shown 
that high potassium levels prevent oligomerization of ASC [255]. Multiple 
inflammasome activators have been shown to trigger potassium efflux and/or 
reactive oxygen species (ROS), as well as frustrated phagocytosis that eventually 
leads to activation of the NLRP3 inflammasome, examples are bacterial toxins, 
such as Aerolysin (A.hydrophila), Maitotoxin (Dinoflagellates), α-toxin (S.aureus) 
and Listerolysin (LLO, L.monocytogenes), and danger signals, such as 
monosodium urate (MSU), calcium pyrophosphate dehydrate crystals (CPPD), 
Alum, Asbestos and silica, ATP and UV [164, 236, 238, 255, 272-274, 280, 355, 
364, 368-371] (Figure 4.1).  
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Figure 4.1; NLRP3 inflammasome activation 
Multiple inflammasome activators trigger potassium efflux and reactive oxygen species (ROS), 
which leads to activation of the NLRP3 inflammasome. Abbreviations; MSU; monosodium urate, 
CPPD; calcium pyrophosphate dihydrate, UV; ultraviolet light. Figure adapted from [161, 372].  
 
Extracellular ATP acts as a danger signal to the immune system and it was shown 
early to mediate IL-1β release [296, 373]. Extracellular ATP triggers efflux of 
intracellular potassium, as well as IL-1β secretion, which led to the assumption 
that IL-1β is released in response to intracellular potassium depletion [373]. The 
role for ATP as a danger signal is still unclear since high levels of ATP (2 to 5 
mM) are required to activate the NLRP3 inflammasome in vitro. The 
physiological importance of this inflammasome activation is still to be confirmed 
in vivo. In healthy tissues there is a very low extracellular concentration of ATP, 
whereas the intracellular concentration is high [374]. The intracellular ATP is 
rapidly released when cell damage occurs [374], but it has been shown that 
extracellular ATP in vivo is rapidly hydrolysed by ectonucleotidases [375]. In 
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contrast however, there is emerging evidence of ATP as a modulator of 
inflammation [376]. Upon cellular damage or stress ATP is released into the 
extracellular space. It has been shown that the NLRP3 inflammasome can bind 
ATP or dATP, as well as having a function as an ATPase [243]. This was shown 
using purified full-length protein [243]. The binding is mediated within the 
nucleotide binding region (NACHT) and mutation within this region disrupts 
binding [243]. Furthermore, NLRP3 requires ATP binding to mediate 
inflammatory signalling [243]. These studies do not distinguish whether 
nucleotide binding by NLRP3 controls signal transduction, or whether it is 
required for proper folding or stabilisation of a signalling component protein. In 
comparison, binding of dATP by Apaf-1 is a critical step in apoptosome formation 
[377].  
4.1.2 Role of pannexin-1 in inflammasome activation 
Plasma membrane receptors for extracellular nucleotides are called P2 
receptors, which are classified into two different families; P2Y, coupled to G-
proteins, and P2X, cation-selective channels [378]. ATP can bind the 
purinoreceptor P2X7R, which was identified using P2X7-specific inhibitors and 
P2X7-/- mice, respectively [379, 380]. Upon activation of the P2X7R, a typical ion 
channel is opened within milliseconds, which mediates passage of small cations. 
Sustained activation (2-10 s) of the P2X7R results in the formation of a reversible 
plasma membrane pore permeable to hydrophilic solutes with a molecular mass 
up to 900 Da [378, 381]. This activation leads to activation of the NLRP3 
inflammasome (Figure 4.2) [164, 297, 355, 363, 364]. The P2X7-dependent 
inflammasome activation is dependent on potassium efflux [382]. The pore 
formed upon P2X7R activation is open as long as ATP is bound to the receptor 
due to its nondesensitising nature (Figure 4.2) [378]. This pore is nonselective 
and permeable to dyes, such as ethidium bromide and YoPro1, which can be 
used to assay passage through the pore [346, 378, 381]. Prolonged ATP 
stimulation (over 30 min) leads to irreversibly injured cells which are committed 
to death [383]. 
Pannexin-1 was identified as the P2X7R-activated large pore (Figure 4.2) [346, 
383]. Pannexin-1 is a member of the pannexin protein family, which are proteins 
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expressed on the plasma membrane [374]. In addition to its function as a 
specific ATP-release channel, pannexin-1 can form functional gap junctions 
[384]. This has only been demonstrated in vitro and there is no evidence to date 
suggesting that this occurs in vivo. Within the plasma membrane of isolated 
cells, pannexin-1 is capable of forming a hemichannel [346, 384]. This is because 
in isolated cells only half of the gap junction channel is assembled, which allows 
release of cytoplasmic content into the extracellular space [385]. The function 
as an ATP-release channel, which has been suggested to allow ATP to enter into 
the cell, leads to amplified P2X7-mediated inflammasome activation, which has 
been observed in vitro [386]. Furthermore, the P2X7R and pannexin-1 are up-
regulated in response to LPS and other inflammatory stimuli [346, 378].  
Pannexin-1 is an ion-channel and thus it might be responsible for the change in 
intracellular potassium concentration seen after ATP binding to the P2X7R. It 
was shown by Pelegrin et al. [333] that inhibition of pannexin-1 blocks 
inflammasome activation and thus IL-1β secretion. These published results were 
performed on noncytolytic pathways. This inhibition had no effect on the ATP-
stimulated potassium efflux, indicating that the large P2X7R pore is not the main 
conduit for ATP-stimulated potassium-efflux, but also that potassium efflux 
alone can not drive inflammasome activation (Figure 4.2) [333]. However, when 
potassium efflux was blocked in these experiments, so was the inflammasome 
activation and IL-1β secretion. This indicates that in the sequence leading to 
inflammasome activation, potassium efflux is upstream of pannexin-1 
involvement, and also that potassium efflux is necessary for activation of 
pannexin-1 [333]. There is no evidence of any binding of pannexin-1 to 
inflammasome components. The functional significance of potassium efflux in 
inflammasome activation is unknown, but data suggests that it might facilitate 
or even precipitate this process.  
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Figure 4.2; Pannexin-1 dependent inflammasome activation 
High extracellular ATP activates the ion-channel properties of P2X7R. ATP binding to P2X7R 
results in activation of pannexin-1. The activation of pannexin-1 might result in ATP uptake through 
the pore. In addition, pannexin-1 is involved in the initial rapid dye uptake as a result of P2X7R 
activation. The dye-uptake is downstream of potassium efflux and upstream of inflammasome 
activation. Figure adapted from [333, 387].  
 
Pelegrin et al. has shown that there are two distinct outcomes following P2X7R 
activation and pannexin-1 inhibition regarding dye uptake, a rapid initial phase 
and a slower pannexin-1-independent phase. Other activators of the NLRP3 
inflammasome were not affected when it came to dye uptake inhibition by 
pannexin-1, such as maitotoxin. Furthermore, nigericin, which has been shown 
to activate the NLRP3 inflammasome, did not activate the P2X7R and no dye 
uptake could be detected. The inflammasome activation by maitotoxin and 
nigericin could be inhibited by the pannexin-1 peptide, indicating that a 
mechanism that is not dependent on pannexin-1 functioning as a hemichannel 
must be responsible for the effects seen [333].  
Pannexin-1 has also been shown to have a role in inflammasome activation by 
MDP [388]. The study described a NLRP3-dependent inflammasome activation by 
MDP which was also dependent on ATP and pannexin-1. This was shown to be 
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independent of Nod2. The induction of pro-IL-1β by MDP was shown to be 
dependent on Nod2. This suggests that the MDP primes the cells similar to LPS, 
and following ATP treatment, the pro-IL-1β is processed by the caspase-1, which 
is activated in a NLRP3-dependent fashion by the ATP. MDP was first identified 
as an inflammasome activator by Martinon et al. [389].  
4.1.3 Inflammasome activation by Salmonella 
Salmonella typhimurium activates the NLRC4 inflammasome, which was shown 
to be dependent on ASC [234, 350, 355]. In addition it is dependent on a 
functional T3SS, as well as flagellin [337, 365, 390]. However, at high MOIs the 
inflammasome activation by Salmonella is not dependent on flagellin [337]. 
NLRC4-/- mice infected orally with Salmonella did not have enhanced 
susceptibility to infection, whereas caspase-1 deficient mice did [350]. This 
reflects a possibility of additional undefined pathways that lead to Salmonella 
induced caspase-1 activation which is not dependent on NLRC4. Inflammasome 
activation by Salmonella has also been shown to be independent of potassium 
efflux, at certain extracellular potassium concentrations [236, 238].  
4.1.4 T3SS and pore formation upon contact with the host cell 
Upon contact with the host cell the T3SS of Gram-negative bacteria forms a pore 
in the host cell membrane, as previously discussed in section 3.1.2. Håkansson et 
al. observed that Yersinia has a contact dependent lytic activity upon contact 
with the host cell with its T3SS [90]. This suggested that the T3SS involves some 
kind of pore in the host cell membrane which is involved in translocation [90]. 
However, the lytic activity was higher when the strain lacked effectors passing 
through the T3SS, suggesting that the pore is normally filled with effectors [90]. 
The lytic activity was inhibited by osmoprotectants of a given size and lead to 
the conclusion that the pore formed is between 1.2 nm and 3.5 nm [90]. It has 
previously been shown for Yersinia that the T3SS can allow passage of molecules 
smaller than 623 Da, and that the injectisome thus does not form a tight 
association with the host cell [332]. This was shown for a mutant strain of 
Yersinia lacking effectors passing through the T3SS. When effectors were passing 
through the T3SS, no dye uptake or release could be detected [332]. In addition, 
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it has been shown for Salmonella that the T3SS of the Salmonella pathogenicity 
Island (SPI)-1 promote calcium influx [391]. This was further confirmed by Roy et 
al. who found that the permeabilization by the SPI-1 T3SS is dependent on a 
functional T3SS but not on any effectors [392]. This study used entry of ethidium 
bromide into the host cell as a measurement of the permeabilisation ability of 
the T3SS [392]. Bacterial pore-forming toxins, such as Streptolysin O (SLO), can 
be used to deliver molecules or proteins into living cells [393]. This property was 
used as a positive control when investigating pore-formation by the T3SS [332] 
4.1.5 Membrane repair via lysosomal exocytosis and involvement 
of Synaptotagmin VII 
Upon plasma membrane disruption it is vital for the cell to rapidly reseal or 
repair the damage [394]. This was first described by Chambers et al. [395] and 
Heilbrunn et al. [396] in the early 1960s. Rapid repair is mediated by 
endomembrane via activation of cytoskeletal and membrane fusion proteins 
[397-399]. The endomembrane is delivered in a calcium-dependent manner to 
the plasma membrane by exocytosis [397-399]. Failure to reseal or repair its 
membrane has fatal consequences for the cell, which results in disease for the 
host, examples being muscular dystrophy and diseases releated to keratin 
mutations (Epidermolysa bullosa simplex, EBS) [394]. Cell wounding occurs in 
vivo under normal physiological conditions during, for example, skeletal and 
cardiac muscle contraction [394]. However, several adaptations exist in 
mammalian bodies and cells to prevent membrane disruptions [394]. Examples 
of adaptations are architectural design of organs, highly elastic connective 
tissue, expression of keratin and the dystrophin-glycoprotein complex, as well as 
dynamic responses [394]. There are two possible models proposed for calcium-
triggered repair of membranes: reduction of membrane tension and patch 
formation. Both methods require internal membrane and exocytosis. The 
reduction of membrane tension promotes resealing [400]. The patch formation 
involves larger disruptions of the plasma membrane, where a homotypic fusion 
response results in repair [399, 401, 402]. Following disruption, calcium enters 
the cell which triggers vesicle-vesicle homotypic fusion resulting in a large patch 
vesicle, which fuses with the membrane and repairs the damage [398, 401, 403]. 
There are several calcium-sensitive exocytic compartments involved in 
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membrane repair, such as cortical granules [397, 399], yolk granules [396, 397, 
399, 401, 402], endosomal compartments [398, 400], lysosomes [404-409] and 
enlargosomes [407, 410-412]. 
Following treatment with a calcium ionophor, calcium-dependent membrane 
proximal lysosomal exocytosis is triggered [405]. Membrane proximal lysosomes 
are already associated with the plasma membrane prior to calcium stimulation 
[405]. Lysosomal exocytosis results in relocation of lysosomal associated 
membrane protein 1 (LAMP-1) to the cellular surface, as well as release of 
lysosomal content into the extracellular space, for example the enzyme β-
hexosaminidase (Figure 4.3) [335, 336, 408, 409, 413].  
Synaptotagmins are calcium binding proteins, first identified in synaptic 
junctions, involved in calcium triggered exocytosis [414]. The cytoplasmic 
domains of synaptotagmins consist of tandem C2-domains, which are calcium-
binding motifs [415]. These proteins were originally known as p65 but were 
subsequently renamed to synaptotagmins [416]. Over thirteen isoforms of 
synaptotagmins have been identified [417]. Synaptotagmins span the vesicle 
membrane once, with a short intravesicular domain and large cytoplasmic 
domain composed of two C2 domains [418, 419]. Synaptotagmins undergo 
calcium-dependent oligomerization upon calcium binding [420]. The majority of 
synaptotagmins are primarily expressed in brain, but isoforms such as Syt VII are 
more widely expressed [421-423]. Synaptotagmin VII have been shown to 
regulate lysosomal exocytosis (Figure 4.3) [406], as well as being involved as 
plasma membrane calcium sensors for secretion from cells [424]. Moreover, it 
has been shown to be involved in phagolysosome fusion, which is also a calcium-
dependent process [392, 425-427]. The identification of Syt VII explained the 
occurrence of lysosomal exocytosis as a membrane repair event, as Syt VII is 
located, but not exclusively, on the membrane of lysosomes (Figure 4.3) [406, 
408, 424, 428]. Syt VII is translocated to the plasma membrane following 
calcium-dependent lysosomal exocytosis (Figure 4.3) [408]. Syt VII KO mice were 
shown to have impaired membrane repair but accelerated lysosomal exocytosis 
[429, 430]. This was also shown using a gene silencing approach where Syt VII 
was shown to be indispensable for exocytosis [431]. One of the C2 domains in Syt 
VII, the C2B region was shown to be essential for exocytosis [406]. However, 
when the C2B domain is blocked it has no effect on lysosomal exocytosis, which 
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implies that lysosomes are not exclusively used in membrane repair [432]. This is 
further strengthened by the fact that vacuolin-1 could block lysosomal 
exocytosis without affecting membrane resealing [335, 413, 433]. One 
explaination to these results could be the involvement of enlargosomes, an 
organelle which have been identified to be involved in calcium-dependent 
membrane repair [335, 410]. 
 
Figure 4.3; Mechanism of lysosomal exocytosis 
Upon membrane damage (1.) the plasma membrane is disrupted. This results in calcium influx (2.) 
and binding of calcium to Syt VII, located on lysosomes. Upon binding lysosomal exocytosis is 
triggered (3.) and Syt VII and LAMP-1 can be found on the cellular surface as well as β-
hexosaminidase in the extracellular medium.  
 
Syt VII has also been shown to be involved in the controlling of intracellular 
bacterial infections [392]. It was shown that Syt VII is required for 
phagolysosomal fusion, which inhibits intracellular growth of pathogenic 
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bacteria. Furthermore, the study by Roy et al. investigated the effect of a T3SS 
from intracellular pathogenic bacteria, which was shown to trigger membrane 
permeabilization and lysosomal exocytosis [392]. These results were also 
confirmed for Yersinia, which induced lysosomal exocytosis in a T3SS-dependent 
manner and had enhanced intracellular survival in Syt VII KO [392]. 
Another method to repair membrane injury has been described by Idone et al. 
[434]. This study illustrates a role for calcium-dependent endocytosis following 
mechanical injury, as well as injury from microbial toxins and pore-forming 
proteins. It is suggested that endocytosis is capable of removing the lesions from 
the plasma membrane.  
The work described in this chapter investigates whether inflammasome 
activation by P.aeruginosa is dependent on potassium efflux, and whether the 
pore formed by the T3SS upon contact with the host cell forms a tight 
association with the host cell membrane, or if it allows passage of extracellular 
and intracellular molecules. Finally, the role of Syt VII was explored following 
infection with P.aeruginosa. The results reveal that the inflammasome 
activation by P.aeruginosa, as well as Salmonella, originally used as a positive 
control, is dependent on extracellular potassium, which has not previously been 
described. Furthermore, the results show that upon association with the host 
cell, the T3SS from P.aeruginosa does not allow passage of molecules from 
within the cell or extracellular molecules. The final section of this chapter 
demonstrates that membrane repair is triggered upon contact with a T3SS, but 
the involvement of Syt VII is still unknown.  
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4.2 Results 
4.2.1 Potassium-dependent inflammasome activation by 
Pseudomonas aeruginosa 
4.2.1.1 Potassium-dependent inflammasome activation by PA103 
As described in previous sections, potassium efflux is important for the 
activation of the NLRP3 inflammasome. In response to LPS-priming, followed by 
ATP treatment, the inflammasome activation is NLRP3 dependent, as well as 
potassium efflux dependent.  
In order to investigate whether the inflammasome activation by P.aeruginosa 
PA103 is dependent on potassium efflux, we infected BMDM in buffers containing 
low (2 mM KCl) or high (130 mM KCl) potassium concentrations (Figure 4.4). As a 
positive control BMDM were primed with LPS and then treated with ATP, as 
previously described [333, 346]. Unprimed BMDM were infected with PA103 ΔUΔT 
and PA103 ΔpcrV at a MOI of 100 for 90 min in high and low potassium buffers. 
As expected, LPS with ATP were dependent on potassium efflux for 
inflammasome activation and thus IL-1β release (Figure 4.4A). Inflammasome 
activation following infection with PA103 ΔUΔT was also dependent on potassium 
efflux, as the IL-1β release was completely abrogated in the presence of high 
extracellular potassium (Figure 4.4A), similar to LPS with ATP. PA103 ΔpcrV was 
used as a negative control and increasing the extracellular potassium 
concentration had no effect on IL-1β release from this strain.  
Hank’s buffer has previously been used during investigation of potassium-
dependent inflammasome activation [280]. Rather than just increasing the 
potassium concentration as in previous studies, the sodium chloride 
concentration was adjusted to produce an isotonic buffer, which is less harmful 
to cells. The buffer was further supplemented with vitamins, amino acids and 
sodium pyruvate in order to make the buffer as close to normal cell culture 
media as possible. When BMDM were infected with PA103 ΔUΔT at a MOI of 20, in 
this supplemented Hank’s buffer with high or low potassium, the inflammasome 
activation was still potassium-dependent (Figure 4.4B). Furthermore, the 
141 
potassium-dependence was not altered with increasing infection times, from 90 
min up to 180 min. Although there was an increase in IL-1β release following the 
longer infection time, this was true both in low and high potassium 
concentrations. The percent cytotoxicity was below 10% and remained constant 
for all time points (results not shown). 
 
Figure 4.4; The inflammasome activation by PA103 is dependent on potassium efflux and a 
functional T3SS.  
A; BMDM were treated with LPS followed by ATP or infected with PA103 ΔUΔT and PA103 ΔpcrV 
at a MOI of 100 for 90 min in high and low potassium buffer. B; BMDM were infected with PA103 
ΔUΔT at indicated infection times at a MOI of 20 in supplemented Hank’s buffers with 5 or 135 mM 
KCl. IL-1β secretion was measured by ELISA. Columns are means of triplicates and error bars are 
SEM. Asterixes indicate significant difference where * is p<0.05, ** is p<0.01 and *** is p<0.001, 
unpaired Student’s t-test. 
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The inflammasome activation by PA103 is dependent on potassium efflux and a 
functional T3SS. To determine whether MOI had any effects on the potassium 
dependence, BMDM were infected with PA103 ΔUΔT at different MOIs for 60 min 
in supplemented Hank’s buffer with high or low potassium concentration. PA103 
ΔUΔT activates the inflammasome in a potassium-dependent manner 
independent of MOI (Figure 4.5). There was a trend of increased IL-1β release 
dependent on MOI. Additionally, more caspase-1 was activated as a result of 
higher MOI (Figure 4.5B). This is probably due to a higher bacterial burden with 
increasing MOIs and as a result more inflammasome complexes and thus caspase-
1 are activated. Finally, percent cytotoxicity was measured. There was no 
correlation between MOI and increasing cell death. Instead, the cell death 
remained constant and below 15% for all samples (Figure 4.5C). Thus, PA103 is 
dependent on potassium efflux for activation of the inflammasome rather than 
an indirect effect caused by dying cells.  
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Figure 4.5; Potassium-dependent inflammasome activation by PA103 is independent of MOI. 
A; LPS-primed BMDM were infected with PA103 ΔUΔT at indicated MOIs for 60 min in 
supplemented Hank’s buffers with high or low K+-conc. IL-1β secretion was measured by ELISA. B; 
Cell lysates from A were immunoblotted with caspase-1 antibody. C; Percent cytotoxicity in 
supernatants were measured using LDH release. Columns are means of triplicates and error bars 
are SEM. Asterixes indicate significant difference where * is p<0.05, ** is p<0.01 and *** is 
p<0.001, unpaired Student’s t-test. 
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The amount of IL-1β release has previously been shown to be dependent on 
extracellular potassium concentration and the length of LPS priming of the cells 
[367]. BMDM were therefore infected with PA103 ΔUΔT at a MOI of 30 for 90 min 
in buffers with varied potassium concentration. The higher the potassium 
concentration during infection, less IL-1β was secreted (Figure 4.6A). This 
correlates with less activation of caspase-1 in the presence of higher potassium 
concentrations (Figure 4.6B). 
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Figure 4.6; The potassium-dependent inflammasome activation by PA103 is dose-
dependent. 
A; BMDM were infected with PA103 ΔUΔT at a MOI of 30 for 90 min in isotonic buffers with 
indicated K+-conc. IL-1β secretion was measured by ELISA. Means of triplicates are plotted and 
error bars are SEM. Significant difference of variation in IL-1β secretion is analysed by one-way 
ANOVA significant linear trend for decrease in IL-1β with increasing extracellular potassium 
p<0.01. B; Cell lysates from A were immunoblotted with caspase-1 antibody.  
 
Changing the extracellular potassium concentration might influence other 
aspects of the cell than just inflammasome activation, such as membrane 
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potential, signalling etc. Glybenclamide is an inhibitor of ATP-dependent 
potassium channels, which are one of the main potassium channels in cells [435]. 
In order to test the effect of Glybenclamide on inflammasome activation by 
PA103, BMDM were treated with 100 µM Glybenclamide 30 min before infection. 
Treatment with Glybenclamide inhibits IL-1β release following infection with 
PA103 ΔUΔT (Figure 4.7A), but does not affect cell death (Figure 4.7B). The 
inhibition of inflammasome activation following Glybenclamide treatment is not 
as dramatic as after infection in high potassium extracellular media. This 
indicates that there is more than one potential potassium channel involved and 
the effect of Glybenclamide might be limited by the activity of other channels.  
 
Figure 4.7; Inflammasome activation by PA103 can be inhibited using Glybenclamide. 
A; BMDM were treated with Glybenclamide 30 min before infection with PA103 ΔUΔT at a MOI of 
30 for 90 min in complete media without antibiotics. IL-1β secretion was measured by ELISA. B; 
Percent cytotoxicity were measured by LDH release in supernatants from A. Columns are means of 
triplicates and error bars are SEM. * indicate significant difference p<0.05, ns is non-significant 
difference p>0.05, unpaired Student’s t-test. 
 
Glybenclamide treatment had no detectable effect on caspase-1 cleavage 
(Figure 4.8). As mentioned above; the effect of Glybenclamide might be masked 
by activating other potassium channels. Considering this possibility it is likely 
that a small effect on caspase-1 cleavage might not be detected on the Western 
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blot. Other potassium channel inhibitors need to be used to rule out 
upregulation of activity.  
 
Figure 4.8; There is no noticeable difference in caspase-1 activation following 
Glybenclamide treatment.  
Cell lysates from Figure 4.7 were immunoblotted with caspase-1 antibody.  
 
4.2.1.2 Potassium-dependent inflammasome activation by PAO1 
PAO1 is a flagellated strain of P.aeruginosa, as previously described. Flagellin 
has been linked to activation of the NLRC4 inflammasome. In order to determine 
if PAO1 is dependent on potassium efflux for inflammasome activation the 
experiments performed for PA103 were repeated using PAO1. The inflammasome 
is activated in a T3SS- and potassium-dependent manner by PAO1, similar to 
PA103 (Figure 4.9). There is some residual activation in the presence of high 
extracellular potassium, but it can be concluded that the activation is highly 
dependent on potassium efflux. The residual activity might be due to the 
differences seen with this strain compared to PA103. PAO1 does have flagellin, 
which might be involved in a potassium-independent inflammasome activation.  
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Figure 4.9; The inflammasome activation by PAO1 is dependent on potassium and a 
functional T3SS.  
BMDM were primed with LPS followed by stimulation with ATP or infected with PAO1 strains at a 
MOI of 100 for 90 min in high and low potassium buffer. IL-1β secretion was measured by ELISA. 
Columns are means of triplicates and error bars are SEM. * and ** indicate significant difference 
where * is p<0.05 and ** is p<0.01, unpaired Student’s t-test. 
 
In order to investigate whether flagellin is involved in the residual activity seen 
in high potassium concentration, BMDM were infected with PAO1 WT, PAO1 FliC- 
and PAOC:PAO1 FliC. There was no effect on potassium dependence following 
infection with either of these strains (Figure 4.10A). However, there was an 
effect in the amount of IL-1β secreted from cells infected in low potassium 
between the different strains used (Figure 4.10A). PAO1 FliC- results in less IL-1β 
than PAO1 WT or the recomplemented strain PAOC:PAO1 FliC. This indicates an 
effect of flagellin on inflammasome activation, which has been previously shown 
for Salmonella [337], Legionella [351] and Pseudomonas [253, 354]. 
Furthermore, there was significantly more IL-1β secreted from the BMDMs 
infected with PAOC:PAO1 FliC than PAO1 WT (Figure 4.10A). This might be a 
result of the recomplementation of this strain with flagellin. The expression 
levels of the complemented protein may vary in the complemented strain 
compared to the WT strain.   
The cytotoxicity of these PAO1 strains was not affected in the presence of high 
extracellular potassium (Figure 4.10B). In addition, there was no effect of 
flagellin on cell death, as all the strains result in similar amount of cell death 
following 90 min infection (Figure 4.10B).  
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Figure 4.10; PAO1 activates the inflammasome in a potassium-dependent manner 
independent of flagellin. 
A; BMDM were primed with LPS and stimulated with ATP or infected with indicated PAO1 strains at 
a MOI of 50 for 90 min in complete media supplemented with KCl. IL-1β secretion was measured 
by ELISA. B; Percent cytotoxicity were measured by LDH release in supernatants from A. Columns 
are means of triplicates and error bars are SEM. ** and *** indicate significant difference where ** 
is p<0.01 and *** is p<0.001, unpaired Student’s t-test. 
 
Similar to PA103 ΔUΔT, the inflammasome activation by PAO1 ΔSTY can be 
partially inhibited by treatment with Glybenclamide (Figure 4.11A). As 
previously described, this has no effect on the cytotoxicity caused by the 
bacteria (Figure 4.11B). Moreover, in contrast to PA103 ΔUΔT the treatment with 
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Glybenclamide results in less caspase-1 activation compared to untreated cells 
(Figure 4.11C).  
 
Figure 4.11; Inflammasome activation by PAO1 can be inhibited by Glybenclamide. 
A; BMDM were treated with Glybenclamide 30 min before infection with PAO1 ΔSTY at a MOI of 
30 for 90 min in complete media. IL-1β secretion was measured by ELISA. B; Percent cytotoxicity 
were measured by LDH release in supernatants from A. Columns are means of triplicates and error 
bars are SEM. * indicate significant difference where * is p<0.05, unpaired Student’s t-test. C; Cell 
lysates were immunoblotted with caspase-1 antibody.  
 
4.2.1.3 Role of pannexin-1 in inflammasome activation by PA103 
Pannexin-1 inhibitory peptide has been shown to block IL-1β secretion from 
BMDM, as well as blocking ethidium bromide uptake [346]. The peptide is 
believed to block the P2X7R pore pannexin-1.  
The method described by Pelegin et al. was used for dye uptake studies [346]. 
BMDM were preincubated with the peptides together with ATP and then imaged 
using time-lapse microscopy, i.e. ATP alone, or with control peptide, or 
pannexin-1 blocking peptide. Following treatment with pannexin-1 peptide the 
uptake of ethidium bromide was blocked in BMDM (Figure 4.12). This is shown by 
a slower uptake rate as well as less increase in mean fluorescence intensity 
(MFI). In comparison ATP treatment results in dye uptake comparable to the 
results seen after treatment with the control peptide (Figure 4.12).  
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Figure 4.12; Pannexin blocks uptake of ethidium bromide in BMDM. 
BMDM were treated with peptide before treatment with ATP when cells were followed using time 
lapse fluorescence microscopy. The ethidium bromide uptake was measured. Arrow indicates 
addition of ATP. Means of 20 individually measured cells are plotted and error bars are SEM. 
Results are representative of three individual experiments.  
 
The effects of peptide preincubation on IL-1β secretion were investigated on 
LPS-primed BMDM, as previously described [346]. LPS-primed BMDM were 
preincubated with pannexin-1 peptide, control peptide or carbenoxolone (CBX) 
at a variety of concentrations. The peptides were used at 500, 250, 100 and 50 
µM, whereas carbenoxolone were used at 100, 50, 20 and 5 µM. Carbenoxolone is 
a nonspecific gap-junction and hemichannel blocking drug derived from licorice 
[333, 383]. Following preincubation, cells were treated with ATP and the IL-1β 
release was measured using ELISA. There was no effect of the peptide treatment 
or carbenoxolone treatment on IL-1β secretion compared to ATP treatment 
alone (Figure 4.13).  
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Figure 4.13; Pannexin-1 peptide cannot block secretion of IL-1β from BMDM. 
LPS-primed BMDM were treated with peptides or CBX at varied conc. (Peptides 500, 250, 100 and 
50 µM, CBX 100, 50, 20, 5 µM) for 30 min following treatment with ATP. IL-1β secretion was 
measured by ELISA. Columns are means of triplicates and error bars are SEM. 
 
The effects of pannexin-1 treatment on IL-1β secretion triggered by infection 
were investigated. BMDM were preincubated with peptides and then infected. 
The effects on IL-1β secretion were investigated with ELISA. As previously 
described (Figure 4.13), there was no effect of the peptides on IL-1β secretion 
from LPS-primed BMDM treated with ATP (Figure 4.14). The preincubation with 
peptides resulted in less IL-1β secretion from PA103 ΔUΔT infected BMDM, 
compared to untreated infected BMDM (Figure 4.14). This effect was not specific 
for pannexin-1, as the control peptide resulted in less IL-1β secretion compared 
to untreated cells and there was no difference between the two different 
peptides (Figure 4.14). The peptides have no effect on infection by PA103 ΔpcrV, 
as expected since this strain lacks a functional T3SS and can not induce 
inflammasome activation (Figure 4.14). Together these results suggest that the 
pannexin-1 channel is not involved in the inflammasome activation by ATP or 
PA103 ΔUΔT.  
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Figure 4.14; There is no effect of pannexin-1 peptide treatment on IL-1β release following 
infection. 
LPS-primed BMDM were treated with peptides followed by ATP treatment or infection. IL-1β 
secretion was measured by ELISA. Columns are means of triplicates and error bars are SEM. ** 
indicate significant difference where p<0.01, ns is non-significant difference, unpaired Student’s t-
test.  
 
4.2.2 Potassium-dependent inflammasome activation by 
Salmonella 
Salmonella SL1344 has previously been shown to activate the inflammasome in a 
potassium-independent manner, as described above in section 4.1.3. The reason 
for using Salmonella in this study was originally as a positive control. However, 
under all conditions used, it was found that inflammasome activation by 
Salmonella was dependent on the extracellular potassium concentration. This 
will be discussed further at the end of this chapter.  
Following infection with SL1344 of LPS-primed BMDM in media supplemented 
with 130 mM KCl, there was clear potassium-dependent inflammasome 
activation (Figure 4.15A). This potassium-dependent IL-1β secretion cannot be 
explained by increased cell death upon infection in high extracellular potassium. 
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The cytotoxicity is significantly less in low potassium, but below 10% in all 
samples, however, this does not seem to have an effect on IL-1β secretion 
(Figure 4.15B). 
 
Figure 4.15; Salmonella activates the inflammasome in a potassium-dependent manner. 
A; LPS-primed BMDM were treated with ATP or infected with Salmonella SL1344 at a MOI of 20 
for 90 min in media. IL-1β secretion was measured by ELISA. B; Percent cytotoxicity were 
measured by LDH release in supernatants from A. Columns are means of triplicates and error bars 
are SEM. * and *** indicate significant difference where * is p<0.05 and *** is p<0.001, unpaired 
Student’s t-test. 
 
Previous reports have treated the BMDM with Gentamicin following an initial 
period of infection with Salmonella, in order to limit extracellular bacterial 
growth. In order to test whether this had an effect on the potassium dependent 
inflammasome activation seen, BMDM were infected with Salmonella at a MOI of 
20 for 60 min. This was followed by Gentamicin treatment for 30, 60 and 120 
min. The limiting of extracellular bacterial growth by Gentamicin had no effect 
on potassium-dependent inflammasome activation by Salmonella (Figure 4.16). 
More IL-1β is secreted the longer infection time, but this is true for both low and 
high extracellular potassium and is thus not a specific effect dependent on 
extracellular medium (Figure 4.16).  
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Figure 4.16; Salmonella activates the inflammasome in a potassium-dependent manner 
independent of Gentamicin treatment. 
BMDM were primed with LPS and infected with Salmonella at a MOI of 20 for 60 min in 
supplemented Hank’s buffers, followed by Gentamicin treatment to kill extracellular bacteria for 
indicated time points. IL-1β secretion was measured by ELISA. Columns are means of triplicates 
and error bars are SEM. ** and *** indicate significant difference where ** is p<0.01 and *** is 
p<0.001, unpaired Student’s t-test.  
 
As previously described for PA103 in section 4.2.1.1, the potassium-dependent 
inflammasome activation is not dependent on MOI. To test whether the same 
hypothesis holds true for Salmonella, BMDM were infected in supplemented 
Hank’s buffer for 60 min at various MOIs. Independent of MOI, the IL-1β 
secretion seen is dependent on potassium efflux (Figure 4.17A). No caspase-1 
activation can be detected by Western blot in the cell lysates from the infected 
cells in the presence of high extracellular potassium (Figure 4.17B). The 
cytotoxicity is below 15% for all samples and there is no correlation between 
higher cytotoxicity results in increased IL-1β release, as previously shown (Figure 
4.15B, results not shown).  
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Figure 4.17; Potassium-dependent inflammasome activation by Salmonella is independent 
of MOI. 
A; BMDM were primed with LPS and then infected with Salmonella at indicated MOIs for 60 min in 
supplemented Hank’s buffer. IL-1β secretion was measured by ELISA. Columns are means of 
triplicates and error bars are SEM. Asterixes indicate significant difference where * is p<0.05, ** is 
p<0.01 and *** is p<0.001, unpaired Student’s t-test. B; Cell lysates from A were immunoblotted 
with caspase-1 antibody. 
 
Similar to inflammasome activation by PA103, the amount of IL-1β secretion 
following Salmonella infection is dependent on extracellular potassium 
concentration. BMDM were infected with Salmonella in isotonic buffers with 
varied concentrations of KCl. There is less IL-1β secreted in higher 
concentrations of potassium (Figure 4.18A). This is due to less caspase-1 
activation in higher concentrations of potassium as shown by Western blot of cell 
lysates (Figure 4.18B). 
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Figure 4.18; Potassium-dependent inflammasome activation by Salmonella is dose-
dependent. 
A; LPS-primed BMDM were infected with Salmonella at a MOI of 30 for 90 min in isotonic buffers 
with indicated KCl conc. IL-1β secretion was measured by ELISA. Means of triplicates are plotted 
and error bars are SEM. Significant difference of variation in IL-1β secretion is analysed by one-
way ANOVA significant linear trend for decrease in IL-1β with increasing extracellular potassium 
p<0.001. B; Cell lysates from A were immunoblotted with caspase-1 antibody.  
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The inflammasome activation and thus IL-1β secretion by both PA103 and PAO1 
can be inhibited by glybenclamide as shown in section 4.2.1.1 and 4.2.1.2. 
Salmonella induced IL-1β secretion is significantly inhibited in glybenclamide 
treated cells (Figure 4.19A). This further strengthens the hypothesis concerning 
potassium-dependent inflammasome activation by Salmonella. There is no 
difference in cell death between glybenclamide treated and untreated cells 
following infection, as expected (Figure 4.19B). Surprisingly no difference could 
be seen in caspase-1 activation following glybenclamide treatment (Figure 
4.19C). The lack of difference in caspase-1 activation is possibly due to very low 
levels in lysates, which therefore mask any difference. Also, the cytotoxicity in 
this experiment is relatively high and as a result less caspase-1 would be 
available.  
 
Figure 4.19; Inflammasome activation by Salmonella can be inhibited by Glybenclamide. 
A; BMDM were treated with Glybenclamide 30 min before infection with Salmonella at a MOI of 30 
for 90 min in complete media. IL-1β secretion was measured by ELISA. B; Percent cytotoxicity 
were measured by LDH release in supernatants from A. Columns are means of triplicates and error 
bars are SEM. *** indicate significant difference where p<0.001, unpaired Student’s t-test. C; Cell 
lysates were immunoblotted with caspase-1 antibody. 
 
4.2.3 Measurement of intracellular potassium concentration  
Intracellular potassium concentration can be measured using flame photometry, 
a method commonly used by inorganic chemists to measure metal ion 
concentrations in solutions. Following infection with Salmonella, PA103 ΔUΔT 
and PAO1 or treatment with ATP, BMDM lysates were analysed using a flame 
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photometer. After treatment with ATP, the intracellular potassium 
concentration is significantly decreased (Figure 4.20), as expected. Infection 
with PA103 ΔUΔT and Salmonella however, does not result in significant changes 
in intracellular potassium concentration (Figure 4.20A). Surprisingly, infection 
with PAO1 results in rapid loss of intracellular potassium, as after 30 min the 
concentration is significantly less compared to infection with PA103 ΔUΔT 
(Figure 4.20B). The effect is never as profound as seen after ATP treatment.  
 
Figure 4.20; Only infection with PAO1 results in changes in intracellular potassium 
concentration.  
A; BMDM were infected with PA103 ΔUΔT and Salmonella at a MOI of 30, or treated with ATP for 
indicated time points in complete media. Intracellular potassium concentration were analysed in cell 
lysates using flame photometry. B; BMDM were infected with PAO1 ΔSTY at a MOI of 30. Means 
of triplicates are plotted and error bars are SEM. ** and *** indicate significant difference from 
untreated cells (t=0) where ** is p<0.01 and *** is p<0.001, unpaired Student’s t-test.  
 
Intracellular potassium concentration was also measured using the fluorescent 
potassium indicator PBFI. BMDM were traced on the microscope and imaged 
during infection. The changes in mean fluorescence intensity were plotted 
against time. No change in intracellular potassium concentration could be 
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detected following infection with either PA103 ΔUΔT or PA103 ΔpcrV (Figure 
4.21). There is a general decline in potassium concentration for the infected 
samples, however there is no differences between PA103 ΔUΔT and PA103 ΔpcrV 
(Figure 4.21). This indicates a general effect on the dye due to long incubation 
times, rather than an effect of the T3SS.  
 
Figure 4.21; There is no change in intracellular potassium concentration following infection. 
Changes in intracellular potassium concentration in BMDM during infection at a MOI of 10 were 
measured using PFBI and time lapse imaging. Arrow denotes addition of bacteria. Representative 
traces from 3 separate experiments with at least ten isolated cells for each condition is plotted. 
 
4.2.4 The T3SS of Pseudomonas aeruginosa does not form a 
leaky pore upon contact with the host cell 
4.2.4.1 Investigation of dye-exclusion following infection 
Dye exclusion experiments have previously been shown to indicate whether a 
bacterial T3SS upon contact with a host cell forms a tight pore, or if dyes can 
leak into the host cell from the extracellular environment [332]. If a pore is 
formed in the plasma membrane Lucifer yellow is able to enter the cell during 
incubation in media containing this dye. This can then be visualised on a 
fluorescent microscope. This method was used to see whether the T3SS of 
P.aeruginosa forms a leaky pore upon contact with the host cell. Ionomycin, a 
161 
calcium ionophore produced by Streptomyces conglobatus was used as a positive 
control. After ionomycin treatment Lucifer Yellow can enter the cells through 
the pores formed as indicated by FITC-positive cells (Figure 4.22). Following 
infection with PA103 ΔpcrV and also for cells alone, no FITC signal can be 
detected in cells, as expected due to lack of functional T3SS, or lack of infection 
(Figure 4.22). The PA103 ΔUΔT with a functional T3SS does not result in dye 
entry into the cells following infection (Figure 4.22). As an additional positive 
control, the PA103 ΔUΔT:exoU was used. Upon infection with this strain, Lucifer 
Yellow can enter the cells due to the cytotoxic effect of the ExoU effector 
(Figure 4.22).  
 
Figure 4.22; There is not a leaky pore formed by the T3SS in the host cell during infection. 
RAW 264.7 cells were infected with indicated PA103 strains at a MOI of 300 for 60 min or treated 
with ionomycin for 10 min at indicated conc. Dye exclusion was investigated using Lucifer yellow 
and fluorescence microscope. Images are representative of results from three separate 
experiments.  
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Streptolysin O (SLO) is a cytolytic toxin produced by group A, C and G 
streptococci. It binds to membrane cholesterol where, following polymerisation, 
it forms transmembrane channels. SLO has previously been used to permeabilise 
the plasma membrane of the host cell, in order to introduce molecules or 
proteins [393]. Following treatment with SLO, Lucifer Yellow can enter the cells, 
as indicated by FITC-positive staining (Figure 4.23). As a comparison, infection 
with PA103 ΔUΔT and PA103 ΔpcrV does not result in FITC-positive cells (Figure 
4.23). These results indicate that the T3SS of P.aeruginosa does not form a leaky 
pore upon contact with the host cell.  
 
Figure 4.23; SLO mediates dye uptake into the cells but a functional T3SS does not. 
HeLa cells were infected with indicated PA103 strains at a MOI of 200 for 90 min or treated with 
SLO for 30 min. Dye exclusion was investigated using Lucifer yellow and fluorescence microscope. 
Images are representative of three separate experiments.  
 
4.2.4.2 Investigation of ion-permeability through the pore formed 
by the T3SS 
Lucifer Yellow has a molecular size of 457 Da, and as described in section 
4.2.4.1 it cannot enter the host cell following infection with PA103 ΔUΔT and 
thus a functional T3SS. Ions are smaller than Lucifer Yellow and in order to 
address this, calcium entry into host cells following infection was studied using 
Fluo 4-AM, a fluorescent calcium indicator. Cells were traced and the MFI were 
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plotted against time. After treatment with ionomycin, calcium enters the cell 
and there is an increase in MFI (Figure 4.24). After a peak in intensity the Fluo-4 
signal is lost, indicated by decrease in MFI, as the cell dies (Figure 4.24). No 
changes in calcium can be seen during infection with either PA103 ΔUΔT or 
PA103 ΔpcrV (Figure 4.24).  
 
Figure 4.24; There is no calcium influx during infection with PA103. 
Calcium influx were measured using Fluo 4-AM in HeLa cells during infection with indicated PA103 
strains at a MOI of 150 for indicated time or treated with ionomycin. Arrow indicates addition of 
bacteria or ionomycin. Inset shows changes in calcium concentration following treatment with 
ionomycin at time points 100, 260, 330 and 500 (s). Representative traces for at least three 
separate experiments with at least ten isolated cells measured for each condition are plotted. 
 
Calcium is an important ion for membrane potential and signalling within cells. 
To rule out the possibility that calcium is maintained following infection via 
intracellular stores and thus does not produce a change in MFI, passage of zinc 
ions was used instead. The intracellular concentration of zinc is extremely low in 
most cell types, which makes this method ideal to investigate whether the T3SS 
forms a leaky pore upon contact with the host cell. With zinc in the extracellular 
media and the Fluo-Zin 3 dye loaded into the cells the increase in fluorescence 
upon binding of the ion to the dye is easily detected. There is no change in MFI 
following infection by PA103 ΔUΔT or PA103 ΔpcrV (Figure 4.25). After addition 
of the zinc ionophore, pyrithione there is an increase in MFI due to Zn2+-influx 
into the cell (Figure 4.25). Infection with PA103 ΔUΔT:exoU results in Zn2+-
influx, as a result of the strains cytotoxic properties (Figure 4.25), similar to the 
effects observed for the dye exclusion experiments described in section 4.2.4.1.  
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Figure 4.25; There is no Zn2+-influx during infection with PA103. 
Zinc influx was measured using Fluo Zin-3 in BMDM during infection with indicated PA103 strains 
at a MOI of 20 for indicated time. Black arrow indicates addition of bacteria and grey arrow 
indicates treatment with pyrithione. Representative traces for at least three separate experiments 
with at least ten isolated cells measured for each condition are plotted. 
 
4.2.4.3 Investigation of BCECF release upon contact with a 
functional T3SS 
BCECF, a pH-sensitive small intracellular marker molecule has a molecular 
weight of 623 Da. It was previously described that BCECF was released from cells 
infected with a strain of Yersinia which lacks any effectors passing through the 
T3SS [332]. This strain is similar to PA103 ΔUΔT. Furthermore, it was shown that 
this release of the loaded dye was inhibited when the T3SS had any effectors 
passing through [332]. In order to investigate whether infection with PA103 ΔUΔT 
results in release of BCECF from loaded cells, the method described by Neyt et 
al. was repeated. Cells (HeLa) were originally loaded in Margo’s solution; this 
proved unsuccessful as uninfected samples released more BCECF than infected 
samples. This can be explained by a centrifugation step to collect samples at 250 
x g, as described [332]. Following further investigation this centrifugation step 
was discovered to be too slow and bacteria were left in the sample, which 
interferes with the measurement. After optimization of the method, cells were 
loaded with BCECF in HBSS, followed by infection in Phenol red free complete 
culture medium and samples were collected after a centrifugation step at 16100 
x g.  
SLO was used as a positive control for BCECF release. Increasing concentrations 
of SLO results in increasing amount of released BCECF (Figure 4.26A). In contrast 
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to SLO (400U/ml), which results in 100% lysis of cells, infection with PA103 ΔUΔT 
or PA103 ΔpcrV does not result in release of BCECF (Figure 4.26B). This is true 
for all cell types tested, HeLa (Figure 4.26B), CHO and RAW264.7 (results not 
shown). Furthermore, PA103 ΔUΔT:exoU results in lysis of the cells as a result of 
the ExoU toxin, and ionomycin treatment cause BCECF release due to cell death 
(Figure 4.26B).  
 
Figure 4.26; BCECF can not pass through the pore formed by the T3SS. 
A; HeLa cells were loaded with BCECF and then treated with SLO at indicated concentrations for 
30 min at 37°C. Supernatants were collected and analysed for BCECF release. B; HeLa cells were 
loaded with BCECF and then infected with PA103 strains at a MOI of 300 for 2h or treated with 
ionomycin or SLO. Supernatants were collected and analysed for BCECF release. 
 
4.2.5 The T3SS trigger membrane repair upon contact with the 
host cell 
It has previously been shown that upon contact with a T3SS, membrane repair 
and lysosomal exocytosis is triggered [392]. This was shown for Yersinia and it is 
not known whether P.aeruginosa has the same effect. Yersinia and Pseudomonas 
have homologous T3SS which indicate that they might behave in the same way.  
4.2.5.1 LAMP-1 relocates to the cellular surface following 
contact with a T3SS 
Lysosomal exocytosis and thus membrane repair can be detected by relocation 
of LAMP-1 to the cellular surface. LAMP-1 relocates to the cellular surface after 
ionomycin treatment (for 10 min at 10µM) by LAMP-1 specific fluorescent 
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staining of the cellular surface (Figure 4.27). HeLa cells are treated with 
ionomycin, fixed and then stained with LAMP-1 specific antibody.  
 
Figure 4.27; Ionomycin treatment results in relocation of LAMP-1 to the cellular surface. 
HeLa cells were treated with ionomycin for 10 min and then immunofluorescently stained with 
LAMP-1 antibody or mouse IgG1κ as a control, followed by imaging on a fluorescence microscope. 
Scale bar is 50 µm. Images are representative of three separate experiments.  
 
Ionomycin can be used as a positive control for lysosomal exocytosis (Figure 
4.27). Infection with PA103 ΔpcrV does not result in relocation of LAMP-1 to the 
cellular surface (Figure 4.28), as expected since this strain lacks a functional 
T3SS. In contrast PA103 ΔUΔT has a functional T3SS and following infection with 
this strain LAMP-1 is relocated to the surface of the cell (Figure 4.28). Following 
infection with PA103 ΔUΔT:exoU, which has a functional T3SS and a functional 
ExoU effector passing through the T3SS, following infection with this strain 
LAMP-1 can be detected on the cellular surface (Figure 4.28). There seems to be 
more LAMP-1 relocated following infection with PA103 ΔUΔT:exoU than PA103 
ΔUΔT, which might be due to the cytotoxic effect of the ExoU toxin.  
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Figure 4.28; Following contact with a functional T3SS LAMP-1 relocates to the cellular 
surface. 
HeLa cells were treated with ionomycin for 10 min or infected with indicated PA103 strains at a 
MOI of 200 for 90 min, cells were then fixed and immunofluorescence stained with LAMP-1 
antibody. Scale bar is 50 µm. Images are representative of three separate experiments.  
 
To quantify the amount of LAMP-1 specific staining on the cellular surface, 
attempts were made at using FACS. This proved unsuccessful mainly due to 
technical difficulties and staining problems.  
Instead LSC, explained in chapter 2, was used to quantify the LAMP-1 specific 
staining. This was done in collaboration with Dr. Angela Morton, University of 
Glasgow. Quantification of the LAMP-1 specific staining following infection with 
PA103 ΔUΔT results in increased amount of LAMP-1 on the cellular surface 
compared to uninfected samples as well as unspecific staining (Figure 4.29). 
Increasing MOI results in more LAMP-1 being relocated to the cellular surface, as 
expected due to higher bacterial burden and more T3SS. PA103 ΔpcrV has similar 
amount of LAMP-1 on the cellular surface as cells alone stained with anti-LAMP-1 
(results not shown).  
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Figure 4.29; LAMP-1 relocates to the cellular surface following contact with a functional 
T3SS. 
HeLa cells were infected with PA103 ΔUΔT at indicated MOIs for 90 min. Cells were 
immunofluorescence stained with LAMP-1 or mouse IgG1κ antibody and LAMP-1 staining were 
quantified using LSC.  
 
4.2.5.2 Investigation of β-hexosaminidase release following 
contact with a functional T3SS 
Lysosomal exocytosis results in release of lysosomal contents into the 
extracellular environment. The enzyme β-hexosaminidase resides in lysosomes 
and it is released during lysosomal exocytosis. This enzyme can be used in an 
assay where 4-methylumbelliferyl N-acetyl-βD-Glucosaminide dehydrate is 
cleaved by β-hexosaminidase to 4-methylumbelliferone, which can be measured 
using a spectrofluorimeter. This method was previously described by [335, 336]. 
First attempts at this method proved unsuccessful due to incubation in PBS 
(results not shown). Lysosomal exocytosis is triggered by calcium influx, so if 
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there is no calcium in the extracellular media the exocytosis will be inhibited. 
The fluorescence measured from 4-methylumbelliferone is higher in alkaline pH 
than physiological pH (Sigma): therefore, the samples were measured in the 
presence of 0.1 M glycine pH 10. Surprisingly, ionomycin did not trigger 
lysosomal exocytosis as measured by β-hexosaminidase release (Figure 4.30). 
Lysosomal exocytosis could only be triggered by PA103 ΔUΔT:ExoU (Figure 4.30), 
which is due to its cytotoxic effects. Lysosomal exocytosis and β-hexosaminidase 
release could never be seen following infection of either PA103 ΔUΔT or PA103 
ΔpcrV (Figure 4.30 and results not shown). Similar results were obtained from 
HeLa cells, CHOs and RAW264.7.  
 
Figure 4.30; Lysosomal exocytosis is not triggered after contact with a functional T3SS. 
HeLa cells were infected with PA103 strains at a MOI of 300 or treated with ionomycin. 
Supernatants were collected and analysed for β-hexosaminidase release. Columns are means of 
triplicates and error bars are SEM. *** indicate significant increase where p<0.001, unpaired 
Student’s t-test. nd; non detected.  
 
4.2.5.3 Role of Synaptotagmin VII during infection and 
membrane repair 
Synaptotagmin VII is a calcium binding protein located in the lysosomal 
membranes. When the plasma membrane is damaged this triggers calcium influx, 
which binds synaptotagmin VII and lysosomal exocytosis is triggered [406]. In 
order to investigate the role of Syt VII during infection with P.aeruginosa siRNA 
was used to silence the expression of the protein. Syt VII has several isoforms, 
these have different molecular weights: E (70.6 kDa), D (68 kDa), C (63 kDa) and 
45 kDa isoform, as well as a truncated form at much lower molecular weight. 
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siRNA sequence used were based on results previously published [345]. The gene 
target was in gene NM_004200 SYT7. There was never any success in silencing 
Syt VII using purified siRNA. HeLa cells were transfected with Lipofectamine 
2000, which was successful for other transfections described in this thesis. 
Various concentrations of siRNA, as well as other transfection reagents (FuGENE 
HD and siRNA X-treme GENE transfection reagent, Roche) were tried without any 
success in silencing the gene. Using the siRNA X-treme GENE transfection 
reagent resulted in weaker bands for isoform E and also a band at a higher 
molecular weight (Figure 4.31). However, as these bands disappeared the 45 kDa 
isoform seemed to be getting stronger (Figure 4.31). This result could not be 
repeated, using as identical conditions as possible.  
 
Figure 4.31; Silencing of Syt VII isoform E results in increased amounts of the 45 kDa 
isoform. 
HeLa cells were transfected with Syt VII and control siRNA at indicated concentrations. After 48 h 
incubation cells were lysed and immunoblotted with Syt VII antibody. Actin was used as a loading 
control.  
 
As a final attempt to silence Syt VII, hairpin siRNA was used in the vector 
pSilencer Syt VII. Various amounts of vector were tried using Lipofectamine 2000 
without successful silencing of Syt VII. The pSilencer vector with Syt VII targeted 
the same sequence as previously described, but it was believed to be more 
stable than purified siRNA. This vector was also used in an attempt to stable 
transfect HeLas with Syt VII siRNA under selection of G418. This was only tried 
once, due to time constraints and without success. The silencing of Syt VII was 
never successful.  
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Thus, as a more reliable alternative, Syt VII -/- bone marrow was kindly provided 
by N.W. Andrews (Yale School of Medicine). These cells were used to investigate 
the role of Syt VII during inflammasome activation during infection with PA103 
and PAO1. Following infection with PA103 ΔUΔT, there was no significant 
difference between IL-1β secretion from KO compared to WT cells (Figure 
4.32A). This is also true for cell death where there is no difference in percent 
cytotoxicity in WT compared to KO after infection with PA103 ΔUΔT (Figure 
4.32B). This is also true for LPS primed BMDM stimulated with ATP, no 
differences can be detected in IL-1β secretion, percent cytotoxicity or caspase-1 
activation in WT compared to KO cells (Figure 4.32). In contrast, infection with 
PAO1 results in significantly more IL-1β secretion and cell death in Syt VII KO 
cells compared to WT (Figure 4.32A & B). However, no differences can be seen 
in caspase-1 activation for this strain in WT compared to KO cells (Figure 4.32C).  
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Figure 4.32; Syt VII is not involved in inflammasome activation by PA103 or PAO1. 
A; BMDM WT and SYT7-/- were infected with PA103 ΔUΔT or PAO1 ΔSTY at a MOI of 20 for 90 
min or primed with LPS followed by ATP stimulation at 5 mM for 20 min. Supernatants were 
analysed for IL-1β secretion by ELISA. B; Supernatants from A were analysed for percent 
cytotoxicity by LDH release. Columns are means of triplicates and error bars are SEM. ** indicate 
significant difference where p<0.01, ns is non-significant difference, unpaired Student’s t-test. C; 
BMDM WT and SYT7-/- were infected with PAO1 ΔSTY at a MOI of 20 for 30 and 90 min or primed 
with LPS followed by ATP stimulation. Cell lysates were immunoblotted with caspase-1 antibody.  
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4.3 Discussion 
4.3.1 Potassium-dependent inflammasome activation 
As previously described in chapter 3, P.aeruginosa activates the NLRC4 
inflammasome during infection. This has also been reported by Sutterwala et al. 
[249], Franchi et al. [253] and Miao et al. [354]. Potassium-dependent activation 
of the NLRC4 inflammasome has not been shown previously. Thus, these results 
demonstrate a novel potassium-dependent pathway for activation of the NLRC4 
inflammasome. Inflammasomes are activated by danger signals and pathogen 
products [161]. These results imply that the same danger signal, such as 
potassium efflux, can activate different inflammasome complexes, for example 
the NLRP3 and NLRC4. There are more than 23 members of the NLR-protein 
family in humans and mice. Only a few have a described function. Due to this 
the field is likely to get more complicated and more inflammasome complexes 
are likely to exist. It is therefore not unlikely that the same danger signal could 
trigger different inflammasome complexes. The triggering is therefore probably 
dependent on the sensing of DAMPs, as well as PAMPs. Certain combinations of 
these stimuli are likely to trigger different inflammasome complexes.  
The NLRC4 has been shown to respond to bacterial products delivered by 
bacterial secretion systems [161]. In contrast, NLRP3 responds to a wide variety 
of products and danger signals, such as potassium-efflux triggered by pore-
forming toxins, large foreign particles, UV etc. [161]. Considering the T3SS- and 
potassium-dependent activation of the inflammasome by P.aeruginosa this 
implies potassium efflux being made possible by the T3SS. Four potential 
explanations exist; i) where potassium can pass through the pore formed by the 
T3SS, ii) an indirect triggering of a potassium channel in the plasma membrane 
as a result of an effect by the T3SS, iii) the depolarization of the plasma 
membrane as a trigger of the inflammasome complex, and iv) involvement of 
intracellular potassium stored in intracellular compartments. During this study 
no ions or molecules could be detected entering or exiting the host cell 
following contact with a T3SS. Furthermore, no changes in intracellular 
potassium could be detected following infection. This favours the model where 
the plasma membrane is depolarized followed by inflammasome activation. The 
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fact that no changes can be seen in intracellular potassium concentration, as 
well as other ions and molecules, indicate that only a very small amount of 
potassium is needed to change in order to depolarize the membrane. Another 
possibility is that potassium flux out of critical intracellular compartments is 
responsible for the changes seen. Presumably these changes are below detection 
level for the methods used.  
The potassium-dependent triggering of the NLRC4 inflammasome demonstrates 
that potassium-dependence can not be used as the sole determinant for NLRP3-
dependence. Instead other methods should be used to determine what 
inflammasome is triggered by a certain stimuli. These could include the use of 
KO animals, as well as shRNAs. In addition, it has been shown that Anthrax toxin 
triggers potassium efflux, which is dependent on NLRP1 [240-242], further 
strengthening that potassium-dependence can not be used as a sole determinant 
for NLRP3-dependence.  
Potassium efflux might trigger inflammasome activation by altering the ionic 
composition or the ionic strength around the inflammasome complex [374]. 
Changes in ionic strength have been shown to trigger isolated pro-caspase-1 
[436]. The apoptosome is inactive in the presence of physiological 
concentrations of potassium, which indicate that this prevents APAF-1 
oligomerization and thus apoptosome formation. Cytochrome C is the mediator 
which overcomes potassium inhibition and drives the apoptosome into an active 
state [437].  
The resting membrane potential of a cell is -70 mV. The equilibrium potential is 
when the influx and efflux of ions are equal over the plasma membrane. The 
concentration gradient for potassium is outward from the cell, whereas the 
electrical is inward. This results in an equilibrium potential of -90 mV for 
potassium, which is different from the resting membrane potential. Sodium, on 
the other hand, has inward directed concentration and electrical gradient. This 
implies that the cell gradually gains sodium and lose potassium ions in order to 
maintain their resting membrane potential. However, due to the Na+-K+ ATPase 
there is an active transport of sodium out of the cell against its electrical 
gradient and this is coupled to an active transport of potassium into the cell. As 
discussed in the introduction, low intracellular potassium act as a danger signal 
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and activates the inflammasome complexes. When an ion on one side of the 
plasma membrane is inhibited in diffusion other ions will be affected in order to 
maintain the membrane potential [438]. At equilibrium there is an excess of 
cations on the outside of the cell and as a consequence an excess of anions on 
the inside, this is maintained by Na+-K+ ATPase [438]. This ATPase is electrogenic 
since it pumps out three sodium ions per two potassium ions, which contributes 
to the membrane potential. The number of ions required to maintain the 
membrane potential is a minute number of the total ion number present. 
Furthermore the concentrations of positive and negative ions are equal except 
along the cellular membrane. The cell membrane is more permeable to 
potassium due to potassium channels, due to this sodium does not compensate 
for the potassium efflux. A change in membrane potential could possibly trigger 
inflammasome activation, it has previously been shown to be involved in 
apoptosis [439]. Since the change in membrane potential is triggered by a 
minute number of the total ion concentration this would be impossible to 
measure using flame photometry and fluorescent microscopy imaging methods. 
In this study no change in intracellular potassium concentration could be seen 
with these methods, but when potassium efflux was inhibited so was the 
inflammasome activation. To further investigate this, a patch-clamp experiment 
could be performed where the membrane potential is changed and 
inflammasome activation following this treatment is investigated. Interestingly, 
infection with PAO1 leads to decreased intracellular potassium concentration in 
the host cell. The reason for this is unknown but might involve an additional lytic 
toxin.  
The amount of IL-1β secreted was found in this study to be dependent on 
extracellular potassium concentration, both for P.aeruginosa and Salmonella. 
Increasing amounts of extracellular potassium resulted in decreasing amounts of 
IL-1β secretion. This has been shown previously following stimulation with α-
toxin, where a clear dose-response was observed [367]. Interestingly the 
potassium-dependent inhibition decreased with the duration of LPS stimulation 
[367]. In this study cells were primed with LPS for 3 h before infection, 
furthermore LPS was present throughout the infection, which means the total 
time in LPS was 4.5 h. This was shown in a previously published study [367] to 
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result in some IL-1β secretion, which was also detected in this study, presumably 
due to the decreased potassium-dependent inhibition described.  
It was shown by Franchi et al. that inflammasome activation by extracellular 
bacteria such as E.coli and S.aureus requires ATP stimulation [236]. 
Furthermore, inflammasome activation by intracellular bacteria, such as 
Salmonella and Listeria, was shown to be independent of ATP and potassium 
efflux via the P2X7-receptor [236]. 
The results in this chapter describe potassium-dependent inflammasome 
activation by Salmonella, SL1344. This is in contrast to previously published 
results [236, 238]. Salmonella was originally intended to be used as a positive 
control. The differences from previous publications might be due to different 
conditions used. In the study by Petrilli et al. the high extracellular potassium 
media was added after 1 h of infection, which might give different results from 
this study where the potassium media was present throughout the infection. The 
inflammasome independent activation by Salmonella seen by Petrilli et al. might 
be due to activation of the inflammasome before addition of the high 
extracellular potassium, which is then detected upon analysis. The study by 
Franchi et al. used 20 mM KCl as their high potassium media, whereas all other 
conditions were identical to the results presented in this thesis. However, 20 mM 
KCl does not inhibit inflammasome activation for Salmonella or Pseudomonas, as 
seen in this study. Therefore, the results obtained in this thesis are similar to 
previously published data by Franchi et al. The potassium-dependent 
inflammasome activation by Salmonella has thus never been investigated in a 
similar manner to the results presented here.  
Addition of extracellular potassium to the media will have an effect on other 
ions as well, since the cell will try to maintain the membrane potential. Muruve 
et al. [440], used Glybenclamide to investigate the effects of inhibited 
potassium efflux on inflammasome activation by DNA. Glybenclamide is a 
blocker of ATP-dependent potassium channels in the plasma membrane. It will 
possibly still have an effect on the membrane potential, but not on the total ion 
concentration in the extracellular media. In this chapter, it was shown that 
inhibition by Glybenclamide resulted in inhibited inflammasome activation by 
P.aeruginosa as well as Salmonella. This further strengthens the theory that 
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inflammasome activation by these bacteria involves a crucial change in ionic 
environment.  
Pannexin-1 was identified as the protein responsible for the large pore formed 
upon activation of the P2X7R, as discussed in section 4.1.2. In the study by 
Pelegrin et al. pannexin-1-mimetic inhibitory peptide were used and this was 
shown to block ethidium bromide uptake as well as caspase-1 cleavage and IL-1β 
processing [346]. In this study pannexin-1 peptide was shown to block uptake of 
ethidium bromide. However, no effect could be detected on caspase-1 
activation and IL-1β release in any of the samples studied. The experiments 
were performed as described by Pelegrin et al. The pannexin-1 peptide was able 
to block ethidium bromide uptake in the experiments shown in this chapter, 
section 4.2.1.3. This means it is a fully functional reagent and the cell type used 
(BMDM) has P2X7R. However, no changes in IL-1β secretion were seen, which 
contradicts previously published results. In this study BMDM were used, whereas 
in the previously published results human THP1 macrophages, mouse J774 
macrophages and human alveolar macrophages were used. This indicates a 
difference depending on what cell type is being used. This suggests that there is 
not a role for IL-1β secretion by the pannexin-1 channel. Furthermore, there 
have not been any other publications describing the effect of a pannexin-1 
inhibitory peptide in IL-1β secretion, which suggests that the reagent is not very 
effective.  
In this study there was no effect of CBX treatment on IL-1β secretion from 
BMDM. This correlates with the lack of effect seen with the pannexin-1 inhibitory 
peptide. It is likely that there is no effect following CBX treatment when there is 
also a lack of effect following pannexin-1 treatment. In previously published 
results [346], a greater effect was seen following pannexin-1 treatment 
compared to CBX treatment. No conclusions can be drawn for the role of CBX in 
ethidium bromide uptake in this study as this was never investigated. 
A further study by Pelegrin et al. [333], showed that the dye-uptake via 
pannexin-1 following P2X7R activation is not necessary for inflammasome 
activation. It was found that the inflammasome activation by nigericin and 
maitotoxin is dependent on pannexin-1. Only noncytolytic pathways were 
investigated by using time periods where no LDH release could be observed. 
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Noncytolytic conditions for ATP stimulation following LPS priming has been 
shown to be 5 mM ATP for 20 min in J774 macrophages [333]. This also worked 
well in this study using BMDM. During the study presented in this thesis the LDH 
release following LPS-priming and ATP stimulation never resulted in significantly 
increased cytotoxicity. It has been known for some time that extracellular ATP 
triggers IL-1β secretion from macrophages in a potassium-dependent manner 
[379]. Previously published result also showed that the IL-1β secretion is not 
necessarily associated with cell death, since IL-1β was released before other 
cytoplasmic markers [379]. However, the bacteria do result in cell death 
following infection but for PA103 ΔUΔT it is rarely above 20 %. As previously 
discussed, the ethidium bromide uptake could be blocked by the pannexin-1 
inhibitory peptide in this study, whereas there was no effect on IL-1β secretion 
and thus inflammasome activation. The study by Pelegrin et al. shows that dye 
uptake is separate from inflammasome activation, but there is a role for 
pannexin-1 in the inflammasome activation. The previously published results 
used J774 macrophages, whereas in this study primary BMDM were used. This 
might explain the differences seen. Furthermore, the pannexin-1 inhibitory 
peptide has not been shown to block potassium-efflux, which has been shown to 
be a trigger for inflammasome activation. In the study by Pelegrin et al. it is 
discussed that the slow dye uptake seen might be due to incomplete block by 
the pannexin-1 peptide, which they believe is highly unlikely as the hemichannel 
function can be completely blocked in HEK cells stably expressing P2X7R. This 
further strengthens the possibility that different experimental set-ups might be 
responsible for the differences seen between previously published results and 
results presented in this study. The published study had the conditions optimized 
for J774 macrophages and the conditions needed to block the pannexin-1 in 
BMDM might be slightly different.  
The ethidium bromide uptake was not altered in high extracellular potassium in 
the investigation by Pelegrin et al. This is not something that was investigated in 
this study.  
Both Salmonella and P.aeruginosa have a T3SS, and both bacteria have been 
shown to activate the NLRC4 inflammasome dependent on ASC. In this study 
potassium-dependent inflammasome activation is seen during infection with 
both Salmonella and P.aeruginosa. This suggests a model where NLRC4 is 
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triggered by a functional T3SS as well as depolarization of the membrane via 
potassium efflux. In contrast NLRP3 has also been shown to be activated by 
potassium efflux triggered by bacterial toxins and other danger signals but not 
bacterial secretion systems or products delivered by these. Thus, the triggering 
of the different inflammasome complexes is dependent on the method by which 
the triggering signal is delivered. 
4.3.2 Pore formation by the T3SS and membrane repair 
As discussed in the introduction of this chapter, it was previously shown for 
Yersinia strains lacking effectors that this would allow dye uptake and release 
from infected cells through the pore formed by the T3SS. This was investigated 
in this study, but no leaky pore could be detected. Yersinia and Pseudomonas 
have homologous T3SS and these can complement each other [71]. We therefore 
hypothesized that the T3SS pore formed by Pseudomonas would behave similar 
to Yersinia. PA103 ΔUΔT used in this study lacks functional effectors passing 
through the T3SS and is therefore similar to the Yersinia used in previously 
published results [332]. The results shown in this study indicate that there are 
differences between the two different T3SS. Similar results to previously 
published data were obtained when SLO was used as a pore-forming toxin.  
Neyt et al. showed that the pore formed by the Yersinia T3SS allows passage of 
extra- or intracellular dyes when there are no effectors passing through the 
system. Under normal conditions where there are effectors being translocated, 
these block any T3SS leak. This study therefore shows a difference between the 
T3SS of P.aeruginosa compared to Yersinia, which was not previously known. 
Furthermore, it was shown by Roy et al. [392], that the T3SS of Yersinia and 
Salmonella allows passage of ethidium bromide into the host cell, a process 
which was shown to be dependent on a functional T3SS. This was shown for 
strains with and without effectors passing through the T3SS. The results 
presented in this chapter indicate that the T3SS of P.aeruginosa forms a tight 
association with the host cell and does not allow entry or exit of other molecules 
or ions. It has previously been shown by Sundin et al. that less than 0.1% of 
secreted effectors escape to the extracellular milieu, strengthening the theory 
of a tight association with the host cell [89]. However, the ethidium uptake was 
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never investigated during infection with P.aeruginosa, but results with the other 
experiments suggest that no uptake would be detected. 
It has been shown that the T3SS of Salmonella allows passage of calcium [391, 
392]. The ability of the T3SS formed by P.aeruginosa to allow passage of ions 
was investigated in this study. No passage of ions could be detected during 
infection with P.aeruginosa. Other work in the laboratory showed that calcium 
entered the cells following infection with P.aeruginosa, which has a functional 
ExoU toxin, which is a result of its cytolytic activity. The microscopic methods 
for measuring changes in ion concentrations following infection described in this 
chapter, have not been described previously. 
Membrane repair can be analysed by detection of LAMP-1 on the cellular 
surface, as well as release of lysosomal contents such as β-hexosaminidase. Both 
of these methods were used to investigate membrane repair following infection 
by P.aeruginosa. LAMP-1 was detected on the cellular surface following infection 
in a T3SS-dependent manner similar to results previously published for 
Salmonella and Yersinia [392], using fluorescent microscopy method. This 
staining was quantified using LSC. It was previously described that LAMP-1 
relocation can be detected by LAMP-1 specific FACS-staining [413, 441]. During 
this study the LAMP-1 FACS-staining was unsuccessful.  
In contrast to LAMP-1 staining however, no release of β-hexosaminidase could be 
detected, not even for the positive control with ionomycin, which is in contrast 
to previous publication [413]. This method would need further optimisation, but 
due to the time constraints for this project this has not been done.  
As discussed in the introduction, it has been shown that Syt VII is involved in the 
cellular response to Salmonella, as well as Yersinia [392]. One of the aims of this 
study was to investigate the role of Syt VII during infection with P.aeruginosa. 
Attempts were made to silence Syt VII using siRNA and then investigate the 
effects following infection. However, no success was made in the attempts to 
silence the Syt VII expression. There are several different isoforms and splice 
variants of Syt VII [424] and all of them were never silenced at once. Due to this 
unsuccessful result, attempts were made to investigate the role of Syt VII in 
inflammasome activation by P.aeruginosa using KO BMDM provided by N.W 
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Andrews at Yale University. This has not been investigated previously. However, 
no role for Syt VII in inflammasome activation by P.aeruginosa could be 
determined. The trends in IL-1β secretion in Syt VII KO mice suggest a role for 
Syt VII in the release of IL-1β, since more IL-1β is secreted in these cells in 
response to ATP and infection. Further studies are needed in order to determine 
a role for Syt VII in IL-1β secretion. It has recently been proposed that Syt VII has 
a role in translocation of MHC to the cell surface during DC maturation [442]. 
In conclusion, the results presented in this chapter show a novel potassium-
dependent inflammasome activation by P.aeruginosa, as well as a not previously 
described potassium-dependent inflammasome activation by Salmonella. 
Furthermore, it is shown that the T3SS of P.aeruginosa forms a tight association 
upon contact with the host cell, which does not allow entry or exit of other 
molecules and ions. These results are in contrast to previously published results. 
Finally, it is shown that membrane repair from lysosomes is triggered following 
infection, but no conclusions can be drawn considering the involvement of Syt 
VII.  
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5 Inflammasome activation by Pseudomonas 
aeruginosa – Role of flagellin and pilin 
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5.1 Introduction 
5.1.1 NLRC4-dependent inflammasome activation 
Activation of the NLRC4 inflammasome has been shown to be important in host 
defence for a number of pathogens. The first bacterium described to activate 
the inflammasome in a NLRC4-dependent manner was Salmonella typhimurium 
[234]. Despite this NLRC4-deficient mice did not have enhanced susceptibility to 
infection with S.typhimurium but caspase-1-deficient mice did [350]. This 
indicates that additional pathways are involved in the caspase-1 activation by 
Salmonella. L.pneumophila also activates the inflammasome in a NLRC4-
dependent manner [352]. In addition, NLRC4 plays a role in L.pneumophila 
mediated phagosome maturation, NLRC4- and caspase-1 deficient mice allowed 
bacterial phagosomal replication due to a deficient phagosome-lysosome fusion 
[443]. S.flexneri is another example of a pathogen which activates caspase-1 
dependent on NLRC4 [254]. As previously discussed, P.aeruginosa has also been 
shown to activate the inflammasome in a NLRC4-dependent manner [249, 253, 
354]. Additionally it has been shown that NLRC4-deficient mice are more 
susceptible to infection by P.aeruginosa in a pulmonary and peritoneal in vivo 
infection model [249, 253].  
NLRC4 can interact directly with pro-caspase-1 through a CARD-CARD 
interaction. Therefore the role of the adaptor molecule ASC is unclear. It might 
have a role in stabilizing the complex or facilitating caspase-1 recruitment [161]. 
Despite this, a number of publications have detected a role for ASC in NLRC4-
dependent caspase-1 activation. Infection with S.typhimurium, S.flexneri and 
P.aeruginosa are all dependent on ASC [234, 249, 254]. In addition it has been 
shown, as previously discussed in chapter 3.1.2., that NAIP5 plays a role in 
NLRC4-dependent inflammasome activation by L.pneumophila [251, 352, 357]. In 
contrast, it has been shown that A/J mice (NAIP5-deficient) were unaffected by 
the NAIP5-deficiency following infection by S.typhimurium, P.aeruginosa and 
L.monocytogenes [354].  
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So far a critical component to activate the NLRC4-inflammasome is a functional 
type III or type IV secretion system. This has been shown for S.typhimurium, 
P.aeruginosa, L.pneumophila and S.flexneri (Figure 5.1) [246, 248, 249, 352].  
5.1.2 Flagellin-dependent inflammasome activation 
Flagellin-deficient mutants from S.typhimurium and L.pneumophila are 
defective in their ability to activate the inflammasome complex [251, 337, 351, 
352, 390]. Furthermore, following transfection of flagellin it was shown that the 
NLRC4-inflammasome was activated [337, 390]. This led to the hypothesis that 
flagellin monomers gain entry into the cytosol of infected cells through a T3SS or 
T4SS (Figure 5.1) [337, 390]. It has been shown that the T3SS can act as a 
conduit for flagellin, strengthening this hypothesis further [365]. In addition, 
flagellin monomers are assembled into a flagellum by passage through a flagellar 
T3SS [444]. The direct binding of flagellin to the LRR-region of NLRC4 has not 
been demonstrated. The molecular basis of inflammasome activation in response 
to flagellin from L.pneumophila was recently described [312]. It was shown that 
the C-terminal portion of flagellin is enough to trigger a NLRC4- and NAIP5-
dependent inflammasome response. 
However, flagellin cannot be the only NLRC4 activator since the non-flagellated 
bacterium S.flexneri, as well as P.aeruginosa, previously described in chapter 3, 
can still activate the NLRC4-inflammasome (Figure 5.1) [227, 249]. Furthermore, 
at high MOIs it was shown that flagellin-deficient S.typhimurium were still able 
to induce IL-1β secretion [337].  
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Figure 5.1; Flagellin-dependent inflammasome activation 
Activation of caspase-1 following infection of S.typhimurium, P.aeruginosa, S.flexneri or 
L.pneumophila requires a functional type III or type IV secretion system. Caspase-1 binds NLRC4 
via homophilic CARD-CARD interactions, which leads to activation of caspase-1. ASC is required 
for NLRC4-mediated caspase-1 activation by S.typhimurium, P.aeruginosa and S.flexneri, whereas 
L.pneumophila requires NAIP5. P.aeruginosa, S.typhimurium and L.pneumophila activates the 
NLRC4 in a flagellin-dependent manner. NLRC4-activation can also occur independently of 
flagellin following infection by P.aeruginosa and S.flexneri. 
 
5.1.3 Pilin 
Pili are located at the bacterial surface as protruding hair-like organelles. Type 
IV pili are expressed by many Gram-negative bacteria such as EPEC, EHEC, 
Salmonella enterica serovar Typhi, Pseudomonas aeruginosa, Legionella 
pneumophila, Neisseria gonorrhoeae, Neisseria miningitidis and Vibrio cholerae 
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[26], as previously described in chapter 1.2.2.2. The type IV pili are composed of 
a homopolymer of a single pilin subunit, such as PilA in P.aeruginosa. The pili 
are formed at the cytoplasmic membrane and the intact organelle is extruded 
across the outer membrane [50]. Type IV pili are able to retract through the 
bacterial cell wall while the tip remains adhered to the target surface, resulting 
in bacterial cell movement known as twitching motility. Pilin monomers in the 
bacterial cell are used to retract and rebuild the pili structure [48-50].  
The work in this chapter investigates the role of pilin, as well as flagellin as 
inflammasome activators. This is investigated by transfection experiments and 
infection models. The results reveal pilin as a novel inflammasome activator, 
thus providing an explanation to how flagellin-deficient bacteria can activate 
the NLRC4-inflammasome.  
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5.2 Results 
5.2.1 Flagellin-dependent inflammasome activation 
Flagellin have been shown to activate the inflammasome in a number of 
publications [251, 253, 337, 351, 354, 390, 443]. Here recombinant flagellin 
from Salmonella muenchen was used to confirm that flagellin was able to 
activate the inflammasome. Following transfection into BMDM IL-1β was released 
into the supernatant in a flagellin-dependent manner (Figure 5.2). As a control, 
cells treated with ATP were used, which also triggers IL-1β release (Figure 5.2). 
In addition, transfection with flagellin results in some cytotoxicity of the cells, 
whereas ATP-dependent inflammasome activation does not (Figure 5.2), as 
previously described in chapter 4.  
 
Figure 5.2; Flagellin-dependent inflammasome activation 
LPS-primed BMDM were transfected with Flagellin (630 ng / 2.5x105 cells) together with FuGene or 
treated with ATP. Supernatants were analysed by ELISA for IL-1β release (A) and by LDH release 
for percent cytotoxicity (B). Columns are means for triplicates and error bars are SEM.  
 
Transfected flagellin results in caspase-1 activation, which could be detected by 
immunoblotting of the p10 fragment (Figure 5.3). The transfection reagent or 
flagellin alone did not result in caspase-1 activation, as no p10 band could be 
detected for these samples (Figure 5.3). This corresponds to the IL-1β secretion 
seen from these samples (Figure 5.2).  
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Figure 5.3; Flagellin transfection results in caspase-1 activation 
Cell lysates from LPS-primed BMDM transfected with Flagellin together with FuGene were 
immunoblotted with caspase-1 antibody. Activated caspase-1 (p10) can be detected when cells are 
treated with flagellin together with FuGene.  
 
It has previously been shown that P.aeruginosa can activate the inflammasome 
in a flagellin-dependent manner [253, 354]. This was shown for the strains PAK 
and PAO1. Following infection with a flagellin-deficient mutant of PAO1 
significantly less IL-1β is released compared to the WT strain (Figure 5.4). 
Furthermore, if a strain which lacks flagellin (PAOC) is complemented with 
flagellin from PAO1 the inflammasome activation is restored (Figure 5.4). 
Infection with the complemented strain results in significant higher levels of IL-
1β release compared to the WT strain. This can possibly be explained by a higher 
level of expression from the complementing plasmid compared to wildtype 
levels.  
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Figure 5.4; PAO1 activates the inflammasome in a flagellin-dependent manner 
BMDM were primed with LPS and treated with ATP or left unprimed and were infected with PAO1 
WT, PAO1 FliC- and PAOC:PAO1 FliC for 90 min at a MOI of 50. Columns are mean of triplicates 
and error bars are SEM. ** and *** indicate significant difference where ** is p<0.01 and *** is 
p<0.001, unpaired Student’s t-test.  
 
The caspase-1 activation was also investigated following infection with PAO1 
WT, FliC- and complemented PAOC; PAOC:PAO1 FliC. The caspase-1 activation 
corresponds to the IL-1β release detected, where the strains with flagellin are 
able to activate caspase-1, whereas the flagellin deficient strain does not 
(Figure 5.5 Top panel). Pro-caspase-1 levels were similar in all samples (Figure 
5.5 Lower panel).  
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Figure 5.5; PAO1 activates caspase-1 in a flagellin-dependent manner 
Cell lysates from Figure 5.4 were immunoblotted with caspase-1 antibody. Top panel shows pro-
caspase-1 and activated caspase-1 (p10), whereas bottom panel shows a shorter exposure of pro-
caspase-1. 
 
Flagellin can be purified from bacteria by simply vortexing the culture, as 
described in chapter 2. It is previously known that PAO1 express flagellin 
whereas PA103 does not [23, 445]. Flagellin was purified from PAO1 WT and 
proteins were stained with colloidal Coomassie blue after resolving on a SDS-
PAGE gel (Figure 5.6). At the same time proteins that were shed from PA103 
ΔUΔT during the purification was resolved and stained. As expected, no flagellin 
could be detected from PA103 ΔUΔT. However, there was another protein of ~16 
kDa detected in the cell-free supernatant (Figure 5.6).  
 
Figure 5.6; PA103 ΔUΔT lacks flagellin, whereas PAO1 WT express flagellin 
Surface proteins were purified from PA103 ΔUΔT and PAO1 WT, two concentrations of these 
proteins were resolved by SDS-PAGE and stained with Colloidal Coomassie blue. 
191 
 
Attempts were made to detect flagellin from whole cell cultures of PA103 ΔUΔT 
and PAO1 by immunoblotting. This was never successful, possibly due to the high 
concentration of protein. Instead, surface proteins were purified from these 
strains and resolved using SDS-PAGE, as above (Figure 5.6). Following 
immunoblotting with a flagellin antibody, flagellin could be detected from PAO1 
WT but not from PA103 ΔUΔT, as expected (Figure 5.7). Flagellin from PAO1 has 
a molecular mass of approximately 53 kDa [446]. 
 
Figure 5.7; PAO1 WT express flagellin 
Purified surface proteins from PA103 ΔUΔT and PAO1 WT were immunoblotted with flagellin 
antibody.  
 
Flagellin expression allows the bacteria to swim on an agar plate with low 
percentage agar (0.5%) [447]. PAO1 WT and PA103 ΔUΔT were inoculated onto 
swimming plates, following incubation, a distinct swimming pattern could be 
seen for PAO1 WT, whereas PA103 ΔUΔT did not swim (Figure 5.8).  
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Figure 5.8; PAO1 WT can swim whereas PA103 ΔUΔT cannot 
PAO1 WT and PA103 ΔUΔT were inoculated onto a swimming plate (LB with 0.5% agar) and 
incubated overnight at 37°C. Black scale bar is 10 mm.  
 
Together these results show that flagellin can activate the inflammasome and 
that PAO1 activates the inflammasome in a flagellin-dependent manner. 
However, PA103 ΔUΔT can activate the inflammasome, described in chapter 3, 
independent of flagellin. The results here confirm that PA103 ΔUΔT lacks 
flagellin.  
5.2.2 Pilin-dependent inflammasome activation 
When PA103 ΔUΔT is exposed to a flagellin purification method no flagellin can 
be detected, instead a protein of roughly 16 kDa was found (Figure 5.6). Since 
PA103 ΔUΔT can activate the NLRC4 inflammasome dependent on ASC but 
independent of flagellin, this detected protein could be a candidate for the 
inflammasome activation. The 16 kDa protein was isolated by SDS-PAGE and 
blotting and digested with trypsin. Peptides were separated by liquid 
chromatography and individual peptides isolated and sequenced by mass 
spectroscopy at the University of Dundee by K. Beattie. Matches to the peptide 
sequences were obtained using the programme MASCOT (Matrix science). The 
sequencing revealed that the protein purified was pilin from PA103 with a mass 
of 15.8 kDa (Table 5.1). The other proteins which were identified correspond to 
contaminants, such as keratin and trypsin at low abundance (Table 5.1). The 
entire MASCOT result is presented in appendix 1.  
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Table 5.1; Results obtained after Mass-spec sequencing of purified PA103 ΔUΔT surface 
protein 
Protein gi # Mass 
(Da) 
Score Queries 
matched 
emPAI 
Pilin strain PA103 120436 15789 830 24 17.27 
Cytokeratin-1 1346343 65978 174 2 0.13 
PilE strain PAO1 15599752 15270 85 1 0.28 
Keratin 9 453155 61950 66 1 0.07 
Trypsin precursor 
bovine 
67549 23978 65 1 0.18 
gi #; gene info identifier, emPAI; exponentially modified protein abundance index 
 
To confirm this result, pilin was purified from PA103ΔUΔT using published 
protocols. Again, a significant release of IL-1β following transfection with PA103 
pilin compared to the transfection reagent alone were found (Figure 5.9A), 
similar to levels obtained using transfected flagellin. Furthermore, no effect was 
detected from PA103 pilin alone (Figure 5.9A). In this experiment the 
cytotoxicity resulting from transfections was relatively high (Figure 5.9B). This is 
most likely to be due to an effect of the transfection reagent DOTAP rather than 
a specific effect of pilin, discussed below.  
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Figure 5.9; PA103 pilin-dependent inflammasome activation 
LPS-primed BMDM were treated with DOTAP, Flagellin or PA103 pilin as indicated for 3h. 
Supernatants were analysed for IL-1β release by ELISA (A) and percent cytotoxicity by LDH 
release assay (B). Columns are means of triplicates and error bars are SEM. * and ** indicate 
significant difference where * is p<0.05 and ** is p<0.01, unpaired Student’s t-test.  
 
Both flagellin and pilin are able to trigger inflammasome activation. PA103 pilin 
was transfected into cells and compared to the response seen following OVA 
transfection. Significantly more IL-1β is released from cells after transfection 
with PA103 pilin compared to transfected OVA (Figure 5.10). OVA transfection 
does not result in IL-1β release compared to the transfection reagent alone 
(Figure 5.10).  
195 
 
Figure 5.10; Pilin-dependent inflammasome activation 
LPS-primed BMDM were treated with DOTAP, pilin and OVA, as indicated. Supernatants were 
analysed for IL-1β release by ELISA. Columns are means of triplicates and error bars are SEM. * 
indicate significant difference where * is p<0.05, unpaired Student’s t-test.  
 
Previous publications have investigated the response following protein 
transfection after 2 and 3 h, respectively [337, 390]. The response to PA103 pilin 
was investigated at different time-points, up to 3 h. It was found that the 
amount of IL-1β secreted increased with increasing transfection time (Figure 
5.11A). The cytotoxicity caused remains below 10% for the transfected protein 
over the entire time period tested (Figure 5.11B). In this experiment the cell 
death caused by DOTAP alone is low (Figure 5.11B).  
 
Figure 5.11; Increasing transfection time results in increasing inflammasome activation by 
PA103 pilin 
LPS-primed BMDM were treated with DOTAP and PA103 pilin for indicated times. Supernatants 
were analysed for IL-1β release by ELISA (A) and percent cytotoxicity by LDH release assay (B). 
Means of triplicates are plotted, error bars are SEM. * and ** indicate significant difference where * 
is p<0.05 and ** is p<0.01, ns is non significant difference p>0.05, unpaired Student’s t-test. 
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The inflammasome activation by transfected flagellin could be completely 
abrogated after overnight treatment with Proteinase K [337]. To investigate 
whether the same was true for transfected pilin, PA103 pilin was treated with 
Proteinase K for 60 min according to manufacturer’s instructions. In addition, 
the pilin preparation was boiled in order to investigate whether this has an 
effect on the inflammasome activation observed following pilin transfection. 
Both transfected Proteinase K treated and boiled pilin results in less, but not 
significantly less, IL-1β secretion compared to pilin alone (Figure 5.12A). The 
transfected Proteinase K and boiled pilin are not significantly different from 
DOTAP alone, but the trend suggests that they are not completely without effect 
(Figure 5.12A). The cytotoxicity remains low and constant for all samples (Figure 
5.12B).  
 
Figure 5.12; Less IL-1β is released following boiling or Proteinase K treatment of pilin 
Pilin were boiled, treated with Proteinase K or left untreated and transfected into LPS-primed 
BMDM for 3.5 h. Supernatants were analysed for IL-1β release by ELISA (A) and percent 
cytotoxicity by LDH release assay (B). Columns are means of triplicates and error bars are SEM. * 
indicate significant difference where * is p<0.05, ns is non-significant difference p>0.05, unpaired 
Student’s t-test. 
 
The Proteinase K treated and boiled pilin were also visualised using SDS-PAGE 
and colloidal Coomassie blue staining. Following Proteinase K treatment, an 
undigested core of pilin could be observed at approximately 7 kDa (Figure 5.13). 
Not surprisingly, the boiled pilin has the same molecular weight as the purified 
pilin, since they are both boiled prior to loading onto the gel (Figure 5.13).  
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Figure 5.13; PA103 pilin has a core which is unaffected by Proteinase K treatment 
PA103 pilin was left untreated, boiled or treated with Proteinase K. These samples were then 
resolved by SDS-PAGE and stained by Colloidal Coomassie blue.  
 
The results presented in this section shows that PA103 pilin can activate the 
inflammasome, comparable to inflammasome activation seen by flagellin.  
5.2.3 PA103 and PAO1 pilin-dependent inflammasome activation 
PA103 pilin was shown, in the previous section, to be able to activate the 
inflammasome response. To investigate whether PAO1 pilin activates the 
inflammasome in a similar manner, attempts were made to purify pilin from the 
PAO1 strain. When pilin is purified from PAO1 WT, using the protocol described 
in section 2.2.18, the same protocol which is used to purify pilin from PA103, the 
resulting proteins are flagellin (Figure 5.6). In order to obtain pilin from PAO1 
using this purification protocol it is necessary to use flagellin-deficient PAO1; 
PAO1 FliC-. Pilin purification from this strain results in a band comparable to 
that of PA103 pilin (Figure 5.14).  
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Figure 5.14; Pilin purified from PA103 ΔUΔT and PAO1 FliC- 
Pilin was purified from PA103 ΔUΔT and PAO1, resolved by SDS-PAGE and stained with Colloidal 
Coomassie blue.  
 
The ability of PAO1 pilin to activate the inflammasome complex was compared 
to that of PA103 pilin. Cells were transfected with increasing amounts of pilin 
(Figure 5.15). As a control OVA was used, as well as DOTAP alone. Increasing 
amounts of PA103 pilin being transfected into the BMDM results in increasing 
amounts of IL-1β secretion (Figure 5.15A). Transfection with PAO1 pilin does 
result in significantly more IL-1β secretion compared to transfection reagent 
alone (Figure 5.15A), but not to the same degree as PA103 pilin. The cytotoxicity 
mediated by the two different pilins are not significantly different from the 
cytotoxicity observed following treatment with DOTAP alone (Figure 5.15B).  
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Figure 5.15; Pilin-dependent inflammasome activation by PA103 and PAO1 pilin 
LPS-primed BMDM were transfected with indicated conditions for 3.5 h. Supernatants were 
analysed for IL-1β release by ELISA (A) and percent cytotoxicity by LDH release assay (B). Means 
of triplicates are plotted with error bars (SEM). Asterixes indicate significant difference where * is 
p<0.05, ** is p<0.01 and *** is p<0.001, ns is non-significant difference p>0.05, unpaired Student’s 
t-test.  
 
Transfected PA103 pilin can activate caspase-1, since a p10 band can be 
detected following pilin transfection (Figure 5.16). Neither pilin alone, DOTAP 
alone, nor OVA, with or without DOTAP, activates caspase-1 (Figure 5.16).  
 
Figure 5.16; PA103 pilin-dependent caspase-1 activation 
Cell lysates from indicated samples from Figure 5.15 were immunoblotted with caspase-1 antibody. 
Only pilin together with DOTAP results in caspase-1 activation (p10 band, black arrow head). Pro-
casapse-1 can be detected in all samples (white arrow head).  
 
Increasing transfected amounts of both PA103 pilin and PAO1 pilin results in 
increasing caspase-1 activation (Figure 5.17). The PAO1 pilin does not seem as 
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potent as the PA103 pilin, since PAO1 pilin transfection results in less caspase-1 
activation. This is comparable to the IL-1β secretion seen (Figure 5.15A).  
 
Figure 5.17; PA103 pilin activates more caspase-1 than PAO1 pilin 
Cell lysates from Figure 5.15 were immunoblotted with caspase-1 antibody. Top panel shows 
caspase-1 activation in these samples. Bottom panel is a longer exposure of the same film.  
 
Pilin transfection does not result in increased secretion of IL-6 or TNF-α 
compared to cells alone (Figure 5.18).  
 
Figure 5.18; IL-6 and TNF-α release are not dependent on pilin transfection 
Supernatants from Figure 5.15 were analysed for IL-6 release (A) and TNF-α release (B) by ELISA. 
Columns are pooled triplicate samples.  
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The results presented in this section show that both pilin from PA103 and PAO1 
can activate the inflammasome complex. PA103 pilin seems to be more potent 
than PAO1 pilin, discussed in more detail below.  
5.2.4 Recombinant pilin-dependent inflammasome activation 
Purification of recombinant pilin and crystallisation is impossible unless the 
expressed protein lacks the N-terminal hydrophobic α-helix [40], as this 
produces aggregation and renders the recombinant protein insoluble. A 
truncated version of the PA103 pilin coding DNA was constructed, lacking the N-
terminal hydrophobic helix. This was engineered to contain a His-tag by cloning 
into the pET41c vector, which produces the pilin fused to the Glutathione S-
transferase (GST) protein which increases expression levels and solubility. The 
recombinant truncated form of PA103 pilin fused to GST was then expressed by 
E.coli and purified from bacterial lysates on a Ni-NTA His-Bind column, as 
described in chapter 2.2.22. The eluted His-tagged pilin-GST was then cleaved 
with recombinant Enterokinase and the His-tagged GST protein was removed on 
a second Ni-NTA His-Bind column (Figure 5.19).  
 
Figure 5.19; Purification of recombinant PA103 pilin 
Following expression of PA103 pilin in E.coli the proteins were eluted from the NiNTA agarose 
column in indicated fractions. This was then cleaved by recombinant Enterokinase and cleaned on 
NiNTA agarose again. The elutes, cleaved and pure proteins were resolved on a SDS-PAGE gel 
and stained by Colloidal Coomassie blue. Pure pilin from fraction 3 was used in subsequent 
experiments. 
 
The purified recombinant pilin was transfected into BMDM to investigate 
whether it could activate the inflammasome complex. Following transfection 
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with recombinant pilin, IL-1β is secreted from BMDM (Figure 5.20A). The 
cytotoxicity remains low for all samples (Figure 5.20B).  
 
Figure 5.20; Recombinant PA103 pilin can activate the inflammasome 
LPS-primed BMDM were transfected with 500 ng OVA or recombinant PA103 pilin for 3.5 h. 
Supernatants were analysed for IL-1β release by ELISA (A) and percent cytotoxicity by LDH 
release assay (B). Columns are means for triplicates and error bars are SEM.  
 
So far, it has been shown that PA103, PAO1 and recombinant pilin can activate 
the inflammasome complex. The three different pilin preparations were 
compared in their ability to induce secretion of IL-1β. All of the pilin 
preparations result in significantly more IL-1β secretion than the transfection 
reagent alone (Figure 5.21A). As previously seen, OVA transfection does not 
result in IL-1β secretion (Figure 5.21A). Furthermore, PA103 pilin transfection 
results in significantly more IL-1β secretion than PAO1 and recombinant pilin 
(Figure 5.21A). This further strengthens the theory that PA103 pilin is more 
potent than PAO1 pilin. It also suggests a role for the N-terminal α-helix, which 
is lacking in the recombinant pilin.  
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Figure 5.21; Comparison between PA103, PAO1 and recombinant pilin  
LPS-primed BMDM were transfected with 500 ng of indicated proteins for 3.5 h. Supernatants were 
analysed for IL-1β release by ELISA (A) and percent cytotoxicity by LDH release assay (B). 
Columns are means of triplicates and error bars are SEM. ** and *** indicates significant difference 
where ** is p<0.01 and *** is p<0.001, ns is non-significant difference p>0.05, unpaired Student’s t-
test.  
 
It was recently shown that DNA can activate the inflammasome complex and 
result in IL-1β secretion, as well as caspase-1 activation [440]. Following digest 
of the DNA by DNase I this activation was completely abrogated. In order to 
determine if the pilin preparations were contaminated by DNA, which would 
then be responsible for the inflammasome activation, the DNA content in the 
preparations were investigated by agarose gel-dependent determination of DNA 
concentration and following DNase I treatment. The DNA concentration found in 
the pilin preparations was less than 2 µg/ml for both PA103 and PAO1, the limit 
of detectability of the ethidium binding assay. This means that for a 20 ng/µl 
pilin preparation, when this is transfected into cells at an amount of 300 ng, a 
maximum of 30 ng of DNA is transfected with the pilin. It was therefore 
investigated whether 50 ng DNA (plasmid) was able to activate the 
inflammasome, as well as whether DNase I treatment of PA103 and recombinant 
pilin had any effect on the inflammasome activation seen. Transfection of DNase 
I treated pilin had no effect on the inflammasome activation (Figure 5.22). 
Significantly more IL-1β was secreted following transfection with all the pilin 
preparations, independent of DNase I treatment, compared to the transfection 
reagent alone (Figure 5.22). If anything there was an increase in IL-1β secretion 
following transfection with DNase I treated samples. In contrast, the DNA was 
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able to induce IL-1β secretion, but this was completely abrogated following 
treatment with DNase I (Figure 5.22).  
 
Figure 5.22; DNA contamination of pilin preparations are not responsible for the 
inflammasome activation seen 
PA103 pilin, pCDNA3 plasmid and recombinant pilin were treated with DNase I. LPS-primed 
BMDM were then transfected with indicated samples for 3.5 h. Supernatants were analysed for IL-
1β release by ELISA. Columns are means for triplicates and error bars are SEM. *** indicate 
significant difference compared to DOTAP alone where *** is p<0.001, unpaired Student’s t-test. 
 
5.2.5 The inflammasome component dependence of pilin 
Inflammasome activation by P.aeruginosa PA103 is dependent on a functional 
T3SS, NLRC4 and ASC, as described in section 3.2.2. BMDM with deletions for 
specific inflammasome components were transfected with PA103 pilin. 
Surprisingly, inflammasome activation by PA103 pilin was dependent on caspase-
1 but independent of NLRC4, NLRP3 and ASC (Figure 5.23A). Slightly higher 
cytotoxicity was seen in the samples transfected with pilin (Figure 5.23B). The 
caspase-1 activation corresponds to the IL-1β secretion seen, both for cell 
lysates and precipitated proteins (results not shown).  
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Figure 5.23; PA103 pilin-dependent inflammasome activation is dependent on caspase-1 
LPS-primed BMDM from mice with KO:s for specific inflammasome components were transfected 
with DOTAP (2 µg/well), PA103 pilin (300 ng) or DOTAP together with PA103 pilin. Supernatants 
were analysed for IL-1β release by ELISA (A) and percent cytotoxicity by LDH release assay (B). 
Columns are means of triplicates and error bars are SEM. Nd is non-detected.  
 
Similar to PA103 pilin, the inflammasome component dependence of 
recombinant pilin transfection was also investigated. Unexpectedly, it was found 
that inflammasome activation by transfected recombinant pilin is dependent on 
NLRP3, ASC and caspase-1 (Figure 5.24A). The cytotoxicity is equivalent and low 
in all samples (Figure 5.24B).  
 
Figure 5.24; Recombinant pilin activates the inflammasomes dependent on NLRP3, ASC and 
caspase-1 
LPS-primed BMDM from mice with KO:s for specific inflammasome components were transfected 
with DOTAP (2 µg/well), recombinant pilin (300 ng) or DOTAP together with recombinant pilin. 
Supernatants were analysed for IL-1β release by ELISA (A) and percent cytotoxicity by LDH 
release assay (B). Columns are means of triplicates and error bars are SEM. ** indicate significant 
difference compared to DOTAP alone where ** is p<0.01, unpaired Student’s t-test.  
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The caspase-1 activation detected by immunoblotting in cell lysates following 
transfection with recombinant pilin corresponds to the IL-1β secretion seen. 
Caspase-1 is activated in a NLRP3, ASC and caspase-1 dependent manner (Figure 
5.25).  
 
Figure 5.25; Caspase-1 activation by recombinant pilin is dependent on NLRP3, ASC and 
caspase-1 
Cell lysates from Figure 5.24 were immunoblotted with caspase-1 antibody.  
 
No difference could be detected in IL-1 release between A/J mice and C57Bl/6 
mice following infection with P.aeruginosa, which implies that NAIP5 is not 
involved in the inflammasome activation by this bacterium, described in chapter 
3.2.3. No difference in IL-1β secretion following transfection with PA103 pilin 
could be seen in A/J mice compared to C57/BL6 (Figure 5.26A). Similar to 
effects seen during infection, a slightly higher cytotoxicity could be detected in 
the C57/BL6 cells compared to A/J cells for all samples tested (Figure 5.26B). 
The reason for this remains unknown.  
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Figure 5.26; Inflammasome activation by PA103 pilin is not affected in A/J mice 
LPS-primed BMDM from C57/BL6 and A/J mice were transfected with indicated samples (500 ng 
protein and 2 µg/well DOTAP). Supernatants were analysed for IL-1β release by ELISA (A) and 
percent cytotoxicity by LDH release assay (B). Columns are means of triplicates and error bars are 
SEM.  
 
5.2.6 Retroviral transduction of pilin 
A recently published method investigated the effect of retrovirally transduced 
flagellin on inflammasome activation, using inflammasome-dependent cell 
death, pyroptosis, as the marker of inflammasome activation [312]. It is argued 
that this eliminates the possibility that bacterial secretion systems, transfection 
reagents and/or bacterial contaminants that might contribute to the activation 
of caspase-1 [312]. So far the results presented in this chapter have investigated 
a pilin-dependent inflammasome activation following transfection of the 
protein. To investigate whether pilin can activate caspase-1 after retroviral 
transduction similar to flagellin, PA103 pilin was cloned into the retroviral MigR1 
vector. This vector will express cloned DNA, as well as GFP, via an internal 
ribosomal entry site (IRES). Thus, GFP expression can serve as a surrogate for 
expression of the cloned DNA. Retroviruses were generated from the retroviral 
packaging cell line GP+E.86 and BMDM were transduced with these viruses. 
Following incubation, the BMDM were analysed using FACS to detect GFP-
expression. Untransduced BMDM were used as a control. Cells analysed on FACS 
were gated based on their side-scatter and forward-scatter properties (Figure 
5.27). The cells were stained with 7AAD (a marker of cell viability) and the cells 
gated based on their FSC and SSC were further gated based on their 7AAD 
staining (Figure 5.27). 7AAD negative cells were then gated based on their GFP-
expression into a high and total GFP-expressing population (Figure 5.27). 
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Untransduced cells do not express any GFP, as expected (Figure 5.27). Of the 
BMDM transduced with retroviral expression vector alone 6.21% expressed GFP 
and 1.69% of these were GFP high (Figure 5.27). In contrast BMDM transduced 
with MigR1 pilin had a lower level of GFP expression, 3.96%, and virtually no 
cells had high GFP expression (Figure 5.27). These results indicated that the 
cells could tolerate a low level of GFP expression following transfection with 
MigR1 pilin, but GFP high cells would die due to cytotoxicity caused by 
inflammasome activation by pilin.  
 
Figure 5.27; Gating during FACS analysis of retroviral transduced BMDM 
Transduced or untransduced BMDM were first gated based on their forward and side scatter (SSC 
vs FSC where the gate is for 59.7% (-), 61.7% MigR1 and 63.1% MigR1 pilin, top panel). These 
were then gated based on 7AAD staining (Percent 7AAD- 97.4% (-), 94.1% MigR1 and 94.3% 
MigR1 pilin, middle panel). 7AAD- cells were finally gated based on GFP expression (bottom 
panel). Two populations were indentified, GFP low (0.2% (-), 6.21% MigR1 and 3.96% MigR1 pilin) 
and GFP high (0% (-), 1.69% MigR1 and 0.048% MigR1 pilin). 
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Previously, it was shown that the GFP-expression following transduction with 
flagellin initially increased, but as the cells died the expression then decreased 
[312]. Therefore, BMDM were transduced with MigR1 or MigR1 pilin and analysed 
at set time points following this transduction. There was more GFP-expression at 
a higher level after transduction with MigR1 compared to MigR1 pilin at all time 
points (Figure 5.28). Again this indicates that there is a selective loss of cells 
transfected with MigR1 pilin that have high pilin expression levels. 
 
Figure 5.28; There are more GFP+ cells following transduction with MigR1 compared to 
MigR1 pilin 
BMDM were transduced with MigR1 or MigR1 pilin and incubated for indicated time points. 7AAD- 
cells were gated based on GFP expression. GFP+ cells were after 24 h 4.44% for MigR1 compared 
to 0.79% for MigR1 pilin, after 48 h 14.3% MigR1 and 6.68% MigR1 pilin, after 72 h 25.4% MigR1 
and 10.2% MigR1 pilin and after 96 h 25.9% MigR1 and 4.84% MigR1 pilin.  
 
There were less GFP-positive cells expressed by the MigR1 pilin transduced BMDM 
compared to MigR1 transduced cells after 24 h. Due to this, earlier time points 
were investigated following transduction. Untransduced BMDM do not express 
any GFP (Figure 5.29A). The GFP-expression for both MigR1 and MigR1 pilin 
transduced cells increase over a 24 h time period (Figure 5.29A). However, the 
GFP-expression for MigR1 pilin remains lower than that for MigR1 for all time 
points. The GFP-expression for the samples shown in Figure 5.28 was also 
plotted against time for easier comparison (Figure 5.29B). Again, this shows a 
lower and steadier GFP-expression for MigR1 pilin transduced cells compared to 
MigR1 transduced cells. Finally the mean fluorescent intensity of the GFP-
expression was plotted against time from the samples in Figure 5.28. This clearly 
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shows that the GFP-expression is at a higher level for cells transduced with 
MigR1 compared to cells transduced with MigR1 pilin (Figure 5.29C).  
 
Figure 5.29; There are more GFP+ cells for MigR1 transduced cells compared to MigR1 pilin 
BMDM were transduced with MigR1 or MigR1 pilin and left for indicated time points. Cells were 
then analysed by FACS for GFP-expression. A, GFP-expression increase over 24 h for both MigR1 
and MigR1 pilin, untransduced cells remains unaltered. % GFP+ cells against time are plotted for 
each sample. B, GFP-expression increase over 96 h for MigR1 whereas MigR1 pilin has a much 
slower increase. % GFP+ cells against time were plotted from Figure 5.28. C, MFI increase over 96 
h for MigR1 whereas MigR1 pilin remains constant. Mean fluorescence intensity (MFI) for GFP+ 
cells from B were plotted against time.  
 
To investigate whether expression of pilin following transduction of BMDM is 
dependent on any known inflammasome components, cells from inflammasome 
KO mice were transduced with MigR1 and MigR1 pilin. More cells are 7AAD-
positive when caspase-1 KO cells are transduced with MigR1 pilin compared to 
MigR1 (Figure 5.30A). All the other inflammasome KO cells have similar levels of 
cytotoxicity following transduction with MigR1 compared to MigR1 pilin (Figure 
5.30A). The 7AAD-negative cells were further investigated for their GFP-
expression. Similar levels of GFP-expression were observed for MigR1 and MigR1 
pilin transduced cells in all KOs (Figure 5.30B). Thus, no inflammasome 
dependence could be observed for cells transduced with MigR1 pilin. This implies 
another reason to why the level of GFP-expression is lower in these cells, which 
will be discussed further in the discussion of this chapter.  
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Figure 5.30; Retroviral transduction of inflammasome KO BMDM 
BMDM from inflammasome KO mice were transduced with MigR1 or MigR1 pilin (PILIN) and 
analysed for GFP expression after 3 days. A, Cells were gated based on 7AAD-staining. % 7AAD- 
cells for each condition; WT 74.6% MigR1 and 83.1% MigR1 pilin, NLRC4 71.3% MigR1 and 
72.5% MigR1 pilin, NLRP3 78.6% MigR1 and 74.1% MigR1 pilin, ASC 77.3% MigR1 and 78.2% 
MigR1 pilin and caspase-1 74.9% MigR1 and 66.6% MigR1 pilin. B, 7AAD- cells were gated based 
on GFP expression. GFP+ cells; WT 25.5% MigR1 and 9.62% MigR1 pilin, NLRC4 16.7% MigR1 
and 10.6% MigR1 pilin, NLRP3 34.1% MigR1 and 23.5% MigR1 pilin, ASC 18.7% MigR1 and 
8.08% MigR1 pilin and caspase-1 26.2% MigR1 and 10.2% MigR1 pilin. 
 
The GFP-expression is consistently lower when BMDM are transduced with MigR1 
pilin compared to MigR1 alone. To investigate whether mutations of the pilin 
gene would result in increasing GFP-expression the MigR1 pilin was mutated by 
site-directed mutagenesis. This was performed by Prof. Tom Evans in the lab. 
The mutations chosen were based on the pilin structure [40]. The pilin gene in 
the MigR1 vector was truncated by insertion of a stop codon immediately 
upstream of the disulfide bond, MigR1 pilin T133*. The second mutation 
introduced replaced the cysteine, which is important in disulphide bonded loop 
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formation [40, 448], MigR1 pilin C134A. BMDM were then transduced with these 
constructs. No difference could be seen in GFP-expression comparing the 
different MigR1 pilin constructs (Figure 5.31). In addition cells were treated with 
LPS 12 h before analysis on the FACS, in order to investigate whether any IL-1β 
secretion or caspase-1 activation could be detected from these cells. The LPS 
treatment resulted in a lot of cell death and even less GFP-expression, but the 
levels were similar between samples, as seen before (Figure 5.31). No IL-1β 
secretion could be detected in any of the samples (results not shown). 
Transduced cells were also sorted based on their GFP-expression. GFP-positive 
cells were lysed and immunoblotted with caspase-1 antibody to investigate 
whether pilin transduction results in caspase-1 activation, but no active caspase-
1 could be detected (results not shown).  
 
Figure 5.31; Mutation of pilin does not alter its ability for GFP expression following 
transduction 
BMDM were transduced with indicated MigR1 constructs, after 3 days cells were treated with 50 
ng/ml LPS for 12 h and then analysed using FASC for GFP expression. Percent GFP+ cells without 
LPS; 0.076% (-), 21.9% MigR1, 4.85% MigR1 pilin, 5.93% MigR1 pilin C134A and 7.07% MigR1 
pilin T133*. Percent GFP+ cells following treatment with LPS; 0.077% (-), 31.3% MigR1, 3.43% 
MigR1 pilin, 3.97% MigR1 pilin C134A and 5.7% MigR1 pilin T133*. 
 
5.2.7 Role of pilin in infection; PA103 pilA- 
Pilin transfection activates the inflammasome in a caspase-1 dependent manner, 
as shown in section 5.2.5 of this chapter. Furthermore, it was shown in chapter 3 
that a non-flagellated strain of P.aeruginosa can activate the NLRC4 
inflammasome, dependent on ASC. This has also been shown previously [249]. 
Therefore, the effect of pilin in infection was investigated next. Pilin is 
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important for attachment to the cells [44-46], therefore a deletion of pilin might 
influence the ability of the bacteria to cause infection. PA103 pilA- was available 
in the lab and the effect of this strain on inflammasome activation was 
investigated. Following infection with PA103 pilA- significantly less IL-1β was 
secreted compared to cells infected with PA103 ΔUΔT (Figure 5.32A). The lack of 
IL-1β secretion was present in all strains exhibiting a functional ExoU effector 
i.e. PA103 WT, pilA- and ΔUΔT:ExoU (Figure 5.32A). In contrast IL-1β was 
secreted from PA103 strains lacking ExoU, i.e. ΔUΔT and ΔUΔT:ExoUS142A 
(Figure 5.32A). Even though no IL-1β was secreted from strains with a functional 
ExoU effector these strains still caused cytotoxicity (Figure 5.32B). This indicates 
that all strains tested with a functional ExoU can translocate the toxin, which 
results in ExoU-dependent cytotoxicity.  
 
Figure 5.32; PA103 pilA- can translocate ExoU 
BMDM were infected with indicated PA103 strains at a MOI of 30 for 90 min. Supernatants were 
analysed for IL-1β release by ELISA (A) and percent cytotoxicity by LDH release assay (B). 
Columns are means of triplicates and error bars are SEM. ** indicate significant difference where ** 
is p<0.01, ns is non-significant difference p>0.05, unpaired Student’s t-test.  
 
The IL-6 and TNF-α released following infection with the PA103 strains were also 
measured. A similar level of IL-6 was released following infection with all these 
strains (Figure 5.33A) and the same was true for TNF-α (Figure 5.33B).  
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Figure 5.33; The same amount of IL-6 and TNF-α is released following infection with PA103 
mutants 
BMDM were infected with indicated PA103 strains at a MOI of 50 for 90 min. Supernatants were 
analysed for IL-6 release (A) and TNF-α release (B) by ELISA. Columns are means of triplicates 
and error bars are SEM.  
 
The strains with a functional ExoU, PA103 WT and pilA-, fail to activate IL-1β 
secretion following infection (Figure 5.32). These strains also fail to activate 
caspase-1, as expected from the IL-1β secretion results (Figure 5.34). In 
contrast, the strains lacking a functional ExoU, PA103 ΔUΔT and 
ΔUΔT:ExoUS142A, activate caspase-1 and a p10 band can be detected by 
immunoblotting (Figure 5.34). This is dependent on a functional T3SS, as 
described in chapter 3 and shown here, since PA103 ΔpcrV does not result in 
caspase-1 activation (Figure 5.34).  
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Figure 5.34; ExoU inhibits caspase-1 activation 
BMDM were infected with indicated PA103 strains for 90 min at a MOI of 30. Cell lysates were 
immunoblotted with caspase-1 antibody. Activated caspase-1 (p10) and pro-caspase-1 is detected.  
 
MAFP is an irreversible phospholipase A inhibitor, which has been shown to 
specifically inhibit ExoU-dependent cytotoxicity [142, 143]. MAFP is able to 
inhibit the ExoU cytotoxicity since ExoU is a potent intracellular phospholipase 
[143]. Previous results indicate that PA103 pilA- can translocate ExoU into the 
cell leading to ExoU dependent cytotoxicity (Figure 5.32B). If the cytotoxicity is 
caused by ExoU translocation it should be possible to inhibit it with MAFP 
treatment. BMDM were treated with MAFP and then infected with a range of 
PA103 strains. All strains with a functional ExoU, PA103 WT, pilA- and 
ΔUΔT:ExoU, caused significantly less cytotoxicity in MAFP treated cells (Figure 
5.35A). In contrast, the cytotoxicity caused by PA103 ΔUΔT and PA103 
ΔUΔT:ExoUS142A was not inhibited by MAFP since these strains lack a functional 
ExoU (Figure 5.35A). The amount of cytotoxicity caused by PA103 pilA- was 
similar to the cytotoxicity caused by PA103 WT (Figure 5.35A), indicating that 
PA103 pilA-, despite lacking pilin is able to translocate toxins at a similar level to 
PA103 WT. Unexpectedly, MAFP had a significant effect on the IL-1β secretion 
from all PA103 strains independent of ExoU expression (Figure 5.35B).  
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Figure 5.35; MAFP can inhibit cell death caused by PA103 pilA-  
LPS-primed BMDM pretreated with 100 µM MAFP 60 min before or left untreated were infected 
with indicated PA103 strains at a MOI of 30 for 90 min. Supernatants were analysed for percent 
cytotoxicity by LDH release assay (A) and IL-1β release by ELISA (B). Columns are means of 
triplicates and error bars are SEM. Asterixes indicate significant difference where * is p<0.05, ** is 
p<0.01 and *** is p<0.001, ns is non-significant difference p>0.05, unpaired Student’s t-test.  
 
In addition to an effect on IL-1β secretion by MAFP treatment the caspase-1 
activation was increased following treatment with MAFP in all PA103 strains 
(Figure 5.36). The reasons for this effect are unknown and require further 
investigation.  
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Figure 5.36; MAFP causes caspase-1 activation 
Cell lysates from Figure 5.35 were immunoblotted with caspase-1 antibody. Top panel shows 
activated caspase-1 (p10). Bottom panel shows pro-caspase-1 on a less exposed film.  
 
The results presented here show that PA103 pilA- is able to translocate ExoU to 
the same extent as PA103 WT. However, due to the effect of ExoU on 
inflammasome activation this strain is not suitable for inflammasome activation 
studies for the role of pilin in infection.  
5.2.8 Role of pilin in infection, PA103 ΔUΔT:pilA- 
In order to investigate the role of pilin in an infection model, PA103 ΔUΔT:pilA- 
was constructed. DNA from PA103 pilA- was transformed into PA103 ΔUΔT and 
following recombination the mutants were selected. As previously described, in 
the introduction, type IV pili mediate attachment, as well as twitching motility 
[55, 449]. Therefore the ability of PA103 ΔUΔT and PA103 ΔUΔT:pilA- to twitch 
was investigated on twitch agar. After incubation a pilin-dependent twitch zone 
was observed for PA103 ΔUΔT (Figure 5.37). In contrast no twitch zone could be 
observed for PA103 ΔUΔT:pilA-, which confirms that this strain lacks pilin 
expression (Figure 5.37).  
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Figure 5.37; PA103 ΔUΔT:pilA- does not twitch 
PA103 ΔUΔT and PA103 ΔUΔT:pilA- were inoculated beneath twitch agar. After two days the agar 
was peeled off and the twitch zone was photographed. White scale bar is 10 mm.  
 
Since PA103 pilA- were able to translocate effectors during infection, it was 
presumed that PA103 ΔUΔT:pilA- was fully functional despite its pilin deletion. 
The effect of this strain on inflammasome activation was therefore investigated. 
No IL-1β secretion can be detected following infection with PA103 ΔUΔT:pilA- at 
varied MOIs (Figure 5.38A). In contrast to PA103 ΔUΔT, which results in 
significantly more IL-1β secretion at all conditions tested compared to cells 
alone (Figure 5.38A). No difference could be detected between PA103 ΔUΔT and 
PA103 ΔUΔT:pilA- in cytotoxicity caused or in IL-6 and TNF-α secretion (Figure 
5.38B,C,D).  
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Figure 5.38; PA103 ΔUΔT:pilA- fail to activate the inflammasome 
BMDM were infected with indicated PA103 strains for 90 min at indicated MOIs. Supernatants were 
analysed for IL-1β (A), IL-6 (C) and TNF-α (D) release by ELISA and for percent cytotoxicity by 
LDH release assay (D). Means for triplicates are plotted and error bars are SEM. * and *** indicate 
significant difference compared to cells alone where * is p<0.05 and *** is p<0.001, unpaired 
Student’s t-test.  
 
Caspase-1 activation is also impaired in PA103 ΔUΔT:pilA- compared to PA103 
ΔUΔT. A very weak p10 band could be detected in all PA103 ΔUΔT:pilA- samples 
compared to a stronger band in PA103 ΔUΔT samples by immunoblotting (Figure 
5.39).  
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Figure 5.39; PA103 ΔUΔT:pilA- does not activate caspase-1 to the same extent as PA103 
ΔUΔT.  
Cell lysates from Figure 5.38 were immunoblotted with caspase-1 antibody. Activated caspase-1 
(p10) and pro-caspase-1 is shown on top panel. The blot was reprobed with actin antibody to show 
even loading (bottom panel).  
 
Attempts were then made to complement the PA103 ΔUΔT:pilA- strain with a 
plasmid containing pilin from PA103 to restore its ability to activate the 
inflammasome complex. Unfortunately this was never successful; any double 
resistant mutants obtained could not be further propagated either in liquid broth 
or following restreaking onto a new agar plate. The reason for this is unknown. 
However, we were successful in complementing PAO1 pilin mutants with an 
expression vector encoding pilin from PAO1, described below in section 5.2.9. 
The results presented in this section show that PA103 ΔUΔT activates the 
inflammasome in a T3SS- and pilin-dependent manner.  
5.2.9 Role of pilin in infection by PAO1 
PAO1 was previously shown to activate the inflammasome in a flagellin-
dependent manner, section 5.2.1. To investigate whether pilin has a role in the 
inflammasome activation by this strain pilin mutants was studied. PAO1 WT 
express pilin and form twitch zones after incubation under twitch agar (Figure 
5.40). As expected, no twitch zone could be detected for PAO1 FliC-pilA-, but 
this could be restored by transforming this strain with a PA1O3 pilin expressing 
plasmid (Figure 5.40).  
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Figure 5.40; PAO1 WT PAO1 FliC-pilA-:PA103 pilA pucp20 twitch, whereas PAO1 FliC-pilA- 
does not 
PAO1 strains were inoculated beneath twitch agar. After two days the agar was peeled off and the 
twitch zone was photographed. White scale bar is 10 mm.  
 
The IL-1β secretion following infection with PAO1 pilA- is similar to the secretion 
seen after infection with PAO1 WT (Figure 5.41A). In contrast, strains lacking 
flagellin, PAO1 FliC- and FliC-pilA- do not induce IL-1β secretion after infection 
(Figure 5.41A). Note that the activation of the inflammasome by PAO1 pilA- is 
additional evidence that pili are not required for effective type III secretion into 
macrophages, since inflammasome activation by this strain is entirely dependent 
on the T3SS. 
The IL-1β secretion by FliC-pilA- could be restored by transforming the strain 
with a PAO1 pilin expression plasmid (Figure 5.41A). Following transformation 
with a PA103 expression plasmid (Figure 5.41A), IL-1 β secretion was also 
increased, but this did not achieve statistical significance, which will be 
discussed further below. The PA103 strains are included as reference and the 
effects seen are similar to those described in section 5.2.8. The cytotoxicity 
resulting from PAO1 infection is also dependent on flagellin with a pattern 
similar to the IL-1β secretion seen (Figure 5.41B).  
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Figure 5.41; Flagellin-dependent inflammasome activation by PAO1 
BMDM were infected with indicated PA103 and PAO1 strains at a MOI of 20 for 90 min. 
Supernatants were analysed for IL-1β release by ELISA (A) and percent cytotoxicity by LDH 
release assay (B). Columns are means of triplicates and error bars are SEM. Asterixes indicate 
significant difference where ** is p<0.01 and *** is p<0.001, ns is non-significant difference p>0.05, 
unpaired Student’s t-test.  
 
The IL-1β secretion following infection with PAO1 strains are dependent on 
flagellin. The caspase-1 activation also corresponds to these results, where 
strains that lack flagellin fail to activate caspase-1 (Figure 5.42). In contrast the 
caspase-1 activation in a flagellin and pilin deficient strain can be restored by 
the expression of PAO1 pilin (Figure 5.42). There is some p10 detected following 
infection of BMDMs with PAO1 FliC-pilA-: pUCP20 PA103 pilin, which can be 
detected after a longer exposure (Figure 5.42). There is a small non-significant 
increase in IL-1β secretion following infection with this strain compared to PAO1 
FliC-pilA-, which could be explained by the caspase-1 activation seen (Figure 
5.41 & 1.44).  
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Figure 5.42; Flagellin-dependent caspase-1 activation by PAO1 
BMDM were infected with indicated PAO1 strains at a MOI of 30 for 90 min. Cell lysates were 
immunoblotted with caspase-1 antibody. Top panel shows pro-caspase-1 and activated caspase-1 
(p10). Bottom panel shows a longer exposure of activated caspase-1. 
 
In previous publications, infections by strains lacking flagellin and pilin have 
been centrifuged immediately after bacterial addition to the cell culture [249, 
390]. It is argued that this will help the non-motile bacteria to reach the cells 
and cause infection. In order to investigate this in the infection model used in 
this study, cultures centrifuged immediately following infection were compared 
to cultures which were left unspun. The IL-1β secretion following centrifuged 
cultures is similar in all samples tested (Figure 5.43A). In contrast, when cultures 
are left uncentrifuged the IL-1β secretion corresponds to results described in 
previous figures where IL-1β secretion by PAO1 is dependent on flagellin and the 
secretion can be restored by introducing PAO1 pilin (Figure 5.43A). Furthermore, 
centrifugation of the cultures result in increased cytotoxicity for most of the 
samples (Figure 5.43B), which indicate an added stress for the cells introduced 
by the centrifugation step.  
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Figure 5.43; Inflammasome activation by PAO1 is flagellin-dependent but pilin-indpendent  
BMDM were infected with indicated PAO1 strains at a MOI of 30 for 90 min. Immediately following 
addition of the bacteria half of the samples were centrifuged at 200 x g for 5 min. Supernatants 
were analysed for IL-1β release by ELISA (A) and percent cytotoxicity by LDH release assay (B). * 
and *** indicate significant difference where * is p<0.05 and *** is p<0.001, unpaired Student’s t-
test.  
 
These results show a minor role for pilin-dependent inflammasome activation by 
PAO1 in the presence of flagellin expression. This will be discussed further 
below.  
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5.3 Discussion 
P.aeruginosa activates the inflammasome in a NLRC4- and ASC-dependent 
manner during infection, as described in chapter 3. This has also been described 
in the literature [249, 253, 354]. The results in this chapter show that PA103 
ΔUΔT can activate the inflammasome complex independent of flagellin, since 
this strain does not express flagellin. Flagellin-independent activation of the 
NLRC4-inflammasome has also been described by Sutterwala et al. [249]. In 
addition flagellin-independent but T3SS-dependent inflammasome activation by 
Salmonella at higher MOIs was described by Miao et al. [337]. The mediator of 
this inflammasome activation has not yet been identified, but results presented 
in this chapter indicate that type IV pilin can activate the inflammasome and it 
is responsible for the activation produced by PA103 ΔUΔT. 
The amount of IL-1β detected following transfection with pilin, as well as 
flagellin, presented in this chapter is similar to the amount seen for flagellin in 
previous publications [337]. There is a variation between different experiments 
in the amount of IL-1β secretion. Possible explanations include variations 
between batches of primary BMDM, different pilin preparations and, as discussed 
below, differences between batches of DOTAP and transfection efficiency.  
A range of transfection reagents was tried for the protein transfection during the 
time of this project. Following optimisation it was found that DOTAP gave the 
most reproducible results. FuGene (Roche), Proteojuice (Novagen) and TransPass 
P (NEB) were found to cause a high amount of cytotoxicity following transfection 
of the cells. However, DOTAP transfection efficiency and cytotoxicity varies 
from batch to batch. This is the reason to why some experiments have a 
relatively high IL-1β secretion following DOTAP treatment alone. It should be 
noted that the levels for pilin together with DOTAP were always higher than 
DOTAP alone. This also poses a problem for the detection of caspase-1 activation 
by immunoblotting.  
The results presented here show that pilin, as well as flagellin, has to be 
transfected into the cells in order to promote inflammasome activation. No 
effect can be detected following treatment of cells with flagellin, pilin or DOTAP 
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alone. This is in agreement with previously published results [236, 390]. BMDM 
does not express TLR5, which means there will not be an effect of flagellin alone 
via TLR5 signalling [450]. It was found in previous publications that the 
inflammasome activation by flagellin is independent of potassium efflux when 
transfected into the cells [236]. Due to time constraints the role of potassium 
following pilin transfection was not investigated in this study. However, as 
previously discussed in chapter 4, the inflammasome activation following 
infection with PA103 is highly dependent on potassium. This implies that the 
inflammasome activation by pilin is indeed dependent on potassium but studies 
are needed to confirm this hypothesis. However, there is a possibility that the 
method of delivery affects the dependence of potassium. Again, no conclusions 
can be drawn until the experiments have been performed.  
When attempts were made to purify pilin from PAO1 it was found that PAO1 FliC- 
had to be used in order to obtain pilin. Following the pilin purification method 
used in this chapter on PAO1 WT, only purified flagellin with no band for pilin 
were obtained. The reason for this is unknown. Possibly, PAO1 WT does not 
express a lot of pilin when flagellin is expressed, or that pilin is not readily 
released from cells in the presence of flagellin. 
Pilin has been shown to bind DNA [451] and DNA has been shown to activate 
caspase-1 and IL-1β secretion [440]. Therefore, the purified pilin preparations 
might be contaminated by DNA. However, the inflammasome activation 
following DNase I treatment of pilin was unaltered. This further strengthens the 
theory that pilin is able to activate the inflammasome complex and that the 
inflammasome activation seen is not due to DNA contamination of the purified 
pilin. Additionally, DNA activation of the inflammasome is NLRP3 dependent in 
contrast to the activation produced by pilin, discussed below. 
Proteinase K treatment of pilin results in less inflammasome activity, as 
described in section 5.2.2. Previous published results showed a complete 
abrogation of inflammasome activation by Proteinase K treated flagellin [337]. 
The differences might be due to the different properties of flagellin compared 
to pilin, or due to different digest times by Proteinase K. Miao et al. digested 
the flagellin overnight whereas the pilin in this study was digested for 60 min, 
according to manufacturer’s instructions. There was an undigested portion left 
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following Proteinase K treatment of pilin, which might account for the remaining 
inflammasome activation seen. There is a possibility that this undigested core 
would be digested following longer incubation with Proteinase K. Alternatively, 
there is a portion of pilin which is resistant to Proteinase K treatment. Further 
investigation is needed in order to prove these hypotheses.  
Caspase-1 activation by pilin was investigated by immunoblotting of cell lysates 
in this study. This proved successful when the inflammasome activation by 
P.aeruginosa was investigated, described in chapter 3. It proved more difficult 
to detect caspase-1 activation following pilin transfection. There are a lot of 
parameters which affect the detection, such as transfection efficiency, time and 
antibody batch, as well as the streptavidin being used. Several other studies 
have investigated caspase-1 activation in the supernatants [238, 452], however 
this did not provide any better results when tried in this study. Other studies 
have used another antibody for the detection of activated caspase-1 but this 
antibody is not available commercially and thus could not be used in this study. 
However, the IL-1β secretion and the immunoblots that worked clearly 
demonstrate a role for pilin in inflammasome activation. 
IL-6 secretion is not dependent on pilin transfection. In addition, IL-6 secretion 
is unaltered for the PA103 ΔUΔT:pilA- strain. The same results were observed for 
TNF-α. This has previously been reported for flagellin-dependent inflammasome 
activation by Salmonella [390]. 
Individual pilin subunits have been found to be insoluble, full-length pili from 
P.aeruginosa strain PAK could only be crystallised in the presence of detergent 
[42]. This is a useful approach for crystallisation studies but not very useful 
during transfection studies. However, if the hydrophobic N-terminal region of 28 
amino acids is removed this makes it possible to purify soluble pili subunits [40, 
41]. This approach was therefore used in order to purify recombinant PA103 pilin 
from E.coli.  
Transfection with PA103 pilin results in a caspase-1 dependent inflammasome 
response. Any other NLR-proteins involved are yet to be determined. This could 
be initially investigated by shRNA silencing of NLR-proteins or by the use of other 
KO cells. Due to the time constraints of this project it has not yet been 
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investigated. In contrast, infection with PA103 ΔUΔT results in NLRC4- and ASC-
dependent inflammasome activation, which is clearly different from the 
transfected pilin. This has previously been described for DNA-dependent 
inflammasome activation [440]. Internalised adenoviral DNA induce NLRP3- and 
ASC-dependent inflammasome response, whereas transfected DNA results in 
ASC-dependent but NLRP3-independent inflammasome activation. The 
difference seen for pilin-dependent inflammasome activation might be due to 
the different methods of delivery. During transfection pilin is delivered using a 
liposomal transfection reagent, DOTAP, whereas during infection pilin is 
believed to be delivered via the bacterial T3SS. This might therefore influence 
the inflammasome activation by triggering of different cellular responses. 
DOTAP has previously been described to be used for endosomal translocation of 
DNA [453, 454]. This further strengthens the possibility that transfected pilin 
and pilin entering the cell via infection results in a different cellular response 
and thus a different inflammasome response.  
Transfection with purified pilin from PA103 is dependent on caspase-1 but not 
any of the other inflammasome components tested. This is different from the 
results following transfection with recombinant pilin. Recombinant pilin is 
dependent on ASC, caspase-1 and NLRP3. The different inflammasome 
dependence is an unexpected result since the recombinant pilin is homologous 
to PA103 except for the lack of the N-terminal hydrophobic domain. The lack of 
the hydrophobic domain prevents polymerisation of the recombinant pilin, thus 
the recombinant pilin remains as monomers upon transfection. It is unknown if 
this influences the ability to trigger various inflammasome complexes. In 
addition, the recombinant pilin is expressed by E.coli and purified by lysing the 
bacteria rather than from the bacterial surface. This might influence the pilin 
and produce pilin which is slightly different from the pilin expressed on the 
surface of P.aeruginosa. P.aeruginosa might provide modifications of the 
expressed pilin that the E.coli is not able to provide. Further studies are needed 
to evaluate the reason for the different dependence between purified PA103 
pilin and recombinant pilin.  
A method for introducing an inflammasome activating molecule into the host cell 
cytoplasm was recently described [312]. This method use retroviral transduction 
of flagellin, which eliminates the need for bacterial secretion systems, 
229 
transfection reagents and limits the potential bacterial contaminants. Following 
transduction the ability of the transduced protein to cause cytotoxicity was 
measured. Flagellin have been shown to cause pyroptosis [248], which makes the 
transduction method ideal. However, transfection with pilin does not result in a 
high amount of cytotoxicity. This is therefore a possibility to why the retroviral 
transduction method with pilin was unsuccessful. In addition, it seems the 
expression of pilin influence the expression of GFP from the MigR1 plasmid. 
Transduction with the MigR1 plasmid alone produces a higher GFP expression 
than transduction with MigR1 pilin. A control plasmid, which expresses a control 
protein instead of pilin would provide a better control than the empty 
expression plasmid alone, as previously described [312]. Furthermore, mutations 
of the pilin gene did not influence the GFP expression. This might reflect the 
inability of pilin to cause cytotoxicity and therefore no difference is detected. 
Instead it would be interesting to investigate caspase-1 activation and IL-1β 
secretion following transduction of pilin expressing retroviruses. This was 
attempted in this investigation, but due to time constraints it was not 
successful. Following optimization of the amount and time of LPS-treatment, 
transduction efficiency and incubation times it might be possible to detect 
active caspase-1 and IL-1β secretion. This would provide further evidence for 
the ability of pilin to trigger inflammasome activation, independent of bacterial 
secretion systems and transfection reagents. If this would be successful, the 
ability of the mutated pilin-expressing retroviral plasmids to trigger 
inflammasome activation could be further investigated.  
The results presented in this chapter indicate that the effector ExoU inhibits 
inflammasome activation, since any bacterial strain expressing this toxin fail to 
activate caspase-1 and secrete IL-1β. This has previously been shown by 
Sutterwala et al. [249]. It was shown that ExoU was able to inhibit caspase-1 
through ExoU phospholipase activity [249]. Furthermore, it has been shown for 
Yersinia enterocolitica that it can induce inflammasome activation dependent 
on a functional T3SS, however, this is inhibited by the effectors being 
translocated [455]. The effector responsible for this effect has not been 
determined [455]. Due to the ability of ExoU to inhibit inflammasome activation 
the PA103 pilA- strain was unsuitable for the study of the effect of pilin and 
inflammasome activation in an infection model. What the studies presented in 
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this chapter show however, is that even though PA103 pilA- lacks pilin it is able 
to translocate ExoU into the cells. This is proved by the lack of inflammasome 
activation, as well as the cytotoxicity caused, which are both similar to PA103 
WT. P.aeruginosa type IV pili are the main adhesive organelles and type IV pili 
mediated attachment has been implicated in efficient delivery of effectors via 
the T3SS into epithelial cells [44-46]. Despite this the results in this chapter 
clearly demonstrate that pilA-deficient strains are able to translocate toxins 
through the T3SS into macrophages. Type IV pili is not the only surface structure 
that mediates attachment of P.aeruginosa to cells: other examples are porin F 
[456], lectins [457] alginate [458, 459] and outer membrane proteins [34].  
The translocation ability of PA103 pilA- is also strengthened by the results 
following treatment with MAFP. MAFP is an irreversible inhibitor of the 
intracellular lipase cPLA2 [460]. MAFP is clearly able to inhibit the ExoU-
dependent cell death caused by the ExoU-dependent phospholipase A2 activity 
for all strains expressing ExoU. The cytotoxicity caused by the strains lacking 
ExoU is unaffected. This has also been seen in previously published results [142, 
143]. Interestingly, MAFP treatment has a positive effect on the caspase-1 
activation and IL-1β secretion following infection with all strains, independent of 
ExoU-expression. As expected, the IL-1β secretion and caspase-1 activation for 
the ExoU-expressing strains are restored to levels similar to that of ExoU-
defective strains following MAFP treatment. However, the ExoU-defective strains 
are also affected. Further experiments are needed to evaluate these results. It 
implies a role for MAFP in inflammasome activation via a yet unexplored 
pathway. Similar results were previously published by Sutterwala et al. using 
another inhibitor of A2 phospholipases, AACOCF3 (Arachidonyl trifluoromethyl 
ketone) [249].  
PA103 pilA- was shown to translocate effectors in this study. Therefore it is also 
believed that PA103 ΔUΔT:pilA- is able to translocate effectors. A system using 
β-lactamase reporter gene constructs could also be used to prove translocation. 
Examples of this system have previously been used in the study by Sun et al. 
[365]. In addition, fluorescent imaging based methods could be used for the 
detection of translocation; however, described methods all involve fusion of the 
translocated protein with another gene to facilitate detection in the host cell 
[461]. 
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Attempts were made to recomplement PA103 ΔUΔT:pilA- with pilin expressing 
plasmid encoding PA103 and PAO1 pilin respectively. However, this was never 
successful. There is nothing wrong with the pilin expressing plasmids as the 
complementation of PAO1 FliC-pilA- was successful, discussed further below. 
Instead there seems to be a specific problem preventing transformation of PA103 
with a pilin-expressing plasmid, since other plasmids (e.g. pucp20 ExoY) were 
successfully transformed into this strain. Several attempts were made but each 
time a double resistant colony grew, it eventually stopped growing after 
restreaking or growth in liquid media. This suggests that the plasmid is lost by 
the strain for reasons that are currently unexplainable. This is also surprising due 
to the fact that it has been shown that pili can be artificially transferred 
between bacterial species, where they assemble and function in twitching 
motility [462-464]. The differences might be due to different use of expression 
plasmids and experimental conditions.  
Inflammasome activation by PAO1 does not seem to be dependent on pilin; 
rather it is very strongly dependent on flagellin expression. The PAO1 pilA- strain 
still expresses flagellin, which can activate the inflammasome. This further 
strengthens the conclusion that the T3SS is able to function in a pilin-deficient 
strain, since the flagellin is believed to pass through the T3SS and this is 
unaffected in the PAO1 pilA- strain. In addition, the inflammasome activation by 
the PAO1 FliC-pilA- strain is not further affected by the pilin-deficiency 
compared to PAO1 FliC-. In some experiments the IL-1β secretion by the 
flagellin- and pilin-deficient strain is increased compared to the flagellin-
deficient strain. This indicates the involvement of another bacterial product, 
separate from flagellin and pilin, involved in the inflammasome activation. It is 
possible that this yet unidentified product is upregulated as a response to the 
flagellin- and pilin-deficiency. In addition, the expression level of pilin might be 
different in PAO1 compared to PA103, which is indicated by the fact pilin can 
only be purified from flagellin-deficient PAO1, as previously discussed.  
Interestingly, the IL-1β secretion can be restored in PAO1 FliC-pilA- with the 
expression of a PAO1 pilin expressing plasmid. This shows that PAO1 pilin is able 
to activate the inflammasome in an infection model. Complementation with 
PA103 pilin also increased IL-1β secretion but not to a statistically significant 
degree. This may reflect different levels of protein expression. 
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The results presented in this chapter indicate that pilin is necessary for 
inflammasome activation by PA103, but not PAO1. As previously discussed, the 
expression levels of pilin in these strains might not be at the same level. It has 
been shown that strains lacking flagellin express higher levels of the T3SS genes 
[6]. In addition, there are sequence differences between the strains which might 
influence the inflammasome activation [28]. The amino acid sequence for PA103 
is 80% identical to that of PAO1 and 65% to that of PAK [28]. Furthermore, PA103 
does not express flagellin whereas PAO1 does, which can also influence the 
inflammasome activation. Further studies are needed to determine whether the 
sequence differences seen between PA103 and PAO1 account for the differences 
in inflammasome activation. Variability in the sequence might allow the 
bacterium to evade immune responses. It has previously been shown that 
sequence variation in flagellin between species results in evasion of the TLR5 
response [178]. Therefore, it would also be interesting to investigate the ability 
of pilins from other bacterial strains to activate the inflammasome complex. 
First of all, pilin from strains belonging to the same type IV pilin class as 
P.aeruginosa, such as pilin from Neisseria gonorrhoeae. However, this was not 
possible within the time frame of this project.  
Several previous publications have introduced a centrifugation step immediately 
following infection with flagellin-deficient strains [249, 253, 390]. However, as 
described in this study, PA103 lacks flagellin but is still able to infect cells 
without the need for a centrifugation step. Furthermore, following 
centrifugation of the flagellin-deficient PAO1 strains it was found that it caused 
increased cell death, which possibly alters the inflammasome response due to 
increased stress of the cells. In addition, although cells can be pelleted at these 
centrifugal speeds, bacteria cannot. Instead they require much higher speeds, 
thus, a centrifugation step at this low speed would not increase infection 
efficiency only provide an unnecessary step.  
Studies for both L.pneumophila and Salmonella have shown that the flagellum 
secretion apparatus is not needed for caspase-1 activation [337, 351, 390]. The 
flagellum secretion apparatus is required specifically for transport of flagellin to 
the bacterial cell surface and assembly of the flagellum [444]. This suggests that 
other specialized secretion systems in the bacteria may be delivering flagellin 
directly into the cytosol of the host cell. This has been shown for flagellin 
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passing through the SPI-1 T3SS of Salmonella [365]. The flagellar assembly 
apparatus is similar to the T3SS of bacteria [18, 19]. It has been shown that 
flagella can secrete, but not translocate, some T3SS effectors under specific 
circumstances [465]. It is therefore not surprising that the T3SS can accidentally 
translocate flagellin into the host cell cytosol. In contrast the type IV pili are 
related to bacterial T2SS. Homologs of all proteins involved in type VI pili 
synthesis can be found as components of the T2SS [466]. Pili formation is 
believed to occur when the growing type IV pilus structure is translocated to the 
cell surface via the secretin PilQ [50]. This allows machinery at the inner 
membrane-periplasm interface to mediate retraction, fibre formation mediated 
by PilF and depolymerisation by PilT [50].  
Due to the nature of bacterial secretion system it is believed that in order for 
flagellin to pass through the system it needs to be in monomeric form. The 
results published in this study do not investigate whether it is pilin monomers or 
polymers that activate the inflammasome complex. Furthermore, it might be 
different for the transfection model compared to the infection model. In 
addition, if monomers pass through the T3SS they could possibly reassemble in 
the cytosol of the host cell. The recombinant pilin used in this study lacks the N-
terminal hydrophobic domain and can thus not form polymeric structures. It was 
shown in this chapter that recombinant pilin is not as potent as purified PA103 
pilin in inflammasome activation. These results imply that in order for maximum 
inflammasome activation the structure of pilin is polymeric. The results 
presented in this chapter further suggest that pilin can pass through the T3SS, 
since a functional T3SS is required for the inflammasome activation by 
P.aeruginosa. Type IV pili constantly retract and extend from the bacterium. 
This results in available pilin monomers inside the bacterial cell, which are 
available for pili synthesis [48-50]. Similar to flagellin, pilin might accidentally 
be engaged by a bacterial secretion system and thus ‘mistakenly’ delivered into 
the host cell cytosol. However, the inflammasome activation by P.aeruginosa 
might be detrimental for the host. This will be discussed further in chapter 7. It 
would be interesting to investigate whether pilin could be detected in the host 
cell following infection, however due to lack of suitable antibodies this has not 
been tested in this study. Furthermore, the amount of pilin needed to activate 
the inflammasome complex might be below detection level of for example 
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immunoblot methods. Pilin has previously been detected by immunoblotting of 
proteins from a growing colony [55]; however the concentration of pilin in this 
case will presumably be a lot higher than the concentration inside the host cell. 
Another potential detection system would be to tag pilin with glycogen synthase 
kinase (GSK) and track the host cell kinase-dependent phosphorylation of this 
tag [467]. However, the amount of translocated material might influence the 
detection via this method as well. 
The direct binding of flagellin to NLRC4 has not yet been demonstrated. Thus, 
flagellin, as well as pilin, during infection, might trigger NLRC4-dependent 
inflammasome activation via another molecule or sensor. In the study by 
Lightfield et al. [312] it was shown that point mutations of the flagellin C-
terminal abolished its ability to activate the inflammasome. This suggests a 
direct interaction between flagellin and NLRC4. Another possibility is that the 
flagellin peptide indirectly triggers the inflammasome via interference with a 
cellular process. Considering the possibility that flagellin, as well as pilin, trigger 
NLRC4 activation and the differences between these molecules the second 
explanation seems more likely. There might also be additional, yet unidentified, 
bacterial molecules which trigger NLRC4 activation. Furthermore, transfected 
pilin is not dependent on NLRC4 activation, which indicates an involvement of an 
additional host sensor in the response to pilin. However, a wide variety of 
molecules can activate, for example, the innate immune receptor TLR2, which 
suggests that other innate immune sensors might also have evolved to detect 
several danger signals. Further studies are needed to be able to draw any final 
conclusions.  
Flagellin-dependent inflammasome activation by L.pneumophila was shown to 
be dependent on NLRC4 and NAIP5 [251, 352, 357]. However, NAIP5-independent 
but NLRC4-dependent inflammasome activation has also been described [312]. 
NLRC4 might therefore provide a scaffold for the assembly of many distinct 
inflammasomes, some which require NAIP5 and others which require yet 
unidentified proteins.  
The results presented in this chapter identify pilin as a novel inflammasome 
activator. The activation is dependent on a functional T3SS. Previous published 
results have shown NLRC4-dependent but flagellin-independent inflammasome 
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activation, but have failed to identify a potential activating protein [227, 249, 
337]. Recent data presented by E. Miao at Keystone Symposia, Banff April 2009, 
identified the rod protein of the T3SS as a potential candidate for the flagellin-
independent inflammasome activation. This was shown by retroviral 
transduction. There are still several problems with this model. For instance, how 
does the rod protein enter the host cell, since upon T3SS-assembly the rod 
protein is incorporated before the needle proteins and the needle length is 
determined by the molecular ruler, as described in chapter 1.3.1.1. The 
retroviral transduction eliminates the need for a bacterial secretion system, but 
makes it hard to prove the biological significance. If the rod protein were to be 
mutated this would render the T3SS non-functional and thus the relevance in an 
infection model is difficult to prove.  
In conclusion, the results presented in this chapter identify pilin as a novel 
inflammasome activator. This is the first demonstration of recognition of type IV 
pili by pathogen recognition receptors. Pilin from both PAO1 and PA103 is able to 
trigger caspase-1 activation and IL-1β secretion following transfection. The role 
of pilin in an infection model was also investigated, which identifies pilin-
dependent inflammasome activation by PA103. Pilin is therefore proposed as the 
bacterial molecule which mediates inflammasome activation in flagellin-
deficient bacteria, thus adding to the understanding of the complex process of 
inflammasome activation by various bacterial molecules.  
236 
6 Nod1 activation by Pseudomonas aeruginosa 
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6.1 Introduction 
6.1.1 NF-κB activation by Pseudomonas aeruginosa 
NF-κB is a transcription factor expressed in virtually all cell types. It is involved 
in the expression of numerous cytokines and adhesion molecules [468, 469]. 
Thus, NF-κB has an essential role in the host response to infections, stress and 
injury [468]. The name NF-κB originates from its first identification as a nuclear 
factor necessary for immunoglobulin kappa light chain transcription in B-cells 
[470]. NF-κB is located in the cytoplasm as an inactive form bound to the 
inhibitor IκB. This masks the nuclear localization signal of NF-κB and thus retains 
it in the cytoplasm [471]. Following activation, NF-κB translocates to the nucleus 
and upregulates transcription of specific genes of a common purpose; enhancing 
the immune response [468]. 
There have been several reports concerning NF-κB activation by P.aeruginosa. 
Several publications have investigated the role of NF-κB activation in cystic 
fibrosis sufferers. A wide variety of mechanisms have been reported and a select 
few will be described here. As previously described, TLR-signalling leads to NF-
κB activation and P.aeruginosa possess a wide range of TLR activating factors, 
such as LPS, flagellin and CpG DNA [472-474].  
The NF-κB activation by P.aeruginosa has been shown to be dependent on pilin 
attachment to epithelial cells [475]. In addition, it has also been shown that NF-
κB activation in airway epithelial cells is dependent on flagellin [476]. This was 
shown for the pseudomonal strains PAK, PAO-1 and PA14. Furthermore, it was 
shown by Travassos et al. that the pseudomonal strain PAK, as well as PAO-1, 
can activate NF-κB [17]. This was shown to be dependent on peptidoglycan and 
Nod1 activation, which will be discussed below.  
6.1.2 Nod protein activation 
Nod1 was the first NLR-protein identified in mammals. It is homologous to CED-
4, which regulates apoptosis in C.elegans [197, 217]. Nod1 has similar structure 
to other NLR-proteins, with a central nucleotide-binding and oligomerization 
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domain, an N-terminal CARD domain and C-terminal leucine-rich repeats. When 
Nod1 is overexpressed it activates NF-κB. Nod1 is ubiquitously expressed [197], 
whereas Nod2 is mainly found within monocytes and macrophages [477].  
The first Nod1 activator was thought to be LPS [478]. However, it was later 
shown that the activation by LPS was due to contaminating material. Both Nod1 
and Nod2 sense bacterial peptidoglycan through their carboxy-terminal LRRs 
[343, 478-481]. Peptidoglycan is one of the major components of Gram-positive 
bacterial cell wall [482]. In Gram-negative bacteria it is found as a thin layer in 
the periplasmic space. Peptidoglycan provides shape and mechanical rigidity to 
bacteria [482]. Nod1 responds to γ-D-glutamyl-meso-diaminopimelic acid (iE-
DAP) (Figure 6.1) [343, 479, 483]. This acid is found in all Gram-negative 
bacteria, as well as in certain Gram-positive species, such as Bacillus and 
Listeria spp. In contrast, Nod2 responds to muramyl dipeptide (MDP), which is 
found in both Gram-positive and –negative bacteria (Figure 6.1) [480, 481, 484]. 
Muramyl dipeptide is the minimal motif in all peptidoglycans [485]. 
Peptidoglycan is a complex structure of carbohydrate chains of β (1-4)-linked, 
alternating N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid (MurNAc) 
sugars cross-linked by short peptide bridges (Figure 6.1) [486]. Gram-negative 
bacteria and some Gram-positive have diaminopimelic acid (DAP) in the third 
position of the peptide chain, in contrast most Gram-positive bacteria have a 
lysine at this position [484, 485]. Bacteria can generate small molecules 
containing iE-DAP or MDP structures, which are generated as intermediates of 
PGN biosynthesis [487, 488]. Furthermore, PGN is remodelled by bacteria for cell 
division and growth and this process generates small PGN fragments containing 
these motifs [489]. In the host, lysozyme can cleave the glycan chain of PGN 
generating small muropeptides, which contain the iE-DAP and MDP structures 
[490, 491].  
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Figure 6.1; Peptidoglycan motifs recognised by Nod1 and Nod2 
Structure of peptidoglycan. MDP (red box) and iE-DAP (orange box) is the minimal peptidoglycan 
motif required for recognition by Nod2 and Nod1 respectively. Adapted from [486]. 
 
Experiments on Nod1 knock-out mice demonstrated an important role for Nod1 
as a sensor of intracellular peptidoglycan in epithelial cells [343]. Nod proteins 
are the only known receptors for peptidoglycan in mammalian cells [492]. TLR2 
was previously identified as a receptor for peptidoglycan [493, 494] but it was 
later shown, similar to LPS and Nod1 activation, that the activation was 
mediated by contaminants in the peptidoglycan preparations. These 
contaminants are believed to be lipoteicoic acid or lipoproteins [492]. However, 
there is still a debate whether PGN activates TLR2 or not, as it was subsequently 
shown that PGN from S.aureus activates TLR2 [495]. 
Nod1 plays an important role in the epithelium in the NF-κB activation following 
infection with Gram-negative bacteria that do not activate NF-κB through TLR 
signalling pathways [197]. The Nod1 pathway provides an additional signalling 
pathway for activation of NF-κB following infection, which favours host survival 
when bacteria bypass TLR recognition [496]. Both pathways have a common 
kinase (RIP2 or RICK), described in more detail below [497], even if this is 
controversial and has been challenged [498].  
Activation and oligomerization of Nod1 and Nod2 leads to activation of kinase 
receptor-interacting protein2 kinase (RIP2 also known as RICK) eventually 
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leading to activation of NF-κB and MAFP [197, 217, 477] (Figure 6.2). RICK 
contains an N-terminal domain which is homologous to serine/threonine kinases 
and a C-terminal CARD domain [499]. The CARD of RICK interacts with the CARDs 
of Nod1 and Nod2 [477, 500]. Following interaction RICK directly activates the 
NF-κB pathway through activation of the IKK complex via ubiquitinylation [501-
505]. This leads to the phosphorylation and subsequently degradation of IκBα 
and release of NF-κB, which translocates to the nucleus where it drives the 
transcription of pro-inflammatory target genes [485, 505]. The ultimate result of 
Nod1 and Nod2 activation is an inflammatory response which aids host defence 
(Figure 6.2). NF-κB responsive genes include acute phase response proteins such 
as C3 complement, adhesion molecules such as VCAM-1 and ICAM-1 and cytokines 
such as IL-1, IL-2, IL-6, IL-8 and TNF-α [468]. 
 
Figure 6.2; Nod1 and Nod2 NF-κB signalling pathway 
Peptidoglycan activates Nod1 and Nod2. Upon activation the serine/threonine kinase RICK is 
recruited. RICK then directly activates the IKK complex which leads to degradation of IκBα. NF-κB 
is released and translocated into the nucleus where it binds to the promoter of pro-inflammatory 
genes. The expressed factors are then involved in the host response. Figure adapted from [485]. 
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6.1.3 Nod1 activation by bacteria 
Many bacteria remain extracellular and thus limit the need for an intracellular 
pathogen detection system. The commensal bacteria within the gut have the 
same molecular motifs as pathogenic bacteria, which limits the use of an 
extracellular detection system. An intracellular system could be used to detect 
invasion by bacteria, which indicates a threat to the host.  
The extracellular pathogen Helicobacter pylori was shown to activate the 
intracellular Nod1 [222]. It was shown that the host response to H.pylori is 
mediated by intracellular peptidoglycan recognition by Nod1. Nod1 knock-out 
mice had higher susceptibility to H.pylori. The activation was shown to be 
dependent on a functional T4SS [222]. Peptidoglycan is believed to pass through 
this T4SS into the host cell where it activates Nod1. Commensal bacteria do not 
have a secretion system, thus the host has developed a system which can 
discriminate between commensal and pathogenic bacteria. It is not known how 
peptidoglycan enters the T4SS.  
Following Shigella flexneri infection NF-κB is activated in a Nod1-dependent 
manner [506, 507]. S.flexneri is a Gram-negative bacterium responsible for 
shigellosis (bloody diarrhoea). It was subsequently shown that Nod1 localise at 
the plasma membrane [508]. This maximises the interaction possibilities 
between the intracellular sensor and invading pathogens. Nod1 was shown to 
localise to the site of bacterial entry during S.flexneri infection, which was 
shown to be dependent on membrane binding [508]. Thus, Nod1 is activated very 
rapidly after bacterial invasion and association with the plasma membrane is 
essential for the host response. Other bacteria which have been identified as 
Nod1-dependent NF-κB activators include enteroinvasive E.coli [496], Chlamydia 
spp. [509, 510], Campylobacter jejuni [511], Salmonella [512], L.monocytogenes 
[498, 513-515], Bacillus spp. [516] and P.aeruginosa (as mentioned above) [17].  
Nod2 has also been shown to relocate to the plasma membrane together with 
RIP2 (also known as RICK) [517, 518]. Specific localisation of the sensor increases 
the efficiency by which the cell recognises invading pathogens, as previously 
mentioned. Membrane recruitment of Nod2 was shown to increase binding to 
erbin which leads to the inhibition of signalling. Thus, as well as increasing 
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efficiency, membrane recruitment might also be important in terminating 
proinflammatory signalling events [519].  
It is not just bacterial secretion systems which can mediate delivery of 
peptidoglycan to the intracellular space. This can also be mediated by bacterial 
pore-forming toxins such as pneumolysin [520]. Furthermore, it has been shown 
that the intestinal apical di/tripeptide transporter (hPepT1) can transport 
muramyl dipeptide into the cytoplasm [521, 522]. These can then activate Nod2, 
whereas the peptidoglycan derived activator of Nod1 cannot be transported by 
this transporter [521]. 
The work presented in this chapter investigates whether NF-κB activation by 
P.aeruginosa is dependent on a functional T3SS and peptidoglycan activation of 
Nod1. The cell line HEK293 was used since these cells have been shown to 
respond to intracellular stimulation with Gram-negative bacteria, or 
peptidoglycan via a Nod-1 dependent pathway [17, 222, 343, 507]. The results 
show that P.aeruginosa is able to activate NF-κB in a T3SS-dependent manner, 
independent of translocated effectors. Furthermore, it is shown that the NF-κB 
activation by P.aeruginosa is independent of Nod1 activation.  
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6.2 Results 
6.2.1 Pseudomonas aeruginosa activates NF-κB during infection 
NF-κB activation during P.aeruginosa infection has previously been described, as 
discussed above. In order to investigate whether this activation is dependent on 
a functional T3SS, a NF-κB reporter gene system was used. HEK293 cells were 
transfected with a NF-κB-luciferase reporter plasmid together with a β-
galactosidase reporter plasmid, as a control for transfection efficiency. After 24 
h of incubation the transfected cells were infected with PA103 ΔUΔT, PA103 
ΔpcrV and PA103 ΔUΔT:ExoUS142A. The NF-κB induction was measured following 
infection, as well as β-galactosidase induction. NF-κB will only be induced in 
cells where NF-κB activation occurs, whereas the β-galactosidase will be 
produced in all living transfected cells. This provides a control, which can be 
used to calculate fold NF-κB activation in living cells. Following infection with 
P.aeruginosa, it was shown that NF-κB is activated in a T3SS-dependent manner 
(Figure 6.3). Furthermore, this activation was shown to be independent of 
translocated effectors, as PA103 ΔUΔT:ExoUS142A activates NF-κB to the same 
extent as PA103 ΔUΔT (Figure 6.3).  
 
Figure 6.3; P.aeruginosa activates NF-κB during infection, dependent on a functional T3SS 
but independent of translocated effectors 
HEK293 cells were transfected with pNF-κB-Luc and p-β-gal, after 24 h cells were infected with 
P.aeruginosa strains as indicated at a MOI of 200 for 90 min. Gentamicin were then added for 12 h 
and then luciferase and β-galactosidase activity in cell lysates were measured. Columns are 
means of duplicates and error bars are SEM. * indicate significant difference, where p<0.05, 
unpaired Student’s t-test.  
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P.aeruginosa has LPS, but HEK293 cells lack TLR4 and TLR2 and should therefore 
not respond to LPS stimulation [523, 524]. This was investigated using the NF-
κB/β-gal reporter gene system. Following LPS treatment, with highly purified 
LPS preparations (ion-exchange chromatography), of HEK293 cells no NF-κB 
activation could be detected (Figure 6.4). There was a significant increase in NF-
κB activation after treatment with LPS from the pseudomonal strain PA10 
compared to control and LPS from E.coli (Figure 6.4). However, the degree of 
stimulation was minimal. This might be due to contaminating bacterial products 
in the LPS preparation, as discussed previously and below.  
 
Figure 6.4; HEK293 cells do not have TLR4 and TLR2 and lacks response to LPS 
HEK293 cells were tranfected with pNF-κB-Luc and p-β-gal. Together with the transfection mixture 
LPS were added, cell lysates were analysed for luciferase and β-galactosidase activity 24 h later. 
Columns are means of triplicates and error bars are SEM. * indicates significant difference 
compared to control (-) where p<0.05, unpaired Student’s t-test.  
 
Peptidoglycan was identified as a molecule which activates NF-κB dependent on 
Nod1 and Nod2 [343, 479-481]. Peptidoglycan was therefore purified from the 
E.coli SM10 strain. Following stimulation of NF-κB/β-gal transfected HEK293 cells 
with PGN, significant activation of NF-κB compared to untreated cells could be 
detected (Figure 6.5). However, the activation was fairly modest.  
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Figure 6.5; NF-κB is activated following treatment of HEK293 cells with peptidoglycan 
HEK293 cells were tranfected with pNF-κB-Luc and p-β-gal. Together with the transfection mixture 
PGN from E.coli SM10 were added, cell lysates were analysed for luciferase and β-galactosidase 
activity 24 h later. Columns are means of triplicates and error bars are SEM. * indicates significant 
difference where p<0.05, unpaired Student’s t-test. 
 
In conclusion, P.aeruginosa activates NF-κB during infection in a T3SS-dependent 
manner. Furthermore, as previously described HEK293 cells do not respond to 
LPS, due to lack of TLR4 and TLR2. However, PGN is able to activate NF-κB in 
HEK293 cells.  
Previous publications investigating Nod1 dependent NF-κB activation by bacteria 
have used HEK293 cells transfected with a range of constructs to inhibit Nod1. In 
order to further investigate the role of Nod1 in NF-κB activation by P.aeruginosa 
a variety of Nod1 constructs were used, described below.  
6.2.2 Nod1 is not involved in the NF-κB response to 
Pseudomonas aeruginosa 
As previously described, Nod1 is involved in the triggering of NF-κB as a response 
to peptidoglycan. Previous section in this chapter described a T3SS-dependent 
NF-κB activation following infection with P.aeruginosa. To investigate whether 
siRNA silencing of Nod1 had any effect on NF-κB activation by PA103 ΔUΔT, a 
luciferase reporter gene assay was performed after siRNA transfection. The 
siRNA sequences used were previously published and validated by Viala et al. 
[222]. HEK293 cells were transfected with siRNA, two days later they were 
infected with PA103 ΔUΔT and after another day luciferase activity were 
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measured. The siRNA transfection had no effect on the NF-κB activation (Figure 
6.6).  
 
Figure 6.6; siRNA silencing of Nod1 has no effect on NF-κB activation by P.aeruginosa  
HEK293 cells were transfected with indicated siRNAs and after 24 h cells were transfected again 
with p-NF-κB-Luc and p-β-gal. After additional 24 h cells were infected with PA103 ΔUΔT at a MOI 
of 200 for 90 min. Gentamicin was added for 12 h and then luciferase and β-galactosidase activity 
in cell lysates were measured. Columns are means of duplicates and error bars are SEM. 
 
In addition, the silencing with Nod1 siRNA could not be detected by Western 
blot. This was not successful and no silencing could be observed (Figure 6.7). 
The antibody from Abcam detects a band at 32 kDa, which corresponds to Nod1. 
However, the predicted size of Nod1 is 106 kDa, and a very weak band can be 
observed at this weight (Figure 6.7).  
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Figure 6.7; Nod1 could not be silenced by siRNA in HEK293 cells 
HEK293s were transfected with siRNA against Nod1 and control scrambled siRNA. After 24 h cell 
lysates were analysed by immunoblotting with Nod1 antibody (Abcam). Band at about 32 kDa is 
Nod1 even though the predicted size is 106 kDa, indicated with asterix (*).  
 
To try and improve sensitivity, we instead used an antibody against Nod1 from 
Cell signalling. HEK293 cell lysates were immunoblotted with this antibody. In 
normal untransfected cells, no Nod1 could be detected (Figure 6.8), indicating a 
very low expression level of Nod1 in HEK293 cells. However, Nod1 could be 
detected in HEK293 cells transfected with hNod1 expression plasmid (Figure 
6.8). Increasing amounts of Nod1 expression plasmid resulted in increasing Nod1 
expression, as expected.  
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Figure 6.8; Nod1 can be detected in HEK293s following overexpression with pCDNA3 hNod1 
HEK293s were transfected with indicated amounts of pCDNA3 hNod1, after 24 h cell lysates were 
analysed by immunoblotting with Nod1 antibody (Cell signalling). Increasing amounts of hNod1 
results in increasing amount of Nod1 detected in the cell lysates (top panel). Lower panel shows 
actin reprobe to show even loading of the gel, there is less protein loaded in the 25 ng lane.  
 
Expression of exogenous Nod1 resulted in a detectable amount of Nod1 by 
Western blot, molecular weight of 106 kDa (Figure 6.8). Exogenous Nod1 also 
had an effect on NF-κB activation by LPS, purified by phenol extraction, and 
peptidoglycan purified from E.coli SM10. Transfection with Nod1 resulted in 
significant increased NF-κB activation after LPS and PGN treatment compared to 
control (Figure 6.9). This LPS was purified by phenol extraction and thus 
contains contaminating peptidoglycan. No effect could be detected after these 
treatments in cells which were transfected with the expression plasmid alone 
(Figure 6.9). Previous results showed only minor changes following LPS and PGN 
treatment in NF-κB activation in HEK293 cells alone (Figure 6.4 and 6.5).  
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Figure 6.9; NF-κB is activated in HEK293 cells following treatment with LPS purified by 
phenol extraction and peptidoglycan 
HEK293 cells were transfected with pNF-κB-Luc and p-β-gal as well as pCDNA3 hNod1 or 
pCDNA3. Together with the transfection mixture PGN from E.coli SM10 or LPS purified by phenol 
extraction was added, cell lysates were analysed for luciferase and β-galactosidase activity 24 h 
later. Columns are means of triplicates and error bars are SEM. * and ** indicates significant 
difference where * is p<0.05 and ** is p<0.01, unpaired Student’s t-test.  
 
LPS purified by phenol extraction contain contaminating peptidoglycan which 
can activate Nod1. In contrast, LPS purified by ion-exchange chromatography 
lacks contaminating material. The effect of these different preparations of LPS 
was investigated in HEK293 cells transfected with exogenous Nod1 and 
cotransfected with a dominant-negative construct of Nod1 (ΔCARD), which lacks 
the CARD necessary for NF-κB activation. No NF-κB activation can be detected in 
cells treated with ion-exchange LPS compared to control (Figure 6.10). A 
significant increase was detected following treatment with phenol extraction 
LPS (Figure 6.10). This effect was inhibited when cells were cotransfected with 
ΔCARD, bringing the NF-κB activation back to base-line (Figure 6.10). The ΔCARD 
construct also had an effect on the untreated and ion-exchange LPS treated 
cells. So even though there is an effect on the phenol extraction LPS treated 
cells, it also suggests that background levels of expressed hNod1 are activating 
NF-κB in the transfected cells.  
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Figure 6.10; NF-κB activation by LPS purified by Phenol extraction is dependent on Nod1 
HEK293 cells were transfected with pNF-κB-Luc, p-β-gal and pCDNA3 hNod1 indicated samples 
were also transfected with pCDNA3 ΔCARD. After 5 h LPS purified by ion-exchange 
chromatography and phenol extraction was added, cell lysates were analysed for luciferase and β-
galactosidase activity 24 h later. Columns are means of duplicates and error bars are SEM. * 
indicates significant difference where * is p<0.05, unpaired Student’s t-test. 
 
siRNA silencing of Nod1 had no effect on the NF-κB activation by P.aeruginosa. 
However, this might be due to unsuccessful silencing of Nod1. As another 
method, HEK293 cells were transfected with ΔCARD (Figure 6.11). No 
concentrations of ΔCARD had any effect on the NF-κB activation by PA103 ΔUΔT 
(Figure 6.11A and B). This further strengthens the conclusion that Nod1 is not 
involved in the NF-κB activation by P.aeruginosa.  
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Figure 6.11; NF-κB activation by P.aeruginosa is not dependent on Nod1 
HEK293 cells were transfected with pNF-κB-Luc and p-β-gal as well as pCDNA3 ΔCARD, at 
indicated amounts, or pCDNA3 at an amount corresponding to the highest amount of pCDNA3 
ΔCARD. After 24 h cells were infected with PA103 ΔUΔT or PA103 ΔpcrV at a MOI of 100 for 90 
min. Gentamicin was added for 12 h. Cell lysates were analysed for luciferase and β-galactosidase 
activity. Columns are means of triplicates and error bars are SEM. A, pCDNA3 ΔCARD at 100 ng, 
250 ng and 500 ng. B, pCDNA3 ΔCARD at 250 ng, 500 ng and 1000 ng.  
 
To further investigate the NF-κB activation following expression of exogenous 
Nod1 and cotransfection with ΔCARD, the effect of phenol extraction LPS was 
investigated. As previously described, after treatment with phenol extraction 
LPS the NF-κB activation is abrogated in cells cotransfected with ΔCARD (Figure 
6.12). In this experiment, ΔCARD cotransfection had no effect on cells alone 
(Figure 6.12).  
 
Figure 6.12; NF-κB activation by LPS purified by Phenol extraction is dependent on Nod1 
HEK293 cells were transfected with pNF-κB-Luc, p-β-gal and pCDNA3 hNod1 indicated samples 
were also transfected with pCDNA3 ΔCARD. Together with the transfection mixture LPS purified by 
phenol extraction was added, cell lysates were analysed for luciferase and β-galactosidase activity 
24 h later. Columns are means of triplicates and error bars are SEM. * indicates significant 
difference where * is p<0.05, ns is non significant difference p>0.05, unpaired Student’s t-test. 
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Varied amounts of ΔCARD were used in the cotransfection together with Nod1. In 
this experiment, there was an increased NF-κB activation in Nod1 transfected 
PA103 ΔUΔT infected cells, compared to infected cells transfected with the 
expression plasmid alone (Figure 6.13). This increase might be due to the effect 
also seen in cells alone, where the NF-κB activation is increased following 
transfection with hNod1 (Figure 6.13), as previously described. However, 
infected cells transfected with pCDNA3 alone have an increased NF-κB activation 
compared to cells alone (Figure 6.13), as previously seen. The NF-κB activation 
in the infected cells is not altered following cotransfection with ΔCARD (Figure 
6.13). Cotransfection resulted in less NF-κB activation in cells alone compared to 
cells transfected with hNod1 (Figure 6.13), further indicating that there are 
background levels of NF-κB activated by transfected hNod1 in these cells. This 
provides additional evidence that Nod1 is not involved in the NF-κB activation by 
P.aeruginosa.  
 
Figure 6.13; P.aeruginosa activates NF-κB independent of Nod1 
HEK293 cells were transfected with pNF-κB-Luc, p-β-gal and pCDNA3 hNod1 indicated samples 
were also transfected with pCDNA3 ΔCARD. After 24 h cells were infected with PA103 ΔUΔT at a 
MOI of 50 for 90 min. Gentamicin was added for 12 h. Cell lysates were then analysed for 
luciferase and β-galactosidase activity. Columns are means of triplicates and error bars are SEM. 
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6.3 Discussion 
NF-κB is a transcription factor involved in a range of processes. It mediates 
transcription of proinflammatory chemokines and cytokines. As a result several 
NF-κB activators have been described, as previously discussed. It has previously 
been shown that P.aeruginosa can activate NF-κB during infection [17, 475, 
476].  
The silencing of Nod1 by siRNA was never successful in this study. According to a 
previous publication by Viala et al. the half-life of endogenous Nod1 is relatively 
long which results in more time required to silence Nod1 (72 h) [222]. The same 
time periods were used during the experiments presented in this chapter. 
Further optimization would be needed; perhaps the construction of stably Nod1 
siRNA silenced HEK293 cells or the use of cells from a Nod1 KO mouse. The 
antibody from Abcam, which recognise Nod1 results in several non-specific 
bands. The predicted size of Nod1 is 106 kDa, but the antibody recognises a band 
at 32 kDa. Instead of this antibody, an antibody from Cell signalling was used. 
After overexpression of Nod1 in HEK293 cells, it was possible to detect Nod1 at 
the correct size of 106 kDa. This indicates that the endogenous level of Nod1 in 
HEK293 cells is very low. However, it might also reflect the quality of 
commercial antibodies available directed towards Nod1. Therefore, the reporter 
gene assay was tested in siRNA transfected cells. No effect on the NF-κB 
activation by P.aeruginosa could be detected. This could be due to the protein 
not being silenced, but also that Nod1 is not involved in the NF-κB activation by 
P.aeruginosa. In this study it was also attempted to use siRNA to silence Nod1 in 
Nod1 transfected cells (results not shown). All the attempts resulted in blank 
blots and this approach was therefore abandoned. The silencing by siRNA of 
Nod1 in HEK293 cells was successful in the study by Viala et al. [222]. However, 
the antibody used in that study was in-house and thus not available 
commercially.  
Instead of using siRNA to investigate the effects of Nod1 on NF-κB activation by 
P.aeruginosa, a dominant-negative construct of Nod1, ΔCARD, was used. The 
results for untreated cells transfected with Nod1 plasmid and cotransfected with 
ΔCARD vary between the different experiments described in this chapter. The 
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untreated cells seem to be affected in some of the experiments by ΔCARD. This 
might be due to an underlying Nod1 effect in the cells, but more likely reflects 
variations in the experiment due to the cells used, transfection reagent etc. The 
same transfection reagent and cells are used throughout this chapter but there 
might be slight differences between the confluency of cells, as well as the batch 
of transfection reagent. However, the results observed for P.aeruginosa is never 
affected by transfection and thus conclusions from these experiments can still 
be drawn. The variation seen for the results where cells are treated with LPS 
might also reflect variations in the batch of LPS used. LPS purified by phenol 
extraction can be used as a source of peptidoglycan, this will inevitably vary 
between batches and the exact amount of NF-κB stimulatory molecules added 
will be unknown.  
The results presented in this chapter confirm that HEK293 cells do not respond 
to pure LPS (purified by ion-exchange chromatography), because these cells lack 
TLR2 and TLR4 expression [523, 524]. HEK293 cells do express TLR5 however, 
but this is irrelevant in this study since PA103 lacks flagellin.  
Nod1 responds to the iE-DAP part of peptidoglycan from Gram-negative bacteria, 
as well as some Gram-positives. This reagent is commercially available and 
attempts were made during this investigation to use it for NF-κB activation. No 
conclusions could be drawn from these experiments and results are therefore 
excluded. Further optimisation with concentrations would have to be performed, 
but due to the time constraints of this project there was no time for these 
experiments. According to previously published data; high molecular-weight PGN 
is poorly stimulatory compared to synthetic molecules containing the minimal 
Nod1 stimulating structure [479, 481]. The molecular basis that accounts for 
these differences in activity is not understood. This offers some explanation to 
why the purified PGN is poorly stimulatory in the experiments with 
untransfected HEK293 cells.  
Travassos et al. have described a role for Nod1 in NF-κB activation by 
P.aeruginosa [17]. This publication used the ΔCARD construct used in this study 
as well as fibroblasts from Nod1 KO mice. The pseudomonal strains used were 
PAK and PAO-1, which might contribute to the differences seen between this 
study and previous published results, since results presented here are from the 
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PA103 strain. The increase in luciferase activity observed by Travassos et al. 
corresponds to the increase seen in this study. The contradicting results for the 
Nod1-dependence presented in this chapter might be due to different 
experimental procedures. It should be mentioned however, that a flagellin 
deficient strain used by Travassos et al. was still able to activate NF-κB. PA103 
does not have flagellin and thus the results presented here are, in this respect, 
similar to previous published results. Travassos et al. describes the Nod1 
signalling pathway as a back-up system to the detection via TLRs. This indicates 
a more important role for other systems, which indeed agree with the results 
presented in this chapter. However, it is argued that a flagellin deficient strain 
will activate NF-κB via Nod1 even though it is able to avoid detection via TLR5. 
However, additional systems must exist, discussed in more detail below, since 
the flagellin deficient strain PA103 is able to activate NF-κB independent of both 
Nod1 and TLR5.  
It was shown that Nod1 can respond to peptidoglycan which is delivered by the 
T4SS of H.pylori [222]. Similar to P.aeruginosa, H.pylori is a non-invasive Gram-
negative pathogen. The study by Viala et al. not only investigated Nod1 
involvement using the ΔCARD construct, but also used Nod1 KO mice. According 
to the results published by Viala et al. HEK293 cells express Nod1, which was 
investigated by mRNA expression. In this study no Nod1 could be detected in 
HEK293 cells alone, but mRNA expression was never investigated, instead 
Western blot was used which might not be as sensitive. In the H.pylori study the 
NF-κB activation could be abrogated when cells were cotransfected with the 
ΔCARD construct. This was not observed during this study, which might simply be 
due to the fact that different bacterial strains activate different receptors. This 
activation subsequently results in NF-κB activation.  
The results presented in this chapter imply T3SS-dependent NF-κB activation by 
P.aeruginosa. There is an increase in NF-κB activation in cells infected with the 
PA103 strain which lacks a functional T3SS (PA103 ΔpcrV) compared to untreated 
cells, but a significantly increased activation when the bacteria has a functional 
T3SS. The activation seen following infection with PA103 ΔpcrV is probably due 
to activation of other receptors which lead to NF-κB activation.  
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P.aeruginosa clearly activates NF-κB during infection of HEK293 cells. This was 
shown here to be dependent on a functional T3SS, similar to previously 
published results for T4SS-dependent NF-κB activation by H.pylori [222]. In the 
study by Viala et al. the T4SS-dependent activation was mediated by specific 
peptidoglycan moieties passing through the secretion system. The mechanism for 
this however remains unknown. It is likely that the T3SS of P.aeruginosa could 
act as a conduit for NF-κB activating molecules such as peptidoglycan. From 
results presented in this chapter P.aeruginosa does not activate NF-κB in a Nod1-
dependent manner. Nod2 is the other receptor which has been identified as a 
peptidoglycan receptor in mammalian cells [480, 481]. It would therefore be 
interesting to investigate the role of Nod2 in NF-κB activation by P.aeruginosa. 
There is also the possibility that P.aeruginosa activates NF-κB via a yet 
undiscovered receptor and / or an undiscovered mediator. It would be 
interesting to investigate the NF-κB activation following infection with 
P.aeruginosa in Nod1 KO mice to confirm the results seen in this study. Other KO 
mice could potentially also be used to investigate involvement of other 
receptors in the NF-κB activation seen.  
All the results presented in this chapter indicate that Nod1 is not involved in the 
NF-κB activation following infection with P.aeruginosa. The same results have 
been found for Yersinia, which is very similar to P.aeruginosa (Presented by V. 
Auerbuch Stone at ASM, Boston 2008). This, compared to previous published 
results [17], implies that further studies are needed in order to determine the 
role of Nod1 in NF-κB activation by P.aeruginosa. 
In conclusion, the results presented in this chapter describe a novel NF-κB 
activation by P.aeruginosa independent of Nod1 and TLR signalling. 
Furthermore, the NF-κB activation is increased when the bacteria has a 
functional T3SS, but is unaltered by the presence of translocated effectors. This 
implies a role for the T3SS as a conduit for a molecule, which is capable of 
activating NF-κB, via a hitherto unknown receptor.  
257 
7 General discussion and conclusions 
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P.aeruginosa is a Gram-negative, extracellular pathogen. It mainly causes 
infection in immuno-compromized individuals and treatment is difficult due to 
high levels of antibiotic resistance. This and the ability of P.aeruginosa to 
survive in a wide range of environments results in 10.1 % of all hospital acquired 
infections being caused by this pathogen. Among these infections only 50 % are 
treatable. Several vaccines and monoclonal antibodies against P.aeruginosa have 
been developed, but none of them has obtained market authorization [525]. The 
antigens that have been explored for vaccine development include LPS, 
extracellular proteins, flagella, pcrV of the T3SS, pili as well as whole killed 
bacteria and attenuated bacteria [525]. Due to the high antibiotic resistance of 
P.aeruginosa there is a need for other treatment options. New potential targets 
and options can be developed if the understanding of this pathogen is increased, 
for example the mechanism by which infection is caused and the host-response 
to this infection.  
Innate immunity is the first response against infection. Even though it has been 
extensively studied over the years new PRRs and PAMPs are still being identified. 
NLRs were recently discovered as intracellular PRRs, as discussed in section 
1.5.4. The aim of this thesis was to investigate whether and by which mechanism 
the extracellular P.aeruginosa can trigger intracellular PRR. To achieve this, the 
ability of P.aeruginosa to trigger inflammasome activation was investigated by 
the detection of mature IL-1β secretion and active caspase-1, as well as the 
ability to trigger Nod1 activation by detection of activated NF-κB. These studies 
resulted in a number of novel findings, which will be discussed below.  
The results in chapter 3 show that P.aeruginosa is able to activate the 
inflammasome complex dependent on NLRC4 and ASC. This was shown to be 
dependent on a functional T3SS. Similar results have been published, confirming 
the results presented in this thesis. Further studies revealed that this activation 
is dependent on extracellular potassium (chapter 4) and pilin (chapter 5), both 
identifying novel ways to trigger the NLRC4 inflammasome complex.  
In the context of an infection bacteria are likely activate the innate immune 
response through several PRRs. This study, as well as previously published 
results, have identified several receptors being activated upon infection with 
P.aeruginosa; LPS via TLR4 [474], flagellin via TLR5 [472] and CpG DNA via TLR9 
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[473], as well as the activation of the NLRC4 inflammasome [249, 253, 354]. The 
results presented in this thesis shows that Nod1 activation is not involved in the 
innate immune response to P.aeruginosa, at least not under the conditions used 
in this study, chapter 6. Only a few of the 23 NLR-proteins identified in humans 
have had the activating PAMP or DAMP identified [172]. In addition, new stimuli, 
activating already described NLR-proteins, are constantly being presented, for 
example in this study for NLRC4. It is therefore likely that other receptors and 
PAMPs involved in the immune response against P.aeruginosa will be identified in 
the future, adding to our knowledge of this pathogen further. Furthermore, it is 
highly likely that several more NLR-protein complexes and collaborations 
between receptors will be identified. This will add to our understanding of the 
innate immune response, as well as the ability of pathogens to trigger 
inflammation. Costimulation of receptors contributes to a full blown 
inflammatory response, which the host requires to be specific, rapid and self-
limiting [160]. Furthermore, involvement of several receptors has been shown to 
potentiate their activity through interactions between the receptors. Nod1 have 
been shown to act synergistically with TLR4 in the induction of proinflammatory 
cytokines [317, 318]. Dectin-1, involved in antifungal responses, has been shown 
to act synergistically in the same way with various TLRs [167].  
P.aeruginosa has evolved mechanisms to inhibit NLRC4-mediated caspase-1 
activation, by ExoU- and ExoS-dependent inhibition of caspase-1 activation and 
IL-1β maturation [249, 526]. This suggests that the NLRC4-dependent pathway is 
important for host defence against Gram-negative bacterial infections. On the 
other hand, IL-1β production can be detrimental for the host. Schultz et al. 
found that IL-1R deficiency had a protective effect in response to pulmonary 
infection with P.aeruginosa [527]. It has also been shown that neutralisation of 
IL-1β with antibodies protected acid sphingomyelinase-deficient mice from 
lethal P.aeruginosa infection [528]. In addition, Thakur et al. found in a 
P.aeruginosa keratitis model, that caspase-1 deficiency results in less corneal 
damage [529, 530]. It should be noted however that it remains unclear from 
these studies if the adverse effects mediated by IL-1β and caspase-1 are caused 
by inflammatory damage or lack of control of bacterial replication. It has also 
been published, in contrast to these studies, that IL-1R-deficient mice had 
greater colonization with P.aeruginosa compared with WT mice after oral 
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exposure to the pathogen in drinking water [531]. In the study by Sutterwala et 
al. it was shown that the NLRC4-inflammasome plays an important role in host 
defence against P.aeruginosa infection [249]. NLRC4-deficiency resulted in 
increased bacterial burden in the peritoneum and spleen of intraperitoneally 
infected mice. The mice were infected with PA103 ΔU and the infection 
correlated with a decrease in serum IL-1β and IL-18 [249]. Furthermore, IL-1β 
has a critical role in gut-derived sepsis caused by P.aeruginosa. IL-1β-deficient 
mice had a lower survival rate than that of WT mice. In vitro phagocytosis and 
cytokine production by macrophages was impaired in IL-1β-deficient mice 
compared to WT mice [532]. 
Therefore it can be argued that P.aeruginosa uses the inflammasome activation 
as a virulence mechanism. It has been shown, that an absence or reduction in 
endogenous IL-1β activity improves host defence against P.aeruginosa caused 
pneumonia while suppressing the inflammatory response [527]. However, the 
inflammasome activation and IL-1β secretion is clearly also important for host 
defence. This implies that the level of activation is important, where too much 
IL-1β might aid the bacteria rather than the host. The fact that P.aeruginosa has 
evolved effectors that inhibit IL-1β secretion suggests that the inflammasome 
activation is beneficial for the host but not the bacteria. This is further 
strengthened by the fact that P.aeruginosa is able to trigger inflammasome 
activation independent of effectors passing through the secretion system, 
indicating that the host has evolved mechanisms to detect PAMPs ‘mistakenly’ 
translocated into the host cell. If the level of activation is important a 
therapeutic model could be to dampen, but not completely abrogate the 
inflammasome response during, for example, infection. Inappropriate activation 
of the NLRP3 inflammasome has been linked to gout and silicosis. It was recently 
shown that Glybenclamide is able to inhibit NLRP3-induced IL-1β secretion, 
which was independent of its activity as a potassium-channel inhibitor [533]. 
Glybenclamide is already approved for the treatment of type 2 diabetes and thus 
this result provides hope for patients suffering from silicosis. In addition, 
glybenclamide could potentially be used to dampen, at the correct dose, the 
inflammasome activation during infection, which would allow the innate immune 
response to combat infection without the detrimental effects leading to 
bacterial spread rather than clearance.  
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Glybenclamide was used in this study as an inhibitor of potassium-channels, to 
investigate the role of extracellular potassium in the inflammasome activation 
by P.aeruginosa. It was shown that following Glybenclamide treatment the IL-1β 
secretion was inhibited, although not completely abrogated. Recently published 
results indicate that this effect has nothing to do with potassium-channels, 
rather an effect on the NLRP3 inflammasome [533]. However, it is known from 
previous publications, as well as from results presented in this thesis, that the 
inflammasome activation by P.aeruginosa is dependent on the NLRC4 
inflammasome. Maybe the inhibitory effect of Glybencalmide also affects the 
NLRC4 inflammasome, as the results presented here would suggest, but further 
studies are needed to confirm this hypothesis.  
It was shown in chapter 4 that both P.aeruginosa and Salmonella are dependent 
on extracellular potassium concentration for the activation of the 
inflammasome. Several potential mechanisms were proposed for this activation. 
The most likely, based on results in this thesis, include the disruption of 
membrane potential and / or involvement of intracellular potassium storage 
compartments. These hypotheses are difficult to examine, since the disruption 
of membrane potential experimentally most likely involves potassium, and it is 
already known that changes in extracellular potassium levels will affect the 
inflammasome activation. Furthermore, not much is known about intracellular 
potassium compartments, which means investigation of this hypothesis would 
involve the development of entire new methodology. The other suggestions for 
the triggering of inflammasome activation by the bacteria involve the formation 
of a T3SS pore in the host cell membrane, which, as well as effectors, allow 
passage of other small molecules and ions. The results presented in this thesis 
indicate that the pore formed by the T3SS of P.aeruginosa forms a tight 
association with the host cell membrane and does not allow other molecules or 
ions to pass through. Despite the lack of a leaky pore, a membrane repair 
response could be seen, as LAMP-1 relocates to the cellular surface following 
infection. It has been shown for Neisseria meningitidis that binding of its type IV 
pili to CD46 on human epithelial cells induces an increase in the concentration of 
cytosolic free calcium [534]. This pilus-induced calcium flux triggers lysosomal 
exocytosis, which would lead to relocation of LAMP-1 to the cellular surface. 
However the consequences of these effects are not yet known [534]. The results 
262 
presented in this thesis could not detect a change in intracellular calcium, but 
that might be explained by the method used. 
A wide range of PAMPs and DAMPs have been identified as inflammasome 
complex activators, as previously described. In addition, the results presented in 
this thesis have identified a role for extracellular potassium in the activation of 
the NLRC4 inflammasome complex. Potassium also plays an important role in the 
activation of the NLRP3 and NLRP1 inflammasome complexes. The NLRC4 
inflammasome is activated by PAMPs which pass through a bacterial secretion 
system, such as flagellin, previously published, and pilin, described in chapter 5 
of this thesis. This suggests that the NLRC4 inflammasome is triggered by an 
effect mediated by the secretion systems, either T3SS or T4SS. In contrast, the 
NLRP3 inflammasome is triggered by pore-forming toxins and cellular damage 
caused by various crystals [371].  
Pilin is able to activate the inflammasome, as shown in chapter 5. This occurs in 
a T3SS-dependent manner. In addition, previous studies have identified flagellin 
as an inflammasome trigger, also dependent on a functional T3SS. This suggests 
that flagellin and pilin are able to pass through the T3SS, even though it was 
believed that the translocation through the T3SS is regulated [535]. The finding 
that flagellin is able to pass through the T3SS of Salmonella further strengthens 
this hypothesis. In addition, it has been shown that PGN is able to pass through 
the T4SS of H.pylori. Together these results suggest that the host has developed 
mechanisms to detect bacterial mediators that might pass through the bacterial 
secretion systems by mistake.  
Furthermore, this is the first demonstration of recognition of type IV pilin by a 
PRR. Type IV pili shares features with other PAMPs such as adhesion, which is an 
important virulence determinant. In addition, there are sequence similarities of 
the pilin gene between different bacterial species. These and other factors most 
likely mediate a strong selection pressure for the development of a pilin specific 
PRR. In addition the Nod-proteins, Nod1 and Nod2 are the only known sensors of 
PGN [492], although this have been questioned [495]. Furthermore, it has been 
shown that TLR2 and TLR4 are not the major receptors responding to 
P.aeruginosa infection [536].This clearly demonstrates a very important role for 
the NLR proteins in innate immunity.  
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The results presented in this thesis have answered a number of questions 
regardning the triggering of PRRs by P.aeruginosa, but there are still a lot of 
questions to be answered. However, in conclusion the results provide a deeper 
understanding for the mechanism by which P.aeruginosa triggers the 
inflammatory response and how the host responds to infection by this pathogen. 
These are all important points for the discovery and development of new 
treatment options.  
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1375.3824
92   
1375.6408
23   
-
0.2583
31  
0   85   0.00047  1   
 R.YYSQNPGV
GYTK.D 
 
  
       Proteins matching the same set of peptides: 
       gi|84323198    Mass: 13809    Score: 85     Queries matched: 1 
  
COG4968: Tfp pilus assembly protein PilE [Pseudomonas aeruginosa 
2192] 
 
4.     gi|453155    Mass: 61950    Score: 66     Queries matched: 1   emPAI: 0.07 
  keratin 9 [Homo sapiens] 
   
    
Que
ry 
  
Observe
d   
Mr(expt
)   
Mr(calc
)   
 Del
ta  
Mi
ss
  
Sco
re  
Exp
ect
  
Ra
nk
  
 Peptide 
  
129
   
1075.10
0490   
3222.27
9642   
3222.27
4384   
0.00
5258
  
0 
  
66 
  
0.0
27  
1 
  
 R.GGSGGSHGGGSGFGGESGGSY
GGGEEASGSGGGYGGGSGK.S 
 
  
       Proteins matching the same set of peptides: 
       gi|55956899    Mass: 62027    Score: 66     Queries matched: 1 
  keratin 9 [Homo sapiens] 
       gi|81175178    Mass: 62092    Score: 66     Queries matched: 1 
  
Keratin, type I cytoskeletal 9 (Cytokeratin-9) (CK-9) (Keratin-9) 
(K9) 
       gi|113197968    Mass: 48057    Score: 66     Queries matched: 1 
  KRT9 protein [Homo sapiens] 
       gi|114667176    Mass: 107386   Score: 66     Queries matched: 1 
  
PREDICTED: similar to Keratin, type I cytoskeletal 14 
(Cytokeratin-14) (CK-14) (Keratin-14) (K14) [Pan troglodytes] 
 
5.     gi|67549    Mass: 23978    Score: 65     Queries matched: 1   emPAI: 0.18 
  trypsin (EC 3.4.21.4) precursor - bovine 
   
    
Quer
y   
Observe
d   
Mr(expt)
   
Mr(calc)
   
 Delt
a  
Mis
s  
Sco
re  
Expe
ct  
Ran
k   Peptide 
  
109 
  
758.271
463   
2271.792
561   
2272.152
130   
-
0.359
569  
0   65   
0.04
5  1   
 K.SIVHPSYNSNTLN
NDIMLIK.L 
 
  
       Proteins matching the same set of peptides: 
       gi|230338    Mass: 23290    Score: 65     Queries matched: 1 
  
Chain E, Trypsin (E.C.3.4.21.4) Complex With Bowman-Birk Inhibitor 
(AB-I) 
       gi|230765    Mass: 22871    Score: 65     Queries matched: 1 
  
Chain E, Bovine Trypsin (E.C.3.4.21.4) Complex With A Modified SSI 
(Streptomyces Subtilisin Inhibitor) With Met 70 Replaced By Gly 
And Met 73 Replaced By Lys (SSI(M70G,M73K)) 
       gi|1421532    Mass: 23975    Score: 65     Queries matched: 1 
296 
  Chain , Trypsinogen-Ca From Peg 
       gi|2392548    Mass: 23276    Score: 65     Queries matched: 1 
  Chain A, Bovine Trypsin Complexed To Appi 
       gi|2392803    Mass: 23314    Score: 65     Queries matched: 1 
  Chain , Structure Of Hydrolase (Serine Proteinase) 
       gi|2507249    Mass: 25408    Score: 65     Queries matched: 1 
  
Cationic trypsin precursor (Beta-trypsin) [Contains: Alpha-trypsin 
chain 1; Alpha-trypsin chain 2] 
       gi|5542503    Mass: 24704    Score: 65     Queries matched: 1 
  Chain A, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes 
       gi|9955040    Mass: 23288    Score: 65     Queries matched: 1 
  
Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of 
Serine Proteases 
       gi|13096612    Mass: 23879    Score: 65     Queries matched: 1 
  
Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base 
Magnesium(Ii) Chelate 
       gi|34810822    Mass: 25392    Score: 65     Queries matched: 1 
  
Chain B, Non-Covalent Complex Between Alpha-1-Pi-Pittsburgh And 
S195a Trypsin 
       gi|49259456    Mass: 23288    Score: 65     Queries matched: 1 
  
Chain T, Benzamidine In Complex With Bovine Trypsin Variant 
X(Ssri) Bt.C1 
       gi|49259463    Mass: 23318    Score: 65     Queries matched: 1 
  
Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant 
X(Sswi)bt.B4 
       gi|49259467    Mass: 23203    Score: 65     Queries matched: 1 
  
Chain T, Benzamidine In Complex With Bovine Trypsin Varinat 
X(Ssai) Bt.D1 
       gi|61873128    Mass: 25769    Score: 65     Queries matched: 1 
  
PREDICTED: similar to pancreas cationic pretrypsinogen isoform 1 
[Bos taurus] 
       gi|88193016    Mass: 23287    Score: 65     Queries matched: 1 
  
Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser) In 
Complex With Trypsin 
       gi|88193018    Mass: 23402    Score: 65     Queries matched: 1 
  
Chain E, Crystal Structure Of A Bpti Variant (Cys38->ser) In 
Complex With Trypsin 
       gi|49259465    Mass: 23321    Score: 63     Queries matched: 1 
  
Chain T, Benzamidine In Complex With Bovine Trypsin Variant 
X(Ssfi.Glu)bt.D1 
       gi|49259461    Mass: 23295    Score: 62     Queries matched: 1 
  
Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant 
X(Ssyi)bt.B4 
       gi|112490427    Mass: 23134    Score: 61     Queries matched: 1 
  Chain A, Structure Of Hyper-Vil-Trypsin 
 
Mascot:  http://www.matrixscience.com/  
Top scoring peptide matches to query 19 
File: dUFr.wiff, Sample: dUFr (sample number 1), Elution: 16.43 to 
16.51 min, Period: 1, Cycle(s): 405 (Experiment 3), 404 (Experiment 4) 
Score greater than 53 indicates homology 
Score greater than 64 indicates identity 
Score    Expect       Delta  Hit  Protein    Peptide 
 77.8    0.0022   -1.294220    1   gi|120436 K.FNFATGQSSPK.N 
 37.5        23   -1.261200                  -.MNFAVVEDSR.S 
 37.0        26   -0.266602                  K.NMRRSNMNK.D 
 35.6        36   -0.375061                  R.MIYAASKSALK.A 
 34.4        47   -0.265931                  R.DNLMPTAFNK.D 
 34.4        47   -0.313538                  K.IYQRTAMNK.E 
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Score greater than 64 indicates identity 
Score    Expect       Delta  Hit  Protein    Peptide 
 77.8    0.0022   -1.294220    1   gi|120436 K.FNFATGQSSPK.N 
 37.5        23   -1.261200                  -.MNFAVVEDSR.S 
 37.0        26   -0.266602                  K.NMRRSNMNK.D 
 35.6        36   -0.375061                  R.MIYAASKSALK.A 
 34.4        47   -0.265931                  R.DNLMPTAFNK.D 
 34.4        47   -0.313538                  K.IYQRTAMNK.E 
 34.4        47   -0.349945                  -.MSRIVTAFNK.T 
 34.0        51   -0.265946                  K.ACSDIVDAFNK.R 
 34.0        51   -0.277161                  K.GGMNAEKAFNK.H 
 33.8        54   -0.313553                  -.MAKSQQTFNK.S 
 
Top scoring peptide matches to query 20 
File: dUFr.wiff, Sample: dUFr (sample number 1), Elution: 25.51 to 
27.95 min, Period: 1, Cycle(s): 527-530, 541, 551 (Experiment 3), 539-
540, 552-553 (Experiment 4) 
Score greater than 53 indicates homology 
Score greater than 64 indicates identity 
Score    Expect       Delta  Hit  Protein    Peptide 
 77.1    0.0026   -0.287590    1   gi|120436 K.FNFATGQSSPK.N 
 37.1        25   -0.254570                  -.MNFAVVEDSR.S 
 34.0        53    0.740699                  R.DNLMPTAFNK.D 
 34.0        53    0.693092                  K.IYQRTAMNK.E 
 34.0        53    0.656685                  -.MSRIVTAFNK.T 
 33.7        56    0.740684                  K.ACSDIVDAFNK.R 
 33.7        56    0.729469                  K.GGMNAEKAFNK.H 
 31.5        92    0.631569                  R.MIYAASKSALK.A 
 30.9   1.1e+02   -0.283074                  M.ESIMKVAMDK.A 
 29.3   1.5e+02    0.693077                  -.MAKSQQTFNK.S 
 
Top scoring peptide matches to query 21 
File: dUFr.wiff, Sample: dUFr (sample number 1), Elution: 15.14 to 15.4 
min, Period: 1, Cycle(s): 390 (Experiment 3), 391-392 (Experiment 5) 
Score greater than 49 indicates homology 
Score greater than 64 indicates identity 
Score    Expect       Delta  Hit  Protein    Peptide 
 65.2     0.039   -0.283554    1   gi|120436 K.FNFATGQSSPK.N 
 34.2        50    0.744735                  R.DNLMPTAFNK.D 
 34.2        50    0.697128                  K.IYQRTAMNK.E 
 34.2        50    0.660721                  -.MSRIVTAFNK.T 
 33.9        53    0.744720                  K.ACSDIVDAFNK.R 
 33.9        53    0.733505                  K.GGMNAEKAFNK.H 
 33.9        53   -0.250534                  -.MNFAVVEDSR.S 
 29.9   1.3e+02   -0.224915                  -.MSNMVPVMDK.K 
 26.7   2.8e+02   -0.224030                  R.DETKETAMDK.I 
 25.1   4.1e+02   -0.290940                  -.MIWISQFDK.F 
 
Top scoring peptide matches to query 23 
File: dUFr.wiff, Sample: dUFr (sample number 1), Elution: 23.11 to 
24.34 min, Period: 1, Cycle(s): 501, 514 (Experiment 3), 513 
(Experiment 4), 502 (Experiment 5) 
Score greater than 53 indicates homology 
Score greater than 64 indicates identity 
Score    Expect       Delta  Hit  Protein    Peptide 
 74.9    0.0042   -0.252302    1   gi|120436 K.FNFATGQSSPK.N 
 37.2        25   -0.219282                  -.MNFAVVEDSR.S 
 34.1        51    0.775987                  R.DNLMPTAFNK.D 
 34.1        51    0.728380                  K.IYQRTAMNK.E 
 34.1        51    0.691973                  -.MSRIVTAFNK.T 
 33.8        54    0.775972                  K.ACSDIVDAFNK.R 
 33.8        54    0.764757                  K.GGMNAEKAFNK.H 
 30.8   1.1e+02    0.783357                  K.QDSSTQQFNK.I 
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 28.6   1.8e+02   -0.193663                  -.MSNMVPVMDK.K 
 28.5   1.8e+02   -0.192778                  R.DETKETAMDK.I 
 
Top scoring peptide matches to query 24 
File: dUFr.wiff, Sample: dUFr (sample number 1), Elution: 28.84 to 
29.02 min, Period: 1, Cycle(s): 565-567 (Experiment 3) 
Score greater than 53 indicates homology 
Score greater than 64 indicates identity 
Score    Expect       Delta  Hit  Protein    Peptide 
 68.6     0.018   -0.250120    1   gi|120436 K.FNFATGQSSPK.N 
 37.3        24   -0.217100                  -.MNFAVVEDSR.S 
 34.1        50    0.778169                  R.DNLMPTAFNK.D 
 34.1        50    0.730562                  K.IYQRTAMNK.E 
 34.1        50    0.694155                  -.MSRIVTAFNK.T 
 33.8        54    0.778154                  K.ACSDIVDAFNK.R 
 33.8        54    0.766939                  K.GGMNAEKAFNK.H 
 30.3   1.2e+02   -0.190596                  R.DETKETAMDK.I 
 30.0   1.3e+02   -0.154219                  K.NSSTLDDMDK.F 
 29.1   1.6e+02    0.785539                  K.QDSSTQQFNK.I 
 
Top scoring peptide matches to query 25 
File: dUFr.wiff, Sample: dUFr (sample number 1), Elution: 19.6 to 20.15 
min, Period: 1, Cycle(s): 456 (Experiment 4), 462 (Experiment 5) 
Score greater than 53 indicates homology 
Score greater than 64 indicates identity 
Score    Expect       Delta  Hit  Protein    Peptide 
 73.8    0.0054   -0.247228    1   gi|120436 K.FNFATGQSSPK.N 
 37.4        24   -0.214208                  -.MNFAVVEDSR.S 
 34.3        48    0.781061                  R.DNLMPTAFNK.D 
 34.3        48    0.733454                  K.IYQRTAMNK.E 
 34.3        48    0.697047                  -.MSRIVTAFNK.T 
 34.0        51    0.781046                  K.ACSDIVDAFNK.R 
 34.0        51    0.769831                  K.GGMNAEKAFNK.H 
 32.2        78   -0.187704                  R.DETKETAMDK.I 
 28.8   1.7e+02    0.814082                  K.MASLMNAGADK.E 
 28.6   1.8e+02    0.671931                  R.MIYAASKSALK.A 
 
Top scoring peptide matches to query 26 
File: dUFr.wiff, Sample: dUFr (sample number 1), Elution: 18.47 to 
18.65 min, Period: 1, Cycle(s): 442-443 (Experiment 3), 444 (Experiment 
5) 
Score greater than 53 indicates homology 
Score greater than 64 indicates identity 
Score    Expect       Delta  Hit  Protein    Peptide 
 70.4     0.012   -0.238372    1   gi|120436 K.FNFATGQSSPK.N 
 37.4        24   -0.205352                  -.MNFAVVEDSR.S 
 34.3        49    0.789917                  R.DNLMPTAFNK.D 
 34.3        49    0.742310                  K.IYQRTAMNK.E 
 34.3        49    0.705903                  -.MSRIVTAFNK.T 
 34.1        51    0.789902                  K.ACSDIVDAFNK.R 
 34.1        51    0.778687                  K.GGMNAEKAFNK.H 
 31.1     1e+02   -0.233856                  M.ESIMKVAMDK.A 
 30.4   1.2e+02   -0.178848                  R.DETKETAMDK.I 
 28.2     2e+02   -0.322357                  R.FIERGHLSPK.E 
 
Top scoring peptide matches to query 27 
File: dUFr.wiff, Sample: dUFr (sample number 1), Elution: 17.42 to 
17.56 min, Period: 1, Cycle(s): 426 (Experiment 3), 425 (Experiment 4), 
427 (Experiment 5) 
Score greater than 53 indicates homology 
Score greater than 64 indicates identity 
Score    Expect       Delta  Hit  Protein    Peptide 
 72.7    0.0071   -0.181452    1   gi|120436 K.FNFATGQSSPK.N 
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 37.0        26   -0.148432                  -.MNFAVVEDSR.S 
 33.9        53    0.846837                  R.DNLMPTAFNK.D 
 33.9        53    0.799230                  K.IYQRTAMNK.E 
 33.9        53    0.762823                  -.MSRIVTAFNK.T 
 33.6        56    0.846822                  K.ACSDIVDAFNK.R 
 33.6        56    0.835607                  K.GGMNAEKAFNK.H 
 29.0   1.7e+02   -0.170207                  K.FQDAIEAFDK.T 
 28.7   1.7e+02    0.854207                  K.QDSSTQQFNK.I 
 28.6   1.8e+02   -0.170191                  R.YGQAIEAFDK.R 
 
Top scoring peptide matches to query 37 
File: dUFr.wiff, Sample: dUFr (sample number 1), Elution: 18.36 min, 
Period: 1, Cycle(s): 440 (Experiment 4) 
Score greater than 64 indicates identity 
Score    Expect       Delta  Hit  Protein     Peptide 
 64.3     0.053   -0.257799    2   gi|1346343 TNAENEFVTIK 
 64.0     0.055   -1.241823                   R.TDAENEFVTLK.K 
 64.0     0.055    0.701063                   R.TIAENEFVTLK.K 
 59.7      0.15    0.737455                   R.TAAENEFVTLK.K 
 31.8        92    0.747343                   K.AITENEFWVR.G 
 30.1   1.4e+02    2.753095                   IVAENFETDPK 
 29.6   1.5e+02    2.774198                   K.WPEADGFVVDK.A 
 29.5   1.6e+02    1.685057                   R.GGGASATLFVTLK.D 
 28.9   1.8e+02   -1.246523                   R.VGRMFENELR.L 
 27.5   2.5e+02    2.719419                   R.GIAERSFERR.F 
 
Top scoring peptide matches to query 42 
File: dUFr.wiff, Sample: dUFr (sample number 1), Elution: 23.13 to 
26.26 min, Period: 1, Cycle(s): 501, 508, 534 (Experiment 4), 516, 521, 
528 (Experiment 5) 
Score greater than 56 indicates homology 
Score greater than 64 indicates identity 
Score    Expect       Delta  Hit  Protein    Peptide 
 79.2    0.0017   -0.300061    1   gi|120436 R.SEGASALATINPLK.T 
 39.7        15   -1.306516                  R.RAEKAEAAISQAK.T 
 35.7        38   -0.301404                  K.QWRDVALAERK.A 
 30.9   1.1e+02   -0.265042                  R.RGHFESLGATRV.- 
 28.6   1.9e+02   -0.249783                  R.QNGGGREGIAEGVK.G 
 27.2   2.7e+02    1.693118                  R.LQDAEQAIAVRR.R 
 27.1   2.8e+02   -0.325253                  R.VTEILADVGSVVK.K 
 26.8   2.9e+02    0.607181                  R.KIFALAKEALPK.L 
 26.7     3e+02   -1.258908                  K.DAKNLTALEAER.E 
 26.6   3.1e+02   -0.347714                  K.AVRGTVGDLLDKK.D 
 
Top scoring peptide matches to query 43 
File: dUFr.wiff, Sample: dUFr (sample number 1), Elution: 28.01 to 
28.64 min, Period: 1, Cycle(s): 554, 556 (Experiment 4), 560, 562 
(Experiment 5) 
Score greater than 55 indicates homology 
Score greater than 64 indicates identity 
Score    Expect       Delta  Hit  Protein    Peptide 
100.2   1.3e-05   -0.232203    1   gi|120436 R.SEGASALATINPLK.T 
 37.0        28   -1.238658                  R.RAEKAEAAISQAK.T 
 36.0        35   -1.191050                  K.DAKNLTALEAER.E 
 35.5        40   -0.273295                  R.SQMRLATLAPRK.A 
 28.7   1.9e+02   -0.166834                  K.SKESAIFDSMIK.T 
 26.6   3.1e+02   -1.252619                  K.EVEVVSAITGAKK.A 
 26.4   3.2e+02    0.740560                  R.VRSGAVDALANIGK.V 
 26.2   3.4e+02   -1.177149                  K.QGEGLAASNARTR.R 
 25.9   3.6e+02   -0.195841                  R.VDEVVTAIADAAR.T 
 25.4   4.1e+02   -1.282465                  K.CNVPLTKIASAKK.I 
 
Top scoring peptide matches to query 44 
300 
File: dUFr.wiff, Sample: dUFr (sample number 1), Elution: 20.2 to 20.29 
min, Period: 1, Cycle(s): 463-464 (Experiment 3) 
Score greater than 54 indicates homology 
Score greater than 64 indicates identity 
Score    Expect       Delta  Hit  Protein    Peptide 
 87.3   0.00026   -0.171213    1   gi|120436 R.SEGASALATINPLK.T 
 37.1        27   -1.177668                  R.RAEKAEAAISQAK.T 
 34.2        54   -1.130060                  K.DAKNLTALEAER.E 
 32.0        88   -0.136194                  R.RGHFESLGATRV.- 
 25.6   3.9e+02   -0.218805                  K.SEKRIAALENLK.P 
 24.5   5.1e+02   -0.212305                  R.SQMRLATLAPRK.A 
 23.5   6.3e+02   -1.127588                  K.PLHYATLMNVR.F 
 23.2   6.8e+02    2.839682                  K.ALDEITALLDPR.L 
 23.0   7.1e+02   -1.116175                  R.QGRLDDALASGNR.Y 
 23.0   7.1e+02   -1.202829                  K.RLEELDLASKAK.E 
 
Top scoring peptide matches to query 45 
File: dUFr.wiff, Sample: dUFr (sample number 1), Elution: 15.27 to 
15.45 min, Period: 1, Cycle(s): 392-393 (Experiment 3), 391 (Experiment 
4) 
Score greater than 48 indicates homology 
Score greater than 64 indicates identity 
Score    Expect       Delta  Hit  Protein      Peptide 
 84.8   0.00047   -0.258331    3   gi|15599752 R.YYSQNPGVGYTK.D 
 30.6   1.2e+02   -0.257675                    K.QQDQNMTKPTK.S 
 26.6   3.1e+02    1.786987                    R.YVMMAVNQSNK.I 
 24.9   4.5e+02   -0.319214                    K.VKEGAVIPDGMTK.G 
 22.7   7.6e+02   -0.311798                    K.KSETKENQSPTK.N 
 22.5   8.1e+02   -0.265030                    K.YMSEKLNCKTK.M 
 17.7   2.4e+03   -0.338303                    R.QTIAKNFNDAVR.D 
 17.6   2.5e+03   -0.305924                    R.YYSQIREYVR.S 
 17.5   2.5e+03   -0.217438                    R.MVSLEPGMSYSK.K 
 17.2   2.7e+03    1.702972                    K.PMSQLLHTMIR.V 
 
Top scoring peptide matches to query 53 
File: dUFr.wiff, Sample: dUFr (sample number 1), Elution: 22 min, 
Period: 1, Cycle(s): 488 (Experiment 4) 
Score greater than 56 indicates homology 
Score greater than 64 indicates identity 
Score    Expect       Delta  Hit  Protein    Peptide 
107.6   2.4e-06   -0.346672    1   gi|120436 R.SEGASALATINPLK.T 
 38.3        21   -1.414696                  R.IVEIETADRKIK.R 
 37.9        23   -1.341957                  R.DQTQLGAIQTGLK.K 
 37.5        25   -1.389549                  K.VARSKTALDNLGK.E 
 27.2   2.6e+02   -0.365318                  K.ICGAVAQIAGEIVK.L 
 26.4   3.2e+02   -1.357201                  R.HDFSPTALSALKK.A 
 26.0   3.5e+02   -0.256126                  K.EEKSAALSEYMR.K 
 26.0   3.5e+02   -1.389565                  K.NISVQTVRSQLK.S 
 25.9   3.6e+02   -1.341927                  R.SPQDGAASLASKLK.D 
 25.8   3.7e+02   -0.355431                  R.GLWKGTMPNIVR.N 
 
Top scoring peptide matches to query 74 
File: dUFr.wiff, Sample: dUFr (sample number 1), Elution: 27.18 to 
28.78 min, Period: 1, Cycle(s): 544, 548 (Experiment 4), 558-559, 564 
(Experiment 5) 
Score greater than 53 indicates homology 
Score greater than 64 indicates identity 
Score    Expect       Delta  Hit  Protein    Peptide 
 81.6   0.00096   -0.303418    1   gi|120436 K.LGTVAVTIKDTGDGTIK.F 
 36.4        32    2.848376                  -.MQAVAEAAVSASHAER.C 
 27.6   2.4e+02   -0.184339                  K.SPTGVEAYNDNGLVPR.T 
 26.4   3.2e+02    1.652072                  R.PRAVQLAVLVDRGHR.E 
 26.2   3.3e+02    2.885226                  K.IEMMEQMGITVAER.V 
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 26.2   3.3e+02    2.885226                  K.IEMMEQMGITVAER.V 
 25.0   4.3e+02    2.775592                  R.TAPPGTGRLMLAEAER.R 
 23.6     6e+02    2.885226                  K.IEMMEQMGITVAER.V 
 23.6     6e+02    2.885226                  K.IEMMEQMGITVAER.V 
 23.6     6e+02    2.885226                  K.IEMMEQMGITVAER.V 
 
Top scoring peptide matches to query 77 
File: dUFr.wiff, Sample: dUFr (sample number 1), Elution: 18.92 to 
19.05 min, Period: 1, Cycle(s): 449-450 (Experiment 3), 448 (Experiment 
4) 
Score greater than 45 indicates homology 
Score greater than 64 indicates identity 
Score    Expect       Delta  Hit  Protein    Peptide 
 87.0   0.00028   -0.164122    1   gi|120436 K.LGTVAVTIKDTGDGTIK.F 
 27.9   2.3e+02   -0.070159                  K.KELAEALDQDWKDK.Q 
 26.9   2.8e+02   -0.103881                  R.SHHTVSRSLTEKHK.R 
 26.8   2.9e+02   -0.201842                  R.LGTLGVRGFDRGTVLK.S 
 24.8   4.6e+02   -0.127715                  R.LGGDVLSLGSVDASSIAK.G 
 22.3   8.2e+02   -0.008162                  R.ESMDTIIQIMSNYK.R 
 22.3   8.2e+02   -0.062301                  R.GKITVPADMAEEEIK.R 
 21.8   9.2e+02   -0.012008                  R.AQEAVDAGITCLGENR.D 
 21.5   9.9e+02   -0.960524                  K.YNQAMMDIGATVCTR.S 
 21.4     1e+03   -0.091338                  R.TVSPQTGETPTATASLK.T 
 
Top scoring peptide matches to query 78 
File: dUFr.wiff, Sample: dUFr (sample number 1), Elution: 17.62 to 
17.83 min, Period: 1, Cycle(s): 430-431 (Experiment 3), 428 (Experiment 
4) 
Score greater than 47 indicates homology 
Score greater than 64 indicates identity 
Score    Expect       Delta  Hit  Protein    Peptide 
 88.3    0.0002   -0.041266    1   gi|120436 K.LGTVAVTIKDTGDGTIK.F 
 30.1   1.3e+02   -0.078986                  R.LGTLGVRGFDRGTVLK.S 
 25.7   3.7e+02    0.012933                  K.QLTALDKDNMLADLK.P 
 24.1   5.3e+02    0.052697                  K.KELAEALDQDWKDK.Q 
 23.7   5.9e+02   -0.004859                  R.LGGDVLSLGSVDASSIAK.G 
 22.2   8.4e+02    0.012963                  K.EQAAEALKLTAKDMK.K 
 21.3     1e+03    0.001718                  R.QMQSDERLLKAEIK.Q 
 21.2     1e+03    0.006417                  K.ASLAAVEVLSTEELEK.A 
 21.2   1.1e+03    3.147378                  K.IEMMEQMGITVAER.V 
 21.2   1.1e+03    3.147378                  K.IEMMEQMGITVAER.V 
 
Top scoring peptide matches to query 84 
File: dUFr.wiff, Sample: dUFr (sample number 1), Elution: 19.31 min, 
Period: 1, Cycle(s): 453 (Experiment 4) 
Score greater than 44 indicates homology 
Score greater than 64 indicates identity 
Score    Expect       Delta  Hit  Protein    Peptide 
 89.7   0.00015   -0.408903    1   gi|120436 K.DTGDGTIKFNFATGQSSPK.N 
 26.4   3.2e+02    3.490831                  K.GLYNQGYALGIATGKSRR.G 
 25.6   3.8e+02   -0.379911                  K.TAFDGIGAMGGFDDVALQK.Y 
 24.5   4.9e+02    1.631716                  R.AAMQGMSRSDMVTANSGVR.A 
 24.0   5.6e+02   -0.398283                  R.ACNNTXDRKHADSILEK.Y 
 20.7   1.2e+03    0.560579                  R.ACNNTXDRKHADSILEK.Y 
 20.7   1.2e+03    0.560579                  R.ACNNTXDRKHADSILEK.Y 
 18.9   1.8e+03   -0.369337                  K.RCESISVFECQQDTAVR.S 
 18.8   1.8e+03    2.565630                  M.QAPPPTPNSGYLSLSGSPSK.D 
 18.8   1.8e+03   -0.390455                  R.SSLSSVGDMMSRLNLSGR.G 
 
Top scoring peptide matches to query 89 
File: dUFr.wiff, Sample: dUFr (sample number 1), Elution: 20.49 to 
20.59 min, Period: 1, Cycle(s): 468-469 (Experiment 3), 467 (Experiment 
4) 
302 
Score greater than 45 indicates homology 
Score greater than 64 indicates identity 
Score    Expect       Delta  Hit  Protein    Peptide 
131.5   9.8e-09   -0.047145    1   gi|120436 K.ILIGTTASTADTTYVGIDEK.A 
 25.4     4e+02    0.902333                  R.MARIGMQVRIATSALVFR.K 
 19.4   1.6e+03    3.093831                  K.KGPMDCFLTSSLSTTACSGK.R 
 18.9   1.8e+03   -0.107493                  K.ILGLTATPYRLGMGWIYK.Y 
 17.0   2.8e+03    1.873281                  R.IPAITTATSAATPNTPALTVR.R 
 16.9   2.8e+03   -0.055842                  R.PKATYVPNMAPPKLPDGEK.V 
 16.2   3.3e+03    0.094182                  R.AMYMTTLLNSPGSATTSMK.W 
 15.9   3.5e+03    1.040487                  -.MAYMATSTADIAAMPRGGPR.A 
 15.0   4.4e+03    0.954641                  R.LDLTEVKMTDNTLGFGKK.R 
 14.9   4.4e+03    0.094197                  R.AMYMTTLLNSPGSATTSMK.W 
 
Top scoring peptide matches to query 90 
File: dUFr.wiff, Sample: dUFr (sample number 1), Elution: 21.77 to 
29.37 min, Period: 1, Cycle(s): 485-487, 499-500, 510-512, 522-523, 
525, 533-534, 536, 545-547, 558-559, 571 (Experiment 3), 498, 560 
(Experiment 4) 
Score greater than 46 indicates homology 
Score greater than 64 indicates identity 
Score    Expect       Delta  Hit  Protein    Peptide 
 94.8   4.5e-05   -0.022482    1   gi|120436 K.ILIGTTASTADTTYVGIDEK.A 
 28.3   2.1e+02    0.926996                  R.MARIGMQVRIATSALVFR.K 
 23.2   6.6e+02    1.001093                  R.MQGVEVMTTAIKNLIDTR.S 
 18.8   1.8e+03    2.177607                  R.HEDTWICDSDYVADLDK.R 
 18.2   2.1e+03    0.931711                  R.YNILMTRTPDTKVIATAK.N 
 18.0   2.2e+03    1.050593                  R.FSYYGMRAIFTLYMIK.A 
 17.5   2.5e+03    1.008311                  K.LAVIADVDIQTYGMEMLK.A 
 17.4   2.5e+03   -0.071447                  R.RFSLGTGQGQVDPLDLPLR.Q 
 17.4   2.5e+03    0.956187                  K.INHVPLYVADFPVGIESR.V 
 16.9   2.8e+03    2.118723                  R.QDMLGHVTGTSTYFNDHK.L 
 
Top scoring peptide matches to query 92 
File: dUFr.wiff, Sample: dUFr (sample number 1), Elution: 21.57 to 
29.63 min, Period: 1, Cycle(s): 482, 484, 496-498, 509, 521, 535, 560 
(Experiment 3), 485, 512, 522, 533, 545-547, 558-559, 571-572 
(Experiment 4), 511, 523, 534, 574 (Experiment 5) 
Score greater than 43 indicates homology 
Score greater than 64 indicates identity 
Score    Expect       Delta  Hit  Protein    Peptide 
136.5   3.1e-09    0.102275    1   gi|120436 K.ILIGTTASTADTTYVGIDEK.A 
 23.0     7e+02    1.051753                  R.MARIGMQVRIATSALVFR.K 
 19.3   1.6e+03    3.243251                  K.KGPMDCFLTSSLSTTACSGK.R 
 18.9   1.8e+03    0.093578                  R.PKATYVPNMAPPKLPDGEK.V 
 18.0   2.2e+03   -0.858784                  R.GFIDVKTMTWCRTPNIR.V 
 17.4   2.5e+03    1.189907                  -.MAYMATSTADIAAMPRGGPR.A 
 17.0   2.8e+03    2.022701                  R.IPAITTATSAATPNTPALTVR.R 
 15.2   4.2e+03    0.198513                  R.QMWMNVNLPLMKAMGEK.I 
 15.2   4.2e+03    0.198513                  R.QMWMNVNLPLMKAMGEK.I 
 14.8   4.5e+03    0.057811                  M.TLVTVRKTDMTMVLTATR.N 
 
Top scoring peptide matches to query 97 
File: dUFr.wiff, Sample: dUFr (sample number 1), Elution: 22.96 min, 
Period: 1, Cycle(s): 499 (Experiment 4) 
Score greater than 35 indicates homology 
Score greater than 64 indicates identity 
Score    Expect       Delta  Hit  Protein    Peptide 
 72.6    0.0074   -0.519258    1   gi|120436 R.TAEGVWTCTSTQEEMFIPK.G 
 19.0   1.7e+03    2.517454                  K.GSVLTNNEMVEMDASVMDGR.N 
 19.0   1.7e+03    0.539076                  R.ENLGDDDEDMVSSSSGKSIR.A 
 17.9   2.2e+03   -0.494264                  R.KVETACLEMLNAACMNSACR.E 
 16.7   2.9e+03    3.278670                  R.SGVINGMQIGKGGLNAIHFLK.A 
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 16.6   2.9e+03   -0.541704                  K.NSDVGVMDFMSTYKRPER.L 
 16.4   3.1e+03    2.417555                  R.NMTMWSLHTQNYKFLPK.L 
 16.3   3.2e+03   -0.536791                  M.QNDEEPAAAAGTSGLSNGESLR.S 
 15.8   3.6e+03   -0.603227                  K.PKMIVCGASAYTREIEFDK.F 
 14.9   4.4e+03   -0.733995                  K.RTASTDLKQLNQVNFTLPK.K 
 
Top scoring peptide matches to query 98 
File: dUFr.wiff, Sample: dUFr (sample number 1), Elution: 21.5 to 21.65 
min, Period: 1, Cycle(s): 481 (Experiment 4), 483 (Experiment 5) 
Score greater than 41 indicates homology 
Score greater than 64 indicates identity 
Score    Expect       Delta  Hit  Protein    Peptide 
 90.2   0.00013   -0.111122    1   gi|120436 R.TAEGVWTCTSTQEEMFIPK.G 
 23.7   5.7e+02   -0.133568                  K.NSDVGVMDFMSTYKRPER.L 
 19.1   1.7e+03    1.743950                  K.VMAWAAERAPGRVTLTADPK.E 
 18.9   1.7e+03   -0.155357                  R.VCRGETYKFVEPQDEFK.A 
 15.8   3.6e+03   -1.273445                  R.SNKSQASEYTLNPIAIIQR.G 
 14.6   4.7e+03    1.965858                  K.CNCHVSTTTNSNCMCLSLPK.L 
 14.6   4.7e+03   -0.267708                  R.NSMLTPSRGVTIGGTGGNIRK.L 
 14.2   5.1e+03   -1.099113                  K.NEMMMIPAAAASSSKEMRR.E 
 14.2   5.1e+03   -1.099113                  K.NEMMMIPAAAASSSKEMRR.E 
 14.0   5.3e+03   -1.175102                  R.KDDAILDNPVPGMEMTAGIR.R 
 
Top scoring peptide matches to query 109 
File: dUFr.wiff, Sample: dUFr (sample number 1), Elution: 20.81 min, 
Period: 1, Cycle(s): 471 (Experiment 5) 
Score greater than 57 indicates homology 
Score greater than 64 indicates identity 
Score    Expect       Delta  Hit  Protein   Peptide 
 64.8     0.045   -0.359569    5   gi|67549 K.SIVHPSYNSNTLNNDIMLIK.L 
 41.7         9   -1.343593                 K.SIVHPSYDSNTLNNDIMLIK.L 
 30.2   1.3e+02   -0.505107                 K.STTPLLIPHILNNPKMNIIK.N 
 29.2   1.6e+02   -0.144619                 R.CMQAADEHLEQPNEVGNADK.D 
 25.4   3.8e+02   -0.326564                 K.GIMSDPRMNGVINPDSSISLK.D 
 25.1   4.2e+02   -0.457485                 K.LELTEMARLLPVQENFLLK.F 
 22.8   7.1e+02   -1.332347                 K.SMNLDNVLLTNIQSSLYFK.N 
 22.6   7.3e+02    0.449727                 R.SLSLSWRILTLVFPIMLLK.E 
 22.5   7.5e+02   -0.257808                 K.EAPINWCPSCLTGLANEEVK.D 
 22.5   7.5e+02   -0.257808                 K.EAPINWCPSCLTGLANEEVK.D 
 
Top scoring peptide matches to query 112 
File: dUFr.wiff, Sample: dUFr (sample number 1), Elution: 22.07 to 
22.31 min, Period: 1, Cycle(s): 489, 491-492 (Experiment 3) 
Score greater than 45 indicates homology 
Score greater than 64 indicates identity 
Score    Expect       Delta  Hit  Protein    Peptide 
 88.3   0.00019   -0.310342    1   gi|120436 
R.SEGASALATINPLKTTVEESLSR.G 
 27.6   2.3e+02   -0.399728                  K.VALLRVDPERLDPHFLAGSLR.A 
 26.6   2.9e+02   -0.501016                  
M.ARVPLLAALVVAMAVLVASSLGPR.A 
 26.1   3.2e+02   -0.177606                  R.NTWTLAVGGDYKVTDQWTMR.A 
 24.3   4.9e+02   -0.311227                  -
.TVLPVATIQNASTAMLMAASVAR.K 
 21.9   8.6e+02   -0.352075                  K.YLKKLQPFLDANNGNLSAAVR.D 
 21.4   9.5e+02   -0.322458                  K.IADMSNCTEQVIILTARLAVR.F 
 20.7   1.1e+03   -0.311227                  -
.TVLPVATIQNASTAMLMAASVAR.K 
 19.9   1.4e+03   -0.322458                  K.DAMNALALLTLQGLLVRSDGMR.A 
 18.3     2e+03   -1.201349                  R.QTMRFVAAYLMATIGGNASPTK.D 
 
Top scoring peptide matches to query 113 
File: dUFr.wiff, Sample: dUFr (sample number 1), Elution: 22.16 to 
304 
22.33 min, Period: 1, Cycle(s): 490 (Experiment 3), 491-492 (Experiment 
4) 
Score greater than 55 indicates homology 
Score greater than 64 indicates identity 
Score    Expect       Delta  Hit  Protein    Peptide 
129.9   1.4e-08   -0.026187    1   gi|120436 
R.SEGASALATINPLKTTVEESLSR.G 
 35.3        39   -0.027072                  -
.TVLPVATIQNASTAMLMAASVAR.K 
 28.0   2.1e+02   -0.027072                  -
.TVLPVATIQNASTAMLMAASVAR.K 
 20.6   1.2e+03   -0.005069                  K.ETETLAVPEIHVEQRPATPSK.K 
 19.8   1.4e+03    2.972104                  R.ARSFDDLTDQIPGGIVQNLRR.A 
 19.1   1.6e+03    2.075955                  K.APGMKALFDRFTTSLEEGEEK.Q 
 18.9   1.7e+03    0.099866                  R.DLCIEATLSMLEDRFTRMR.I 
 18.8   1.8e+03    1.084729                  K.KKQTSAQVTPESEPNDEGMVR.L 
 18.2     2e+03    3.059766                  
R.DAKKGLATLCIGGGMGIAMCLAR.D 
 17.7   2.3e+03    1.144025                  K.PDCGAVVHCHSPRATALSCHR.R 
 
Top scoring peptide matches to query 115 
File: dUFr.wiff, Sample: dUFr (sample number 1), Elution: 19.22 to 
19.38 min, Period: 1, Cycle(s): 453-454 (Experiment 3), 452 (Experiment 
4) 
Score greater than 39 indicates homology 
Score greater than 64 indicates identity 
Score    Expect       Delta  Hit  Protein    Peptide 
110.0   1.3e-06   -0.252742    1   gi|120436 
K.ILIGTTASTADTTYVGIDEKANK.L 
 20.2   1.3e+03    0.901066                  
K.QMALEMGGGDGGFVAATPQAGIDR.T 
 16.5     3e+03    0.889866                  R.RLNVSTSGVGQSPHMSSEMFR.Q 
 15.9   3.5e+03    1.739552                  
K.VGVVLLAACPGGTTSNLLTHMAR.G 
 15.1   4.1e+03    2.815663                  K.KLDASKFEDTSLFTSATFGSGK.K 
 15.1   4.1e+03    2.815663                  K.KLDASKFEDTSLFTSATFGXGK.K 
 15.0   4.3e+03   -0.225078                  K.PGELYVIRNMGNVIPSQTSYK.E 
 14.9   4.4e+03    1.721638                  R.QLLIFDMIFVKNMEAVAASLK.K 
 14.8   4.5e+03    2.662953                  
K.LAAVTQLEAQLGTDAAQAAIILR.L 
 14.6   4.6e+03   -1.186474                  
R.AETGITTELSTTGGTSDGRFIAR.I 
 
Top scoring peptide matches to query 116 
File: dUFr.wiff, Sample: dUFr (sample number 1), Elution: 14.04 to 
14.26 min, Period: 1, Cycle(s): 377-379 (Experiment 3) 
Score greater than 46 indicates homology 
Score greater than 64 indicates identity 
Score    Expect       Delta  Hit  Protein     Peptide 
109.8   1.4e-06   -0.051940    2   gi|1346343 
R.GGGGGGYGSGGSSYGSGGGSYGSGGGGGGGR.G 
 26.9   2.7e+02   -0.081054                   
M.SSWNSPYYDTSSYGAGSGGGGGGGR.R 
 22.1   8.2e+02   -0.135391                   
R.LCCHDAADDEKPAAAAVSGGGGGGGR.E 
 19.7   1.4e+03    1.833100                   
K.VGSCIGSGMGGMTSLSKMFRDR.R 
 18.9   1.7e+03    2.679688                   R.LVMAYIPMPDSLSTRTAELTR.A 
 18.5   1.9e+03    1.833100                   
K.VGSCIGSGMGGMTSLSKMFRDR.R 
 17.7   2.3e+03    0.743317                   
K.NDGQFTAMQLVGMLRGIASGMK.Y 
 17.5   2.4e+03    1.811356                   R.CNNILWMGSAENVEMTDLGLR.- 
305 
 16.9   2.7e+03   -0.320587                   K.DIKMPPKEFELLYYLANNK.N 
 16.6   2.9e+03   -0.172653                   R.QCMTVVYERPGGNRVMANMR.S 
 
Top scoring peptide matches to query 129 
File: dUFr.wiff, Sample: dUFr (sample number 1), Elution: 14.55 to 
14.68 min, Period: 1, Cycle(s): 382 (Experiment 4), 383 (Experiment 5) 
Score greater than 48 indicates homology 
Score greater than 63 indicates identity 
Score    Expect       Delta  Hit  Protein    Peptide 
 66.4     0.027    0.005258    4   gi|453155 
R.GGSGGSHGGGSGFGGESGGSYGGGEEASGSGGGYGGGSGK.S 
 32.2        71    1.911493                  
R.YVQACFGEEAEETAMQAERGMSHLMGSAR.N 
 26.4   2.7e+02   -1.212439                  
K.FFGTLLDAGYVTFCGEESFGTGSNHIREK.D 
 25.2   3.6e+02    2.826074                  
K.YFGNLMDAGRLCLCGEESFGTGSNHIREK.D 
 25.1   3.7e+02    1.911493                  
R.YVQACFGEEAEETAMQAERGMSHLMGSAR.N 
 25.1   3.7e+02    1.911478                  
R.YVQACFGEEAEETAMQAERGMSHLMGSAR.N 
 23.6   5.2e+02   -1.310553                  
K.IEKGCLMCGCGLGSVAGSIGLFGEVAINIWK.P 
 23.6   5.2e+02   -1.310553                  
K.IEKGCLMCGCGLGSVAGSIGLFGEVAINIWK.P 
 23.6   5.2e+02   -1.310553                  
K.IEKGCLMCGCGLGSVAGSIGLFGEVAINIWK.P 
 23.5   5.3e+02   -0.100302                  
K.AMAIMNSFINDISECIAGEASCLMHYNK.H 
 
 
 
